<!DOCTYPE html> <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control - Vos, RC - 2016 | Cochrane Library</title> <meta property="og:title" content="Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control - Vos, RC - 2016 | Cochrane Library" /> <meta property="og:url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006992.pub2/references" /> <meta property="og:type" content="article" /> <meta property=”og:image” content=”https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png” /> <meta content="initial-scale=1.0, width=device-width" name="viewport" /> <meta name="dc.identifier" scheme="DOI" content="10.1002/14651858.CD006992.pub2" /> <meta name="citation_title" content="Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control" /> <meta name="citation_author" content="Rimke C Vos" /> <meta name="citation_author_institution" content="University Medical Center Utrecht" /> <meta name="citation_author_email" content="R.C.Vos-3@umcutrecht.nl" /> <meta name="citation_author" content="Mari&euml;lle JP van Avendonk" /> <meta name="citation_author_institution" content="Guideline Development and Research" /> <meta name="citation_author" content="Hanneke Jansen" /> <meta name="citation_author_institution" content="University Medical Center Utrecht" /> <meta name="citation_author" content="Alexander N Goudswaard" /> <meta name="citation_author" content="Maureen van den Donk" /> <meta name="citation_author_institution" content="Guideline Development and Research" /> <meta name="citation_author" content="Kees Gorter" /> <meta name="citation_author" content="Anneloes Kerssen" /> <meta name="citation_author_institution" content="University Medical Center Utrecht" /> <meta name="citation_author" content="Guy EHM Rutten" /> <meta name="citation_author_institution" content="University Medical Center Utrecht" /> <meta name="citation_journal_title" content="Cochrane Database of Systematic Reviews" /> <meta name="citation_publisher" content="John Wiley &amp; Sons, Ltd" /> <meta name="citation_issue" content="9" /> <meta name="citation_doi" content="10.1002/14651858.CD006992.pub2" /> <meta name="citation_date" content="2016" /> <meta name="citation_online_date" content="2016/09/18" /> <meta name="citation_abstract_html_url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006992.pub2/abstract" /> <meta name="citation_fulltext_html_url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006992.pub2/full" /> <meta name="citation_pdf_url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006992.pub2/pdf/CDSR/CD006992/CD006992.pdf" /> <meta name="citation_issn" content="1465-1858" /> <meta name="citation_language" content="en" /> <script type="text/javascript" src="//script.crazyegg.com/pages/scripts/0056/6375.js" async="async"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <script type="text/javascript">var o={auth:{customerIds:["P#DRAAEAC","EAL00000056729","DRAA3TITLES","TSINGH009S","EAL0001468","EAL00000045347"],individualId:null,brandedCustomer:"EAL0001468",roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=UTF-8" http-equiv="content-type" /> <link href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/favicon.ico" rel="Shortcut Icon" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006992&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006992&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" rel="canonical" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;zh&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006992&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006992&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="zh-CN" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;zh_TW&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006992&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006992&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="zh-TW" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;hr&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006992&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006992&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="hr-HR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006992&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006992&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="x-default" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006992&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006992&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="en-US" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;fr&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006992&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006992&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="fr-FR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;de&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006992&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006992&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="de-DE" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ja&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006992&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006992&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ja-JP" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ko&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006992&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006992&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ko-KR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ms&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006992&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006992&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ms-MY" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;fa&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006992&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006992&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="fa-IR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;pl&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006992&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006992&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="pl-PL" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;pt&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006992&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006992&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="pt-PT" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ru&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006992&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006992&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ru-RU" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;es&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006992&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006992&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="es-ES" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ta&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006992&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006992&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ta-IN" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;th&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006992&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006992&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="th-TH" rel="alternate" /> <link class="lfr-css-file" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;cochrane-theme&#x2f;css&#x2f;main&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1581423095000" rel="stylesheet" type="text/css" /> <link class="lfr-css-file" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;cochrane-theme&#x2f;css&#x2f;aui&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1581423095000" rel="stylesheet" type="text/css" /> <link href="&#x2f;html&#x2f;css&#x2f;main&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1559916431000" rel="stylesheet" type="text/css" /> <link href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" rel="stylesheet" type="text/css" /> <link href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1581717708000" rel="stylesheet" type="text/css" /> <link href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1581717784000" rel="stylesheet" type="text/css" /> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 13},getRevision:function(){return"605.1"},getVersion:function(){return"13.0"},isAir:function(){return false},isChrome:function(){return false},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return false},isMac:function(){return true},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="y8F68iId";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dreferences\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD006992\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD006992\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006992\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006992\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article References"},article:{availableLanguage:["en","ru","fr","hr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD006992.pub2",title:"Insulin monotherapy compared with the addition of oral glucose\\u2010lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control",firstPublishedDate:"Sep 18, 2016 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Metabolic and Endocrine Disorders Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;cochrane-theme&#x2f;css&#x2f;custom&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1581423095000" rel="stylesheet" type="text/css" /> <style type="text/css"></style> <script src="//assets.adobedtm.com/6e626c9ec247e474f6b98eb15a79a185cf7e26a5/satelliteLib-b0f13d7a13ebe8b0b1b00a9f0730a084926e292f.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1581423095000" type="text/javascript"></script> <![endif]--> </head> <body class=" yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div id="js-cookie-message" class="cookie-message cookie-message--hidden system-message-container"> <div class="container"> <a href="#" class="fa fa-times js-cookie-close pull-right" aria-label="Close cookies message"></a> <div class="system-message-wrapper container"> <i class="fa fa-exclamation-triangle" aria-hidden="true"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7XGCZUQPW4C675JNSTYTLUDN7XB/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a href="#" class="btn secondary js-cookie-close js-cookie-accept">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/"> <span class="brand-name">The Cochrane Library</span> <img class="brand-logo" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/en-US_logo.png" alt="Cochrane Library logo" title="Cochrane Library" /> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end " id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img id="owel__null__null" src="/scolaris-search/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_auth=y8F68iId&p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=1&p_p_state=normal&p_p_mode=view&_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input type="hidden" name="searchType" value="basic" /> <input type="hidden" name="facetDisplayName" value="" /> <input type="hidden" name="facetQueryTerm" value="" /> <input type="hidden" name="facetQueryField" value="" /> <input type="hidden" name="facetCategory" value="" /> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select title="Search by options" aria-label="Search by options" name="searchBy" class="custom-select-enabled search-type"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" style="display: none;" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=topics-list&p_p_cacheability=cacheLevelPage"> <select class="search-select-topic-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input type="text" size="30" class="field browser-search search-text ui-autocomplete-input" value="" aria-label="Enter search term" id="searchText" name="searchText" placeholder="Search">
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button type="submit" class="searchByBtn" aria-label="Search">
<i class="fa fa-search" aria-hidden="true"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=references&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006992.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006992.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a href="/en/browse-by-topic" class="btn secondary">Browse</a>
<a href="/en/advanced-search" class="btn primary advanced-search-button">Advanced search</a>
</div>
</div>
<a href="#" class="toggle-menu-switch"><i class="fa fa-bars" aria-hidden="true"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<p class="auxiliary-menu-item access">Access provided by: <strong>Tsinghua University</strong></p>
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_  portlet-static portlet-static-end  " id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img id="bvrs__null__null" src="/scolaris-language-portlet/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hr, ja, ko, ms, pl, pt, ru, ta, th, zh, za]"> <a title="Select your preferred language" class="open-language-modal" href="#"> <i class="fa fa-file-text"></i> English </a> <a title="Select your preferred language" class="open-language-modal" href="#"> <i class="fa fa-globe"></i> English </a> </div> <div class="language-selector-modal-content" style="display: none;" data-modal-title="Language selection" data-size="large"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane Review language</h3> <p>Select your preferred language for Cochrane Reviews. You will see translated Review sections in your preferred language. Sections without translation will be in English.</p> <div> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de" class="content-language-selector " data-languagecode="de">Deutsch</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en" class="content-language-selector is-active" data-languagecode="en">English</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es" class="content-language-selector " data-languagecode="es">Español</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa" class="content-language-selector " data-languagecode="fa">فارسی</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr" class="content-language-selector " data-languagecode="fr">Français</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr" class="content-language-selector " data-languagecode="hr">Hrvatski</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja" class="content-language-selector " data-languagecode="ja">日本語</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko" class="content-language-selector " data-languagecode="ko">한국어</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms" class="content-language-selector " data-languagecode="ms">Bahasa Malaysia</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl" class="content-language-selector " data-languagecode="pl">Polski</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt" class="content-language-selector " data-languagecode="pt">Português</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru" class="content-language-selector " data-languagecode="ru">Русский</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta" class="content-language-selector " data-languagecode="ta">தமிழ்</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th" class="content-language-selector " data-languagecode="th">ภาษาไทย</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh" class="content-language-selector " data-languagecode="zh">简体中文</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=za" class="content-language-selector " data-languagecode="za">繁體中文</a> </div> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div> <a href="/en/cdsr/doi/10.1002/14651858.CD006992.pub2/references/en" class="portal-language-selector is-active" data-portallanguage="en">English</a> <a href="/es/cdsr/doi/10.1002/14651858.CD006992.pub2/references/es" class="portal-language-selector " data-portallanguage="es">Español</a> </div> </div> <button class="btn primary btn-cancel" type="button">Cancel</button> <a class="btn secondary ok-btn pull-right" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/c/portal/login?p_l_id=20757&redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006992.pub2%2Freferences" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
</a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
<div class="access-provider-mobile">
<p class="access">Access provided by: <strong>Tsinghua University</strong></p>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class=" nav-root-item parent">
<a href="#">Cochrane Reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_14" role="presentation">
<a aria-labelledby="layout_14" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;reviews" role="menuitem">
Search Reviews (CDSR)
</a>
</li>
<li class=" child-nav-item" id="layout_15" role="presentation">
<a aria-labelledby="layout_15" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;reviews&#x2f;topics" role="menuitem">
Browse Reviews
</a>
</li>
<li class=" child-nav-item" id="layout_18" role="presentation">
<a aria-labelledby="layout_18" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;table-of-contents" role="menuitem">
Issues
</a>
</li>
<li class=" child-nav-item" id="layout_17" role="presentation">
<a aria-labelledby="layout_17" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;editorials" role="menuitem">
Editorials
</a>
</li>
<li class=" child-nav-item" id="layout_19" role="presentation">
<a aria-labelledby="layout_19" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;special-collections" role="menuitem">
Special Collections
</a>
</li>
<li class=" child-nav-item" id="layout_20" role="presentation">
<a aria-labelledby="layout_20" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;supplements" role="menuitem">
Supplements
</a>
</li>
<li class=" child-nav-item" id="layout_13" role="presentation">
<a aria-labelledby="layout_13" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;about-cdsr" role="menuitem">
About the CDSR
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">Trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_22" role="presentation">
<a aria-labelledby="layout_22" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;central" role="menuitem">
Search Trials (CENTRAL)
</a>
</li>
<li class=" child-nav-item" id="layout_114" role="presentation">
<a aria-labelledby="layout_114" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;central&#x2f;about-central" role="menuitem">
About CENTRAL
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_29" role="presentation">
<a aria-labelledby="layout_29" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cca" role="menuitem">
Browse Clinical Answers
</a>
</li>
<li class=" child-nav-item" id="layout_91" role="presentation">
<a aria-labelledby="layout_91" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cca&#x2f;about" role="menuitem">
About Clinical Answers
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_116" role="presentation">
<a aria-labelledby="layout_116" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;about-cochrane-library" role="menuitem">
About the Cochrane Library
</a>
</li>
<li class=" child-nav-item" id="layout_34" role="presentation">
<a aria-labelledby="layout_34" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochrane&#x2e;org&#x2f;about-us" role="menuitem">
About Cochrane
</a>
</li>
<li class=" child-nav-item" id="layout_121" role="presentation">
<a aria-labelledby="layout_121" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;about-cochrane-reviews" role="menuitem">
About Cochrane Reviews
</a>
</li>
<li class=" child-nav-item" id="layout_92" role="presentation">
<a aria-labelledby="layout_92" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;author-information" role="menuitem">
Information for authors
</a>
</li>
<li class=" child-nav-item" id="layout_188" role="presentation">
<a aria-labelledby="layout_188" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;releases" role="menuitem">
What&#039;s new
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_177" role="presentation">
<a aria-labelledby="layout_177" href="https&#x3a;&#x2f;&#x2f;www&#x2e;wiley&#x2e;com&#x2f;network&#x2f;cochranelibrarytraining" role="menuitem">
Cochrane Library Training
</a>
</li>
<li class=" child-nav-item" id="layout_44" role="presentation">
<a aria-labelledby="layout_44" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;access" role="menuitem">
Access options
</a>
</li>
<li class=" child-nav-item" id="layout_150" role="presentation">
<a aria-labelledby="layout_150" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;permissions" role="menuitem">
Permissions and reprints
</a>
</li>
<li class=" child-nav-item" id="layout_93" role="presentation">
<a aria-labelledby="layout_93" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;media" role="menuitem">
Media information
</a>
</li>
<li class=" child-nav-item" id="layout_97" role="presentation">
<a aria-labelledby="layout_97" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;contact-us" role="menuitem">
Contact us
</a>
</li>
<li class=" child-nav-item" id="layout_125" role="presentation">
<a aria-labelledby="layout_125" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;terms-and-conditions" role="menuitem">
Terms and conditions
</a>
</li>
<li class=" child-nav-item" id="layout_176" role="presentation">
<a aria-labelledby="layout_176" href="https&#x3a;&#x2f;&#x2f;hub&#x2e;wiley&#x2e;com&#x2f;docs&#x2f;cochrane-library&#x2f;cochrane-library-known-issues-DOC-16221&#x3f;referrer&#x3d;cochrane" role="menuitem">
Known issues
</a>
</li>
</ul>
</li>
<li class="about-link"><a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_  portlet-static portlet-static-end  " id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img id="etlj__null__null" src="/scolaris-language-portlet/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <section class="content-language-banner system-message-container" data-content-language="en" data-portal-language="en" style="display: none"> <div class="container"> <a href="#0" class="fa fa-times content-language-banner-close pull-right" aria-label="Close"></a> <i class="fa fa-globe" aria-hidden="true"></i> <div class="system-message-title">Content Language Selection</div> <div class="system-message-description">Your language preference is set to <strong class="language">English</strong>. Where translations are available, article sections will display in this language. Return to <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=reset-content-language&p_p_cacheability=cacheLevelPage" class="language secondary">English</a>.</div> </div> </section> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
<div id="content" class="">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_  portlet-static portlet-static-end scolaris-content-display-portlet " id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img id="rjus__column1__0" src="/scolaris-content-display/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools"> <li class="cdsr-nav-link pulldown-menu readcube-menu closed"> <a href="#0" class="pulldown-menu-trigger"> <i class="icon fa fa-file-pdf-o"></i>View PDF <i aria-hidden="true" class="fa fa-caret-up"></i> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/pdf/full/en" class="download media pdf-link-full pdf-link" title="Article in PDF format"> <span class="readcube-label "> Full </span> <span class="readcube-description "> All content </span> </a> <a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/epdf/full/en" class="download media pdf-link-full readcube-epdf-link" title="Article in PDF format"> <span class="readcube-label "> Full </span> <span class="readcube-description "> All content </span> </a> </li> <li class=""> <a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/pdf/standard/en" class="download media pdf-link-standard pdf-link" title="Article in PDF format"> <span class="readcube-label "> Standard </span> <span class="readcube-description "> Excludes data and analyses, and appendices </span> </a> <a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/epdf/standard/en" class="download media pdf-link-standard readcube-epdf-link" title="Article in PDF format"> <span class="readcube-label "> Standard </span> <span class="readcube-description "> Excludes data and analyses, and appendices </span> </a> </li> <li class=""> <a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/pdf/abstract/en" class="download media pdf-link-abstract pdf-link" title="Article in PDF format"> <span class="readcube-label "> Summary </span> <span class="readcube-description "> Abstract and plain language summary only </span> </a> <a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/epdf/abstract/en" class="download media pdf-link-abstract readcube-epdf-link" title="Article in PDF format"> <span class="readcube-label "> Summary </span> <span class="readcube-description "> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="cdsr-nav-link cite-article-link" data-article-id="CD006992.PUB2" data-modal-title="Cite this Review"> <a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/#"> <i class="icon fa fa-share"></i>Cite this Review </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-english-only-message="Please note, that requesting permissions is available in English only. Apologies for any inconvenience." href="/cdsr/doi/10.1002/14651858.CD006992.pub2/#" data-copyright="Copyright © 2016 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false"> <span class="request-permissions-icon"></span> Request Permissions </a> </li> <li class="cdsr-nav-link comment-on-review"> <a id="comment-on-review" class="js-old-version-modal-trigger" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/comment" data-new-version="" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience."> <i class="icon fa fa-comment"></i>Comment on Review </a> </li> <li class="cdsr-nav-link comment-on"> <span>Read comments on this Review(0)</span> </li> </ul> <ul class="share clearfix"> <li class="cdsr-nav-link print-cdsr-link" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD006992.pub2/print" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Data and analysis&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;}]}]"> <a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/#"> <i class="icon fa fa-print"></i>Print </a> </li> <li class="cdsr-nav-link share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD006992.pub2/full"> <a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/#"> <i class="icon fa fa-share-alt"></i>Share </a> </li> <li class="cdsr-nav-link"> <a href="/c/portal/login" class="article-not-followed cochrane-link signin"> <span class="article-follow-display"><i class="icon fa fa-plus"></i>Follow</span> </a> </li> </ul> <ul id="linked-articles" data-type="cdsr" class="linked-content tools clearfix linked-content-trigger"> <li> <a href="#0"> <span class="linked-to-this"> Linked to this Review <span class="linked-content-count"></span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> </li> </ul> <ul class="linked-content-dropdown"> <li data-type="cca" class="linked-cca"> <p>Cochrane Clinical Answers</p> </li> <li data-type="editorial" class="linked-editorials"> <p>Editorials</p> </li> <li data-type="podcast" class="linked-podcasts"> <p>Podcasts</p> </li> <li data-type="sc" class="linked-sc"> <p>Special Collections</p> </li> </ul> <ul class="nav-long-form"> <li class="cdsr-nav-link bold-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/full#CD006992-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/full#CD006992-sec1-0007"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/full#CD006992-sec1-0001"> Summary of findings </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/full#CD006992-sec1-0002"> Background </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/full#CD006992-sec1-0003"> Objectives </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/full#CD006992-sec1-0004"> Methods </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/full#CD006992-sec1-0005"> Results </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/full#CD006992-sec1-0006"> Discussion </a> </li> </ul> <ul class="tools"> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/appendices#CD006992-sec1-0012"> Appendices </a> </li> </ul> <ul> <li class="cdsr-nav-link article-section-link"> <a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/information"> Information </a> </li> <li class="cdsr-nav-link article-section-link"> <a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/information#authors"> Authors </a> </li> <li class="cdsr-nav-link article-section-link"> <a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/information#history"> History </a> </li> </ul> <ul> <li class="cdsr-nav-link bold-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/#"> <i class="icon fa fa-globe"></i>Translation notes </a> </li> </ul> <ul> <li class="cdsr-nav-link references-link"> <a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/references"> References </a> </li> <li class="cdsr-nav-link references-link"> <a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link references-link"> <a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/references#dataAndAnalyses"> Data and analyses </a> </li> </ul> <ul class="tools"> <li class="cdsr-nav-link "> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/#"> <i class="icon fa fa-line-chart"></i>Figures and tables </a> </li> <li class="cdsr-nav-link download-stats-data-link " data-download-href="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/table_n/CD006992StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/table_n/CD006992StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <i class="icon fa fa-download"></i>Download statistical data </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i>Related content <span class="note podcast-indicator">Podcast available</span> </a> </li> </ul> </nav> </div> <article class="information" data-article-id="CD006992.PUB2"> <header> <h1 class="publication-title"><h1 lang="en" class="publication-title">Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control </h1></h1> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div><h2 class="title section-collapse-title"> References <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <section class="references bibliographies" id="references"> <section> <div class="section-header" id="CD006992-bbs1-0001"> <h3 class="title">References to studies included in this review</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a class="jump-to" href="#CD006992-bbs1-0002">excluded studies</a></li> <li><a class="jump-to" href="#CD006992-bbs1-0003">studies awaiting assessment</a></li> <li><a class="jump-to" href="#CD006992-bbs1-0004">ongoing studies</a></li> <li><a class="jump-to" href="#CD006992-bbs1-0005">additional references</a></li> <li><a class="jump-to" href="#CD006992-bbs1-0006">other published versions</a></li> </ul> </div> </div> <div class="bibliographies references_includedStudies" id="CD006992-bbs2-0001"> <div class="reference-title-banner"> <h4 class="title">Avilés 1999 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0001"> <div class="citation-journal">Avilés‐Santa L, Sinding J, Raskin P. <span class="citation-title">Effects of metformin in patients with poorly controlled, insulin‐treated type 2 diabetes mellitus. A randomized, double‐blind, placebo‐controlled trial</span>. <span class="citation"> Annals of Internal Medicine </span><span class="pubYear">1999</span>;<span class="volume">131</span>:182‐8. <a class="crsref citation-link central-link" data-crsref="4363017" href="" ref="info:x-wiley/crsRef/4363017" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.7326%2F0003-4819-131-3-199908030-00004" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10428734" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+metformin+in+patients+with+poorly+controlled,+insulin%E2%80%90treated+type+2+diabetes+mellitus.+A+randomized,+double%E2%80%90blind,+placebo%E2%80%90controlled+trial+&author=L+Avil%C3%A9s%E2%80%90Santa&author=J+Sinding&author=P+Raskin&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000081788700003&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 129</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006992-bbs2-0002"> <div class="reference-title-banner"> <h4 class="title">Barnett 2013 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0002"> <div class="citation-journal">Barnett AH, Charbonnel B, Li J, Donovan M, Fleming D, Iqbal N. <span class="citation-title">Saxagliptin add‐on therapy to insulin with or without metformin for type 2 diabetes mellitus: 52‐week safety and efficacy</span>. <span class="citation"> Clinical drug investigation </span><span class="pubYear">2013</span>;<span class="volume">33</span>(10):707‐17. [PUBMED: 23949898]<a class="crsref citation-link central-link" data-crsref="4363019" href="" ref="info:x-wiley/crsRef/4363019" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1007%2Fs40261-013-0107-8" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/23949898" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Saxagliptin+add%E2%80%90on+therapy+to+insulin+with+or+without+metformin+for+type+2+diabetes+mellitus:+52%E2%80%90week+safety+and+efficacy+&author=AH+Barnett&author=B+Charbonnel&author=J+Li&author=M+Donovan&author=D+Fleming&author=N+Iqbal&publication_year=2013&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BC3sXhvVSmt73O" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000324491500002&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 14</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006992-bbs2-0003"> <div class="reference-title-banner"> <h4 class="title">Casner 1988 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0003"> <div class="citation-journal">Casner PR. <span class="citation-title">Insulin‐glyburide combination therapy for non‐insulin‐dependent diabetes mellitus: a long‐term double‐blind, placebo‐controlled trial</span>. <span class="citation"> Clinical Pharmacology and Therapeutics </span><span class="pubYear">1988</span>;<span class="volume">44</span>:594‐603. <a class="crsref citation-link central-link" data-crsref="4363021" href="" ref="info:x-wiley/crsRef/4363021" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1038%2Fclpt.1988.199" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/3141099" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Insulin%E2%80%90glyburide+combination+therapy+for+non%E2%80%90insulin%E2%80%90dependent+diabetes+mellitus:+a+long%E2%80%90term+double%E2%80%90blind,+placebo%E2%80%90controlled+trial+&author=PR+Casner&publication_year=1988&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaL1M%2FivFCktg%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1988R175800014&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 20</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006992-bbs2-0004"> <div class="reference-title-banner"> <h4 class="title">Chiasson 1994 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0004"> <div class="citation-journal">Chiasson J‐L, Josse R, Hunt J, Palmason C, Rodger W, Ross S, et al. <span class="citation-title">The efficacy of acarbose in the treatment of patients with non‐insulin‐dependent diabetes mellitus</span>. <span class="citation"> Annals of Internal Medicine </span><span class="pubYear">1994</span>;<span class="volume">121</span>:928‐35. <a class="crsref citation-link central-link" data-crsref="4363023" href="" ref="info:x-wiley/crsRef/4363023" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.7326%2F0003-4819-121-12-199412150-00004" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/7734015" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+efficacy+of+acarbose+in+the+treatment+of+patients+with+non%E2%80%90insulin%E2%80%90dependent+diabetes+mellitus+&author=J%E2%80%90L+Chiasson&author=R+Josse&author=J+Hunt&author=C+Palmason&author=W+Rodger&author=S+Ross&publication_year=1994&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaK2M%2FmvFCisQ%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1994PW08300004&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 326</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006992-bbs2-0005"> <div class="reference-title-banner"> <h4 class="title">Coniff 1995 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0005"> <div class="citation-journal">Coniff RF, Shapiro JA, Seaton TB, Hoogwerf BJ, Hunt JA. <span class="citation-title">A double‐blind placebo‐controlled trial evaluating the safety and efficacy of acarbose for the treatment of patients with insulin‐requiring type 2 diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1995</span>;<span class="volume">18</span>(7):928‐32. <a class="crsref citation-link central-link" data-crsref="4363025" href="" ref="info:x-wiley/crsRef/4363025" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.18.7.928" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/7555551" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+double%E2%80%90blind+placebo%E2%80%90controlled+trial+evaluating+the+safety+and+efficacy+of+acarbose+for+the+treatment+of+patients+with+insulin%E2%80%90requiring+type+2+diabetes+&author=RF+Coniff&author=JA+Shapiro&author=TB+Seaton&author=BJ+Hoogwerf&author=JA+Hunt&publication_year=1995&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaK28%2Fgt1Oitw%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1995RF11600002&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 77</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006992-bbs2-0006"> <div class="reference-title-banner"> <h4 class="title">Feinglos 1998 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0006"> <div class="citation-journal">Feinglos MN, Thacker CR, Lobaugh B, DeAtkine DD, McNeill DB, English JS, et al. <span class="citation-title">Combination insulin and sulfonylurea therapy in insulin‐requiring type 2 diabetes mellitus</span>. <span class="citation"> Diabetes Research and Clinical Practice </span><span class="pubYear">1998</span>;<span class="volume">39</span>:193‐9. <a class="crsref citation-link central-link" data-crsref="4363027" href="" ref="info:x-wiley/crsRef/4363027" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1016%2FS0168-8227%2898%2900003-5" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9649951" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Combination+insulin+and+sulfonylurea+therapy+in+insulin%E2%80%90requiring+type+2+diabetes+mellitus+&author=MN+Feinglos&author=CR+Thacker&author=B+Lobaugh&author=DD+DeAtkine&author=DB+McNeill&author=JS+English&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DyaK1cXivVKnsL8%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000074108000004&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 8</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006992-bbs2-0007"> <div class="reference-title-banner"> <h4 class="title">Fonseca 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0007"> <div class="citation-journal">Fonseca V, Schweizer A, Albrecht D, Baron MA, Chang I, Dejager S. <span class="citation-title">Addition of vildagliptin to insulin improves glycaemic control in type 2 diabetes</span>. <span class="citation"> Diabetologia </span><span class="pubYear">2007</span>;<span class="volume">50</span>:1148‐55. <a class="crsref citation-link central-link" data-crsref="4363029" href="" ref="info:x-wiley/crsRef/4363029" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1007%2Fs00125-007-0633-0" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17387446" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Addition+of+vildagliptin+to+insulin+improves+glycaemic+control+in+type+2+diabetes&author=V+Fonseca&author=A+Schweizer&author=D+Albrecht&author=MA+Baron&author=I+Chang&author=S+Dejager&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2sXkvFKju7s%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000246271600005&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 214</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006992-bbs2-0008"> <div class="reference-title-banner"> <h4 class="title">Fritsche 2000 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0008"> <div class="citation-journal">Fritsche A, Schmulling RM, Haring HU, Stumvoll M. <span class="citation-title">Intensive insulin therapy combined with metformin in obese type 2 diabetic patients</span>. <span class="citation"> Acta Diabetologica </span><span class="pubYear">2000</span>;<span class="volume">37</span>:13‐8. <a class="crsref citation-link central-link" data-crsref="4363031" href="" ref="info:x-wiley/crsRef/4363031" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1007%2Fs005920070030" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10928231" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Intensive+insulin+therapy+combined+with+metformin+in+obese+type+2+diabetic+patients&author=A+Fritsche&author=RM+Schmulling&author=HU+Haring&author=M+Stumvoll&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD3cXmtlSkt7c%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000088624900003&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 24</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006992-bbs2-0009"> <div class="reference-title-banner"> <h4 class="title">Giugliano 1993 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0009"> <div class="citation-journal">Giugliano D, Quatraro A, Consoli G, Minei A, Ceriello A, Rosa N, et al. <span class="citation-title">Metformin for obese, insulin‐treated diabetic patients: improvement in glycaemic control and reduction of metabolic risk factors</span>. <span class="citation"> European Journal of Clinical Pharmacology </span><span class="pubYear">1993</span>;<span class="volume">44</span>:107‐12. <a class="crsref citation-link central-link" data-crsref="4363033" href="" ref="info:x-wiley/crsRef/4363033" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1007%2FBF00315466" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8453955" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metformin+for+obese,+insulin%E2%80%90treated+diabetic+patients:+improvement+in+glycaemic+control+and+reduction+of+metabolic+risk+factors+&author=D+Giugliano&author=A+Quatraro&author=G+Consoli&author=A+Minei&author=A+Ceriello&author=N+Rosa&publication_year=1993&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DyaK3sXit1GgtL8%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1993KM32300001&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 127</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006992-bbs2-0010"> <div class="reference-title-banner"> <h4 class="title">Groop 1985 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0010"> <div class="citation-journal">Groop L, Harno K, Nikkila EA, Pelkonen R, Tolppannen EM. <span class="citation-title">Transient effect of the combination of insulin and sulfonylurea (glibenclamide) on glycemic control in non‐insulin dependent diabetics poorly controlled on insulin alone</span>. <span class="citation"> Acta Medica Scandinavica </span><span class="pubYear">1985</span>;<span class="volume">217</span>:33‐9. <a class="crsref citation-link central-link" data-crsref="4363035" href="" ref="info:x-wiley/crsRef/4363035" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1111%2Fj.0954-6820.1985.tb01631.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/3919531" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Transient+effect+of+the+combination+of+insulin+and+sulfonylurea+(glibenclamide)+on+glycemic+control+in+non%E2%80%90insulin+dependent+diabetics+poorly+controlled+on+insulin+alone+&author=L+Groop&author=K+Harno&author=EA+Nikkila&author=R+Pelkonen&author=EM+Tolppannen&publication_year=1985&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaL2M7ksFWrtQ%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1985ABZ1800007&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 37</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006992-bbs2-0011"> <div class="reference-title-banner"> <h4 class="title">Hermann 2001 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0011"> <div class="citation-journal">Hermann LS, Kalén J, Katzman P, Lager I, Nilsson A, Norrhamn O, et al. <span class="citation-title">Long‐term glycaemic improvement after addition of metformin to insulin in insulin‐treated obese type 2 diabetes patients</span>. <span class="citation"> Diabetes, Obesity and Metabolism </span><span class="pubYear">2001</span>;<span class="volume">3</span>:428‐34. <a class="crsref citation-link central-link" data-crsref="4363037" href="" ref="info:x-wiley/crsRef/4363037" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1046%2Fj.1463-1326.2001.00160.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Long%E2%80%90term+glycaemic+improvement+after+addition+of+metformin+to+insulin+in+insulin%E2%80%90treated+obese+type+2+diabetes+patients+&author=LS+Hermann&author=J+Kal%C3%A9n&author=P+Katzman&author=I+Lager&author=A+Nilsson&author=O+Norrhamn&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD38XnvVSisg%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000173051600007&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 15</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006992-bbs2-0012"> <div class="reference-title-banner"> <h4 class="title">Hirsch 1999 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0012"> <div class="citation-journal">Hirsch IB. <span class="citation-title">Metformin added to insulin therapy in poorly controlled type 2 diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1999</span>;<span class="volume">22</span>(5):854. <a class="crsref citation-link central-link" data-crsref="4363039" href="" ref="info:x-wiley/crsRef/4363039" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.22.5.854b" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10332695" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metformin+added+to+insulin+therapy+in+poorly+controlled+type+2+diabetes&author=IB+Hirsch&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaK1M3msFSquw%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000080102900035&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 14</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006992-bbs2-0013"> <div class="reference-title-banner"> <h4 class="title">Hong 2012 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0013"> <div class="citation-journal">Hong ES, Khang AR, Yoon JW, Kang SM, Choi SH, Park KS, et al. <span class="citation-title">Comparison between sitagliptin as add‐on therapy to insulin and insulin dose‐increase therapy in uncontrolled Korean type 2 diabetes: CSI study</span>. <span class="citation"> Diabetes, Obesity &amp; Metabolism </span><span class="pubYear">2012</span>;<span class="volume">14</span>(9):795‐802. [PUBMED: 22443183]<a class="crsref citation-link central-link" data-crsref="4363041" href="" ref="info:x-wiley/crsRef/4363041" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1111%2Fj.1463-1326.2012.01600.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/22443183" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparison+between+sitagliptin+as+add%E2%80%90on+therapy+to+insulin+and+insulin+dose%E2%80%90increase+therapy+in+uncontrolled+Korean+type+2+diabetes:+CSI+study+&author=ES+Hong&author=AR+Khang&author=JW+Yoon&author=SM+Kang&author=SH+Choi&author=KS+Park&publication_year=2012&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BC38XhtFOmsLbF" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000306807800004&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 29</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006992-bbs2-0014"> <div class="reference-title-banner"> <h4 class="title">Kitabchi 1987 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0014"> <div class="citation-journal">Kitabchi AE, Soria AG, Radparvar A, Lawson‐Grant V. <span class="citation-title">Combined therapy of insulin and tolazamide decreases insulin requirement and serum triglycerides in obese patients with non‐insulin‐dependent diabetes mellitus</span>. <span class="citation"> American Journal Medical Science </span><span class="pubYear">1987</span>;<span class="volume">294</span>(1):10‐4. <a class="crsref citation-link central-link" data-crsref="4363043" href="" ref="info:x-wiley/crsRef/4363043" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1097%2F00000441-198707000-00002" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Combined+therapy+of+insulin+and+tolazamide+decreases+insulin+requirement+and+serum+triglycerides+in+obese+patients+with+non%E2%80%90insulin%E2%80%90dependent+diabetes+mellitus+&author=AE+Kitabchi&author=AG+Soria&author=A+Radparvar&author=V+Lawson%E2%80%90Grant&publication_year=1987&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaL2s3mslOltA%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1987J132300002&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 15</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006992-bbs2-0015"> <div class="reference-title-banner"> <h4 class="title">Krawczyk 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0015"> <div class="citation-journal">Krawczyk A, Gajer G, Greszczak W, Strojek K. <span class="citation-title">The impact of metformin on metabolic control in obese type 2 diabetes patients treated with insulin. Preliminary observation</span> [Wplyw metforminy na wyrównanie metaboliczne u otylych chorych na cukrzyce typu 2 leczonych insulina. Obserwacja wstepna]. <span class="citation"> Diabetologia Doswiadczalna i Kliniczna </span><span class="pubYear">2005</span>;<span class="volume">5</span>(1):47‐51. <a class="crsref citation-link central-link" data-crsref="4363045" href="" ref="info:x-wiley/crsRef/4363045" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+impact+of+metformin+on+metabolic+control+in+obese+type+2+diabetes+patients+treated+with+insulin.+Preliminary+observation+&author=A+Krawczyk&author=G+Gajer&author=W+Greszczak&author=K+Strojek&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006992-bbs2-0016"> <div class="reference-title-banner"> <h4 class="title">Kyllastinen 1985 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0016"> <div class="citation-journal">Kyllastinen M, Groop L. <span class="citation-title">Combination of insulin and glibenclamide in the treatment of elderly non‐insulin dependent (type 2) diabetic patients</span>. <span class="citation"> Annals of Clinical Research </span><span class="pubYear">1985</span>;<span class="volume">17</span>:100‐4. <a class="crsref citation-link central-link" data-crsref="4363047" href="" ref="info:x-wiley/crsRef/4363047" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/3931537" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Combination+of+insulin+and+glibenclamide+in+the+treatment+of+elderly+non%E2%80%90insulin+dependent+(type+2)+diabetic+patients+&author=M+Kyllastinen&author=L+Groop&publication_year=1985&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1985APZ2300004&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 22</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006992-bbs2-0017"> <div class="reference-title-banner"> <h4 class="title">Lewitt 1989 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0017"> <div class="citation-journal">Lewitt MS, Yu VKF, Rennie GC, Carter JN, Marel GM, Yue DKS, et al. <span class="citation-title">Effects of combined insulin‐sulfonylurea therapy in type II patients</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1989</span>;<span class="volume">12</span>(6):379‐83. <a class="crsref citation-link central-link" data-crsref="4363049" href="" ref="info:x-wiley/crsRef/4363049" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.12.6.379" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/2499443" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+combined+insulin%E2%80%90sulfonylurea+therapy+in+type+II+patients&author=MS+Lewitt&author=VKF+Yu&author=GC+Rennie&author=JN+Carter&author=GM+Marel&author=DKS+Yue&publication_year=1989&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaL1M3ns1Shtg%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1989U673400002&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 29</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006992-bbs2-0018"> <div class="reference-title-banner"> <h4 class="title">Lindstrom 1999 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0018"> <div class="citation-journal">Lindstrom T, Nystrom FH, Olsson AG, Ottoson AM, Arnqvist HJ. <span class="citation-title">The lipoprotein profile differs during insulin treatment alone and combination therapy with insulin and sulphonylurea in patients with type 2 diabetes mellitus</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">1999</span>;<span class="volume">16</span>:820‐6. <a class="crsref citation-link central-link" data-crsref="4363051" href="" ref="info:x-wiley/crsRef/4363051" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1046%2Fj.1464-5491.1999.00170.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10547208" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+lipoprotein+profile+differs+during+insulin+treatment+alone+and+combination+therapy+with+insulin+and+sulphonylurea+in+patients+with+type+2+diabetes+mellitus+&author=T+Lindstrom&author=FH+Nystrom&author=AG+Olsson&author=AM+Ottoson&author=HJ+Arnqvist&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DyaK1MXnsVWjurg%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000083542100004&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 8</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006992-bbs2-0019"> <div class="reference-title-banner"> <h4 class="title">Longnecker 1986 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0019"> <div class="citation-journal">Longnecker MP, Elsenhans VD, Leiman SM, Owen OE, Boden G. <span class="citation-title">Insulin and a sulfonylurea agent in non‐insulin‐dependent diabetes mellitus</span>. <span class="citation"> Archives of Internal Medicine </span><span class="pubYear">1986</span>;<span class="volume">146</span>:673‐6. <a class="crsref citation-link central-link" data-crsref="4363053" href="" ref="info:x-wiley/crsRef/4363053" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1001%2Farchinte.1986.00360160075011" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/3516096" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Insulin+and+a+sulfonylurea+agent+in+non%E2%80%90insulin%E2%80%90dependent+diabetes+mellitus&author=MP+Longnecker&author=VD+Elsenhans&author=SM+Leiman&author=OE+Owen&author=G+Boden&publication_year=1986&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaL287osFyjsQ%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1986A816700009&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 30</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006992-bbs2-0020"> <div class="reference-title-banner"> <h4 class="title">Mattoo 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0020"> <div class="citation-journal">Mattoo V, Eckland D, Widel M, Duran S, Fajardo C, Strand J, et al. <span class="citation-title">Metabolic effects of pioglitazone in combination with insulin in patients with type 2 diabetes mellitus whose disease is not adequately controlled with insulin therapy: results of a six‐month, randomized, double‐blind, prospective, multicenter, parallel‐group study</span>. <span class="citation"> Clinical Therapeutics </span><span class="pubYear">2005</span>;<span class="volume">27</span>(5):554‐67. <a class="crsref citation-link central-link" data-crsref="4363055" href="" ref="info:x-wiley/crsRef/4363055" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1016%2Fj.clinthera.2005.05.005" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15978304" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metabolic+effects+of+pioglitazone+in+combination+with+insulin+in+patients+with+type+2+diabetes+mellitus+whose+disease+is+not+adequately+controlled+with+insulin+therapy:+results+of+a+six%E2%80%90month,+randomized,+double%E2%80%90blind,+prospective,+multicenter,+parallel%E2%80%90group+study+&author=V+Mattoo&author=D+Eckland&author=M+Widel&author=S+Duran&author=C+Fajardo&author=J+Strand&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2MXht1WmtL%2FF" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000229558700004&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 51</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006992-bbs2-0021"> <div class="reference-title-banner"> <h4 class="title">Mauerhoff 1986 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0021"> <div class="citation-journal">Mauerhoff T, Ketelslegers JM, Lambert AE. <span class="citation-title">Effect of glibenclamide in insulin‐treated diabetic patients with a residual insulin secretion</span>. <span class="citation"> Diabete &amp; Metabolisme </span><span class="pubYear">1986</span>;<span class="volume">12</span>:34‐8. <a class="crsref citation-link central-link" data-crsref="4363057" href="" ref="info:x-wiley/crsRef/4363057" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/3084315" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+glibenclamide+in+insulin%E2%80%90treated+diabetic+patients+with+a+residual+insulin+secretion+&author=T+Mauerhoff&author=JM+Ketelslegers&author=AE+Lambert&publication_year=1986&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1986A750900007&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 14</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006992-bbs2-0022"> <div class="reference-title-banner"> <h4 class="title">Mezitis 1992 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0022"> <div class="citation-journal">Mezitis NHE, Heshka S, Saitas V, Bailey T, Costa R, Pi‐Sunyer FX. <span class="citation-title">Combination therapy for NIDDM with biosynthetic human insulin and glyburide</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1992</span>;<span class="volume">15</span>(2):265‐9. <a class="crsref citation-link central-link" data-crsref="4363059" href="" ref="info:x-wiley/crsRef/4363059" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.15.2.265" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/1547684" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Combination+therapy+for+NIDDM+with+biosynthetic+human+insulin+and+glyburide&author=NHE+Mezitis&author=S+Heshka&author=V+Saitas&author=T+Bailey&author=R+Costa&author=FX+Pi%E2%80%90Sunyer&publication_year=1992&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaK387ptFOrsg%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1992HA60900014&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 6</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006992-bbs2-0023"> <div class="reference-title-banner"> <h4 class="title">Mudaliar 2010 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0023"> <div class="citation-journal">Mudaliar S, Chang AR, Aroda VR, Chao E, Burke P, Baxi, et al. <span class="citation-title">Effects of intensive insulin therapy alone and with added pioglitazone on renal salt/water balance and fluid compartment shifts in type 2 diabetes</span>. <span class="citation"> Diabetes, Obesity and Metabolism </span><span class="pubYear">2010</span>;<span class="volume">12</span>:133‐8. <a class="crsref citation-link central-link" data-crsref="4363061" href="" ref="info:x-wiley/crsRef/4363061" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1111%2Fj.1463-1326.2009.01126.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+intensive+insulin+therapy+alone+and+with+added+pioglitazone+on+renal+salt/water+balance+and+fluid+compartment+shifts+in+type+2+diabetes+&author=S+Mudaliar&author=AR+Chang&author=VR+Aroda&author=E+Chao&author=P+Burke&author=+Baxi&publication_year=2010&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BC3cXitlWjtr8%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000273179400006&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 7</span></a></li> </ul> </div> </div> <div class="bibliography-section" id="CD006992-bib-0024"> <div class="citation-journal">Shah PK, Mudaliar S, Chang AR, Aroda V, Andre M, Burke P, et al. <span class="citation-title">Effects of intensive insulin therapy alone and in combination with pioglitazone on body weight, composition, distribution and liver fat content in patients with type 2 diabetes</span>. <span class="citation"> Diabetes, Obesity and Metabolism </span><span class="pubYear">2011</span>;<span class="volume">13</span>:505‐10. <a class="crsref citation-link central-link" data-crsref="4363062" href="" ref="info:x-wiley/crsRef/4363062" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1111%2Fj.1463-1326.2011.01370.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+intensive+insulin+therapy+alone+and+in+combination+with+pioglitazone+on+body+weight,+composition,+distribution+and+liver+fat+content+in+patients+with+type+2+diabetes+&author=PK+Shah&author=S+Mudaliar&author=AR+Chang&author=V+Aroda&author=M+Andre&author=P+Burke&publication_year=2011&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BC3MXnvFKrurw%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000289731100004&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 17</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006992-bbs2-0024"> <div class="reference-title-banner"> <h4 class="title">Nemoto 2011 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0025"> <div class="citation-journal">Nemoto M, Tajima N, Kawamori R. <span class="citation-title">Efficacy of combined use of miglitol in type 2 diabetes patients receiving insulin therapy‐placebo‐controlled double‐blind comparative study</span>. <span class="citation"> Acta Diabetologica </span><span class="pubYear">2011</span>;<span class="volume">48</span>:15‐20. <a class="crsref citation-link central-link" data-crsref="4363064" href="" ref="info:x-wiley/crsRef/4363064" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1007%2Fs00592-010-0206-4" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/20617348" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+of+combined+use+of+miglitol+in+type+2+diabetes+patients+receiving+insulin+therapy%E2%80%90placebo%E2%80%90controlled+double%E2%80%90blind+comparative+study+&author=M+Nemoto&author=N+Tajima&author=R+Kawamori&publication_year=2011&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BC3MXisl2kt7Y%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000288016800003&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 8</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006992-bbs2-0025"> <div class="reference-title-banner"> <h4 class="title">Osei 1984 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0026"> <div class="citation-journal">Falko JM, Osei K. <span class="citation-title">Combination insulin/glyburide therapy in type II diabetes mellitus. Effects on lipoprotein metabolism and glucoregulation</span>. <span class="citation"> American Journal of Medicine </span><span class="pubYear">1985</span>;<span class="volume">79</span>(Suppl 3B):92‐101. <a class="crsref citation-link central-link" data-crsref="4363066" href="" ref="info:x-wiley/crsRef/4363066" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1016%2FS0002-9343%2885%2980014-0" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/3931467" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Combination+insulin/glyburide+therapy+in+type+II+diabetes+mellitus.+Effects+on+lipoprotein+metabolism+and+glucoregulation+&author=JM+Falko&author=K+Osei&publication_year=1985&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1985ATG1000014&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 16</span></a></li> </ul> </div> </div> <div class="bibliography-section" id="CD006992-bib-0027"> <div class="citation-journal">Osei K, O'Dorisio TM, Falko JM. <span class="citation-title">Concomitant insulin and sulfonylurea therapy in patients with type II diabetes</span>. <span class="citation"> American Journal of Medicine </span><span class="pubYear">1984</span>;<span class="volume">77</span>:1002‐9. <a class="crsref citation-link central-link" data-crsref="4363067" href="" ref="info:x-wiley/crsRef/4363067" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1016%2F0002-9343%2884%2990179-7" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/6439036" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Concomitant+insulin+and+sulfonylurea+therapy+in+patients+with+type+II+diabetes&author=K+Osei&author=TM+O'Dorisio&author=JM+Falko&publication_year=1984&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaL2M%2FmvFGiug%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1984TV10400009&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 57</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006992-bbs2-0026"> <div class="reference-title-banner"> <h4 class="title">Quatraro 1986 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0028"> <div class="citation-journal">Quatraro A, Consoli G, Ceriello A, Giugliano D. <span class="citation-title">Combined insulin and sulfonylurea therapy in non‐insulin‐dependent diabetics with secondary failure to oral drugs: a one year follow‐up</span>. <span class="citation"> Diabete &amp; Metabolisme </span><span class="pubYear">1986</span>;<span class="volume">12</span>:315‐8. <a class="crsref citation-link central-link" data-crsref="4363069" href="" ref="info:x-wiley/crsRef/4363069" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/3545931" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Combined+insulin+and+sulfonylurea+therapy+in+non%E2%80%90insulin%E2%80%90dependent+diabetics+with+secondary+failure+to+oral+drugs:+a+one+year+follow%E2%80%90up+&author=A+Quatraro&author=G+Consoli&author=A+Ceriello&author=D+Giugliano&publication_year=1986&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1986F825200004&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 32</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006992-bbs2-0027"> <div class="reference-title-banner"> <h4 class="title">Reich 1987 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0029"> <div class="citation-journal">Reich A, Abraira C, Lawrence AM. <span class="citation-title">Combined glyburide and insulin therapy in type II diabetes</span>. <span class="citation"> Diabetes Research </span><span class="pubYear">1987</span>;<span class="volume">6</span>:99‐104. <a class="crsref citation-link central-link" data-crsref="4363071" href="" ref="info:x-wiley/crsRef/4363071" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/3123116" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Combined+glyburide+and+insulin+therapy+in+type+II+diabetes&author=A+Reich&author=C+Abraira&author=AM+Lawrence&publication_year=1987&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1987K751200011&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 15</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006992-bbs2-0028"> <div class="reference-title-banner"> <h4 class="title">Relimpio 1998 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0030"> <div class="citation-journal">Relimpio F, Pumar A, Losada F, Mangas MA, Acosta D, Astorga R. <span class="citation-title">Adding metformin versus insulin dose increase in insulin‐treated but poorly controlled type 2 diabetes mellitus: an open‐label randomized trial</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">1998</span>;<span class="volume">15</span>:997‐1002. <a class="crsref citation-link central-link" data-crsref="4363073" href="" ref="info:x-wiley/crsRef/4363073" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1002%2F%28SICI%291096-9136%281998120%2915%3A12%3C997%3A%3AAID-DIA716%3E3.0.CO%3B2-B" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9868971" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Adding+metformin+versus+insulin+dose+increase+in+insulin%E2%80%90treated+but+poorly+controlled+type+2+diabetes+mellitus:+an+open%E2%80%90label+randomized+trial+&author=F+Relimpio&author=A+Pumar&author=F+Losada&author=MA+Mangas&author=D+Acosta&author=R+Astorga&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaK1M%2FosVeitA%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000077417700002&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 32</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006992-bbs2-0029"> <div class="reference-title-banner"> <h4 class="title">Robinson 1998 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0031"> <div class="citation-journal">Robinson AC, Burke J, Robinson S, Johnston DG, Elkeles RS. <span class="citation-title">The effects of metformin on glycemic control and serum lipids in insulin‐treated NIDDM patients with suboptimal metabolic control</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1998</span>;<span class="volume">21</span>(5):701‐5. <a class="crsref citation-link central-link" data-crsref="4363075" href="" ref="info:x-wiley/crsRef/4363075" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.21.5.701" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9589227" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+effects+of+metformin+on+glycemic+control+and+serum+lipids+in+insulin%E2%80%90treated+NIDDM+patients+with+suboptimal+metabolic+control+&author=AC+Robinson&author=J+Burke&author=S+Robinson&author=DG+Johnston&author=RS+Elkeles&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaK1c3ltFWiuw%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000073296100005&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 78</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006992-bbs2-0030"> <div class="reference-title-banner"> <h4 class="title">Rosenstock 2002 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0032"> <div class="citation-journal">Rosenstock J, Einhorn D, Hershon K, Glazer NB, Yu S, Pioglitazone 014 Study Group. <span class="citation-title">Efficacy and safety of pioglitazone in type 2 diabetes: a randomised, placebo‐controlled study in patients receiving stable insulin therapy</span>. <span class="citation"> International Journal of Clinical Practice </span><span class="pubYear">2002</span>;<span class="volume">56</span>(4):251‐57. <a class="crsref citation-link central-link" data-crsref="4363077" href="" ref="info:x-wiley/crsRef/4363077" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12074206" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+and+safety+of+pioglitazone+in+type+2+diabetes:+a+randomised,+placebo%E2%80%90controlled+study+in+patients+receiving+stable+insulin+therapy+&author=J+Rosenstock&author=D+Einhorn&author=K+Hershon&author=NB+Glazer&author=S+Yu&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000175905500008&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 124</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006992-bbs2-0031"> <div class="reference-title-banner"> <h4 class="title">Schade 1987 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0033"> <div class="citation-journal">Schade DS, Mitchell WJ, Griego G. <span class="citation-title">Addition of sulfonylurea to insulin treatment in poorly controlled type II diabetes. A double‐blind, randomized clinical trial</span>. <span class="citation"> Journal of the American Medical Association </span><span class="pubYear">1987</span>;<span class="volume">257</span>(18):2441‐5. <a class="crsref citation-link central-link" data-crsref="4363079" href="" ref="info:x-wiley/crsRef/4363079" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1001%2Fjama.1987.03390180059023" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/3106656" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Addition+of+sulfonylurea+to+insulin+treatment+in+poorly+controlled+type+II+diabetes.+A+double%E2%80%90blind,+randomized+clinical+trial+&author=DS+Schade&author=WJ+Mitchell&author=G+Griego&publication_year=1987&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaL2s7pvFWjsg%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1987H067000018&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 33</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006992-bbs2-0032"> <div class="reference-title-banner"> <h4 class="title">Schiel 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0034"> <div class="citation-journal">Schiel R, Muller UA. <span class="citation-title">Efficacy and treatment satisfaction of once‐daily insulin glargine plus one or two oral antidiabetic agents versus continuing premixed human insulin in patients with type 2 diabetes previously on long‐term conventional insulin therapy: The Switch pilot study</span>. <span class="citation"> Experimental and Clinical Endocrinology &amp; Diabetes </span><span class="pubYear">2007</span>;<span class="volume">115</span>:627‐33. <a class="crsref citation-link central-link" data-crsref="4363081" href="" ref="info:x-wiley/crsRef/4363081" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1055%2Fs-2007-984445" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+and+treatment+satisfaction+of+once%E2%80%90daily+insulin+glargine+plus+one+or+two+oral+antidiabetic+agents+versus+continuing+premixed+human+insulin+in+patients+with+type+2+diabetes+previously+on+long%E2%80%90term+conventional+insulin+therapy:+The+Switch+pilot+study+&author=R+Schiel&author=UA+Muller&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD1cXitFaisLo%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000251545900001&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 11</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006992-bbs2-0033"> <div class="reference-title-banner"> <h4 class="title">Simpson 1990 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0035"> <div class="citation-journal">Simpson HCR, Sturley R, Stirling CA, Reckless JPD. <span class="citation-title">Combination of insulin with glipizide increases peripheral glucose disposal in secondary failure type 2 diabetic patients</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">1990</span>;<span class="volume">7</span>:143‐7. <a class="crsref citation-link central-link" data-crsref="4363083" href="" ref="info:x-wiley/crsRef/4363083" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1111%2Fj.1464-5491.1990.tb01349.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/2137755" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Combination+of+insulin+with+glipizide+increases+peripheral+glucose+disposal+in+secondary+failure+type+2+diabetic+patients+&author=HCR+Simpson&author=R+Sturley&author=CA+Stirling&author=JPD+Reckless&publication_year=1990&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaK3c7mvVamsQ%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1990CM71400010&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 17</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006992-bbs2-0034"> <div class="reference-title-banner"> <h4 class="title">Stenman 1988 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0036"> <div class="citation-journal">Stenman S, Gropp PH, Saloranta C, Totterman KJ, Fyhrqvist F, Groop L. <span class="citation-title">Effects of the combination of insulin and glibenclamide in type 2 (non‐insulin‐dependent) diabetic patients with secondary failure to oral glucose lowering agents</span>. <span class="citation"> Diabetologia </span><span class="pubYear">1988</span>;<span class="volume">31</span>:206‐13. <a class="crsref citation-link central-link" data-crsref="4363085" href="" ref="info:x-wiley/crsRef/4363085" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1007%2FBF00290586" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/3133266" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+the+combination+of+insulin+and+glibenclamide+in+type+2+(non%E2%80%90insulin%E2%80%90dependent)+diabetic+patients+with+secondary+failure+to+oral+glucose+lowering+agents+&author=S+Stenman&author=PH+Gropp&author=C+Saloranta&author=KJ+Totterman&author=F+Fyhrqvist&author=L+Groop&publication_year=1988&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaL1c3lsFKisA%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1988N283900004&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 50</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006992-bbs2-0035"> <div class="reference-title-banner"> <h4 class="title">Strowig 2002 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0037"> <div class="citation-journal">Strowig S, Avilés‐Santa ML, Raskin P. <span class="citation-title">Comparison of insulin monotherapy and combination therapy with insulin and metformin or insulin and troglitazone in type 2 diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2002</span>;<span class="volume">25</span>(10):1691‐8. <a class="crsref citation-link central-link" data-crsref="4363087" href="" ref="info:x-wiley/crsRef/4363087" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.25.10.1691" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12351463" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparison+of+insulin+monotherapy+and+combination+therapy+with+insulin+and+metformin+or+insulin+and+troglitazone+in+type+2+diabetes+&author=S+Strowig&author=ML+Avil%C3%A9s%E2%80%90Santa&author=P+Raskin&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD38Xos1Whtr4%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000185504500004&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 65</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006992-bbs2-0036"> <div class="reference-title-banner"> <h4 class="title">Wulffelé 2002 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0038"> <div class="citation-journal">Wulffelé MG, Kooy A, Lehert P, Bets D, Ogterop JC, Borger van der Burg B, et al. <span class="citation-title">Combination of insulin and metformin in the treatment of type 2 diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2002</span>;<span class="volume">25</span>:2133‐40. <a class="crsref citation-link central-link" data-crsref="4363089" href="" ref="info:x-wiley/crsRef/4363089" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.25.12.2133" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12453950" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Combination+of+insulin+and+metformin+in+the+treatment+of+type+2+diabetes&author=MG+Wulffel%C3%A9&author=A+Kooy&author=P+Lehert&author=D+Bets&author=JC+Ogterop&author=B+BorgervanderBurg&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000185504800003&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 68</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006992-bbs2-0037"> <div class="reference-title-banner"> <h4 class="title">Yilmaz 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0039"> <div class="citation-journal">Yilmaz H, Gursoy A, Sahin M, Guvener Demirag N. <span class="citation-title">Comparison of insulin monotherapy and combination therapy with insulin and metformin or insulin and rosiglitazone or insulin and acarbose in type 2 diabetes</span>. <span class="citation"> Acta Diabetologica </span><span class="pubYear">2007</span>;<span class="volume">44</span>:187‐92. <a class="crsref citation-link central-link" data-crsref="4363091" href="" ref="info:x-wiley/crsRef/4363091" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1007%2Fs00592-007-0004-9" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17726570" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparison+of+insulin+monotherapy+and+combination+therapy+with+insulin+and+metformin+or+insulin+and+rosiglitazone+or+insulin+and+acarbose+in+type+2+diabetes+&author=H+Yilmaz&author=A+Gursoy&author=M+Sahin&author=N+GuvenerDemirag&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2sXhtlSmu73E" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000250921900004&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 10</span></a></li> </ul> </div> </div> </div> </section> <section> <div class="section-header" id="CD006992-bbs1-0002"> <h3 class="title">References to studies excluded from this review</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a class="jump-to" href="#CD006992-bbs1-0001">included studies</a></li> <li><a class="jump-to" href="#CD006992-bbs1-0003">studies awaiting assessment</a></li> <li><a class="jump-to" href="#CD006992-bbs1-0004">ongoing studies</a></li> <li><a class="jump-to" href="#CD006992-bbs1-0005">additional references</a></li> <li><a class="jump-to" href="#CD006992-bbs1-0006">other published versions</a></li> </ul> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0038"> <div class="reference-title-banner"> <h4 class="title">Abraira 1998 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0040"> <div class="citation-journal">Abraira C, Henderson WG, Colwell JA, Nuttall FQ, Comstock JP, Emanuele NV, et al. <span class="citation-title">Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1998</span>;<span class="volume">21</span>(4):574‐9. <a class="crsref citation-link central-link" data-crsref="4363093" href="" ref="info:x-wiley/crsRef/4363093" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.21.4.574" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9571345" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Response+to+intensive+therapy+steps+and+to+glipizide+dose+in+combination+with+insulin+in+type+2+diabetes.+VA+feasibility+study+on+glycemic+control+and+complications+&author=C+Abraira&author=WG+Henderson&author=JA+Colwell&author=FQ+Nuttall&author=JP+Comstock&author=NV+Emanuele&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaK1c3jt1ygtA%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000072670700020&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 46</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0039"> <div class="reference-title-banner"> <h4 class="title">Al‐Shaikh 2006 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0041"> <div class="citation-journal">Al‐Shaikh AR. <span class="citation-title">Comparison of basal insulin added to oral agents versus twice‐daily premixed insulin as initial insulin therapy for type 2 diabetes</span>. <span class="citation"> Pakistan Journal of Medical Science </span><span class="pubYear">2006</span>;<span class="volume">22</span>(1):14‐7. <a class="crsref citation-link central-link" data-crsref="4363095" href="" ref="info:x-wiley/crsRef/4363095" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparison+of+basal+insulin+added+to+oral+agents+versus+twice%E2%80%90daily+premixed+insulin+as+initial+insulin+therapy+for+type+2+diabetes+&author=AR+Al%E2%80%90Shaikh&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0040"> <div class="reference-title-banner"> <h4 class="title">Altuntas 2003 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0042"> <div class="citation-journal">Altuntas Y, Ozen B, Ozturk B, Sengul A, Ucak S, Ersoy O, et al. <span class="citation-title">Comparison of additional metformin or NPH insulin to mealtime insulin lispro with mealtime human insulin therapy in secondary OAD failure</span>. <span class="citation"> Diabetes, Obesity and Metabolism </span><span class="pubYear">2003</span>;<span class="volume">5</span>:371‐8. <a class="crsref citation-link central-link" data-crsref="4363097" href="" ref="info:x-wiley/crsRef/4363097" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1046%2Fj.1463-1326.2003.00283.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparison+of+additional+metformin+or+NPH+insulin+to+mealtime+insulin+lispro+with+mealtime+human+insulin+therapy+in+secondary+OAD+failure+&author=Y+Altuntas&author=B+Ozen&author=B+Ozturk&author=A+Sengul&author=S+Ucak&author=O+Ersoy&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2cXltVGh" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000186415900002&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 13</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0041"> <div class="reference-title-banner"> <h4 class="title">Bachman 1988 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0043"> <div class="citation-journal">Bachmann W, Lotz N, Mehnert H, Rosak C, Schoffling K. <span class="citation-title">Effectiviness of combined glibenclamide and insulin treatment of patients with secondary sulphonylurea failure: a controlled multi‐center double‐blind trial</span> [Wirksamheit der kombinationsbehandlung mit glibenclamid und insulin bei sulfonylharnstoff‐sekundarversagen]. <span class="citation"> Deutsche Medizinische Wochenschrift </span><span class="pubYear">1988</span>;<span class="volume">113</span>:631‐6. <a class="crsref citation-link central-link" data-crsref="4363099" href="" ref="info:x-wiley/crsRef/4363099" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1055%2Fs-2008-1067696" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/3129273" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effectiviness+of+combined+glibenclamide+and+insulin+treatment+of+patients+with+secondary+sulphonylurea+failure:+a+controlled+multi%E2%80%90center+double%E2%80%90blind+trial+&author=W+Bachmann&author=N+Lotz&author=H+Mehnert&author=C+Rosak&author=K+Schoffling&publication_year=1988&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaL1c7psFylsA%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1988N025900003&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 12</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0042"> <div class="reference-title-banner"> <h4 class="title">Barranco 2006 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0044"> <div class="citation-journal">Barranco C. <span class="citation-title">Early use of combination therapy improves outcome of patients with type 2 diabetes</span>. <span class="citation"> Endocrinology &amp; Metabolism </span><span class="pubYear">2006</span>;<span class="volume">2</span>(4):186‐7. <a class="crsref citation-link central-link" data-crsref="4363101" href="" ref="info:x-wiley/crsRef/4363101" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Early+use+of+combination+therapy+improves+outcome+of+patients+with+type+2+diabetes&author=C+Barranco&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0043"> <div class="reference-title-banner"> <h4 class="title">Berhanu 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0045"> <div class="citation-journal">Berhanu P, Perez A, Yu S. <span class="citation-title">Effect of pioglitazone in combination with insulin therapy on glycaemic control, insulin dose requirement and lipid profile in patients with type 2 diabetes previously poorly controlled with combination therapy</span>. <span class="citation"> Diabetes, Obesity &amp; Metabolism </span><span class="pubYear">2007</span>;<span class="volume">9</span>:512‐20. <a class="crsref citation-link central-link" data-crsref="4363103" href="" ref="info:x-wiley/crsRef/4363103" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1111%2Fj.1463-1326.2006.00633.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17587394" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+pioglitazone+in+combination+with+insulin+therapy+on+glycaemic+control,+insulin+dose+requirement+and+lipid+profile+in+patients+with+type+2+diabetes+previously+poorly+controlled+with+combination+therapy+&author=P+Berhanu&author=A+Perez&author=S+Yu&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2sXosF2lt7w%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000247476100009&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 23</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0044"> <div class="reference-title-banner"> <h4 class="title">Bianchi 1996 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0046"> <div class="citation-journal">Bianchi R, Vries DE, Bravenboer B, Erkelens DW. <span class="citation-title">Effect of benfluorex in addition to insulin therapy in obese type II diabetic patients with secondary failure to conventional oral treatment</span>. <span class="citation"> Diabetes Nutrition Metabolism. </span><span class="pubYear">1996</span>;<span class="volume">9</span>:81‐8. <a class="crsref citation-link central-link" data-crsref="4363105" href="" ref="info:x-wiley/crsRef/4363105" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+benfluorex+in+addition+to+insulin+therapy+in+obese+type+II+diabetic+patients+with+secondary+failure+to+conventional+oral+treatment+&author=R+Bianchi&author=DE+Vries&author=B+Bravenboer&author=DW+Erkelens&publication_year=1996&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1996UP24400005&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 2</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0045"> <div class="reference-title-banner"> <h4 class="title">Buse 1998 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0047"> <div class="citation-journal">Buse JB, Gumbiner BG, Mathias NP, Nelson DM, Faja BW, Whitcomb RW, Troglitazone Insulin study group. <span class="citation-title">Troglitazone use in insulin‐treated type 2 diabetic patients</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1998</span>;<span class="volume">21</span>:1455‐61. <a class="crsref citation-link central-link" data-crsref="4363107" href="" ref="info:x-wiley/crsRef/4363107" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.21.9.1455" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9727891" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Troglitazone+use+in+insulin%E2%80%90treated+type+2+diabetic+patients&author=JB+Buse&author=BG+Gumbiner&author=NP+Mathias&author=DM+Nelson&author=BW+Faja&author=RW+Whitcomb&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaK1czpsVyktg%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000075556800012&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 58</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0046"> <div class="reference-title-banner"> <h4 class="title">Carta 1984 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0048"> <div class="citation-journal">Carta Q, Trovati M, Dani F, Caselle MT, Vitali S, Cavalot F, et al. <span class="citation-title">Insulin or insulin + oral agents in the treatment of type II diabetics after oral agents failure.</span> [Insulina o insulina + farmaci ipoglicemizzanti orali nella terapia del diabete di tipo II di difficile compenso metabolico]. <span class="citation"> Minerva Endocrinologia </span><span class="pubYear">1984</span>;<span class="volume">9</span>:241‐5. <a class="crsref citation-link central-link" data-crsref="4363109" href="" ref="info:x-wiley/crsRef/4363109" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Insulin+or+insulin+++oral+agents+in+the+treatment+of+type+II+diabetics+after+oral+agents+failure.+&author=Q+Carta&author=M+Trovati&author=F+Dani&author=MT+Caselle&author=S+Vitali&author=F+Cavalot&publication_year=1984&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0047"> <div class="reference-title-banner"> <h4 class="title">Castillo 1987 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0049"> <div class="citation-journal">Castillo M, Scheen AJ, Paolisso G, Lefebvre PJ. <span class="citation-title">The addition of glipizide to insulin therapy in type‐II diabetic patients with secondary failure to sulfonylureas is useful only in the presence of a significant residual insulin secretion</span>. <span class="citation"> Acta Endocrinologica </span><span class="pubYear">1987</span>;<span class="volume">116</span>:364‐72. <a class="crsref citation-link central-link" data-crsref="4363111" href="" ref="info:x-wiley/crsRef/4363111" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/3318259" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+addition+of+glipizide+to+insulin+therapy+in+type%E2%80%90II+diabetic+patients+with+secondary+failure+to+sulfonylureas+is+useful+only+in+the+presence+of+a+significant+residual+insulin+secretion+&author=M+Castillo&author=AJ+Scheen&author=G+Paolisso&author=PJ+Lefebvre&publication_year=1987&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1987K512700010&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 30</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0048"> <div class="reference-title-banner"> <h4 class="title">Charbonnel 2010 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0050"> <div class="citation-journal">Charbonnel B, DeFronzo R, Davidson J, Schmitz O, Birkeland K, Pirags V, et al. <span class="citation-title">Pioglitazone use in combination with insulin in the prospective Pioglitazone Clinical Trial in Macrovascular Events Study (PROactive19)</span>. <span class="citation"> Journal of Clinical Endocrinology &amp; Metabolism </span><span class="pubYear">2010</span>;<span class="volume">95</span>:2163‐71. <a class="crsref citation-link central-link" data-crsref="4363113" href="" ref="info:x-wiley/crsRef/4363113" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1210%2Fjc.2009-1974" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Pioglitazone+use+in+combination+with+insulin+in+the+prospective+Pioglitazone+Clinical+Trial+in+Macrovascular+Events+Study+(PROactive19)+&author=B+Charbonnel&author=R+DeFronzo&author=J+Davidson&author=O+Schmitz&author=K+Birkeland&author=V+Pirags&publication_year=2010&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BC3cXmtFegurk%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000277356700021&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 22</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0049"> <div class="reference-title-banner"> <h4 class="title">Chazan 2001 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0051"> <div class="citation-journal">Chazan ACS, Gomes MB. <span class="citation-title">Glicazide and bedtime insulin are more efficient than insulin alone for type 2 diabetic patients with sulfonylurea secondary failure</span>. <span class="citation"> Brazilian Journal of Medical and Biological Research </span><span class="pubYear">2001</span>;<span class="volume">34</span>:49‐56. <a class="crsref citation-link central-link" data-crsref="4363115" href="" ref="info:x-wiley/crsRef/4363115" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1590%2FS0100-879X2001000100006" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11151028" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Glicazide+and+bedtime+insulin+are+more+efficient+than+insulin+alone+for+type+2+diabetic+patients+with+sulfonylurea+secondary+failure+&author=ACS+Chazan&author=MB+Gomes&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000166675700006&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 5</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0050"> <div class="reference-title-banner"> <h4 class="title">Chow1995 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0052"> <div class="citation-journal">Chow C, Tsang LWW, Sorensen JP, Cockram CS. <span class="citation-title">Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1995</span>;<span class="volume">18</span>(3):307‐14. <a class="crsref citation-link central-link" data-crsref="4363117" href="" ref="info:x-wiley/crsRef/4363117" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.18.3.307" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/7555472" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparison+of+insulin+with+or+without+continuation+of+oral+hypoglycemic+agents+in+the+treatment+of+secondary+failure+in+NIDDM+patients+&author=C+Chow&author=LWW+Tsang&author=JP+Sorensen&author=CS+Cockram&publication_year=1995&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaK28%2FgtFyhsg%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1995QM29600004&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 81</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0051"> <div class="reference-title-banner"> <h4 class="title">Clauson 1995 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0053"> <div class="citation-journal">Clauson P, Karlander S, Steen L, Efendic S. <span class="citation-title">Daytime glibenclamide and bedtime NPH insulin compared to intensive insulin treatment in secondary sulphonylurea failure: a 1‐year follow‐up</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">1996</span>;<span class="volume">13</span>:471‐7. <a class="crsref citation-link central-link" data-crsref="4363119" href="" ref="info:x-wiley/crsRef/4363119" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1002%2F%28SICI%291096-9136%28199605%2913%3A5%3C471%3A%3AAID-DIA103%3E3.0.CO%3B2-T" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8737030" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Daytime+glibenclamide+and+bedtime+NPH+insulin+compared+to+intensive+insulin+treatment+in+secondary+sulphonylurea+failure:+a+1%E2%80%90year+follow%E2%80%90up+&author=P+Clauson&author=S+Karlander&author=L+Steen&author=S+Efendic&publication_year=1996&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaK28zks1OhtQ%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1996UM87000013&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 29</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0052"> <div class="reference-title-banner"> <h4 class="title">Cortes 1993 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0054"> <div class="citation-journal">Cortes Aguirre H, Espinosa Lopez FR, Angluo Ververa JA, Diaz Torres J. <span class="citation-title">A comparative study of insulin and glyburide versus glyburide or insulin in the chronic control of patients with type‐2 diabetes</span> [Estudio comparativo de insulina y glyburida contra gliburia o insulina, en el control crónico de pacientes con diabetes tipo II]. <span class="citation"> Gaceta Medica de Mexico </span><span class="pubYear">1993</span>;<span class="volume">129</span>(6):383‐6. <a class="crsref citation-link central-link" data-crsref="4363121" href="" ref="info:x-wiley/crsRef/4363121" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/7926425" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+comparative+study+of+insulin+and+glyburide+versus+glyburide+or+insulin+in+the+chronic+control+of+patients+with+type%E2%80%902+diabetes+&author=H+CortesAguirre&author=FR+EspinosaLopez&author=JA+AngluoVervera&author=J+DiazTorres&publication_year=1993&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0053"> <div class="reference-title-banner"> <h4 class="title">Dashora 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0055"> <div class="citation-journal">Dashora UK, Sibal L, Ashwell SG, Home PD. <span class="citation-title">Insulin glargine in combination with nateglinide in people with type 2 diabetes: a randomized placebo‐controlled trial</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">2007</span>;<span class="volume">24</span>:344‐9. <a class="crsref citation-link central-link" data-crsref="4363123" href="" ref="info:x-wiley/crsRef/4363123" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1111%2Fj.1464-5491.2007.02094.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17298589" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Insulin+glargine+in+combination+with+nateglinide+in+people+with+type+2+diabetes:+a+randomized+placebo%E2%80%90controlled+trial+&author=UK+Dashora&author=L+Sibal&author=SG+Ashwell&author=PD+Home&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2sXlslWjsLc%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000245101400002&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 8</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0054"> <div class="reference-title-banner"> <h4 class="title">Davidson 2006 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0056"> <div class="citation-journal">Davidson J, Perez A, Zhang J and The Pioglitazone 343 Study group. <span class="citation-title">Addition of pioglitazone to stable insulin therapy in patients with poorly controlled type 2 diabetes: results of a double‐blind, multi‐centre, randomized study</span>. <span class="citation"> Diabetes, Obesity and Metabolism </span><span class="pubYear">2006</span>;<span class="volume">8</span>:164‐74. <a class="crsref citation-link central-link" data-crsref="4363125" href="" ref="info:x-wiley/crsRef/4363125" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1111%2Fj.1463-1326.2005.00499.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Addition+of+pioglitazone+to+stable+insulin+therapy+in+patients+with+poorly+controlled+type+2+diabetes:+results+of+a+double%E2%80%90blind,+multi%E2%80%90centre,+randomized+study+&author=J+Davidson&author=A+Perez&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD28XjsFOktr0%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000235041100006&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 26</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0055"> <div class="reference-title-banner"> <h4 class="title">De Luis 2001 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0057"> <div class="citation-journal">Luis DA, Aller R, Cuellar L, Terroba C, Ovalle H, Izaola O, et al. <span class="citation-title">Effect of repaglinide addition to NPH insulin monotherapy on glycemic control in patients with type 2 diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2001</span>;<span class="volume">24</span>:1844‐5. <a class="crsref citation-link central-link" data-crsref="4363127" href="" ref="info:x-wiley/crsRef/4363127" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.24.10.1844" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11574456" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+repaglinide+addition+to+NPH+insulin+monotherapy+on+glycemic+control+in+patients+with+type+2+diabetes+&author=DA+Luis&author=R+Aller&author=L+Cuellar&author=C+Terroba&author=H+Ovalle&author=O+Izaola&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000171321600028&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 14</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0056"> <div class="reference-title-banner"> <h4 class="title">Douek 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0058"> <div class="citation-journal">Douek IF, Allen SE, Ewings P, Gale EAM, Bingley PJ for the Metformin Trial Group. <span class="citation-title">Continuing metformin when starting insulin in patients with type 2 diabetes: a double‐blind randomized placebo‐controlled trial</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">2005</span>;<span class="volume">22</span>:634‐40. <a class="crsref citation-link central-link" data-crsref="4363129" href="" ref="info:x-wiley/crsRef/4363129" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1111%2Fj.1464-5491.2005.01475.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15842521" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Continuing+metformin+when+starting+insulin+in+patients+with+type+2+diabetes:+a+double%E2%80%90blind+randomized+placebo%E2%80%90controlled+trial+&author=IF+Douek&author=SE+Allen&author=P+Ewings&author=EAM+Gale&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2MXkslKlurw%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000228397300018&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 27</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0057"> <div class="reference-title-banner"> <h4 class="title">Fonseca 2006 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0059"> <div class="citation-journal">Fonseca VA, Theuma P, Mundaliar S, Leissinger CA, Clejan S, Henry RR. <span class="citation-title">Diabetes treatments have differential effects on nontraditional cardiovascular risk factors</span>. <span class="citation"> Journal of Diabetes and Its Complications </span><span class="pubYear">2006</span>;<span class="volume">20</span>:14‐20. <a class="crsref citation-link central-link" data-crsref="4363131" href="" ref="info:x-wiley/crsRef/4363131" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1016%2Fj.jdiacomp.2005.05.009" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16389162" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Diabetes+treatments+have+differential+effects+on+nontraditional+cardiovascular+risk+factors+&author=VA+Fonseca&author=P+Theuma&author=S+Mundaliar&author=CA+Leissinger&author=S+Clejan&author=RR+Henry&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000235153200003&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 20</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0058"> <div class="reference-title-banner"> <h4 class="title">Fonseca 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0060"> <div class="citation-journal">Fonseca V, Baron M, Shao Q, Dejager S. <span class="citation-title">Sustained efficacy and reduced hypoglycaemia during one year of treatment with vildagliptine added to insulin in patients with type 2 diabetes mellitus</span>. <span class="citation"> Hormone and Metabolic Research </span><span class="pubYear">2008</span>;<span class="volume">40</span>:427‐30. <a class="crsref citation-link central-link" data-crsref="4363133" href="" ref="info:x-wiley/crsRef/4363133" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1055%2Fs-2008-1058090" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18401832" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Sustained+efficacy+and+reduced+hypoglycaemia+during+one+year+of+treatment+with+vildagliptine+added+to+insulin+in+patients+with+type+2+diabetes+mellitus+&author=V+Fonseca&author=M+Baron&author=Q+Shao&author=S+Dejager&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD1cXpvVKktrw%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000257466100012&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 43</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0059"> <div class="reference-title-banner"> <h4 class="title">Garg 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0061"> <div class="citation-journal">Garg R, Gopal J, Jones GR. <span class="citation-title">Rosiglitazone: safety and efficacy in combination with insulin in poorly controlled type2 diabetes mellitus patients treated with insulin alone</span>. <span class="citation"> Journal of Diabetes and its Complications </span><span class="pubYear">2007</span>;<span class="volume">21</span>:1‐6. <a class="crsref citation-link central-link" data-crsref="4363135" href="" ref="info:x-wiley/crsRef/4363135" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1016%2Fj.jdiacomp.2005.10.004" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17189867" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Rosiglitazone:+safety+and+efficacy+in+combination+with+insulin+in+poorly+controlled+type2+diabetes+mellitus+patients+treated+with+insulin+alone+&author=R+Garg&author=J+Gopal&author=GR+Jones&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000243462800001&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 3</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0060"> <div class="reference-title-banner"> <h4 class="title">Gerstein 2006 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0062"> <div class="citation-journal">Gerstein HC, Yale JF, Harris SB, Issa M, Stewart JA, Dempsey E. <span class="citation-title">A randomized trial of adding insulin glargine vs. avoidance of insulin in people with type 2 diabetes in either no oral glucose‐lowering agents or submaximal doses of metformin and/or sulfonylureas. The Canadian INSIGHT (Implementing new Strategies with Insulin Glargine for Hyperglycaemia Treatment) Study</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">2006</span>;<span class="volume">23</span>:736‐42. <a class="crsref citation-link central-link" data-crsref="4363137" href="" ref="info:x-wiley/crsRef/4363137" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1111%2Fj.1464-5491.2006.01881.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16842477" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+randomized+trial+of+adding+insulin+glargine+vs.+avoidance+of+insulin+in+people+with+type+2+diabetes+in+either+no+oral+glucose%E2%80%90lowering+agents+or+submaximal+doses+of+metformin+and/or+sulfonylureas.+The+Canadian+INSIGHT+(Implementing+new+Strategies+with+Insulin+Glargine+for+Hyperglycaemia+Treatment)+Study+&author=HC+Gerstein&author=JF+Yale&author=SB+Harris&author=M+Issa&author=JA+Stewart&author=E+Dempsey&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD28XptVKjsb8%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000238618400005&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 91</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0061"> <div class="reference-title-banner"> <h4 class="title">Goudswaard 2004a {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0063"> <div class="citation-journal">Goudswaard AN, Stolk RP, Zuithoff P, Valk HW, Rutten GE. <span class="citation-title">Starting insulin in type 2 diabetes: continue oral glucose lowering agents? A randomized trial in primary care</span>. <span class="citation"> Journal of Family Practice </span><span class="pubYear">2004</span>;<span class="volume">53</span>(5):393‐9. <a class="crsref citation-link central-link" data-crsref="4363139" href="" ref="info:x-wiley/crsRef/4363139" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15125825" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Starting+insulin+in+type+2+diabetes:+continue+oral+glucose+lowering+agents?+A+randomized+trial+in+primary+care+&author=AN+Goudswaard&author=RP+Stolk&author=P+Zuithoff&author=HW+Valk&author=GE+Rutten&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000221359800012&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 17</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0062"> <div class="reference-title-banner"> <h4 class="title">Greco 1998 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0064"> <div class="citation-journal">Greco D, Taravella V, Sinagra D, Galluzzo A. <span class="citation-title">Considerations on combined use of insulin and oral antidiabetic agents in the treatment of type 2 diabetes mellitus</span> [Considerazioni sull'uso della &quot;terapia combinata&quot; insulina + antidiabetici orali nel trattamento del diabete mellito di tipo 2]. <span class="citation"> L'Internista </span><span class="pubYear">1998</span>;<span class="volume">6</span>:95‐100. <a class="crsref citation-link central-link" data-crsref="4363141" href="" ref="info:x-wiley/crsRef/4363141" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Considerations+on+combined+use+of+insulin+and+oral+antidiabetic+agents+in+the+treatment+of+type+2+diabetes+mellitus+&author=D+Greco&author=V+Taravella&author=D+Sinagra&author=A+Galluzzo&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0063"> <div class="reference-title-banner"> <h4 class="title">Groop 1984 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0065"> <div class="citation-journal">Groop L, Harno K, Tolppanen E. <span class="citation-title">The combination of insulin and sulphonylurea in the treatment of secondary drug failure in patients with type II diabetes</span>. <span class="citation"> Acta Endocrinologica </span><span class="pubYear">1984</span>;<span class="volume">106</span>:97‐101. <a class="crsref citation-link central-link" data-crsref="4363143" href="" ref="info:x-wiley/crsRef/4363143" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/6428120" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+combination+of+insulin+and+sulphonylurea+in+the+treatment+of+secondary+drug+failure+in+patients+with+type+II+diabetes+&author=L+Groop&author=K+Harno&author=E+Tolppanen&publication_year=1984&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1984SP51900016&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 44</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0064"> <div class="reference-title-banner"> <h4 class="title">Groop 1991 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0066"> <div class="citation-journal">Groop L, Widén E. <span class="citation-title">Treatment strategies for secondary sulfonylurea failure. Should we start insulin or add metformin? Is there place for intermittent insulin therapy?</span>. <span class="citation"> Diabete &amp; Metabolisme </span><span class="pubYear">1991</span>;<span class="volume">17</span>:218‐23. <a class="crsref citation-link central-link" data-crsref="4363145" href="" ref="info:x-wiley/crsRef/4363145" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/1936480" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Treatment+strategies+for+secondary+sulfonylurea+failure.+Should+we+start+insulin+or+add+metformin?+Is+there+place+for+intermittent+insulin+therapy?+&author=L+Groop&author=E+Wid%C3%A9n&publication_year=1991&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1991FP43700023&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 28</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0065"> <div class="reference-title-banner"> <h4 class="title">Gutniak 1987 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0067"> <div class="citation-journal">Gutniak M, Karlander S, Efendic S. <span class="citation-title">Glyburide decreases insulin requirement, increases beta‐cell response to mixed meal, and does not affect insulin sensitivity: effects of short‐ and long‐term combined treatment in secondary failure to sulfonylurea</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1987</span>;<span class="volume">10</span>(5):545‐54. <a class="crsref citation-link central-link" data-crsref="4363147" href="" ref="info:x-wiley/crsRef/4363147" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.10.5.545" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/2890501" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Glyburide+decreases+insulin+requirement,+increases+beta%E2%80%90cell+response+to+mixed+meal,+and+does+not+affect+insulin+sensitivity:+effects+of+short%E2%80%90+and+long%E2%80%90term+combined+treatment+in+secondary+failure+to+sulfonylurea+&author=M+Gutniak&author=S+Karlander&author=S+Efendic&publication_year=1987&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaL1c%2FlsVChsA%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1987K223900002&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 63</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0066"> <div class="reference-title-banner"> <h4 class="title">Hamelbeck 1982 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0068"> <div class="citation-journal">Hamelbeck H, Klein W, Zoltobrocki M, Schoffling K. <span class="citation-title">Glibenclamide‐insulin combination in the management of secondary failure of sulfonylurea medication</span> [Glibenclamid‐Insulin‐Kombinationsbehandlung beim Sekundarversagen der Sulfonylharnstoff‐Therapie]. <span class="citation"> Deutsche Medizinische Wochenschrift </span><span class="pubYear">1982</span>;<span class="volume">107</span>:1581‐3. <a class="crsref citation-link central-link" data-crsref="4363149" href="" ref="info:x-wiley/crsRef/4363149" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1055%2Fs-2008-1070169" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/6813094" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Glibenclamide%E2%80%90insulin+combination+in+the+management+of+secondary+failure+of+sulfonylurea+medication+&author=H+Hamelbeck&author=W+Klein&author=M+Zoltobrocki&author=K+Schoffling&publication_year=1982&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaL3s%2Fis12lsQ%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1982PL85000002&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 36</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0067"> <div class="reference-title-banner"> <h4 class="title">Hermanns 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0069"> <div class="citation-journal">Hermanns N, Burkert A, Haak T. <span class="citation-title">The addition of acarbose to insulin lispro reduces acute glycaemic responses in patients with type 2 diabetes</span>. <span class="citation"> Experimental and Clinical Endocrinology and Diabetes </span><span class="pubYear">2004</span>;<span class="volume">112</span>:310‐4. <a class="crsref citation-link central-link" data-crsref="4363151" href="" ref="info:x-wiley/crsRef/4363151" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1055%2Fs-2004-820908" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15216448" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+addition+of+acarbose+to+insulin+lispro+reduces+acute+glycaemic+responses+in+patients+with+type+2+diabetes+&author=N+Hermanns&author=A+Burkert&author=T+Haak&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2cXlsVOnsLw%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000222296300006&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 3</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0068"> <div class="reference-title-banner"> <h4 class="title">Hollander 2003 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0070"> <div class="citation-journal">Hollander P, Ratner R, Fineman M, Strobel S, Shen L, Maggs D, et al. <span class="citation-title">Addition of pramlintide to insulin therapy lowers hbA1c in conjunction with weight loss in patients with type 2 diabetes approaching glycaemic targets</span>. <span class="citation"> Diabetes, Obesity and Metabolism </span><span class="pubYear">2003</span>;<span class="volume">5</span>:408‐14. <a class="crsref citation-link central-link" data-crsref="4363153" href="" ref="info:x-wiley/crsRef/4363153" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1046%2Fj.1463-1326.2003.00295.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Addition+of+pramlintide+to+insulin+therapy+lowers+hbA1c+in+conjunction+with+weight+loss+in+patients+with+type+2+diabetes+approaching+glycaemic+targets+&author=P+Hollander&author=R+Ratner&author=M+Fineman&author=S+Strobel&author=L+Shen&author=D+Maggs&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2cXltVGn" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000186415900006&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 36</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0069"> <div class="reference-title-banner"> <h4 class="title">Hollander 2003a {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0071"> <div class="citation-journal">Hollander PA, Levy P, Fineman MS, Maggs DG, Shen LZ, Strobel SA, et al. <span class="citation-title">Pramlintide as an adjunct to insulin therapy improves long‐term glycemic and weight control in patients with type 2 diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2003</span>;<span class="volume">26</span>(3):784‐90. <a class="crsref citation-link central-link" data-crsref="4363155" href="" ref="info:x-wiley/crsRef/4363155" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.26.3.784" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12610038" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Pramlintide+as+an+adjunct+to+insulin+therapy+improves+long%E2%80%90term+glycemic+and+weight+control+in+patients+with+type+2+diabetes+&author=PA+Hollander&author=P+Levy&author=MS+Fineman&author=DG+Maggs&author=LZ+Shen&author=SA+Strobel&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD3sXisVClt7Y%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000185505100038&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 163</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0070"> <div class="reference-title-banner"> <h4 class="title">Hollander 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0072"> <div class="citation-journal">Hollander P, Maggs DG, Ruggles JA, Fineman M, Shen L, Kolterman OG, et al. <span class="citation-title">Effect of pramlintide on weight in overweight and obese insulin‐treated type 2 diabetes patients</span>. <span class="citation"> Obesity Research </span><span class="pubYear">2004</span>;<span class="volume">12</span>(4):661‐8. <a class="crsref citation-link central-link" data-crsref="4363157" href="" ref="info:x-wiley/crsRef/4363157" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1038%2Foby.2004.76" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15090634" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+pramlintide+on+weight+in+overweight+and+obese+insulin%E2%80%90treated+type+2+diabetes+patients+&author=P+Hollander&author=DG+Maggs&author=JA+Ruggles&author=M+Fineman&author=L+Shen&author=OG+Kolterman&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2cXktFyjsLk%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000220940600012&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 93</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0071"> <div class="reference-title-banner"> <h4 class="title">Hollander 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0073"> <div class="citation-journal">Hollander P, Dahong Y, Chou HS. <span class="citation-title">Low‐dose rosiglitazone in patients with insulin‐requiring type 2 diabetes</span>. <span class="citation"> Archives of Internal Medicine </span><span class="pubYear">2007</span>;<span class="volume">167</span>:1284‐90. <a class="crsref citation-link central-link" data-crsref="4363159" href="" ref="info:x-wiley/crsRef/4363159" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1001%2Farchinte.167.12.1284" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17592102" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Low%E2%80%90dose+rosiglitazone+in+patients+with+insulin%E2%80%90requiring+type+2+diabetes&author=P+Hollander&author=Y+Dahong&author=HS+Chou&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2sXot12ktLo%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000247474900010&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 13</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0072"> <div class="reference-title-banner"> <h4 class="title">Holman 1987 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0074"> <div class="citation-journal">Holman RR, Steemson J, Turner RC. <span class="citation-title">Sulfonylurea failure in type 2 diabetes: treatment with a basal insulin supplement</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">1987</span>;<span class="volume">4</span>:457‐62. <a class="crsref citation-link central-link" data-crsref="4363161" href="" ref="info:x-wiley/crsRef/4363161" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1111%2Fj.1464-5491.1987.tb00909.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/2959438" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Sulfonylurea+failure+in+type+2+diabetes:+treatment+with+a+basal+insulin+supplement&author=RR+Holman&author=J+Steemson&author=RC+Turner&publication_year=1987&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaL1c%2FivVCitQ%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1987K023100009&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 64</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0073"> <div class="reference-title-banner"> <h4 class="title">Home 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0075"> <div class="citation-journal">Home PD, Bailey CJ, Donaldson J, Chen H, Stewart MW. <span class="citation-title">A double‐blind randomized study comparing the effects of continuing or not continuing rosiglitazone + metformin therapy when starting insulin therapy in people with Type 2 diabetes</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">2007</span>;<span class="volume">24</span>:618‐25. <a class="crsref citation-link central-link" data-crsref="4363163" href="" ref="info:x-wiley/crsRef/4363163" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1111%2Fj.1464-5491.2007.02141.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17403121" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+double%E2%80%90blind+randomized+study+comparing+the+effects+of+continuing+or+not+continuing+rosiglitazone+++metformin+therapy+when+starting+insulin+therapy+in+people+with+Type+2+diabetes+&author=PD+Home&author=CJ+Bailey&author=J+Donaldson&author=H+Chen&author=MW+Stewart&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2sXot12rsr8%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000246707900008&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 13</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0074"> <div class="reference-title-banner"> <h4 class="title">Inoue1998 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0076"> <div class="citation-journal">Inoue M, Satou T, Shimizu T, Tumagari K, Ishihara H, Chino T, et al. <span class="citation-title">Efficacy of sulfonylureas plus α‐glucosidase inhibitor plus bedtime NPH insulin combination therapy in type II diabetes patients with secondary failure using sulfonylureas</span>. <span class="citation"> Journal of the Japan Diabetes Society </span><span class="pubYear">1998</span>;<span class="volume">41</span>(8):683‐90. <a class="crsref citation-link central-link" data-crsref="4363165" href="" ref="info:x-wiley/crsRef/4363165" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+of+sulfonylureas+plus+%CE%B1%E2%80%90glucosidase+inhibitor+plus+bedtime+NPH+insulin+combination+therapy+in+type+II+diabetes+patients+with+secondary+failure+using+sulfonylureas+&author=M+Inoue&author=T+Satou&author=T+Shimizu&author=K+Tumagari&author=H+Ishihara&author=T+Chino&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0075"> <div class="reference-title-banner"> <h4 class="title">Jacob 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0077"> <div class="citation-journal">Jacob AN, Salinas K, Adams‐Huet B, Raskin P. <span class="citation-title">Weight gain in type 2 diabetes mellitus</span>. <span class="citation"> Diabetes, Obesity and Metabolism </span><span class="pubYear">2007</span>;<span class="volume">9</span>:386‐93. <a class="crsref citation-link central-link" data-crsref="4363167" href="" ref="info:x-wiley/crsRef/4363167" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1111%2Fj.1463-1326.2006.00622.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Weight+gain+in+type+2+diabetes+mellitus&author=AN+Jacob&author=K+Salinas&author=B+Adams%E2%80%90Huet&author=P+Raskin&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DC%2BD2s7ptVakuw%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000245154400021&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 36</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0076"> <div class="reference-title-banner"> <h4 class="title">Jacober 2006 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0078"> <div class="citation-journal">Jacober SJ, Scism‐Bacon JL, Zagar AJ. <span class="citation-title">A comparison of intensive mixture therapy with basal insulin therapy in insulin‐naive patients with type 2 diabetes receiving oral antidiabetes agents</span>. <span class="citation"> Diabetes, Obesity and Metabolism </span><span class="pubYear">2006</span>;<span class="volume">8</span>:448‐55. <a class="crsref citation-link central-link" data-crsref="4363169" href="" ref="info:x-wiley/crsRef/4363169" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1111%2Fj.1463-1326.2006.00605.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+comparison+of+intensive+mixture+therapy+with+basal+insulin+therapy+in+insulin%E2%80%90naive+patients+with+type+2+diabetes+receiving+oral+antidiabetes+agents+&author=SJ+Jacober&author=JL+Scism%E2%80%90Bacon&author=AJ+Zagar&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD28XnsFWhsb8%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000237972900011&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 45</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0077"> <div class="reference-title-banner"> <h4 class="title">Janka 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0079"> <div class="citation-journal">Janka HU, Plewe G, Riddle MC, Kliebe‐Frisch C, Schweitzer MA, Yki‐Jarvinen H. <span class="citation-title">Comparison of basal insulin added to oral agents versus twice‐daily premixed insulin as initial insulin therapy or type 2 diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2005</span>;<span class="volume">28</span>:254‐9. <a class="crsref citation-link central-link" data-crsref="4363171" href="" ref="info:x-wiley/crsRef/4363171" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.28.2.254" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15677775" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparison+of+basal+insulin+added+to+oral+agents+versus+twice%E2%80%90daily+premixed+insulin+as+initial+insulin+therapy+or+type+2+diabetes+&author=HU+Janka&author=G+Plewe&author=MC+Riddle&author=C+Kliebe%E2%80%90Frisch&author=MA+Schweitzer&author=H+Yki%E2%80%90Jarvinen&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2MXhsFOmsrY%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000226612900003&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 243</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0078"> <div class="reference-title-banner"> <h4 class="title">Janka 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0080"> <div class="citation-journal">Janka HU, Plewe G, Busch K. <span class="citation-title">Combination of oral antidiabetic agents with basal insulin versus premixed insulin alone in randomized elderly patients with type 2 diabetes mellitus</span>. <span class="citation"> Journal of American Geriatrics Society </span><span class="pubYear">2007</span>;<span class="volume">55</span>:182‐8. <a class="crsref citation-link central-link" data-crsref="4363173" href="" ref="info:x-wiley/crsRef/4363173" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1111%2Fj.1532-5415.2007.01043.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Combination+of+oral+antidiabetic+agents+with+basal+insulin+versus+premixed+insulin+alone+in+randomized+elderly+patients+with+type+2+diabetes+mellitus+&author=HU+Janka&author=G+Plewe&author=K+Busch&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000243869900005&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 43</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0079"> <div class="reference-title-banner"> <h4 class="title">Juurinen 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0081"> <div class="citation-journal">Juurinen L, Kotronen A, Granér M, Yki‐Jarvinen H. <span class="citation-title">Rosiglitazone reduces liver fat and insulin requirements and improves hepatic insulin sensitivity and glycemic control in patients with type 2 diabetes requiring high insulin doses</span>. <span class="citation"> Journal of Clinical Endocrinology and Metabolism </span><span class="pubYear">2008</span>;<span class="volume">93</span>(1):118‐24. <a class="crsref citation-link central-link" data-crsref="4363175" href="" ref="info:x-wiley/crsRef/4363175" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1210%2Fjc.2007-1825" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17956948" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Rosiglitazone+reduces+liver+fat+and+insulin+requirements+and+improves+hepatic+insulin+sensitivity+and+glycemic+control+in+patients+with+type+2+diabetes+requiring+high+insulin+doses+&author=L+Juurinen&author=A+Kotronen&author=M+Gran%C3%A9r&author=H+Yki%E2%80%90Jarvinen&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD1cXnsVyjtw%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000252359400022&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 29</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0080"> <div class="reference-title-banner"> <h4 class="title">Juurinen 2009 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0082"> <div class="citation-journal">Juurinen L, Tiikkainen M, Saltevot J, Nikkila K, Lanki H, Leppavuori E. <span class="citation-title">Nateglinide combination therapy with basal insulin and metformin in patients with type 2 diabetes</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">2009</span>;<span class="volume">26</span>:409‐15. <a class="crsref citation-link central-link" data-crsref="4363177" href="" ref="info:x-wiley/crsRef/4363177" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1111%2Fj.1464-5491.2009.02691.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19388972" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Nateglinide+combination+therapy+with+basal+insulin+and+metformin+in+patients+with+type+2+diabetes+&author=L+Juurinen&author=M+Tiikkainen&author=J+Saltevot&author=K+Nikkila&author=H+Lanki&author=E+Leppavuori&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD1MXlslClsL8%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000264955500014&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 5</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0081"> <div class="reference-title-banner"> <h4 class="title">Kabadi 2003 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0083"> <div class="citation-journal">Kabadi MU, Kabadi UM. <span class="citation-title">Efficacy of sulfonylureas with insulin in type 2 diabetes mellitus</span>. <span class="citation"> The Annals of Pharmacotherapy </span><span class="pubYear">2003</span>;<span class="volume">37</span>:1572‐6. <a class="crsref citation-link central-link" data-crsref="4363179" href="" ref="info:x-wiley/crsRef/4363179" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1345%2Faph.1C492" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/14565810" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+of+sulfonylureas+with+insulin+in+type+2+diabetes+mellitus&author=MU+Kabadi&author=UM+Kabadi&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD3sXptF2qsbY%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000186130700003&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 10</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0082"> <div class="reference-title-banner"> <h4 class="title">Kanda 1996 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0084"> <div class="citation-journal">Kanda T, Imano E, Matsushima H, Wada M, Kubota M, Yamasaki Y, et al. <span class="citation-title">The usefulness of combination therapy with preprandial rapid‐acting insulin injections and α‐glucosidase inhibitor in non‐obese NIDDM patients with secondary failure on oral hypoglycemic agents</span>. <span class="citation"> Journal of Japanese Diabetes Association </span><span class="pubYear">1996</span>;<span class="volume">39</span>(3):183‐90. <a class="crsref citation-link central-link" data-crsref="4363181" href="" ref="info:x-wiley/crsRef/4363181" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+usefulness+of+combination+therapy+with+preprandial+rapid%E2%80%90acting+insulin+injections+and+%CE%B1%E2%80%90glucosidase+inhibitor+in+non%E2%80%90obese+NIDDM+patients+with+secondary+failure+on+oral+hypoglycemic+agents+&author=T+Kanda&author=E+Imano&author=H+Matsushima&author=M+Wada&author=M+Kubota&author=Y+Yamasaki&publication_year=1996&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0083"> <div class="reference-title-banner"> <h4 class="title">Kandalintseva 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0085"> <div class="citation-journal">Kandalintseva OA, Ametov AS. <span class="citation-title">Effects of combined treatment with rosiglitazone and NPH insulin on carbohydrate metabolism in patients with type 2 diabetes mellitus</span>. <span class="citation"> Terapevticeskij Arhiv </span><span class="pubYear">2008</span>;<span class="volume">80</span>(12):40‐4. <a class="crsref citation-link central-link" data-crsref="4363183" href="" ref="info:x-wiley/crsRef/4363183" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+combined+treatment+with+rosiglitazone+and+NPH+insulin+on+carbohydrate+metabolism+in+patients+with+type+2+diabetes+mellitus+&author=OA+Kandalintseva&author=AS+Ametov&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000263513800009&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 1</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0084"> <div class="reference-title-banner"> <h4 class="title">Karlander 1991 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0086"> <div class="citation-journal">Karlander SG, Gutniak MKM, Efendic S. <span class="citation-title">Effects of combination therapy with glyburide and insulin on serum lipid levels in NIDDM patients with secondary sulfonylurea failure</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1991</span>;<span class="volume">14</span>:963‐7. <a class="crsref citation-link central-link" data-crsref="4363185" href="" ref="info:x-wiley/crsRef/4363185" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.14.11.963" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/1797509" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+combination+therapy+with+glyburide+and+insulin+on+serum+lipid+levels+in+NIDDM+patients+with+secondary+sulfonylurea+failure+&author=SG+Karlander&author=MKM+Gutniak&author=S+Efendic&publication_year=1991&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaK387otlGmtA%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1991GM85200005&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 7</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0085"> <div class="reference-title-banner"> <h4 class="title">Kilo 2003 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0087"> <div class="citation-journal">Kilo C, Mezitis N, Jain R, Mersey J, McGill J, Raskin P. <span class="citation-title">Starting patients with type 2 diabetes on insulin therapy using once‐daily injections of biphasic insulin aspart 70/30, biphasic human insulin 70/30, or NPH insulin in combination with metformin</span>. <span class="citation"> Journal of Diabetes and Its Complications </span><span class="pubYear">2003</span>;<span class="volume">17</span>:307‐13. <a class="crsref citation-link central-link" data-crsref="4363187" href="" ref="info:x-wiley/crsRef/4363187" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1016%2FS1056-8727%2803%2900076-X" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/14583174" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Starting+patients+with+type+2+diabetes+on+insulin+therapy+using+once%E2%80%90daily+injections+of+biphasic+insulin+aspart+70/30,+biphasic+human+insulin+70/30,+or+NPH+insulin+in+combination+with+metformin+&author=C+Kilo&author=N+Mezitis&author=R+Jain&author=J+Mersey&author=J+McGill&author=P+Raskin&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000186350500002&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 77</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0086"> <div class="reference-title-banner"> <h4 class="title">Kokic 2003 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0088"> <div class="citation-journal">Kokic S, Bukovic D, Radman M, Capkun V, Gabric N, Lesko V, et al. <span class="citation-title">Lispro insulin and metformin versus other combination in the diabetes mellitus type 2 management after secondary oral antidiabetic drug failure</span>. <span class="citation"> Collegium Antropologicum </span><span class="pubYear">2003</span>;<span class="volume">27</span>:181‐7. <a class="crsref citation-link central-link" data-crsref="4363189" href="" ref="info:x-wiley/crsRef/4363189" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12974145" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Lispro+insulin+and+metformin+versus+other+combination+in+the+diabetes+mellitus+type+2+management+after+secondary+oral+antidiabetic+drug+failure+&author=S+Kokic&author=D+Bukovic&author=M+Radman&author=V+Capkun&author=N+Gabric&author=V+Lesko&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000184463900018&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 8</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0087"> <div class="reference-title-banner"> <h4 class="title">Kothny 2013 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0089"> <div class="citation-journal">Kothny W, Foley J, Kozlovski P, Shao Q, Gallwitz B, Lukashevich V. <span class="citation-title">Improved glycaemic control with vildagliptin added to insulin, with or without metformin, in patients with type 2 diabetes mellitus</span>. <span class="citation"> Diabetes, Obesity &amp; Metabolism </span><span class="pubYear">2013</span>;<span class="volume">15</span>(3):252‐7. [PUBMED: 23039321]<a class="crsref citation-link central-link" data-crsref="4363191" href="" ref="info:x-wiley/crsRef/4363191" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1111%2Fdom.12020" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/23039321" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Improved+glycaemic+control+with+vildagliptin+added+to+insulin,+with+or+without+metformin,+in+patients+with+type+2+diabetes+mellitus+&author=W+Kothny&author=J+Foley&author=P+Kozlovski&author=Q+Shao&author=B+Gallwitz&author=V+Lukashevich&publication_year=2013&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BC3sXhs1ejs74%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000314182500009&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 38</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0088"> <div class="reference-title-banner"> <h4 class="title">Kvapil 2006 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0090"> <div class="citation-journal">Kvapil M, Swatko A, Hilberg C, Shestakova M. <span class="citation-title">Biphasic insulin aspart 30 plus metformin: an effective combination in type 2 diabetes</span>. <span class="citation"> Diabetes, Obesity and Metabolism </span><span class="pubYear">2006</span>;<span class="volume">8</span>:39‐48. <a class="crsref citation-link central-link" data-crsref="4363193" href="" ref="info:x-wiley/crsRef/4363193" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1111%2Fj.1463-1326.2005.00492.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Biphasic+insulin+aspart+30+plus+metformin:+an+effective+combination+in+type+2+diabetes&author=M+Kvapil&author=A+Swatko&author=C+Hilberg&author=M+Shestakova&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD28XitFyjsrw%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000234976500006&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 1</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0089"> <div class="reference-title-banner"> <h4 class="title">LAPToP 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0091"> <div class="citation-other">LAPToP Studie. [Lantus in der BOT ist dem Standard‐Mischinsulin uberlegen]. Krankenpflege<span class="pubYear">2004</span>; Vol. 42:172. <a class="crsref citation-link central-link" data-crsref="4363195" href="" ref="info:x-wiley/crsRef/4363195" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0090"> <div class="reference-title-banner"> <h4 class="title">Lins 1988 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0092"> <div class="citation-journal">Lins P, Lundland S, Persson‐Trotzig E, Adamson U. <span class="citation-title">Glibenclamide improves the response to insulin treatment in non‐insulin‐dependent diabetics with second failure to sulfonylurea therapy</span>. <span class="citation"> Acta Medica Scandinavica </span><span class="pubYear">1988</span>;<span class="volume">223</span>:171‐9. <a class="crsref citation-link central-link" data-crsref="4363197" href="" ref="info:x-wiley/crsRef/4363197" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1111%2Fj.0954-6820.1988.tb15783.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/3126626" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Glibenclamide+improves+the+response+to+insulin+treatment+in+non%E2%80%90insulin%E2%80%90dependent+diabetics+with+second+failure+to+sulfonylurea+therapy+&author=P+Lins&author=S+Lundland&author=E+Persson%E2%80%90Trotzig&author=U+Adamson&publication_year=1988&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaL1c7mtVOrsg%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1988M126600012&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 22</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0091"> <div class="reference-title-banner"> <h4 class="title">Liu 2003 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0093"> <div class="citation-journal">Liu HX, Qin AP, He BX. <span class="citation-title">Clinical observation of efficacy of rosiglitazone combined with insulin in treatment of elderly type 2 diabetes mellitus</span>. <span class="citation"> Journal of Chinese Physician </span><span class="pubYear">2003</span>;<span class="volume">5</span>(11):1502‐4. <a class="crsref citation-link central-link" data-crsref="4363199" href="" ref="info:x-wiley/crsRef/4363199" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Clinical+observation+of+efficacy+of+rosiglitazone+combined+with+insulin+in+treatment+of+elderly+type+2+diabetes+mellitus+&author=HX+Liu&author=AP+Qin&author=BX+He&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0092"> <div class="reference-title-banner"> <h4 class="title">Lotz 1988 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0094"> <div class="citation-journal">Lotz N, Bachmann W, Ladik T, Mehnert H. <span class="citation-title">The combination of insulin and sulfonylureas in the treatment of type 2 diabetes with 'secondary failure of sulfonylurea therapy' ‐ long term results</span> [Die Kombinationstherapie Insulin/Sulfonylharnstoff in der Langzeittherapie des type‐II‐Diabetes nach 'Sekundarversagen']. <span class="citation"> Klinische Wochenschrift </span><span class="pubYear">1988</span>;<span class="volume">66</span>:1079‐84. <a class="crsref citation-link central-link" data-crsref="4363201" href="" ref="info:x-wiley/crsRef/4363201" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1007%2FBF01711922" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/3148787" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+combination+of+insulin+and+sulfonylureas+in+the+treatment+of+type+2+diabetes+with+'secondary+failure+of+sulfonylurea+therapy'+‐+long+term+results+&author=N+Lotz&author=W+Bachmann&author=T+Ladik&author=H+Mehnert&publication_year=1988&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaL1M7nvFKquw%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1988Q700800004&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 7</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0093"> <div class="reference-title-banner"> <h4 class="title">Lund 2009 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0095"> <div class="citation-journal">Lund SS, Tarnow L, Frandsen M, Nielsen BB, Hansen BV, Pedersen O, et al. <span class="citation-title">Combining insulin with metformin or an insulin secretagogue in non‐obese patients with type 2 diabetes: 12 month, randomised, double blinded trial</span>. <span class="citation"> BMJ </span><span class="pubYear">2009</span>;<span class="volume">339</span>(b4324):DOI:10.1136/bmj.b4324. <a class="crsref citation-link central-link" data-crsref="4363203" href="" ref="info:x-wiley/crsRef/4363203" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Combining+insulin+with+metformin+or+an+insulin+secretagogue+in+non%E2%80%90obese+patients+with+type+2+diabetes:+12+month,+randomised,+double+blinded+trial+&author=SS+Lund&author=L+Tarnow&author=M+Frandsen&author=BB+Nielsen&author=BV+Hansen&author=O+Pedersen&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0094"> <div class="reference-title-banner"> <h4 class="title">Lundershausen 1987 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0096"> <div class="citation-journal">Lundershausen R, Orban S, Pissarek D, Panzram G. <span class="citation-title">Long‐term effect of glibenclamide‐insulin combination therapy in the management of secondary drug failure ‐ results of a double‐blind one‐year follow‐up study</span> [Langzeiteffekt der glibenclamid‐insulin‐kombinationsbehandlung beim sekundarversagen der sulfonylharnstofftherapie ‐ ergebnisse einer einjahrigen doppelblindstudie]. <span class="citation"> Wiener Klinische Wochenschrift </span><span class="pubYear">1987</span>;<span class="volume">99</span>:603‐8. <a class="crsref citation-link central-link" data-crsref="4363205" href="" ref="info:x-wiley/crsRef/4363205" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/3118579" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Long%E2%80%90term+effect+of+glibenclamide%E2%80%90insulin+combination+therapy+in+the+management+of+secondary+drug+failure+%E2%80%90+results+of+a+double%E2%80%90blind+one%E2%80%90year+follow%E2%80%90up+study+&author=R+Lundershausen&author=S+Orban&author=D+Pissarek&author=G+Panzram&publication_year=1987&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1987K054200005&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 7</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0095"> <div class="reference-title-banner"> <h4 class="title">Makimattila 1999 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0097"> <div class="citation-journal">Makimatilla S, Nikkila K, Yki‐Jarvinen H. <span class="citation-title">Causes of weight gain during insulin therapy with and without metformin in patients with type II diabetes mellitus</span>. <span class="citation"> Diabetologia </span><span class="pubYear">1999</span>;<span class="volume">42</span>:406‐12. <a class="crsref citation-link central-link" data-crsref="4363207" href="" ref="info:x-wiley/crsRef/4363207" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1007%2Fs001250051172" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10230643" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Causes+of+weight+gain+during+insulin+therapy+with+and+without+metformin+in+patients+with+type+II+diabetes+mellitus+&author=S+Makimatilla&author=K+Nikkila&author=H+Yki%E2%80%90Jarvinen&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000079427100002&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 182</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0096"> <div class="reference-title-banner"> <h4 class="title">Mohan 1990 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0098"> <div class="citation-journal">Mohan V, Snehalatha C, Ramachandran A, Viswanathan M. <span class="citation-title">Combination therapy of glibenclamide and insulin in NIDDM patients with secondary failure to oral drugs</span>. <span class="citation"> Journal of the Association of Physicians of India </span><span class="pubYear">1990</span>;<span class="volume">38</span>:537‐40. <a class="crsref citation-link central-link" data-crsref="4363209" href="" ref="info:x-wiley/crsRef/4363209" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/2123183" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Combination+therapy+of+glibenclamide+and+insulin+in+NIDDM+patients+with+secondary+failure+to+oral+drugs+&author=V+Mohan&author=C+Snehalatha&author=A+Ramachandran&author=M+Viswanathan&publication_year=1990&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0097"> <div class="reference-title-banner"> <h4 class="title">Morrow 2011 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0099"> <div class="citation-journal">Morrow L, Hompesch M, Guthrie H, Chang D, Chatterjee DJ. <span class="citation-title">Co‐administration of liraglutide with insulin detetmir demonstrates additive pharmacodynamic effects with no pharmacokinetic interaction</span>. <span class="citation"> Diabetes, Obesity and Metabolism </span><span class="pubYear">2011</span>;<span class="volume">13</span>:75. <a class="crsref citation-link central-link" data-crsref="4363211" href="" ref="info:x-wiley/crsRef/4363211" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1111%2Fj.1463-1326.2010.01322.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Co%E2%80%90administration+of+liraglutide+with+insulin+detetmir+demonstrates+additive+pharmacodynamic+effects+with+no+pharmacokinetic+interaction+&author=L+Morrow&author=M+Hompesch&author=H+Guthrie&author=D+Chang&author=DJ+Chatterjee&publication_year=2011&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BC3MXlslamuw%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000284698200010&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 19</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0098"> <div class="reference-title-banner"> <h4 class="title">Olsson 2002 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0100"> <div class="citation-journal">Olsson PO, Lindstrom T. <span class="citation-title">Combination‐therapy with bedtime NPH insulin and sulphonylurea gives similar glycaemic control but lower weight gain than insulin twice daily in patients with type 2 diabetes</span>. <span class="citation"> Diabetes and Metabolism </span><span class="pubYear">2002</span>;<span class="volume">28</span>:272‐7. <a class="crsref citation-link central-link" data-crsref="4363213" href="" ref="info:x-wiley/crsRef/4363213" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12442064" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Combination%E2%80%90therapy+with+bedtime+NPH+insulin+and+sulphonylurea+gives+similar+glycaemic+control+but+lower+weight+gain+than+insulin+twice+daily+in+patients+with+type+2+diabetes+&author=PO+Olsson&author=T+Lindstrom&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000178432200003&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 9</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0099"> <div class="reference-title-banner"> <h4 class="title">Ose 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0101"> <div class="citation-journal">Ose H, Fukui M, Kitagawa Y, Hirata C, Ichio N, Kadono M, et al. <span class="citation-title">Efficacy of glimepiride in patients with poorly controlled insulin‐treated type 2 diabetes mellitus</span>. <span class="citation"> Endocrine Journal </span><span class="pubYear">2005</span>;<span class="volume">52</span>(5):563‐9. <a class="crsref citation-link central-link" data-crsref="4363215" href="" ref="info:x-wiley/crsRef/4363215" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1507%2Fendocrj.52.563" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16284434" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+of+glimepiride+in+patients+with+poorly+controlled+insulin%E2%80%90treated+type+2+diabetes+mellitus+&author=H+Ose&author=M+Fukui&author=Y+Kitagawa&author=C+Hirata&author=N+Ichio&author=M+Kadono&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD28Xjs1Cgtw%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000233525800010&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 5</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0100"> <div class="reference-title-banner"> <h4 class="title">Ozbek 2006 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0102"> <div class="citation-journal">Ozbek M, Erdogan M, Karadeniz M, Cetinkalp S, Ozgen AG, Saygili F, et al. <span class="citation-title">Preprandial repaglinide decreases exogenous insulin requirements and HbA1c levels in type 2 diabetic patients taking intensive insulin treatment</span>. <span class="citation"> Acta Diabetologica </span><span class="pubYear">2006</span>;<span class="volume">43</span>:148‐51. <a class="crsref citation-link central-link" data-crsref="4363217" href="" ref="info:x-wiley/crsRef/4363217" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1007%2Fs00592-006-0231-5" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17211567" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Preprandial+repaglinide+decreases+exogenous+insulin+requirements+and+HbA1c+levels+in+type+2+diabetic+patients+taking+intensive+insulin+treatment+&author=M+Ozbek&author=M+Erdogan&author=M+Karadeniz&author=S+Cetinkalp&author=AG+Ozgen&author=F+Saygili&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2sXjtFGnsw%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000243353400012&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 5</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0101"> <div class="reference-title-banner"> <h4 class="title">Pan 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0103"> <div class="citation-journal">Pan C, Sinnassamy P, Chung K, Kim K, on behalf of the LEAD Study Investigators Group. <span class="citation-title">Insulin glargine versus NPH insulin therapy ins Asian type 2 diabetes patients</span>. <span class="citation"> Diabetes Research and Clinical Practice </span><span class="pubYear">2007</span>;<span class="volume">76</span>:111‐8. <a class="crsref citation-link central-link" data-crsref="4363219" href="" ref="info:x-wiley/crsRef/4363219" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1016%2Fj.diabres.2006.08.012" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17011662" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Insulin+glargine+versus+NPH+insulin+therapy+ins+Asian+type+2+diabetes+patients&author=C+Pan&author=P+Sinnassamy&author=K+Chung&author=K+Kim&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2sXhvVCktrs%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000244991900016&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 39</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0102"> <div class="reference-title-banner"> <h4 class="title">Peacock 1984 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0104"> <div class="citation-journal">Peacock I, Tattersall RB. <span class="citation-title">The difficult choice of treatment for poorly controlled maturity onset diabetes: tablets or insulin?</span>. <span class="citation"> British Medical Journal </span><span class="pubYear">1984</span>;<span class="volume">288</span>:1956‐9. <a class="crsref citation-link central-link" data-crsref="4363221" href="" ref="info:x-wiley/crsRef/4363221" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1136%2Fbmj.288.6435.1956" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/6428619" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+difficult+choice+of+treatment+for+poorly+controlled+maturity+onset+diabetes:+tablets+or+insulin?+&author=I+Peacock&author=RB+Tattersall&publication_year=1984&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1984SX60300011&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 86</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0103"> <div class="reference-title-banner"> <h4 class="title">Peyrot 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0105"> <div class="citation-journal">Peyrot M, Rubin RR, Polonsky WH. <span class="citation-title">Diabetes distress and its association with clinical outcomes in patients with type 2 diabetes treated with pramlintide as an adjunct to insulin therapy</span>. <span class="citation"> Diabetes Technology &amp; Therapeutics </span><span class="pubYear">2008</span>;<span class="volume">10</span>(6):461‐6. <a class="crsref citation-link central-link" data-crsref="4363223" href="" ref="info:x-wiley/crsRef/4363223" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1089%2Fdia.2008.0031" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19049375" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Diabetes+distress+and+its+association+with+clinical+outcomes+in+patients+with+type+2+diabetes+treated+with+pramlintide+as+an+adjunct+to+insulin+therapy+&author=M+Peyrot&author=RR+Rubin&author=WH+Polonsky&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD1cXhsVGhurbO" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000261597300005&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 12</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0104"> <div class="reference-title-banner"> <h4 class="title">Ponssen 2000 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0106"> <div class="citation-journal">Ponssen HH, Elte JWF, Lehert P, Schouten JP, Bets D. <span class="citation-title">Combined metformin and insulin therapy for patients with type 2 diabetes mellitus</span>. <span class="citation"> Clinical Therapeutics </span><span class="pubYear">2000</span>;<span class="volume">22</span>(6):709‐18. <a class="crsref citation-link central-link" data-crsref="4363225" href="" ref="info:x-wiley/crsRef/4363225" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1016%2FS0149-2918%2800%2990005-5" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10929918" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Combined+metformin+and+insulin+therapy+for+patients+with+type+2+diabetes+mellitus&author=HH+Ponssen&author=JWF+Elte&author=P+Lehert&author=JP+Schouten&author=D+Bets&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD3cXlvVyitb4%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000088050700005&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 29</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0105"> <div class="reference-title-banner"> <h4 class="title">Pontiroli 1990 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0107"> <div class="citation-journal">Pontiroli AE, Dino G, Capra F, Pozza G. <span class="citation-title">Combined therapy with glibenclamide and ultralente insulin in lean patients with NIDDM with secondary failure of sulfonylureas. Follow up at two years</span>. <span class="citation"> Diabete &amp; Metabolisme </span><span class="pubYear">1990</span>;<span class="volume">16</span>:323‐7. <a class="crsref citation-link central-link" data-crsref="4363227" href="" ref="info:x-wiley/crsRef/4363227" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/2125014" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Combined+therapy+with+glibenclamide+and+ultralente+insulin+in+lean+patients+with+NIDDM+with+secondary+failure+of+sulfonylureas.+Follow+up+at+two+years+&author=AE+Pontiroli&author=G+Dino&author=F+Capra&author=G+Pozza&publication_year=1990&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1990ED80100010&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 7</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0106"> <div class="reference-title-banner"> <h4 class="title">Poulsen 2003 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0108"> <div class="citation-journal">Poulsen MK, Henriksen JE, Hother‐Nielsen O, Beck‐Nielsen H. <span class="citation-title">The combined effect of triple therapy with rosiglitazone, metformin, and insulin aspart in type 2 diabetic patients</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2003</span>;<span class="volume">26</span>(12):3273‐9. <a class="crsref citation-link central-link" data-crsref="4363229" href="" ref="info:x-wiley/crsRef/4363229" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.26.12.3273" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/14633813" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+combined+effect+of+triple+therapy+with+rosiglitazone,+metformin,+and+insulin+aspart+in+type+2+diabetic+patients+&author=MK+Poulsen&author=JE+Henriksen&author=O+Hother%E2%80%90Nielsen&author=H+Beck%E2%80%90Nielsen&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD3sXpvF2ksL4%3D" target="_blank"><span>CAS</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0107"> <div class="reference-title-banner"> <h4 class="title">Raskin 2001 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0109"> <div class="citation-journal">Raskin P, Rendell M, Riddle MC, Dole JF, Freed MI, Rosenstock J, for the Rosiglitazone Clinical Trials Study Group. <span class="citation-title">A randomized trial of rosiglitazone therapy inpatients with inadequately controlled insulin‐treated type 2 diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2001</span>;<span class="volume">24</span>:1226‐32. <a class="crsref citation-link central-link" data-crsref="4363231" href="" ref="info:x-wiley/crsRef/4363231" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.24.7.1226" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11423507" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+randomized+trial+of+rosiglitazone+therapy+inpatients+with+inadequately+controlled+insulin%E2%80%90treated+type+2+diabetes+&author=P+Raskin&author=M+Rendell&author=MC+Riddle&author=JF+Dole&author=MI+Freed&author=J+Rosenstock&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD3MXlsVOrtL8%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000169520000018&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 203</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0108"> <div class="reference-title-banner"> <h4 class="title">Ravnik 1989 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0110"> <div class="citation-journal">Ravnik‐Oblak M. <span class="citation-title">The rationality and effectiveness of insulin therapy in elderly patients with type II diabetes</span>. <span class="citation"> Diabetologia Croatica </span><span class="pubYear">1989</span>;<span class="volume">18</span>:163‐9. <a class="crsref citation-link central-link" data-crsref="4363233" href="" ref="info:x-wiley/crsRef/4363233" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+rationality+and+effectiveness+of+insulin+therapy+in+elderly+patients+with+type+II+diabetes+&author=M+Ravnik%E2%80%90Oblak&publication_year=1989&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0109"> <div class="reference-title-banner"> <h4 class="title">Ravnik 1995 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0111"> <div class="citation-journal">Ravnik‐Oblak M, Mrevlje F. <span class="citation-title">insulin versus a combination of insulin and sulfonylurea in the treatment of NIDDM patients with secondary oral failure</span>. <span class="citation"> Diabetes Research and Clinical Practice </span><span class="pubYear">1995</span>;<span class="volume">30</span>:27‐35. <a class="crsref citation-link central-link" data-crsref="4363235" href="" ref="info:x-wiley/crsRef/4363235" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1016%2F0168-8227%2895%2901137-4" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8745203" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=insulin+versus+a+combination+of+insulin+and+sulfonylurea+in+the+treatment+of+NIDDM+patients+with+secondary+oral+failure+&author=M+Ravnik%E2%80%90Oblak&author=F+Mrevlje&publication_year=1995&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DyaK28XhsVSis78%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1995TR45700004&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 12</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0110"> <div class="reference-title-banner"> <h4 class="title">Raz 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0112"> <div class="citation-journal">Raz I, Stranks S, Filipczak R, Joshi P, Lertoft B, Rastam J, et al. <span class="citation-title">Efficacy and safety of biphasic insulin aspart 30 combined with pioglitazone in type 2 diabetes poorly controlled on glibenclamide (glyburide) monotherapy or combination therapy: an 18‐week randomized, open‐label study</span>. <span class="citation"> Clinical Therapeutics </span><span class="pubYear">2005</span>;<span class="volume">27</span>(9):1432‐43. <a class="crsref citation-link central-link" data-crsref="4363237" href="" ref="info:x-wiley/crsRef/4363237" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1016%2Fj.clinthera.2005.09.001" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16291416" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+and+safety+of+biphasic+insulin+aspart+30+combined+with+pioglitazone+in+type+2+diabetes+poorly+controlled+on+glibenclamide+(glyburide)+monotherapy+or+combination+therapy:+an+18%E2%80%90week+randomized,+open%E2%80%90label+study+&author=I+Raz&author=S+Stranks&author=R+Filipczak&author=P+Joshi&author=B+Lertoft&author=J+Rastam&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2MXhtF2lurjI" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000232617400009&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 16</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0111"> <div class="reference-title-banner"> <h4 class="title">Riddle 1989 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0113"> <div class="citation-journal">Riddle MC, Hart JS, Bouma DJ, Phillipson BE, Youker G. <span class="citation-title">Efficacy of bedtime NPH insulin with daytime sulfonylurea for subpopulation of type II diabetic subjects</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1989</span>;<span class="volume">12</span>(9):623‐9. <a class="crsref citation-link central-link" data-crsref="4363239" href="" ref="info:x-wiley/crsRef/4363239" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.12.9.623" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/2507265" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+of+bedtime+NPH+insulin+with+daytime+sulfonylurea+for+subpopulation+of+type+II+diabetic+subjects+&author=MC+Riddle&author=JS+Hart&author=DJ+Bouma&author=BE+Phillipson&author=G+Youker&publication_year=1989&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaK3c%2FgsVyjug%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1989AT01000005&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 72</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0112"> <div class="reference-title-banner"> <h4 class="title">Riddle 1992 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0114"> <div class="citation-journal">Riddle M, Hart J, Bingham P, Garrison C, McDaniel P. <span class="citation-title">Combined therapy for obese type 2 diabetes: suppertime mixed insulin with daytime sulfonylurea</span>. <span class="citation"> American Journal of Medical Sciences </span><span class="pubYear">1992</span>;<span class="volume">303</span>(3):151‐6. <a class="crsref citation-link central-link" data-crsref="4363241" href="" ref="info:x-wiley/crsRef/4363241" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1097%2F00000441-199203000-00003" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Combined+therapy+for+obese+type+2+diabetes:+suppertime+mixed+insulin+with+daytime+sulfonylurea+&author=M+Riddle&author=J+Hart&author=P+Bingham&author=C+Garrison&author=P+McDaniel&publication_year=1992&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaK383otVyqtw%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1992HG92000003&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 33</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0113"> <div class="reference-title-banner"> <h4 class="title">Riddle 1998 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0115"> <div class="citation-journal">Riddle MC, Schneider J, The Glimepiride Combination Group. <span class="citation-title">Beginning insulin treatment of obese patients with evening 70/30 insulin plus glimepiride versus insulin alone</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1998</span>;<span class="volume">21</span>(7):1052‐7. <a class="crsref citation-link central-link" data-crsref="4363243" href="" ref="info:x-wiley/crsRef/4363243" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.21.7.1052" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9653594" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Beginning+insulin+treatment+of+obese+patients+with+evening+70/30+insulin+plus+glimepiride+versus+insulin+alone+&author=MC+Riddle&author=J+Schneider&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaK1czhslCktA%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000074416800005&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 88</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0114"> <div class="reference-title-banner"> <h4 class="title">Riddle 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0116"> <div class="citation-journal">Riddle M, Frias J, Zhang B, Maier H, Brown C, Lutz K, et al. <span class="citation-title">Pramlintide improved glycemic control and reduced weight in patients with type 2 diabetes using basal insulin</span>. <span class="citation"> Diabetes care </span><span class="pubYear">2007</span>;<span class="volume">30</span>(11):2794‐9. <a class="crsref citation-link central-link" data-crsref="4363245" href="" ref="info:x-wiley/crsRef/4363245" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdc07-0589" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17698615" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Pramlintide+improved+glycemic+control+and+reduced+weight+in+patients+with+type+2+diabetes+using+basal+insulin+&author=M+Riddle&author=J+Frias&author=B+Zhang&author=H+Maier&author=C+Brown&author=K+Lutz&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2sXhtlKhs7rE" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000250704300006&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 47</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0115"> <div class="reference-title-banner"> <h4 class="title">Rosak 1985 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0117"> <div class="citation-journal">Rosak C, Schwarz O, Althoff PH, Schoffling K, Schmidt FH. <span class="citation-title">Combination treatment of type II diabetics with insulin and glibenclamide following secondary failure</span> [Kombinierte behandlung von typ‐II‐diabetikern mit insulin und glibenclamid nach tablettensekundarversagen]. <span class="citation"> Deutsche Medizinische Wochenschrift </span><span class="pubYear">1985</span>;<span class="volume">110</span>:1975‐80. <a class="crsref citation-link central-link" data-crsref="4363247" href="" ref="info:x-wiley/crsRef/4363247" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1055%2Fs-2008-1069123" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/3935405" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Combination+treatment+of+type+II+diabetics+with+insulin+and+glibenclamide+following+secondary+failure+&author=C+Rosak&author=O+Schwarz&author=PH+Althoff&author=K+Schoffling&author=FH+Schmidt&publication_year=1985&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaL28%2FotFamtw%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1985AWN6200004&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 5</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0116"> <div class="reference-title-banner"> <h4 class="title">Sachse 1984 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0118"> <div class="citation-journal">Sachse G, Maser E, Federlin K. <span class="citation-title">Combination of insulin and glibenclamide in secondary failure of sulphonylurea treatment?</span> [Kombinationstherapie mit insulin und sulfonylharnstoffen bei sekundarversagen der sulfonylharnstofftherapie?]. <span class="citation"> Deutsche Medizinische Wochenschrift </span><span class="pubYear">1984</span>;<span class="volume">109</span>:419‐21. <a class="crsref citation-link central-link" data-crsref="4363249" href="" ref="info:x-wiley/crsRef/4363249" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1055%2Fs-2008-1069205" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/6421560" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Combination+of+insulin+and+glibenclamide+in+secondary+failure+of+sulphonylurea+treatment?&author=G+Sachse&author=E+Maser&author=K+Federlin&publication_year=1984&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaL2c7jtFKgtQ%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1984SH39100003&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 14</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0117"> <div class="reference-title-banner"> <h4 class="title">Sangiorgio 2000 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0119"> <div class="citation-journal">Sangiorgio L, Attardo T, Condorelli L, Lunetta M. <span class="citation-title">Effects of the treatment with acarbose in elderly overweight type 2 diabetic patients in poor glycemic control with oral hypoglycemic agents or insulin</span>. <span class="citation"> Archives Gerontology and Geriatrics </span><span class="pubYear">2000</span>;<span class="volume">31</span>:27‐34. <a class="crsref citation-link central-link" data-crsref="4363251" href="" ref="info:x-wiley/crsRef/4363251" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1016%2FS0167-4943%2800%2900064-9" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+the+treatment+with+acarbose+in+elderly+overweight+type+2+diabetic+patients+in+poor+glycemic+control+with+oral+hypoglycemic+agents+or+insulin+&author=L+Sangiorgio&author=T+Attardo&author=L+Condorelli&author=M+Lunetta&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD3cXmtlGktbs%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000089510100005&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 3</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0118"> <div class="reference-title-banner"> <h4 class="title">Schmidt 1986 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0120"> <div class="citation-journal">Schmidt FH, Klujko J, Kuhnle HF, Reiter J. <span class="citation-title">The mode of action of the combination glibenclamide/insulin in type‐II‐diabetics</span> [Untersuchungen zum wirkungsmechanismus de kombinierten gabe von glibenclamid und insulin bei type‐II‐diabetikern mit sekundarversagen auf die orale behandlung]. <span class="citation"> Wiener Klinische Wochenschrift </span><span class="pubYear">1986</span>;<span class="volume">64</span>:1021‐28. <a class="crsref citation-link central-link" data-crsref="4363253" href="" ref="info:x-wiley/crsRef/4363253" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1007%2FBF01757209" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+mode+of+action+of+the+combination+glibenclamide/insulin+in+type%E2%80%90II%E2%80%90diabetics&author=FH+Schmidt&author=J+Klujko&author=HF+Kuhnle&author=J+Reiter&publication_year=1986&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaL2s%2Fmt1arsw%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1986E433600004&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 1</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0119"> <div class="reference-title-banner"> <h4 class="title">Schnell 2006 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0121"> <div class="citation-journal">Schnell O, Mertes G, Standl E, on behalf of the Acarbose‐Insulin Combination Study Group. <span class="citation-title">Acarbose and metabolic control in patients with type 2 diabetes with newly initiated insulin therapy</span>. <span class="citation"> Diabetes, Obesity and Metabolism </span><span class="pubYear">2007</span>;<span class="volume">9</span>:853‐8. <a class="crsref citation-link central-link" data-crsref="4363255" href="" ref="info:x-wiley/crsRef/4363255" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1111%2Fj.1463-1326.2006.00666.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Acarbose+and+metabolic+control+in+patients+with+type+2+diabetes+with+newly+initiated+insulin+therapy+&author=O+Schnell&author=G+Mertes&author=E+Standl&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2sXhtlOlsLjM" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000250012300007&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 15</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0120"> <div class="reference-title-banner"> <h4 class="title">Schwartz 1998 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0122"> <div class="citation-journal">Schwartz S, Raskin P, Fonseca V, Graveline JF, Troglitazone and Exogenous Insulin Study Group. <span class="citation-title">Effect of troglitazone in insulin‐treated patients with type II diabetes mellitus</span>. <span class="citation"> New England Journal of Medicine </span><span class="pubYear">1998</span>;<span class="volume">338</span>:861‐6. <a class="crsref citation-link central-link" data-crsref="4363257" href="" ref="info:x-wiley/crsRef/4363257" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1056%2FNEJM199803263381302" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9516220" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+troglitazone+in+insulin%E2%80%90treated+patients+with+type+II+diabetes+mellitus&author=S+Schwartz&author=P+Raskin&author=V+Fonseca&author=JF+Graveline&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DyaK1cXisFGgtrY%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000072669800002&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 265</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0121"> <div class="reference-title-banner"> <h4 class="title">Sun 1995 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0123"> <div class="citation-journal">Sun Y, Xiong Y, Yang J, et al. <span class="citation-title">The effectiveness of combined insulin and sulfonylurea in treating non‐insulin dependent diabetic patients</span>. <span class="citation"> Zhonghua Nei Ke Za Zhi </span><span class="pubYear">1995</span>;<span class="volume">34</span>(4):246‐9. <a class="crsref citation-link central-link" data-crsref="4363259" href="" ref="info:x-wiley/crsRef/4363259" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/7587604" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+effectiveness+of+combined+insulin+and+sulfonylurea+in+treating+non%E2%80%90insulin+dependent+diabetic+patients+&author=Y+Sun&author=Y+Xiong&author=J+Yang&publication_year=1995&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0122"> <div class="reference-title-banner"> <h4 class="title">Tamemoto 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0124"> <div class="citation-journal">Tamemoto H, Ikoma A, Saitoh T, Ishikawa A, Kawakami M. <span class="citation-title">Comparison of once‐daily glargine plus sulfonylurea with twice‐daily 70/30 aspart premix in insulin‐naive Japanese patients with diabetes</span>. <span class="citation"> Diabetes Technology &amp; Therapeutics </span><span class="pubYear">2007</span>;<span class="volume">9</span>(3):246‐53. <a class="crsref citation-link central-link" data-crsref="4363261" href="" ref="info:x-wiley/crsRef/4363261" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1089%2Fdia.2006.0016" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17561795" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparison+of+once%E2%80%90daily+glargine+plus+sulfonylurea+with+twice%E2%80%90daily+70/30+aspart+premix+in+insulin%E2%80%90naive+Japanese+patients+with+diabetes+&author=H+Tamemoto&author=A+Ikoma&author=T+Saitoh&author=A+Ishikawa&author=M+Kawakami&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2sXmsFWqs7c%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000247337800006&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 9</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0123"> <div class="reference-title-banner"> <h4 class="title">Vilsboll 2010 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0125"> <div class="citation-journal">Vilsboll T, Rosenstock J, Yki‐Jarvinen H, Cefalu WT, Chen Y, Luo E, et al. <span class="citation-title">Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes</span>. <span class="citation"> Diabetes, Obesity and Metabolism </span><span class="pubYear">2010</span>;<span class="volume">12</span>:167‐77. <a class="crsref citation-link central-link" data-crsref="4363263" href="" ref="info:x-wiley/crsRef/4363263" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1111%2Fj.1463-1326.2009.01173.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+and+safety+of+sitagliptin+when+added+to+insulin+therapy+in+patients+with+type+2+diabetes+&author=T+Vilsboll&author=J+Rosenstock&author=H+Yki%E2%80%90Jarvinen&author=WT+Cefalu&author=Y+Chen&author=E+Luo&publication_year=2010&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000273179400010&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 140</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0124"> <div class="reference-title-banner"> <h4 class="title">Willey 1994 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0126"> <div class="citation-journal">Willey KA, Molyneaux LM, Yue DK. <span class="citation-title">Obese patients with type 2 diabetes poorly controlled by insulin and metformin: effects of adjunctive dexflenfluramine therapy on glycaemic control</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">1994</span>;<span class="volume">11</span>:701‐4. <a class="crsref citation-link central-link" data-crsref="4363265" href="" ref="info:x-wiley/crsRef/4363265" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1111%2Fj.1464-5491.1994.tb00336.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/7955998" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Obese+patients+with+type+2+diabetes+poorly+controlled+by+insulin+and+metformin:+effects+of+adjunctive+dexflenfluramine+therapy+on+glycaemic+control+&author=KA+Willey&author=LM+Molyneaux&author=DK+Yue&publication_year=1994&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaK2M%2FksVSmsg%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1994PB18400014&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 22</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0125"> <div class="reference-title-banner"> <h4 class="title">Wolffenbuttel 1991 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0127"> <div class="citation-journal">Wolffenbuttel BHR, Rondas‐Colbers GJWM, Menheere PPCA, Sels JPJE, Nieuwenhuijzen Kruseman AC. <span class="citation-title">The effects of insulin in combination with glibenclamide on glucose and lipid metabolism in patients with type II diabetes mellitus</span> [De effecten van insuline in combinatie met glibenclamide op glucose‐ en vetstofwisseling bij patiënten met diabetes mellitus type II]. <span class="citation"> Nederlands Tijdschrift Voor Geneeskunde </span><span class="pubYear">1991</span>;<span class="volume">135</span>(24):1080‐4. <a class="crsref citation-link central-link" data-crsref="4363267" href="" ref="info:x-wiley/crsRef/4363267" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/1906584" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+effects+of+insulin+in+combination+with+glibenclamide+on+glucose+and+lipid+metabolism+in+patients+with+type+II+diabetes+mellitus+&author=BHR+Wolffenbuttel&author=GJWM+Rondas%E2%80%90Colbers&author=PPCA+Menheere&author=JPJE+Sels&author=AC+NieuwenhuijzenKruseman&publication_year=1991&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0126"> <div class="reference-title-banner"> <h4 class="title">Wolffenbuttel 1999 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0128"> <div class="citation-journal">Wolffenbuttel BHR, Sels JPJE, Rondas‐Colbers JWM, Menheere PPCA. <span class="citation-title">Prognostic factors for successful insulin therapy in subjects with type 2 diabetes</span>. <span class="citation"> Netherlands Journal of Medicine </span><span class="pubYear">1999</span>;<span class="volume">54</span>:63‐9. <a class="crsref citation-link central-link" data-crsref="4363269" href="" ref="info:x-wiley/crsRef/4363269" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1016%2FS0300-2977%2898%2900145-4" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10079680" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Prognostic+factors+for+successful+insulin+therapy+in+subjects+with+type+2+diabetes&author=BHR+Wolffenbuttel&author=JPJE+Sels&author=JWM+Rondas%E2%80%90Colbers&author=PPCA+Menheere&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DyaK1MXpslWltg%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000078637400003&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 10</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0127"> <div class="reference-title-banner"> <h4 class="title">Wong 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0129"> <div class="citation-journal">Wong TY, Szeto C, Chow K, Leung C, Lam CW, Li PK. <span class="citation-title">Rosiglitazone reduces insulin requirement and C‐reactive protein levels in type 2 diabetic patients receiving peritoneal dialysis</span>. <span class="citation"> American Journal of Kidney Diseases </span><span class="pubYear">2005</span>;<span class="volume">46</span>(4):713‐9. <a class="crsref citation-link central-link" data-crsref="4363271" href="" ref="info:x-wiley/crsRef/4363271" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1053%2Fj.ajkd.2005.06.020" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16183427" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Rosiglitazone+reduces+insulin+requirement+and+C%E2%80%90reactive+protein+levels+in+type+2+diabetic+patients+receiving+peritoneal+dialysis+&author=TY+Wong&author=C+Szeto&author=K+Chow&author=C+Leung&author=CW+Lam&author=PK+Li&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2MXhtFGiurfL" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000233933300018&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 52</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0128"> <div class="reference-title-banner"> <h4 class="title">Wright 2002 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0130"> <div class="citation-journal">Wright A, Burden ACF, Paisey RB, Cull CA, Holman RR for the UK Prospective Diabetes Study group. <span class="citation-title">Sulfonylurea inadequacy. Efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57)</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2002</span>;<span class="volume">25</span>:330‐6. <a class="crsref citation-link central-link" data-crsref="4363273" href="" ref="info:x-wiley/crsRef/4363273" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.25.2.330" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11815505" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Sulfonylurea+inadequacy.+Efficacy+of+addition+of+insulin+over+6+years+in+patients+with+type+2+diabetes+in+the+U.K.+Prospective+Diabetes+Study+(UKPDS+57)+&author=A+Wright&author=ACF+Burden&author=RB+Paisey&author=CA+Cull&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD38Xhtlyks74%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000173522600013&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 318</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0129"> <div class="reference-title-banner"> <h4 class="title">Yamada 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0131"> <div class="citation-journal">Yamada S, Watanabe M, Funae O, Atsumi Y, Suzuki R, Yajima K, et al. <span class="citation-title">Effect of combination therapy of a rapid‐acting insulin secretagogue (glinide) with premixed insulin in type 2 diabetes mellitus</span>. <span class="citation"> Internal Medicine </span><span class="pubYear">2007</span>;<span class="volume">46.0415</span>:1893‐7. [DOI: <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2169" target="_blank"><span>10.2169</span></a>]<a class="crsref citation-link central-link" data-crsref="4363275" href="" ref="info:x-wiley/crsRef/4363275" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2169%2Finternalmedicine.46.0415" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+combination+therapy+of+a+rapid%E2%80%90acting+insulin+secretagogue+(glinide)+with+premixed+insulin+in+type+2+diabetes+mellitus+&author=S+Yamada&author=M+Watanabe&author=O+Funae&author=Y+Atsumi&author=R+Suzuki&author=K+Yajima&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000258846200002&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 4</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0130"> <div class="reference-title-banner"> <h4 class="title">Yki‐Jarvinen 1992 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0132"> <div class="citation-journal">Yki‐Jarvinen H, Kauppila M, Kujansuu E, Lahti J, Marjanen T, Niskanen L, et al. <span class="citation-title">Comparison of insulin regimens in patients with non‐insulin‐dependent diabetes mellitus</span>. <span class="citation"> New England Journal of Medicine </span><span class="pubYear">1992</span>;<span class="volume">327</span>:1426‐33. <a class="crsref citation-link central-link" data-crsref="4363277" href="" ref="info:x-wiley/crsRef/4363277" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1056%2FNEJM199211123272005" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/1406860" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparison+of+insulin+regimens+in+patients+with+non%E2%80%90insulin%E2%80%90dependent+diabetes+mellitus&author=H+Yki%E2%80%90Jarvinen&author=M+Kauppila&author=E+Kujansuu&author=J+Lahti&author=T+Marjanen&author=L+Niskanen&publication_year=1992&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaK3s%2FisVOruw%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1992JX47900005&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 240</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0131"> <div class="reference-title-banner"> <h4 class="title">Yki‐Jarvinen 1999 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0133"> <div class="citation-journal">Yki‐Jarvinen H, Ryysy L, Nikkila K, Tulokas T, Vanamo R, Heikkila M. <span class="citation-title">Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus</span>. <span class="citation"> Annals of Internal Medicine </span><span class="pubYear">1999</span>;<span class="volume">130</span>(5):389‐96. <a class="crsref citation-link central-link" data-crsref="4363279" href="" ref="info:x-wiley/crsRef/4363279" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.7326%2F0003-4819-130-5-199903020-00002" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10068412" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparison+of+bedtime+insulin+regimens+in+patients+with+type+2+diabetes+mellitus&author=H+Yki%E2%80%90Jarvinen&author=L+Ryysy&author=K+Nikkila&author=T+Tulokas&author=R+Vanamo&author=M+Heikkila&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DyaK1MXhsl2htrY%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000078898100001&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 246</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0132"> <div class="reference-title-banner"> <h4 class="title">Yki‐Jarvinen 2013 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0134"> <div class="citation-journal">Yki‐Jarvinen H, Duran‐Garcia S, Pinnetti S, Bhattacharya S, Thiemann S, Patel S, et al. <span class="citation-title">Efficacy and safety of linagliptin as add‐on therapy to basal insulin in patients with type 2 diabetes</span>. <span class="citation"> Canadian Journal of Diabetes </span><span class="pubYear">2012</span>;<span class="volume">1</span>:S39. <a class="crsref citation-link central-link" data-crsref="4363281" href="" ref="info:x-wiley/crsRef/4363281" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1016%2Fj.jcjd.2012.07.338" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+and+safety+of+linagliptin+as+add%E2%80%90on+therapy+to+basal+insulin+in+patients+with+type+2+diabetes+&author=H+Yki%E2%80%90Jarvinen&author=S+Duran%E2%80%90Garcia&author=S+Pinnetti&author=S+Bhattacharya&author=S+Thiemann&author=S+Patel&publication_year=2012&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD006992-bib-0135"> <div class="citation-journal">Yki‐Jarvinen H, Rosenstock J, Duran‐Garcia S, Pinnetti S, Bhattacharya S, Thiemann S, et al. <span class="citation-title">Effects of adding linagliptin to basal insulin regimen for inadequately controlled type 2 diabetes: a &gt;/=52‐week randomized, double‐blind study</span>. <span class="citation"> Diabetes care </span><span class="pubYear">2013</span>;<span class="volume">36</span>(12):3875‐81. [PUBMED: 24062327]<a class="crsref citation-link central-link" data-crsref="4363282" href="" ref="info:x-wiley/crsRef/4363282" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdc12-2718" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/24062327" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+adding+linagliptin+to+basal+insulin+regimen+for+inadequately+controlled+type+2+diabetes:+a+>/=52‐week+randomized,+double‐blind+study+&author=H+Yki‐Jarvinen&author=J+Rosenstock&author=S+Duran‐Garcia&author=S+Pinnetti&author=S+Bhattacharya&author=S+Thiemann&publication_year=2013&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BC3sXhvFaksL%2FI" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000327211500032&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 44</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0133"> <div class="reference-title-banner"> <h4 class="title">Yokoyama 2011 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0136"> <div class="citation-journal">Yokoyama H, Sone H, Yamada D, Honjo J, Haneda M. <span class="citation-title">Contribution of glimepiride to basal‐prandial insulin therapy in patients with type 2 diabetes</span>. <span class="citation"> Diabetes Research and Clinical Practice </span><span class="pubYear">2011</span>;<span class="volume">91</span>:148‐53. <a class="crsref citation-link central-link" data-crsref="4363284" href="" ref="info:x-wiley/crsRef/4363284" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1016%2Fj.diabres.2010.10.007" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/21067837" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Contribution+of+glimepiride+to+basal%E2%80%90prandial+insulin+therapy+in+patients+with+type+2+diabetes+&author=H+Yokoyama&author=H+Sone&author=D+Yamada&author=J+Honjo&author=M+Haneda&publication_year=2011&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BC3MXis1art7c%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000287804800018&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 1</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006992-bbs2-0134"> <div class="reference-title-banner"> <h4 class="title">Zargar 2002 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0137"> <div class="citation-journal">Zargar AH, Masoodi SR, Laway BA, Wani AI, Bashir MI. <span class="citation-title">Response to regimens of insulin therapy in type 2 diabetes mellitus subjects with secondary failure</span>. <span class="citation"> Journal of the Association of Physicians of India </span><span class="pubYear">2002</span>;<span class="volume">50</span>:641‐6. <a class="crsref citation-link central-link" data-crsref="4363286" href="" ref="info:x-wiley/crsRef/4363286" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12186116" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Response+to+regimens+of+insulin+therapy+in+type+2+diabetes+mellitus+subjects+with+secondary+failure+&author=AH+Zargar&author=SR+Masoodi&author=BA+Laway&author=AI+Wani&author=MI+Bashir&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> </section> <section> <div class="section-header" id="CD006992-bbs1-0003"> <h3 class="title">References to studies awaiting assessment</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a class="jump-to" href="#CD006992-bbs1-0001">included studies</a></li> <li><a class="jump-to" href="#CD006992-bbs1-0002">excluded studies</a></li> <li><a class="jump-to" href="#CD006992-bbs1-0004">ongoing studies</a></li> <li><a class="jump-to" href="#CD006992-bbs1-0005">additional references</a></li> <li><a class="jump-to" href="#CD006992-bbs1-0006">other published versions</a></li> </ul> </div> </div> <div class="bibliographies references_awaitingAssessmentStudies" id="CD006992-bbs2-0135"> <div class="reference-title-banner"> <h4 class="title">Fargren 2014 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0138"> <div class="citation-journal">Farngren J, Persson M, Schweizer A, Foley J, Ahren B. <span class="citation-title">Glucagon dynamics during hypoglycaemia and food‐re‐challenge following treatment with vildagliptin in insulin‐treated patients with type 2 diabetes</span>. <span class="citation"> Diabetes, Obesity &amp; Metabolism </span><span class="pubYear">2014</span>;<span class="volume">16</span>:812‐8. <a class="crsref citation-link central-link" data-crsref="4363288" href="" ref="info:x-wiley/crsRef/4363288" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1111%2Fdom.12284" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/24612221" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Glucagon+dynamics+during+hypoglycaemia+and+food%E2%80%90re%E2%80%90challenge+following+treatment+with+vildagliptin+in+insulin%E2%80%90treated+patients+with+type+2+diabetes+&author=J+Farngren&author=M+Persson&author=A+Schweizer&author=J+Foley&author=B+Ahren&publication_year=2014&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BC2cXhtlKjtL%2FE" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000340616400005&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 15</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_awaitingAssessmentStudies" id="CD006992-bbs2-0136"> <div class="reference-title-banner"> <h4 class="title">Kaku 2014 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0139"> <div class="citation-journal">Kaku K, Mori M, Kanoo T, Katou M, Seino Y. <span class="citation-title">Efficacy and safety of alogliptin added to insulin in Japanese patients with type 2 diabetes: a randomized, double‐blind, 12‐week, placebo‐controlled trial followed by an open‐label, long‐term extension phase</span>. <span class="citation"> Expert Opinion on Pharmacotherapy </span><span class="pubYear">2014</span>;<span class="volume">15</span>:2121‐30. <a class="crsref citation-link central-link" data-crsref="4363290" href="" ref="info:x-wiley/crsRef/4363290" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1517%2F14656566.2014.956722" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/25190226" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+and+safety+of+alogliptin+added+to+insulin+in+Japanese+patients+with+type+2+diabetes:+a+randomized,+double%E2%80%90blind,+12%E2%80%90week,+placebo%E2%80%90controlled+trial+followed+by+an+open%E2%80%90label,+long%E2%80%90term+extension+phase+&author=K+Kaku&author=M+Mori&author=T+Kanoo&author=M+Katou&author=Y+Seino&publication_year=2014&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BC2cXhsFylsrjN" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000342874400003&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 7</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_awaitingAssessmentStudies" id="CD006992-bbs2-0137"> <div class="reference-title-banner"> <h4 class="title">Mathieu 2015 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0140"> <div class="citation-journal">Mathieu C, Shankar R, Lorber D, Umpierrez G, Wu F, Xu L, et al. <span class="citation-title">A randomized clinical trial to evaluate the efficacy and safety of co‐administration of sitagliptin with intensively titrated insulin glargine</span>. <span class="citation"> Diabetes Therapy </span><span class="pubYear">2015</span>;<span class="volume">6</span>:127‐42. <a class="crsref citation-link central-link" data-crsref="4363292" href="" ref="info:x-wiley/crsRef/4363292" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1007%2Fs13300-015-0105-3" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/25820927" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+randomized+clinical+trial+to+evaluate+the+efficacy+and+safety+of+co%E2%80%90administration+of+sitagliptin+with+intensively+titrated+insulin+glargine+&author=C+Mathieu&author=R+Shankar&author=D+Lorber&author=G+Umpierrez&author=F+Wu&author=L+Xu&publication_year=2015&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BC2MXlslCgsbs%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000363869800003&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 3</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_awaitingAssessmentStudies" id="CD006992-bbs2-0138"> <div class="reference-title-banner"> <h4 class="title">McGill 2015 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0141"> <div class="citation-journal">McGill J, Yki‐Jarvinen H, Crowe S, Woerle HJ, Eynatten M. <span class="citation-title">Combination of the dipeptidyl peptidase‐4 inhibitor linagliptin with insulin‐based regimens in type 2 diabetes and chronic kidney disease</span>. <span class="citation"> Diabetes &amp; Vascular Disease Research </span><span class="pubYear">2015</span>;<span class="volume">12</span>:249‐57. <a class="crsref citation-link central-link" data-crsref="4363294" href="" ref="info:x-wiley/crsRef/4363294" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1177%2F1479164115579001" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/25941160" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Combination+of+the+dipeptidyl+peptidase%E2%80%904+inhibitor+linagliptin+with+insulin%E2%80%90based+regimens+in+type+2+diabetes+and+chronic+kidney+disease+&author=J+McGill&author=H+Yki%E2%80%90Jarvinen&author=S+Crowe&author=HJ+Woerle&author=M+Eynatten&publication_year=2015&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BC2MXitVeksb3K" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000359145700005&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 1</span></a></li> </ul> </div> </div> <div class="bibliography-section" id="CD006992-bib-0142"> <div class="citation-journal">McGill JB, Yki‐Jarvinen H, Duran‐Garcia S, Thiemann S, Hehnke U, Pinnetti S, et al. <span class="citation-title">Efficacy and safety of linagliptin as add‐on to basal insulin in patients with type 2 diabetes and renal impairment</span>. <span class="citation"> Diabetes </span><span class="pubYear">2014</span>;<span class="volume">63</span>:A264. <a class="crsref citation-link central-link" data-crsref="4363295" href="" ref="info:x-wiley/crsRef/4363295" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+and+safety+of+linagliptin+as+add%E2%80%90on+to+basal+insulin+in+patients+with+type+2+diabetes+and+renal+impairment+&author=JB+McGill&author=H+Yki%E2%80%90Jarvinen&author=S+Duran%E2%80%90Garcia&author=S+Thiemann&author=U+Hehnke&author=S+Pinnetti&publication_year=2014&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000359481601353&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 1</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_awaitingAssessmentStudies" id="CD006992-bbs2-0139"> <div class="reference-title-banner"> <h4 class="title">Ning 2014 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0143"> <div class="citation-journal">Ning G, Li L, Ma J, Lv X, Yang M, Wang W, et al. <span class="citation-title">Vildagliptin as add‐on to insulin improves glycaemic control without increased risk of hypoglycaemia in Asian (predominantly Chinese) patients with type 2 diabetes mellitus</span>. <span class="citation"> Diabetologia </span><span class="pubYear">2014</span>;<span class="volume">57</span>:S330. <a class="crsref citation-link central-link" data-crsref="4363297" href="" ref="info:x-wiley/crsRef/4363297" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Vildagliptin+as+add%E2%80%90on+to+insulin+improves+glycaemic+control+without+increased+risk+of+hypoglycaemia+in+Asian+(predominantly+Chinese)+patients+with+type+2+diabetes+mellitus+&author=G+Ning&author=L+Li&author=J+Ma&author=X+Lv&author=M+Yang&author=W+Wang&publication_year=2014&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000344386102079&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 1</span></a></li> </ul> </div> </div> <div class="bibliography-section" id="CD006992-bib-0144"> <div class="citation-journal">Ning G, Wang W, Li L, Ma J, Lv X, Yang M, et al. <span class="citation-title">Vildagliptin as an add‐on therapy to insulin improves glycemic control without an increased risk of hypoglycemia: a dedicated Asian study, in a predominantly Chinese population</span>. <span class="citation"> Diabetes </span><span class="pubYear">2014</span>;<span class="volume">63</span>:A274. <a class="crsref citation-link central-link" data-crsref="4363298" href="" ref="info:x-wiley/crsRef/4363298" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Vildagliptin+as+an+add%E2%80%90on+therapy+to+insulin+improves+glycemic+control+without+an+increased+risk+of+hypoglycemia:+a+dedicated+Asian+study,+in+a+predominantly+Chinese+population+&author=G+Ning&author=W+Wang&author=L+Li&author=J+Ma&author=X+Lv&author=M+Yang&publication_year=2014&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000359481601385&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 1</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_awaitingAssessmentStudies" id="CD006992-bbs2-0140"> <div class="reference-title-banner"> <h4 class="title">Rosenstock 2009 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0145"> <div class="citation-journal">Rosenstock J, Rendell MS, Gross JL, Fleck PR, Wilson CA, Mekki Q. <span class="citation-title">Alogliptin added to insulin therapy in patients with type 2 diabetes reduces HbA1c without causing weight gain or increased hypoglycaemia</span>. <span class="citation"> Diabetes, Obesity and Metabolism </span><span class="pubYear">2009</span>;<span class="volume">11</span>:1145‐52. <a class="crsref citation-link central-link" data-crsref="4363300" href="" ref="info:x-wiley/crsRef/4363300" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1111%2Fj.1463-1326.2009.01124.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Alogliptin+added+to+insulin+therapy+in+patients+with+type+2+diabetes+reduces+HbA1c+without+causing+weight+gain+or+increased+hypoglycaemia+&author=J+Rosenstock&author=MS+Rendell&author=JL+Gross&author=PR+Fleck&author=CA+Wilson&author=Q+Mekki&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD1MXhs1Whsr7K" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000271630500007&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 84</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_awaitingAssessmentStudies" id="CD006992-bbs2-0141"> <div class="reference-title-banner"> <h4 class="title">Sato 2015 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0146"> <div class="citation-journal">Sato S, Saisho Y, Kou K, Meguro S, Tanaka M, Irie J, et al. <span class="citation-title">Efficacy and safety of sitagliptin added to insulin in Japanese patients with type 2 diabetes: the EDIT randomized trial</span>. <span class="citation"> PLoS ONE </span><span class="pubYear">2015</span>;<span class="volume">10</span>:e0121988. <a class="crsref citation-link central-link" data-crsref="4363302" href="" ref="info:x-wiley/crsRef/4363302" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1371%2Fjournal.pone.0121988" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/25816296" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+and+safety+of+sitagliptin+added+to+insulin+in+Japanese+patients+with+type+2+diabetes:+the+EDIT+randomized+trial+&author=S+Sato&author=Y+Saisho&author=K+Kou&author=S+Meguro&author=M+Tanaka&author=J+Irie&publication_year=2015&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000352133600134&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 5</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_awaitingAssessmentStudies" id="CD006992-bbs2-0142"> <div class="reference-title-banner"> <h4 class="title">Sheu 2015 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0147"> <div class="citation-journal">Sheu WH, Park S, Gong Y, Pinnetti S, Bhattacharya S, Patel S, et al. <span class="citation-title">Linagliptin improves glycaemic control after 1 year as add‐on therapy to basal insulin in Asian patients with type 2 diabetes mellitus</span>. <span class="citation"> Current Medical Research and Opinion </span><span class="pubYear">2015</span>;<span class="volume">31</span>:503‐12. <a class="crsref citation-link central-link" data-crsref="4363304" href="" ref="info:x-wiley/crsRef/4363304" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1185%2F03007995.2015.1010638" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/25629790" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Linagliptin+improves+glycaemic+control+after+1+year+as+add%E2%80%90on+therapy+to+basal+insulin+in+Asian+patients+with+type+2+diabetes+mellitus+&author=WH+Sheu&author=S+Park&author=Y+Gong&author=S+Pinnetti&author=S+Bhattacharya&author=S+Patel&publication_year=2015&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BC2MXksFyqsrw%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000351230800014&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 1</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_awaitingAssessmentStudies" id="CD006992-bbs2-0143"> <div class="reference-title-banner"> <h4 class="title">Srivanichakorn 2015 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0148"> <div class="citation-journal">Srivanichakorn W, Sriwijitkamol A, Kongchoo A, Sriussadaporn S, Plengvidhya N, Lertwattanarak R, et al. <span class="citation-title">Withdrawal of sulfonylureas from patients with type 2 diabetes receiving long‐term sulfonylurea and insulin combination therapy results in deterioration of glycemic control: a randomized controlled trial</span>. <span class="citation"> Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy </span><span class="pubYear">2015</span>;<span class="volume">8</span>:137‐45. <a class="crsref citation-link central-link" data-crsref="4363306" href="" ref="info:x-wiley/crsRef/4363306" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2147%2FDMSO.S78008" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/25767401" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Withdrawal+of+sulfonylureas+from+patients+with+type+2+diabetes+receiving+long%E2%80%90term+sulfonylurea+and+insulin+combination+therapy+results+in+deterioration+of+glycemic+control:+a+randomized+controlled+trial+&author=W+Srivanichakorn&author=A+Sriwijitkamol&author=A+Kongchoo&author=S+Sriussadaporn&author=N+Plengvidhya&author=R+Lertwattanarak&publication_year=2015&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_awaitingAssessmentStudies" id="CD006992-bbs2-0144"> <div class="reference-title-banner"> <h4 class="title">Takahashi 2015 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0149"> <div class="citation-journal">Takahashi H, Sakai K, Kawanishi K, Suzuki J, Igawa K, Sankoda K, et al. <span class="citation-title">Efficacy of switching from premix analog insulin twice daily injection to insulin glargine once daily injection with sitagliptin</span>. <span class="citation"> Diabetology International </span><span class="pubYear">2015</span>;<span class="volume">6</span>:33‐8. <a class="crsref citation-link central-link" data-crsref="4363308" href="" ref="info:x-wiley/crsRef/4363308" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1007%2Fs13340-014-0168-9" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+of+switching+from+premix+analog+insulin+twice+daily+injection+to+insulin+glargine+once+daily+injection+with+sitagliptin+&author=H+Takahashi&author=K+Sakai&author=K+Kawanishi&author=J+Suzuki&author=K+Igawa&author=K+Sankoda&publication_year=2015&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000366628300005&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 1</span></a></li> </ul> </div> </div> </div> </section> <section> <div class="section-header" id="CD006992-bbs1-0004"> <h3 class="title">References to ongoing studies</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a class="jump-to" href="#CD006992-bbs1-0001">included studies</a></li> <li><a class="jump-to" href="#CD006992-bbs1-0002">excluded studies</a></li> <li><a class="jump-to" href="#CD006992-bbs1-0003">studies awaiting assessment</a></li> <li><a class="jump-to" href="#CD006992-bbs1-0005">additional references</a></li> <li><a class="jump-to" href="#CD006992-bbs1-0006">other published versions</a></li> </ul> </div> </div> <div class="bibliographies references_ongoingStudies" id="CD006992-bbs2-0145"> <div class="reference-title-banner"> <h4 class="title">EUCTR2011‐004622‐96‐ES {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0150"> <div class="citation-other">EUCTR2011‐004622‐96‐ES. <span class="citation-title">Study to test the safety, tolerability, and effectiveness of sitagliptin when compared to placebo in reducing the amount of insulin (with or without metformin) needed per day, to control blood sugar, over a 24‐week period</span>. http://apps.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2011‐004622‐96‐ES (accessed 28 April 2016). <a class="crsref citation-link central-link" data-crsref="4363310" href="" ref="info:x-wiley/crsRef/4363310" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_ongoingStudies" id="CD006992-bbs2-0146"> <div class="reference-title-banner"> <h4 class="title">IRCT201204229536N1 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0151"> <div class="citation-other">IRCT201204229536N1. <span class="citation-title">The comparison glycemic control in two group patient treated with insulin alone and insulin plus sulfunyl urea</span>. http://apps.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201204229536N1 (accessed 28 April 2016). <a class="crsref citation-link central-link" data-crsref="4363312" href="" ref="info:x-wiley/crsRef/4363312" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_ongoingStudies" id="CD006992-bbs2-0147"> <div class="reference-title-banner"> <h4 class="title">JPRN‐UMIN000011851 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0152"> <div class="citation-other">JPRN‐UMIN000011851. <span class="citation-title">The efficacy of vildagliptin on type 2 diabetic patients with basal‐bolus insulin therapy in the short‐term hospitalization (single‐center, randomized, open‐label, controlled study)</span>. http://apps.who.int/trialsearch/Trial2.aspx?TrialID=JPRN‐UMIN000011851 (accessed 28 April 2016). <a class="crsref citation-link central-link" data-crsref="4363314" href="" ref="info:x-wiley/crsRef/4363314" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_ongoingStudies" id="CD006992-bbs2-0148"> <div class="reference-title-banner"> <h4 class="title">JPRN‐UMIN000018784 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0153"> <div class="citation-other">JPRN‐UMIN000018784. <span class="citation-title">Comparison of the effects of insulin monotherapy and combination therapy with ipragliflozin and insulin on glucose toxicity in type 2 diabetes mellitus : a randomized controlled trial</span>. http://apps.who.int/trialsearch/Trial2.aspx?TrialID=JPRN‐UMIN000018784 (accessed 28 April 2016). <a class="crsref citation-link central-link" data-crsref="4363316" href="" ref="info:x-wiley/crsRef/4363316" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_ongoingStudies" id="CD006992-bbs2-0149"> <div class="reference-title-banner"> <h4 class="title">NCT00329225 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0154"> <div class="citation-other">NCT00329225. <span class="citation-title">Rosiglitazone in subjects with type 2 diabetes mellitus who are inadequately controlled on insulin</span>. https://clinicaltrials.gov/ct2/show/NCT00329225 (accessed 28 April 2016). <a class="crsref citation-link central-link" data-crsref="4363318" href="" ref="info:x-wiley/crsRef/4363318" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_ongoingStudies" id="CD006992-bbs2-0150"> <div class="reference-title-banner"> <h4 class="title">NCT00757588 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0155"> <div class="citation-other">NCT00757588. <span class="citation-title">Safety and efficacy of saxagliptin plus insulin with or without metformin</span>. https://clinicaltrials.gov/ct2/show/NCT00757588 (accessed 28 April 2016). <a class="crsref citation-link central-link" data-crsref="4363320" href="" ref="info:x-wiley/crsRef/4363320" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_ongoingStudies" id="CD006992-bbs2-0151"> <div class="reference-title-banner"> <h4 class="title">NCT02104804 {published data only} </h4> </div> <div class="bibliography-section" id="CD006992-bib-0156"> <div class="citation-other">NCT02104804. <span class="citation-title">Evaluate the efficacy and safety of saxagliptin added to insulin monotherapy or to insulin combined with metformin in Chinese subjects with type 2 diabetes who have inadequate glycaemic control</span>. https://clinicaltrials.gov/ct2/show/NCT02104804 (accessed 28 April 2016). <a class="crsref citation-link central-link" data-crsref="4363322" href="" ref="info:x-wiley/crsRef/4363322" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> </div> </section> <section> <div class="section-header" id="CD006992-bbs1-0005"> <h3 class="title">Additional references</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a class="jump-to" href="#CD006992-bbs1-0001">included studies</a></li> <li><a class="jump-to" href="#CD006992-bbs1-0002">excluded studies</a></li> <li><a class="jump-to" href="#CD006992-bbs1-0003">studies awaiting assessment</a></li> <li><a class="jump-to" href="#CD006992-bbs1-0004">ongoing studies</a></li> <li><a class="jump-to" href="#CD006992-bbs1-0006">other published versions</a></li> </ul> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006992-bbs2-0152"> <div class="reference-title-banner"> <h4 class="title">ACCORD 2008</h4> </div> <div class="bibliography-section" id="CD006992-bib-0157"> <div class="citation-journal">The Action to Control Cardiovascular Risk in Diabetes Study Group. <span class="citation-title">Effects of intensive glucose lowering in type 2 diabetes</span>. <span class="citation"> New England Journal of Medicine </span><span class="pubYear">2008</span>;<span class="volume">358</span>(24):2545‐59. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1056%2FNEJMoa0802743" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18539917" target="_blank"> <span>PubMed</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD1cXnt1Wjs7s%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000256593600003&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 3006</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006992-bbs2-0153"> <div class="reference-title-banner"> <h4 class="title">ADA 1997</h4> </div> <div class="bibliography-section" id="CD006992-bib-0158"> <div class="citation-journal">American Diabetes Association. <span class="citation-title">Report on the Expert Committee on the diagnosis and classification of diabetes mellitus</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1997</span>;<span class="volume">20 Suppl 1</span>:S5‐20. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1997WA46700002&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 1</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006992-bbs2-0154"> <div class="reference-title-banner"> <h4 class="title">ADA 1999</h4> </div> <div class="bibliography-section" id="CD006992-bib-0159"> <div class="citation-journal">The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. <span class="citation-title">Report of the Expert Committee on the diagnosis and classification of diabetes mellitus</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1999</span>;<span class="volume">22 Suppl 1</span>:S5‐19. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006992-bbs2-0155"> <div class="reference-title-banner"> <h4 class="title">ADVANCE 2008</h4> </div> <div class="bibliography-section" id="CD006992-bib-0160"> <div class="citation-journal">The ADVANCE Collaborative Group. <span class="citation-title">Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes</span>. <span class="citation"> New England Journal of Medicine </span><span class="pubYear">2008</span>;<span class="volume">358</span>(24):2560‐72. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1056%2FNEJMoa0802987" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18539916" target="_blank"> <span>PubMed</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD1cXnt1yht7s%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000256593600004&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 2327</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006992-bbs2-0156"> <div class="reference-title-banner"> <h4 class="title">Armitage 2002</h4> </div> <div class="bibliography-section" id="CD006992-bib-0161"> <div class="citation-book">Armitage P, Berry G, Matthews JNS. <span class="citation-title">Paragraph 5.3</span>. <span class="citation">Statistical Methods in Medical Research</span>. 4th Edition. Blackwell Science, <span class="pubYear">2002</span>. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Paragraph+5.3&author=P+Armitage&author=G+Berry&author=JNS+Matthews&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006992-bbs2-0157"> <div class="reference-title-banner"> <h4 class="title">Brunton 2005</h4> </div> <div class="bibliography-section" id="CD006992-bib-0162"> <div class="citation-journal">Brunton S, Carmichael B, Funnell M, Lorber D, Rakel R, Rubin R. <span class="citation-title">Type 2 diabetes: the role of insulin</span>. <span class="citation"> The Journal of Family Practice </span><span class="pubYear">2005</span>;<span class="volume">54</span>(5):445‐52. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15865903" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Type+2+diabetes:+the+role+of+insulin&author=S+Brunton&author=B+Carmichael&author=M+Funnell&author=D+Lorber&author=R+Rakel&author=R+Rubin&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000229193400012&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 8</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006992-bbs2-0158"> <div class="reference-title-banner"> <h4 class="title">De Grauw 2001</h4> </div> <div class="bibliography-section" id="CD006992-bib-0163"> <div class="citation-journal">Grauw WJ, Lisdonk EH, Gerwen WH, Hoogen HJ, Weel C. <span class="citation-title">Insulin therapy in poorly controlled type 2 diabetic patients: does it affect quality of life?</span>. <span class="citation"> British Journal of General Practice </span><span class="pubYear">2001</span>;<span class="volume">51</span>(468):527‐32. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11462311" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Insulin+therapy+in+poorly+controlled+type+2+diabetic+patients:+does+it+affect+quality+of+life?+&author=WJ+Grauw&author=EH+Lisdonk&author=WH+Gerwen&author=HJ+Hoogen&author=C+Weel&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000169749200004&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 24</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006992-bbs2-0159"> <div class="reference-title-banner"> <h4 class="title">De Sonnaville 1998</h4> </div> <div class="bibliography-section" id="CD006992-bib-0164"> <div class="citation-journal">Sonnaville JJ, Snoek FJ, Colly LP, Deville W, Wijkel D, Heine RJ. <span class="citation-title">Well‐being and symptoms in relation to insulin therapy in type 2 diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1998</span>;<span class="volume">21</span>(6):919‐24. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.21.6.919" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9614608" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Well%E2%80%90being+and+symptoms+in+relation+to+insulin+therapy+in+type+2+diabetes&author=JJ+Sonnaville&author=FJ+Snoek&author=LP+Colly&author=W+Deville&author=D+Wijkel&author=RJ+Heine&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000073692200009&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 50</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006992-bbs2-0160"> <div class="reference-title-banner"> <h4 class="title">Deeks 2011</h4> </div> <div class="bibliography-section" id="CD006992-bib-0165"> <div class="citation-other">Deeks JJ, Higgins JPT, Altman DG (editors). <span class="citation-title">Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011</span>. Available from handbook.cochrane.org. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006992-bbs2-0161"> <div class="reference-title-banner"> <h4 class="title">Delahanty 2007</h4> </div> <div class="bibliography-section" id="CD006992-bib-0166"> <div class="citation-journal">Delahanty LM, Grant RW, Wittenberg E, Bosch JL, Wexler DJ, Cagliero E, et al. <span class="citation-title">Association of diabetes‐related emotional distress with diabetes treatment in primary care patients with type 2 diabetes</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">2007</span>;<span class="volume">24</span>(1):48–54. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1111%2Fj.1464-5491.2007.02028.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17227324" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Association+of+diabetes%E2%80%90related+emotional+distress+with+diabetes+treatment+in+primary+care+patients+with+type+2+diabetes+&author=LM+Delahanty&author=RW+Grant&author=E+Wittenberg&author=JL+Bosch&author=DJ+Wexler&author=E+Cagliero&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000243403200008&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 62</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006992-bbs2-0162"> <div class="reference-title-banner"> <h4 class="title">Duckworth 2009</h4> </div> <div class="bibliography-section" id="CD006992-bib-0167"> <div class="citation-journal">Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al. <span class="citation-title">Glucose control and vascular complications in veterans with type 2 diabetes</span>. <span class="citation"> New England Journal of Medicine </span><span class="pubYear">2009</span>;<span class="volume">360</span>(2):129‐39. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1056%2FNEJMoa0808431" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19092145" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Glucose+control+and+vascular+complications+in+veterans+with+type+2+diabetes&author=W+Duckworth&author=C+Abraira&author=T+Moritz&author=D+Reda&author=N+Emanuele&author=PD+Reaven&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD1MXnsFWkug%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000262258300006&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 1796</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006992-bbs2-0163"> <div class="reference-title-banner"> <h4 class="title">Gangji 2007</h4> </div> <div class="bibliography-section" id="CD006992-bib-0168"> <div class="citation-journal">Gangji AS, Cukierman T, Gerstein HC, Goldsmith CH, Clase CM. <span class="citation-title">A systematic review and meta‐analysis of hypoglycaemia and cardiovascular events</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2007</span>;<span class="volume">30</span>(2):389‐94. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdc06-1789" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17259518" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+systematic+review+and+meta%E2%80%90analysis+of+hypoglycaemia+and+cardiovascular+events&author=AS+Gangji&author=T+Cukierman&author=HC+Gerstein&author=CH+Goldsmith&author=CM+Clase&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000244024100037&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 121</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006992-bbs2-0164"> <div class="reference-title-banner"> <h4 class="title">Goddijn 1999</h4> </div> <div class="bibliography-section" id="CD006992-bib-0169"> <div class="citation-journal">Goddijn PP, Bilo HJ, Feskens EJ, Groeniert KH, Zee KI, Meyboom‐de Jong B. <span class="citation-title">Longitudinal study on glycaemic control and quality of life in patients with type 2 diabetes mellitus referred for intensified control</span>. <span class="citation"> Diabetes Medicine </span><span class="pubYear">1999</span>;<span class="volume">16</span>(1):23‐30. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1046%2Fj.1464-5491.1999.00002.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Longitudinal+study+on+glycaemic+control+and+quality+of+life+in+patients+with+type+2+diabetes+mellitus+referred+for+intensified+control+&author=PP+Goddijn&author=HJ+Bilo&author=EJ+Feskens&author=KH+Groeniert&author=KI+Zee&author=B+Meyboom%E2%80%90deJong&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaK1M3ksVaqtw%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000078058900004&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 63</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006992-bbs2-0165"> <div class="reference-title-banner"> <h4 class="title">Goudswaard 2004b</h4> </div> <div class="bibliography-section" id="CD006992-bib-0170"> <div class="citation-journal">Goudswaard AN, Furlong NJ, Rutten GE, Stolk RP, Valk GD. <span class="citation-title">Insulin monotherapy versus combinations of insulin with oral glucose lowering agents in patients with type 2 diabetes mellitus</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2004</span>, Issue 4. [DOI: <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1002/14651858.CD003418.pub2" target="_blank"><span>10.1002/14651858.CD003418.pub2</span></a>] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15495054" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Insulin+monotherapy+versus+combinations+of+insulin+with+oral+glucose+lowering+agents+in+patients+with+type+2+diabetes+mellitus+&author=AN+Goudswaard&author=NJ+Furlong&author=GE+Rutten&author=RP+Stolk&author=GD+Valk&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006992-bbs2-0166"> <div class="reference-title-banner"> <h4 class="title">Higgins 2002</h4> </div> <div class="bibliography-section" id="CD006992-bib-0171"> <div class="citation-journal">Higgins JPT, Thompson SG. <span class="citation-title">Quantifying heterogeneity in a meta‐analysis</span>. <span class="citation"> Statistics in Medicine </span><span class="pubYear">2002</span>;<span class="volume">21</span>:1539‐58. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1002%2Fsim.1186" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12111919" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Quantifying+heterogeneity+in+a+meta%E2%80%90analysis&author=JPT+Higgins&author=SG+Thompson&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000176016900005&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 7768</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006992-bbs2-0167"> <div class="reference-title-banner"> <h4 class="title">Higgins 2003</h4> </div> <div class="bibliography-section" id="CD006992-bib-0172"> <div class="citation-journal">Higgins JPT, Thompson SG, Deeks JJ, Altman DG. <span class="citation-title">Measuring inconsistency in meta‐analysis</span>. <span class="citation"> BMJ </span><span class="pubYear">2003</span>;<span class="volume">327</span>:557‐60. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1136%2Fbmj.327.7414.557" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12958120" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Measuring+inconsistency+in+meta%E2%80%90analysis&author=JPT+Higgins&author=SG+Thompson&author=JJ+Deeks&author=DG+Altman&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000185283700028&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 12871</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006992-bbs2-0168"> <div class="reference-title-banner"> <h4 class="title">Higgins 2009</h4> </div> <div class="bibliography-section" id="CD006992-bib-0173"> <div class="citation-journal">Higgins JPT, Thompson SG, Spiegelhalter DJ. <span class="citation-title">A re‐evaluation of random‐effects meta‐analysis</span>. <span class="citation"> Journal of the Royal Statistical Society. Series A, (Statistics in Society) </span><span class="pubYear">2009</span>;<span class="volume">172</span>(1):137‐59. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1111%2Fj.1467-985X.2008.00552.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19381330" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+re%E2%80%90evaluation+of+random%E2%80%90effects+meta%E2%80%90analysis&author=JPT+Higgins&author=SG+Thompson&author=DJ+Spiegelhalter&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000261962600009&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 381</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006992-bbs2-0169"> <div class="reference-title-banner"> <h4 class="title">Higgins 2011a</h4> </div> <div class="bibliography-section" id="CD006992-bib-0174"> <div class="citation-journal">Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. <span class="citation-title">The Cochrane Collaboration's tool for assessing risk of bias in randomised trials</span>. <span class="citation"> BMJ </span><span class="pubYear">2011</span>;<span class="volume">343</span>:d5928. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1136%2Fbmj.d5928" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/22008217" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+Cochrane+Collaboration's+tool+for+assessing+risk+of+bias+in+randomised+trials&author=JPT+Higgins&author=DG+Altman&author=PC+Gøtzsche&author=P+Jüni&author=D+Moher&author=AD+Oxman&publication_year=2011&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000299015600001&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 1674</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006992-bbs2-0170"> <div class="reference-title-banner"> <h4 class="title">Higgins 2011b</h4> </div> <div class="bibliography-section" id="CD006992-bib-0175"> <div class="citation-other">Higgins JPT, Altman DG, Sterne JAC (editors). <span class="citation-title">Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011</span>. Available from handbook.cochrane.org.. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006992-bbs2-0171"> <div class="reference-title-banner"> <h4 class="title">Higgins 2011c</h4> </div> <div class="bibliography-section" id="CD006992-bib-0176"> <div class="citation-other">Higgins JPT, Deeks JJ, Altman DG (editors). <span class="citation-title">Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors), <i>Cochrane Handbook for Systematic Reviews of Interventions</i> Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011</span>. Available from handbook.cochrane.org. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006992-bbs2-0172"> <div class="reference-title-banner"> <h4 class="title">Holman 2008</h4> </div> <div class="bibliography-section" id="CD006992-bib-0177"> <div class="citation-journal">Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. <span class="citation-title">10‐year follow‐up of intensive glucose control in type 2 diabetes</span>. <span class="citation"> New England Journal of Medicine </span><span class="pubYear">2008</span>;<span class="volume">359</span>(15):1577‐89. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1056%2FNEJMoa0806470" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18784090" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=10%E2%80%90year+follow%E2%80%90up+of+intensive+glucose+control+in+type+2+diabetes&author=RR+Holman&author=SK+Paul&author=MA+Bethel&author=DR+Matthews&author=HA+Neil&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD1cXht1Wgt7nK" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000259903100006&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 2430</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006992-bbs2-0173"> <div class="reference-title-banner"> <h4 class="title">Hróbjartsson 2013</h4> </div> <div class="bibliography-section" id="CD006992-bib-0178"> <div class="citation-journal">Hróbjartsson A, Thomsen AS, Emanuelsson F, Tendal B, Hilden J, Boutron I, et al. <span class="citation-title">Observer bias in randomized clinical trials with measurement scale outcomes: a systematic review of trials with both blinded and nonblinded assessors</span>. <span class="citation"> Canadian Medical Association Journal </span><span class="pubYear">2013</span>;<span class="volume">185</span>(4):E201‐11. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1503%2Fcmaj.120744" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/23359047" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Observer+bias+in+randomized+clinical+trials+with+measurement+scale+outcomes:+a+systematic+review+of+trials+with+both+blinded+and+nonblinded+assessors+&author=A+Hr%C3%B3bjartsson&author=AS+Thomsen&author=F+Emanuelsson&author=B+Tendal&author=J+Hilden&author=I+Boutron&publication_year=2013&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000321626900012&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 44</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006992-bbs2-0174"> <div class="reference-title-banner"> <h4 class="title">Hunt 1997</h4> </div> <div class="bibliography-section" id="CD006992-bib-0179"> <div class="citation-journal">Hunt LM, Valenzuela MA, Pugh JA. <span class="citation-title">NIDDM patients' fears and hopes about insulin therapy. The basis of patient reluctance</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1997</span>;<span class="volume">20</span>(3):292‐8. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.20.3.292" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9051375" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=NIDDM+patients'+fears+and+hopes+about+insulin+therapy.+The+basis+of+patient+reluctance&author=LM+Hunt&author=MA+Valenzuela&author=JA+Pugh&publication_year=1997&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaK2s3gtlyjsQ%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1997WJ36600013&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 192</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006992-bbs2-0175"> <div class="reference-title-banner"> <h4 class="title">Inzucchi 2012</h4> </div> <div class="bibliography-section" id="CD006992-bib-0180"> <div class="citation-journal">Inzucchi SE, Bergenstal RM, Buse JB. <span class="citation-title">Management of hyperglycemia in type 2 diabetes: a patient‐centered approach: position statement of the American Diabetes Association (ADA)and the European Association for the study of Diabetes (EASD)</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2012</span>;<span class="volume">35</span>:1364‐79. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdc12-0413" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/22517736" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Management+of+hyperglycemia+in+type+2+diabetes:+a+patient%E2%80%90centered+approach:+position+statement+of+the+American+Diabetes+Association+(ADA)and+the+European+Association+for+the+study+of+Diabetes+(EASD)+&author=SE+Inzucchi&author=RM+Bergenstal&author=JB+Buse&publication_year=2012&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BC38Xps1Kitb4%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000304631000028&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 1027</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006992-bbs2-0176"> <div class="reference-title-banner"> <h4 class="title">Johnson 1996</h4> </div> <div class="bibliography-section" id="CD006992-bib-0181"> <div class="citation-journal">Johnson JL, Wolf SL, Kabadi UM. <span class="citation-title">Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta‐analysis of the randomized placebo‐controlled trials</span>. <span class="citation"> Archives of Internal Medicine </span><span class="pubYear">1996</span>;<span class="volume">156</span>(3):259‐64. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1001%2Farchinte.1996.00440030049007" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8572835" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+of+insulin+and+sulfonylurea+combination+therapy+in+type+II+diabetes.+A+meta%E2%80%90analysis+of+the+randomized+placebo%E2%80%90controlled+trials+&author=JL+Johnson&author=SL+Wolf&author=UM+Kabadi&publication_year=1996&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DyaK28Xhs1ejtLw%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1996TU54500004&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 90</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006992-bbs2-0177"> <div class="reference-title-banner"> <h4 class="title">Karlsen 2014</h4> </div> <div class="bibliography-section" id="CD006992-bib-0182"> <div class="citation-journal">Karlsen B, Bru E. <span class="citation-title">The relationship between diabetes‐related distress and clinical variables and perceived support among adults with type 2 diabetes: a prospective study</span>. <span class="citation"> International Journal of Nursing Studies </span><span class="pubYear">2014</span>;<span class="volume">51</span>:438‐47. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1016%2Fj.ijnurstu.2013.06.016" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/23891535" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+relationship+between+diabetes%E2%80%90related+distress+and+clinical+variables+and+perceived+support+among+adults+with+type+2+diabetes:+a+prospective+study+&author=B+Karlsen&author=E+Bru&publication_year=2014&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000332819900012&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 5</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006992-bbs2-0178"> <div class="reference-title-banner"> <h4 class="title">Kooy 2009</h4> </div> <div class="bibliography-section" id="CD006992-bib-0183"> <div class="citation-journal">Kooy A, Jager J, Lehert P, Bets D, Wulffele MG, Donker AJM, et al. <span class="citation-title">Long‐term effects of metformin on metabolism and microvascular and macrovascular disease in patients With type 2 diabetes mellitus</span>. <span class="citation"> Archives of Internal Medicine </span><span class="pubYear">2009</span>;<span class="volume">169</span>(9):616‐25. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1001%2Farchinternmed.2009.20" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19307526" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Long%E2%80%90term+effects+of+metformin+on+metabolism+and+microvascular+and+macrovascular+disease+in+patients+With+type+2+diabetes+mellitus+&author=A+Kooy&author=J+Jager&author=P+Lehert&author=D+Bets&author=MG+Wulffele&author=AJM+Donker&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000264487600013&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 106</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006992-bbs2-0179"> <div class="reference-title-banner"> <h4 class="title">Korytkowski 2002</h4> </div> <div class="bibliography-section" id="CD006992-bib-0184"> <div class="citation-journal">Korytkowski M. <span class="citation-title">When oral agents fail: practical barriers to starting insulin</span>. <span class="citation"> International Journal of Obesity Related Metabolic Disorders </span><span class="pubYear">2002</span>;<span class="volume">26 Suppl 3</span>:S18‐24. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1038%2Fsj.ijo.0802173" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12174319" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=When+oral+agents+fail:+practical+barriers+to+starting+insulin&author=M+Korytkowski&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000177952600004&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 233</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006992-bbs2-0180"> <div class="reference-title-banner"> <h4 class="title">Lexchin 2003</h4> </div> <div class="bibliography-section" id="CD006992-bib-0185"> <div class="citation-journal">Lexchin J, Bero LA, Djulbegovic B, Clark O. <span class="citation-title">Pharmaceutical industry sponsorship and research outcome and quality: systematic review</span>. <span class="citation"> BMJ </span><span class="pubYear">2003</span>;<span class="volume">326</span>:1167‐70. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1136%2Fbmj.326.7400.1167" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12775614" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Pharmaceutical+industry+sponsorship+and+research+outcome+and+quality:+systematic+review&author=J+Lexchin&author=LA+Bero&author=B+Djulbegovic&author=O+Clark&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000183309900014&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 983</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006992-bbs2-0181"> <div class="reference-title-banner"> <h4 class="title">Liberati 2009</h4> </div> <div class="bibliography-section" id="CD006992-bib-0186"> <div class="citation-journal">Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. <span class="citation-title">The PRISMA statement for reporting systematic and meta‐analyses of studies that evaluate interventions: explanation and elaboration</span>. <span class="citation"> PLoS Medicine </span><span class="pubYear">2009</span>;<span class="volume">6</span>(7):1‐28. [DOI: <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1371/journal.pmed.1000100" target="_blank"><span>10.1371/journal.pmed.1000100</span></a>] <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1371%2Fjournal.pmed.1000100" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+PRISMA+statement+for+reporting+systematic+and+meta%E2%80%90analyses+of+studies+that+evaluate+interventions:+explanation+and+elaboration+&author=A+Liberati&author=DG+Altman&author=J+Tetzlaff&author=C+Mulrow&author=PC+G%C3%B8tzsche&author=JPA+Ioannidis&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000268452400006&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 1949</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006992-bbs2-0182"> <div class="reference-title-banner"> <h4 class="title">Muis 2005</h4> </div> <div class="bibliography-section" id="CD006992-bib-0187"> <div class="citation-journal">Muis MJ, Bots ML, Bilo HJ, Hoogma RP, Hoekstra JB, Grobbee DE. <span class="citation-title">High cumulative insulin exposure: a risk factor of atherosclerosis in type 1 diabetes?</span>. <span class="citation"> Atherosclerosis </span><span class="pubYear">2005</span>;<span class="volume">181</span>(1):185‐92. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1016%2Fj.atherosclerosis.2005.01.004" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15939071" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=High+cumulative+insulin+exposure:+a+risk+factor+of+atherosclerosis+in+type+1+diabetes?&author=MJ+Muis&author=ML+Bots&author=HJ+Bilo&author=RP+Hoogma&author=JB+Hoekstra&author=DE+Grobbee&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2MXltFWjsb4%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000230215300024&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 18</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006992-bbs2-0183"> <div class="reference-title-banner"> <h4 class="title">Peters 1991</h4> </div> <div class="bibliography-section" id="CD006992-bib-0188"> <div class="citation-journal">Peters AL, Davidson MB. <span class="citation-title">Insulin plus a sulfonylurea agent for treating type 2 diabetes</span>. <span class="citation"> Annals of Internal Medicine </span><span class="pubYear">1991</span>;<span class="volume">115</span>(1):45‐53. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.7326%2F0003-4819-115-1-45" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/1828656" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Insulin+plus+a+sulfonylurea+agent+for+treating+type+2+diabetes&author=AL+Peters&author=MB+Davidson&publication_year=1991&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaK3M3msVChtg%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1991FT93700009&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 57</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006992-bbs2-0184"> <div class="reference-title-banner"> <h4 class="title">Pugh 1992</h4> </div> <div class="bibliography-section" id="CD006992-bib-0189"> <div class="citation-journal">Pugh JA, Wagner ML, Sawyer J, Ramirez G, Tuley M, Friedberg SJ. <span class="citation-title">Is combination sulfonylurea and insulin therapy useful in NIDDM patients? A meta analysis</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1992</span>;<span class="volume">15</span>(8):953‐9. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.15.8.953" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/1387073" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Is+combination+sulfonylurea+and+insulin+therapy+useful+in+NIDDM+patients?+A+meta+analysis&author=JA+Pugh&author=ML+Wagner&author=J+Sawyer&author=G+Ramirez&author=M+Tuley&author=SJ+Friedberg&publication_year=1992&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaK38zntFWmtQ%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1992JF36900002&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 71</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006992-bbs2-0185"> <div class="reference-title-banner"> <h4 class="title">Riley 2011</h4> </div> <div class="bibliography-section" id="CD006992-bib-0190"> <div class="citation-journal">Riley RD, Higgins JP, Deeks JJ. <span class="citation-title">Interpretation of random effects meta‐analyses</span>. <span class="citation"> BMJ </span><span class="pubYear">2011</span>;<span class="volume">342</span>:d549. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1136%2Fbmj.d549" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/21310794" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Interpretation+of+random+effects+meta%E2%80%90analyses&author=RD+Riley&author=JP+Higgins&author=JJ+Deeks&publication_year=2011&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000209545700001&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 248</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006992-bbs2-0186"> <div class="reference-title-banner"> <h4 class="title">Ruige 1998</h4> </div> <div class="bibliography-section" id="CD006992-bib-0191"> <div class="citation-journal">Ruige JB, Assendelft WJ, Dekker JM, Kostense PJ, Heine RJ, Bouter LM. <span class="citation-title">Insulin and risk of cardiovascular disease: a meta‐analysis</span>. <span class="citation"> Circulation </span><span class="pubYear">1998</span>;<span class="volume">97</span>(10):996‐1001. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1161%2F01.CIR.97.10.996" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9529268" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Insulin+and+risk+of+cardiovascular+disease:+a+meta%E2%80%90analysis&author=JB+Ruige&author=WJ+Assendelft&author=JM+Dekker&author=PJ+Kostense&author=RJ+Heine&author=LM+Bouter&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaK1c7ovVWitQ%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000072493700009&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 274</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006992-bbs2-0187"> <div class="reference-title-banner"> <h4 class="title">Schünemann 2011</h4> </div> <div class="bibliography-section" id="CD006992-bib-0192"> <div class="citation-other">Schünemann HJ, Oxman AD, Higgins JPT, Vist GE, Glasziou P, Guyatt GH. <span class="citation-title">Chapter 11: Presenting results and ‘Summary of findings' tables. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011</span>. Available from handbook.cochrane.org. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006992-bbs2-0188"> <div class="reference-title-banner"> <h4 class="title">Snoek 2002</h4> </div> <div class="bibliography-section" id="CD006992-bib-0193"> <div class="citation-journal">Snoek FJ. <span class="citation-title">Breaking the barriers to optimal glycaemic control‐‐what physicians need to know from patients' perspectives</span>. <span class="citation"> International Journal of Clinical Practice </span><span class="pubYear">2002</span>;<span class="volume">129</span>(Supplement):80‐4. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Breaking+the+barriers+to+optimal+glycaemic+control%E2%80%90%E2%80%90what+physicians+need+to+know+from+patients'+perspectives+&author=FJ+Snoek&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000177272800014&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 8</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006992-bbs2-0189"> <div class="reference-title-banner"> <h4 class="title">Sterne 2011</h4> </div> <div class="bibliography-section" id="CD006992-bib-0194"> <div class="citation-journal">Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, et al. <span class="citation-title">Recommendations for examining and interpreting funnel plot asymmetry in meta‐analyses of randomised controlled trials</span>. <span class="citation"> BMJ </span><span class="pubYear">2011</span>;<span class="volume">343</span>:d4002. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1136%2Fbmj.d4002" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/21784880" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Recommendations+for+examining+and+interpreting+funnel+plot+asymmetry+in+meta%E2%80%90analyses+of+randomised+controlled+trials+&author=JA+Sterne&author=AJ+Sutton&author=JP+Ioannidis&author=N+Terrin&author=DR+Jones&author=J+Lau&publication_year=2011&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000293169000008&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 445</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006992-bbs2-0190"> <div class="reference-title-banner"> <h4 class="title">Stout 1990</h4> </div> <div class="bibliography-section" id="CD006992-bib-0195"> <div class="citation-journal">Stout RW. <span class="citation-title">Insulin and atheroma. 20‐yr perspective</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1990</span>;<span class="volume">13</span>(6):631‐54. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.13.6.631" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/2192848" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Insulin+and+atheroma.+20%E2%80%90yr+perspective&author=RW+Stout&publication_year=1990&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaK3c3ptFyksA%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1990DF42700008&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 543</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006992-bbs2-0191"> <div class="reference-title-banner"> <h4 class="title">Turner 1999</h4> </div> <div class="bibliography-section" id="CD006992-bib-0196"> <div class="citation-journal">Turner RC, Cull CA, Frighi V, Holman RR. <span class="citation-title">Glycaemic control with diet, sulfonylurea, metformin or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group</span>. <span class="citation"> Journal of American Medical Association </span><span class="pubYear">1999</span>;<span class="volume">281</span>(21):2005‐12. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1001%2Fjama.281.21.2005" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Glycaemic+control+with+diet,+sulfonylurea,+metformin+or+insulin+in+patients+with+type+2+diabetes+mellitus:+progressive+requirement+for+multiple+therapies+(UKPDS+49).+UK+Prospective+Diabetes+Study+(UKPDS)+Group+&author=RC+Turner&author=CA+Cull&author=V+Frighi&author=RR+Holman&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DyaK1MXjvFOls7g%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000080546700030&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 1301</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006992-bbs2-0192"> <div class="reference-title-banner"> <h4 class="title">UKPDS 33</h4> </div> <div class="bibliography-section" id="CD006992-bib-0197"> <div class="citation-journal">UK Prospective Diabetes Study. <span class="citation-title">Intensive blood‐glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)</span>. <span class="citation"> Lancet </span><span class="pubYear">1998</span>;<span class="volume">352</span>:837‐53. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1016%2FS0140-6736%2898%2907019-6" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9742976" target="_blank"> <span>PubMed</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DyaK1cXmtlOlsbs%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000075857300006&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 9112</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006992-bbs2-0193"> <div class="reference-title-banner"> <h4 class="title">UKPDS 34</h4> </div> <div class="bibliography-section" id="CD006992-bib-0198"> <div class="citation-journal">UK Prospective Diabetes Study (UKPDS). <span class="citation-title">Effect of intensive blood‐glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)</span>. <span class="citation"> Lancet </span><span class="pubYear">1998</span>;<span class="volume">352</span>(9131):854‐65. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1016%2FS0140-6736%2898%2907037-8" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9742977" target="_blank"> <span>PubMed</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DyaK1cXmtlOlsbg%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000075857300007&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 3557</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006992-bbs2-0194"> <div class="reference-title-banner"> <h4 class="title">WHO 1980</h4> </div> <div class="bibliography-section" id="CD006992-bib-0199"> <div class="citation-other">World Health Organization (WHO) Expert Committee on Diabetes Mellitus. <span class="citation-title">Second report. Technical Report Series 646</span>. World Health Organization, Geneva<span class="pubYear">1980</span>. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006992-bbs2-0195"> <div class="reference-title-banner"> <h4 class="title">WHO 1985</h4> </div> <div class="bibliography-section" id="CD006992-bib-0200"> <div class="citation-other">World Health Organization (WHO) Expert Committee on Diabetes Mellitus. <span class="citation-title">Technical Report Series 727</span>. World Health Organization, Geneva<span class="pubYear">1985</span>. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006992-bbs2-0196"> <div class="reference-title-banner"> <h4 class="title">WHO 1998</h4> </div> <div class="bibliography-section" id="CD006992-bib-0201"> <div class="citation-journal">Alberti KM, Zimmet PZ. <span class="citation-title">Definition, diagnosis and classification of diabetes mellitus and its complications. Part I: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">1998</span>;<span class="volume">15</span>:539‐53. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1002%2F%28SICI%291096-9136%28199807%2915%3A7%3C539%3A%3AAID-DIA668%3E3.0.CO%3B2-S" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9686693" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Definition,+diagnosis+and+classification+of+diabetes+mellitus+and+its+complications.+Part+I:+diagnosis+and+classification+of+diabetes+mellitus.+Provisional+report+of+a+WHO+consultation+&author=KM+Alberti&author=PZ+Zimmet&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaK1czkvFCrsA%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000074777700003&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 5835</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006992-bbs2-0197"> <div class="reference-title-banner"> <h4 class="title">Wood 2008</h4> </div> <div class="bibliography-section" id="CD006992-bib-0202"> <div class="citation-journal">Wood L, Egger M, Gluud LL, Schulz KF, Juni P, Altman D, G, et al. <span class="citation-title">Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta‐epidemiological study</span>. <span class="citation"> BMJ </span><span class="pubYear">2008</span>;<span class="volume">336</span>(7644):601‐5. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1136%2Fbmj.39465.451748.AD" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18316340" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Empirical+evidence+of+bias+in+treatment+effect+estimates+in+controlled+trials+with+different+interventions+and+outcomes:+meta%E2%80%90epidemiological+study+&author=L+Wood&author=M+Egger&author=LL+Gluud&author=KF+Schulz&author=P+Juni&author=D+Altman&author=+G&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000254364500034&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 863</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006992-bbs2-0198"> <div class="reference-title-banner"> <h4 class="title">Yki‐Jarvinen 2001</h4> </div> <div class="bibliography-section" id="CD006992-bib-0203"> <div class="citation-journal">Yki‐Jarvinen H. <span class="citation-title">Combination therapies with insulin in type 2 diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2001</span>;<span class="volume">24</span>(4):758‐67. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.24.4.758" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11315844" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Combination+therapies+with+insulin+in+type+2+diabetes&author=H+Yki%E2%80%90Jarvinen&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD3MXivVOmu74%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000167701600029&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 165</span></a></li> </ul> </div> </div> </div> </section> <section> <div class="section-header" id="CD006992-bbs1-0006"> <h3 class="title">References to other published versions of this review</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a class="jump-to" href="#CD006992-bbs1-0001">included studies</a></li> <li><a class="jump-to" href="#CD006992-bbs1-0002">excluded studies</a></li> <li><a class="jump-to" href="#CD006992-bbs1-0003">studies awaiting assessment</a></li> <li><a class="jump-to" href="#CD006992-bbs1-0004">ongoing studies</a></li> <li><a class="jump-to" href="#CD006992-bbs1-0005">additional references</a></li> </ul> </div> </div> <div class="bibliographies references_otherVersions" id="CD006992-bbs2-0199"> <div class="reference-title-banner"> <h4 class="title">Van Avendonk 2008</h4> </div> <div class="bibliography-section" id="CD006992-bib-0204"> <div class="citation-journal">Avendonk MJ, Gorter K, Goudswaard AN, Rutten GEHM, Donk M. <span class="citation-title">Combinations of insulin and oral hypoglycaemic agents for people with type 2 diabetes mellitus on insulin treatment</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2008</span>, Issue 1. [DOI: <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1002/14651858.CD006992" target="_blank"><span>10.1002/14651858.CD006992</span></a>] <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1002%2F14651858.CD006992" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Combinations+of+insulin+and+oral+hypoglycaemic+agents+for+people+with+type+2+diabetes+mellitus+on+insulin+treatment+&author=MJ+Avendonk&author=K+Gorter&author=AN+Goudswaard&author=GEHM+Rutten&author=M+Donk&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> </section> </section> <section class="characteristicStudies" id="characteristicStudies"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title"> Characteristics of studies <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="characteristicIncludedStudiesContent" lang=""> <div class="section-header" id="CD006992-sec2-0029"> <h3 class="title">Characteristics of included studies [ordered by study ID]</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a href="#CD006992-sec2-0030" class="jump-to">excluded studies</a></li> <li><a href="#CD006992-sec2-0031" class="jump-to">awaiting classification</a></li> <li><a href="#CD006992-sec2-0032" class="jump-to">ongoing studies</a></li> </ul> </div> </div> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Avilés 1999 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Parallel randomised controlled clinical trial</b> </p> <p><b>Randomisation ratio:</b> 1:1 </p> <p><b>Superiority design</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Inclusion criteria</b>: type 2 diabetes diagnosed after 30 years of age and treated for at least 2 years with at least 50 units of insulin per day, age at enrolment younger than 70 years and HbA1c level ≥ 8%. </p> <p><b>Exclusion criteria</b>: pregnant women; women trying to become pregnant; patients with a serum creatinine concentration greater than 132.6 mmol/L (1.5 mg/dL) or hepatic enzyme levels greater than twice the upper limit of normal; and patients with medical conditions that could promote lactic acidoses such as renal or hepatic disease, congestive heart failure or chronic obstructive pulmonary disease. </p> <p><b>Diagnostic criteria</b>: not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Number of study centres</b>: 1 </p> <p><b>Treatment before study</b>: insulin: intervention 96.2 ± 44.9 U/day, control 96.9 ± 43.3 U/day </p> <p><b>Titration period</b>: 8 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Outcomes reported in abstract of publication</b>: </p> <p><b>Primary outcome(s)</b> (as stated in the publication): glycaemic control (HbA1c, fasting plasma glucose), C‐peptide, body weight, lipids, insulin dose, adverse events (hypoglycaemia) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Run‐in period</b>: 8 weeks to titrate metformin in maximal dosage </p> <p><b>Study terminated early (for benefit/because of adverse events):</b> no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Language of publication</b>: English </p> <p><b>Funding source</b>: Bristol‐Myers‐Squibb </p> <p><b>Publication status</b>: peer‐reviewed journal </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim of study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Quote from publication: "To evaluate the efficacy of metformin in combination with insulin in patients with type 2 diabetes mellitus poorly controlled with insulin therapy alone". </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: not possible to judge whether the sequence generation was adequate </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: not possible to judge whether the allocation to the intervention and control group was concealed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "Patients who met the inclusion criteria were randomly assigned in a double‐blind fashion to receive metformin or placebo in addition to their current insulin therapy" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "Patients who met the inclusion criteria were randomly assigned in a double‐blind fashion to receive metformin or placebo in addition to their current insulin therapy" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "Patients who met the inclusion criteria were randomly assigned in a double‐blind fashion to receive metformin or placebo in addition to their current insulin therapy" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: it is unclear if the outcome assessor were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: it is unclear if the outcome assessor were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: it is unclear if the outcome assessor were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: in table 3 of the article the incidence of adverse events is listed for both groups </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data were collected, analysed and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: was reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data on blood pressure, medical history and the physical examination is not reported. However this is not likely to bias the results of the other outcomes </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: no incomplete outcome data (attrition bias) Diabetes‐related mortality </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Barnett 2013 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Parallel randomised controlled clinical trial</b> </p> <p><b>Randomisation ratio: 2:1</b> </p> <p><b>Equivalence design</b> </p> <p><b>Controlled clinical trial (CCT): a Phase IIIb, extension of RCT</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Inclusion criteria</b>: Men and women aged 18–78 years with T2DM, fasting<br> C‐peptide C 0.8 ng/mL, body mass index (BMI) B45 kg/m2, and inadequate glycaemic control (HbA1c 7.5%–11.0%) on a stable regimen of insulin (30–150 U/day, with B 20% variation in total daily dose for C 8 weeks before screening). </p> <p><b>Exclusion criteria</b>: poorly controlled diabetes (e.g. marked polyuria and polydipsia with 10% weight loss during the 3 months before screening); history of diabetic ketoacidosis or hyperosmolar nonketotic coma; history of significant cardiovascular disease or haemoglobinopathy; contraindications to DPP‐4 inhibitors, metformin,<br> or insulin; or pregnancy, breast feeding, or not using an acceptable method of birth control </p> <p><b>Diagnostic criteria</b>: not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Number of study centres</b>: unclear </p> <p><b>Treatment before study</b>: intermediate‐acting insulin, long‐acting (basal) insulin, or a premixed formulation in which rapid‐ or short‐acting insulin constituted one component was permitted. Participants could also be taking metformin if the daily dose was stable for C 8 weeks before screening. </p> <p><b>Titration period</b>: 4 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Primary outcome(s)</b> (as stated in the publication): mean change from baseline to 52 weeks in HbA1c </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Total study duration</b>: 56 weeks </p> <p><b>Run‐in period</b>: 4 weeks </p> <p><b>Study terminated early (for benefit/because of adverse events):</b> no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Language of publication</b>: English </p> <p><b>Funding source</b>: Bristol‐Myers‐Squibb and AstraZeneca </p> <p><b>Publication status</b>: peer‐reviewed journal </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim of study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>To evaluate the safety and efficacy of the DPP4 inhibitor saxagliptin vs placebo as add‐on therapy in type 2 diabetes inadequately controlled with insulin with or without metformin </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "Patients were stratified based on metformin use at enrolment and randomised 2:1 via an interactive voice response system using a blocked randomisation schedule to receive saxagliptin 5 mg (Onglyza, Bristol‐Myers Squibb Company, Princeton, NJ, USA, and AstraZeneca Pharmaceuticals LP, Wilmington, DE, USA) or placebo once daily as add‐on to baseline therapy with insulin or insulin plus metformin." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "To maintain blinding to patients and physicians, saxagliptin and placebo tablets were identical in appearance, and bottles were printed with a blinded label." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "To maintain blinding to patients and physicians, saxagliptin and placebo tablets were identical in appearance, and bottles were printed with a blinded label." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: FGP and lipids not assessed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "To maintain blinding to patients and physicians, saxagliptin and placebo tablets were identical in appearance, and bottles were printed with a blinded label." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: no exact SDs are reported as text only in the figures </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: no exact SDs are reported as text only in the figures </p> <p><b>Comment</b>: incomplete for FPG and lipids </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: available </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: no exact SDs are reported as text only in the figures </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: sponsoring by a pharmaceutical company </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Casner 1988 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Parallel randomised controlled clinical trial</b> </p> <p><b>Randomisation ratio: 1:1</b> </p> <p><b>Superiority design</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Inclusion criteria</b>: people with non‐insulin‐dependent diabetes previously treated with an oral hypoglycaemic agent, currently receiving at least 25 U insulin/day with a fasting blood glucose value of 140 mg/dL or greater. </p> <p><b>Exclusion criteria</b>: history of allergic reactions to sulphonylurea therapy or a serious debilitating disease that would limit ability to participate in the study </p> <p><b>Diagnostic criteria</b>: NDDG 1979 </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Number of study centres</b>: 1 </p> <p><b>Treatment before study</b>: insulin: intervention 65.9 U/day and control 66.9 U/day </p> <p><b>Titration period</b>: variable </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Primary outcome(s)</b> (as stated in the publication): glycaemic control (HbA1c, oral glucose tolerance test, fasting blood glucose), side effects, C‐peptide, insulin dose, weight </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Total study duration</b>: 1 year </p> <p><b>Run‐in period</b>: variable </p> <p><b>Study terminated early (for benefit/because of adverse events):</b> no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Language of publication</b>: English </p> <p><b>Funding source</b>: Upjohn Company and an intramural grant from Texas Tech Health Sciences Center </p> <p><b>Publication status</b>: peer‐reviewed journal </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim of study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Can the combination of a sulphonylurea and insulin improve glycaemic control? If this is true, can it be done with lower doses of exogenous insulin? Can the effect be maintained over a long period of time? </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: not possible to judge whether the sequence generation was adequate </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: not possible to judge whether the allocation to the intervention and control group was concealed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "Patients and physicians were blinded regarding laboratory results and study medication but not on insulin" </p> <p><b>Comment</b>: so patients were not blinded for their weight gain (this is the only adverse event mentioned) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "Patients and physicians were blinded regarding laboratory results and study medication but not on insulin" </p> <p><b>Comment</b>: </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "Patients and physicians were blinded regarding laboratory results and study medication but not on insulin" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: it is unclear if the outcome assessment was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: it is unclear if the outcome assessment was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: it is unclear if the outcome assessment was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data on weight gain was reported for both groups </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data were reported for both groups </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data were reported for both groups </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data which was collected was also reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: no other concerns </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Chiasson 1994 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Parallel randomised controlled clinical trial</b> </p> <p><b>Randomisation ratio: 1:1</b> </p> <p><b>Superiority design</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Inclusion criteria</b>: people with non‐insulin‐dependent diabetes of at least 6 months, HbA1c &gt; 7%, normal renal and hepatic function </p> <p><b>Exclusion criteria</b>: poor controlled hypertension, documented gastrointestinal disease, taking medication likely to alter gut motility or absorption, taking medications to lower lipid levels </p> <p><b>Diagnostic criteria</b>: WHO 1985 </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Number of study centres</b>: 7 </p> <p><b>Treatment before study</b>: insulin, dose is not stated in the publication </p> <p><b>Titration period</b>: 6 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Primary outcome(s)</b> (as stated in the publication): glycaemic control (HbA1c, oral glucose tolerance test, fasting blood glucose), side effects, hypoglycaemia, C‐peptide, lipids, blood count, biochemistry, vitamins, minerals </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Total study duration</b>: 12 months </p> <p><b>Run‐in period</b>: 6 weeks </p> <p><b>Study terminated early (for benefit/because of adverse events):</b> no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Language of publication</b>: English </p> <p><b>Funding source</b>: Miles Canada </p> <p><b>Publication status</b>: peer‐reviewed journal </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim of study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Quote from publication: "to evaluate the long‐term efficacy of acarbose, an alpha‐glucosidase inhibitor, in improving glycaemic control in patients with non‐insulin‐dependent diabetes mellitus" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: not possible to judge whether the sequence generation was adequate </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: not possible to judge whether the allocation to the intervention and control group was concealed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: it is not clear whether the physician or the outcome assessor is besides the participants blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: (from the abstract) " Design: a 1‐year, multicenter, randomised, double‐blind, placebo‐controlled study" (from the main text) "Acarbose or placebo was taken with the first sip of the liquid meal" </p> <p><b>Comment</b>: it is not clear whether the physician or the outcome assessor is besides the participants blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: (from the abstract) " Design: a 1‐year, multicenter, randomised, double‐blind, placebo‐controlled study" (from the main text) "Acarbose or placebo was taken with the first sip of the liquid meal" </p> <p><b>Comment</b>: it is not clear whether the physician or the outcome assessor is besides the participants blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: it is not clear whether the physician or the outcome assessor is besides the participants blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: it is not clear whether the physician or the outcome assessor is besides the participants blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: it is not clear whether the physician or the outcome assessor is besides the participants blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data on lipids is only mentioned, no analyses is performed or shown </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data were presented for both groups </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: more figures than tables, that causes unclear reporting </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: funded in part by a pharmaceutical company </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Coniff 1995 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Parallel randomised controlled clinical trial</b> </p> <p><b>Randomisation ratio: 1:1</b> </p> <p><b>Superiority design</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Inclusion criteria</b>: people with type 2 diabetes of at least 6 months, stable body weight, not receiving sulphonylurea for at least 2 months </p> <p><b>Exclusion criteria</b>: not stated </p> <p><b>Diagnostic criteria</b>: WHO 1985 </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Number of study centres</b>: multicentre, number of centres not mentioned, 4 centres are mentioned in the acknowledgements </p> <p><b>Treatment before study</b>: insulin: 56.8 (SE3.4) IU/day (intervention), 62.2 (SE3.3) IU/day </p> <p><b>Titration period</b>: 6 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Primary outcome(s)</b> (as stated in the publication): glycaemic control (HbA1c, glucose tolerance tests, fasting blood glucose), insulin requirements </p> <p><b>Secondary outcomes</b> (as stated in the publication): lipids, hypoglycaemic episodes </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Total study duration</b>: 6 weeks pretreatment, 24 weeks double‐blind, 6 weeks follow‐up (discontinuation acarbose) </p> <p><b>Run‐in period</b>: 6 weeks </p> <p><b>Study terminated early (for benefit/because of adverse events):</b> no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Language of publication</b>: English </p> <p><b>Funding source</b>: Miles pharmaceutical division </p> <p><b>Publication status</b>: peer‐reviewed journal </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim of study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Quote from publication: "To determine whether a forced titration of acarbose (from 50 to 300 mg three times daily) administered over a 24‐week period, in conjunction with diet and insulin therapy, improves glycaemic control and reduce daily insulin requirements in insulin‐requiring type II diabetes." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: not possible to judge whether the sequence generation was adequate </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: not possible to judge whether the allocation to the intervention and control group was concealed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: (abstract and main text): "This double‐blind, randomised, multicenter, placebo‐controlled study..." (main text) "The double‐blind endpoint was defined as last visit observation for each patients" </p> <p><b>Comment</b>: at all measurement occasions the efficacy and safety tests were assessed. However it is not clear whether the physician or the outcome assessor was blinded in addition to the participants </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: (abstract and main text): "This double‐blind, randomised, multicenter, placebo‐controlled study..." (main text)"The double‐blind endpoint was defined as last visit observation for each patients" </p> <p><b>Comment</b>: at all measurement occasions the efficacy and safety tests were assessed. However it is not clear whether the physician or the outcome assessor was blinded in addition to the participants </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data are reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: (abstract and main text): "This double‐blind, randomised, multicenter, placebo‐controlled study..." (main text) "The double‐blind endpoint was defined as last visit observation for each patient" </p> <p><b>Comment</b>: at all measurement occasions the efficacy and safety tests were assessed. However it is not clear whether the physician or the outcome assessor was blinded in addition to the participants </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: (abstract and main text): "This double‐blind, randomised, multicenter, placebo‐controlled study..." (main text) "The double‐blind endpoint was defined as last visit observation for each patient" </p> <p><b>Comment</b>: at all measurement occasions the efficacy and safety tests were assessed. However it is not clear whether the physician or the outcome assessor was blinded in addition to the participants </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: (abstract and main text): "This double‐blind, randomised, multicenter, placebo‐controlled study..." (main text)"The double‐blind endpoint was defined as last visit observation for each patients" </p> <p><b>Comment</b>: at all measurement occasions the efficacy and safety tests were assessed. However it is not clear whether the physician or the outcome assessor was blinded in addition to the participants </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "Most adverse events involved.....There were no significant differences between treatment groups in the incidence of adverse events related to other body systems " </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data were reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: serum lipids and SGOT and SGPT values were not reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: funded by a pharmaceutical company </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Feinglos 1998 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Cross‐over randomised controlled clinical trial</b> </p> <p><b>Randomisation ratio: 1:1</b> </p> <p><b>Superiority design</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Inclusion criteria</b>: insulin‐requiring type 2 diabetes, total daily insulin dose ≥ 40 units, insulin monotherapy ≥ 1 year prior to the study </p> <p><b>Exclusion criteria</b>: not stated </p> <p><b>Diagnostic criteria</b>: not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Number of study centres</b>: 1 </p> <p><b>Treatment before study</b>: insulin NPH and regular 80.8 (range 40‐210) U/day </p> <p><b>Titration period</b>: 1 week </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Primary outcome(s)</b> (as stated in the publication): glycaemic control (plasma glucose, HbA1c), C‐peptide, plasma free insulin levels, lipoprotein (TC, TG, HDL, LDL, VLDL), insulin dose, BMI </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Total study duration</b>: 8 months </p> <p><b>Run‐in period</b>: 1 week </p> <p><b>Study terminated early (for benefit/because of adverse events):</b> no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Language of publication</b>: English </p> <p><b>Funding source</b>: Pfizer Pharmaceuticals, Lifescan, National Center for Research Resources </p> <p><b>Publication status</b>: peer‐reviewed journal </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim of study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Quote from publication: "To determine the effect(s) on glucose control, insulin dose and circulating insulin levels of the addition of a sulphonylurea (glipizide) to the treatment regimen of patients with insulin‐requiring type 2 diabetes mellitus." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: not possible to judge whether the sequence generation was adequate </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: not possible to judge whether the allocation to the intervention and control group was concealed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "This study was a double‐blind crossover comparison of insulin and placebo vs. insulin and glipizide." </p> <p><b>Comment</b>: probably the participant and the personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "This study was a double‐blind crossover comparison of insulin and placebo vs. insulin and glipizide." </p> <p><b>Comment</b>: probably the participant and the personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: it is unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: it is unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: all outcome data were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: all outcome data were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: all outcomes of interest reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: funded by a pharmaceutical company </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Fonseca 2007 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Parallel randomised controlled clinical trial</b> </p> <p><b>Randomisation ratio: 1:1</b> </p> <p><b>Superiority design</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Inclusion criteria</b>: participants had to have received only injectable insulin for at least 3 months, at a dose of at least 30 U/day for a minimum of 4 weeks prior to enrolment. Age 18‐80 years, HbA1c 7.5‐11.0%, fasting plasma glucose &lt; 15 mmol/L and BMI 22‐45 kg/m² </p> <p><b>Exclusion criteria</b>: people with type 1 diabetes, diabetes resulting from pancreatic injury or secondary forms of diabetes. People with acute metabolic diabetic complications within the past 6 months, serious cardiac conditions or clinically significant liver disease. Any of the following laboratory abnormalities: alanine transaminase &gt; 3 x the upper limit of normal; direct bilirubin &gt; 1.3 x the upper limit of normal; serum creatinine &gt; 220 μmol/L; fasting triacylglycerol &gt; 7.9 mmol/L </p> <p><b>Diagnostic criteria</b>: based on the investigator's diagnosis and on the patient's medical record </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Number of study centres</b>: 68 </p> <p><b>Treatment before study</b>: insulin: intervention 81.2 ± 44.8 U/day and control 81.9 ± 49.4 U/day </p> <p><b>Titration period</b>: 4 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Primary outcome(s)</b> (as stated in the publication): glycaemic control (HbA1c, fasting plasma glucose), insulin dose and number of injections, fasting lipids, bodyweight </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Total study duration</b>: 24 weeks </p> <p><b>Run‐in period</b>: 4 weeks </p> <p><b>Study terminated early (for benefit/because of adverse events):</b> no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Language of publication</b>: English </p> <p><b>Funding source</b>: Novartis </p> <p><b>Publication status</b>: peer‐reviewed journal </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim of study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Quote from publication: "To assess the efficacy and tolerability of vildagliptin added to added to insulin therapy in patients with type 2 diabetes." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: not possible to judge whether the sequence generation was adequate </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: not possible to judge whether the allocation to the intervention and control group was concealed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "This was a 24‐week, randomised, double‐blind, placebo‐controlled, parallel‐group study...." </p> <p><b>Comment</b>: probably the participants and the personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "All assessments were made by central laboratories." </p> <p><b>Comment</b>: probably the participants and the personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "This was a 24‐week, randomised, double‐blind, placebo‐controlled, parallel‐group study...." </p> <p><b>Comment</b>: probably the participants and the personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data on weight gain and hypoglycaemia were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data on all outcome measures were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data on insulin dose was collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: post‐treatment BMI not reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: funded by a pharmaceutical company </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Fritsche 2000 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Cross‐over randomised controlled clinical trial</b> </p> <p><b>Randomisation ratio: 1:1</b> </p> <p><b>Superiority design</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Inclusion criteria</b>: not clearly defined: severe obesity, moderate glycaemic control, intensive insulin therapy with regular specialist consultations for regimen adaptation for at least 6 months prior to inclusion </p> <p><b>Exclusion criteria</b>: not stated </p> <p><b>Diagnostic criteria</b>: not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Number of study centres</b>: 1 </p> <p><b>Treatment before study</b>: intervention: insulin: NPH 26 ± 6 U/day and regular 27 ± 5 U/day </p> <p>control: insulin: NPH 20 ± 4 U/day and regular 26 ± 4 U/day</p> <p><b>Titration period</b>: 6 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Primary outcome(s)</b> (as stated in the publication): glycaemic control (HbA1c, blood glucose levels, OGTT), insulin dose, lipids, C‐peptide, lactate </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Total study duration</b>: 24 weeks </p> <p><b>Run‐in period</b>: 6 weeks </p> <p><b>Study terminated early (for benefit/because of adverse events):</b> no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Language of publication</b>: English </p> <p><b>Funding source</b>: Lipha Pharmaceuticals (medication) </p> <p><b>Publication status</b>: peer‐reviewed journal </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim of study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Quote from publication: "To examine the effect of adjunct metformin in 13 severely obese type 2 diabetes patients in sub optimal glucaemic control pretreated with intensified insulin therapy" on glycaemic control, insulin dosage, lipid profile and bodyweight </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "Patients were randomly assigned to either metformin or placebo treatment (double‐blind)...." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: not possible to judge whether the allocation to the intervention and control group was concealed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "patients were randomised in a double‐blind fashion..." </p> <p><b>Comment</b>: probably the participants and the personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "patients were randomised in a double‐blind fashion..." </p> <p><b>Comment</b>: probably the participants and the personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: all outcome data were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: all outcome data were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: all outcomes of interest were reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: funding by a pharmaceutical company </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Giugliano 1993 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Parallel randomised controlled clinical trial</b> </p> <p><b>Randomisation ratio: 1:1</b> </p> <p><b>Superiority design</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Inclusion criteria</b>: age at diagnosis &gt; 40 years, duration of disease &gt; 3 years, duration of previous response to oral drugs &gt; 1 year, inadequate metabolic control even when on maximal doses of sulphonylurea </p> <p><b>Exclusion criteria</b>: age &gt; 70 years, creatinine &gt; 1.2 mg/dL, ischaemic of wasting disease, acute severe diseases </p> <p><b>Diagnostic criteria</b>: not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Number of study centres</b>: 1? </p> <p><b>Treatment before study</b>: intervention: insulin: lente + regular 2 dd 90 ± 9 U/day; control: insulin lente + regular 2 dd 88 ± 9.4 U/day </p> <p><b>Titration period</b>: 4 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Primary outcome(s)</b> (as stated in the publication): glycaemic control (HbA1c, daily glucose levels), lipids, blood pressure, body weight, insulin dose, beta‐cell function (C‐peptide, insulin) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Total study duration</b>: 7 months </p> <p><b>Run‐in period</b>: 4 weeks </p> <p><b>Study terminated early (for benefit/because of adverse events):</b> no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Language of publication</b>: English </p> <p><b>Funding source</b>: not reported </p> <p><b>Publication status</b>: peer‐reviewed journal </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim of study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Quote from publication: "To evaluate the effectiveness and safety of metformin in obese type 2 diabetic patients poorly controlled by conventional insulin therapy." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "Phase II (double‐blind) patients were randomly assigned to continue to receive placebo or to treatment with metformin for six months" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: not possible to judge whether the allocation to the intervention and control group was concealed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "Phase II (double‐blind) patients were randomly assigned to continue to receive placebo or to treatment with metformin for six months </p> <p><b>Comment</b>: probably the participants and the personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "Phase II (double‐blind) patients were randomly assigned to continue to receive placebo or to treatment with metformin fro six months" </p> <p><b>Comment</b>: probably the participants and the personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: all outcome data were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data on insulin dose were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: no </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Groop 1985 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Cross‐over randomised controlled clinical trial</b> </p> <p><b>Randomisation ratio: 1:1</b> </p> <p><b>Superiority design</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Inclusion criteria</b>: onset of non‐ketotic diabetes after the age of 35 years, treated with oral antidiabetic drugs for at least 1 year before insulin therapy was started due to secondary drug failure. </p> <p><b>Exclusion criteria</b>: not stated </p> <p><b>Diagnostic criteria</b>: not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Number of study centres</b>: 1 </p> <p><b>Treatment before study</b>: insulin 0.75 ± 0.11 IU/kg per day </p> <p><b>Titration period</b>: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Primary outcome(s)</b> (as stated in the publication): insulin dose and bodyweight, glycaemic control (HbA1c, FBG, blood glucose profile), serum insulin levels, C‐peptide, lipids </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Total study duration</b>: 24 weeks (2 x 8 = 16 weeks intervention) </p> <p><b>Run in period:</b> 8 weeks </p> <p><b>Study terminated early (for benefit/because of adverse events):</b> no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Language of publication</b>: English </p> <p><b>Funding source</b>: none </p> <p><b>Publication status</b>: peer review journal </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim of study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Quote from publication: "To investigate the metabolic effects of the combination of insulin and sulphonylurea (glibenclamide) during controlled long‐term therapy in NIDDM patients whose hyperglycaemia could not be controlled by insulin alone." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "...the patients were randomly allocated to 8 weeks of treatment with ....." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: not possible to judge whether the allocation to the intervention and control group was concealed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "In a double‐blind cross‐over study we compared the effect of...." </p> <p><b>Comment</b>: probably the participants and the personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "In a double‐blind cross‐over study we compared the effect of...." </p> <p><b>Comment</b>: probably the participants and the personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "In a double‐blind cross‐over study we compared the effect of...." </p> <p><b>Comment</b>: probably the participants and the personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data of adverse events (myocardial infarct, weight gain) were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: all outcome data were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: all data on insulin dose were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear graphical reporting of data </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: none </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Hermann 2001 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Parallel randomised controlled clinical trial</b> </p> <p><b>Randomisation ratio: 1:1</b> </p> <p><b>Superiority design</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Inclusion criteria</b>: people with type 2 diabetes with insulin therapy &gt; 1 year. BMI &gt; 27 kg/m2 for men and &gt; 25 kg/m2 for women. HbA1c value higher than the upper reference limit + 2%. Insulin dose 0.4‐1.0 U/kg/day. C‐peptide after 1 mg glucagon intravenously &gt; 0.6 nmol/L </p> <p><b>Exclusion criteria</b>: treatment with oral antidiabetic agents within the last 6 months. Presence of any of the usual contraindications for metformin. Abnormal serum creatinine concentration. Transaminases &gt; 2 x the upper reference limit. Overconsumption of alcohol </p> <p><b>Diagnostic criteria</b>: not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Number of study centres</b>: 3 </p> <p><b>Treatment before study</b>: insulin: intervention 0.75 ± 0.28 U/kg/day and control 0.73 ± 0.23 U/kg/day </p> <p><b>Titration period</b>: 2 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Primary outcome(s)</b> (as stated in the publication): glycaemic control (HbA1c, FBG), bodyweight and BMI, insulin dose, lipids </p> <p><b>Secondary outcomes</b> (as stated in the publication): waist‐hip ratio, blood pressure, fibrinogen, C‐peptide, serum B12, compliance </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Total study duration</b>: 15 months </p> <p><b>Run‐in period:</b> 12 weeks </p> <p><b>Study terminated early (for benefit/because of adverse events):</b> no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Language of publication</b>: English </p> <p><b>Funding source</b>: none </p> <p><b>Publication status</b>: peer‐reviewed journal </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim of study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Quote from publication: "To assess the adjunct effect of metformin to insulin in type 2 diabetes." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "...the patients entered a 12‐month double‐blind treatment phase randomly allocated to metformin or placebo in parallel groups and as adjunct to their current insulin therapy" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "Randomization was performed by center in block of four." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "The study was a 12‐month double‐blind placebo‐controlled trial..." </p> <p><b>Comment</b>: probably the participants and personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "The study was a 12‐month double‐blind placebo‐controlled trial..." </p> <p><b>Comment</b>: probably the participants and personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "The study was a 12‐month double‐blind placebo‐controlled trial..." </p> <p><b>Comment</b>: probably the participants and personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data on adverse events were reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: outcome data were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data on insulin dose were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data were reported graphically, unclear </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: medication was funded by a pharmaceutical company </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Hirsch 1999 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Parallel randomised controlled clinical trial</b> </p> <p><b>Randomisation ratio: 1:1</b> </p> <p><b>Superiority design</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Inclusion criteria</b>: people with type 2 diabetes with less than optimal control on insulin therapy alone. </p> <p><b>Exclusion criteria</b>: not stated </p> <p><b>Diagnostic criteria</b>: not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Number of study centres</b>: 1 </p> <p><b>Treatment before study</b>: insulin: dose not stated </p> <p><b>Titration period</b>: not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Primary outcome(s)</b> (as stated in the publication): glycaemic control (HbA1c, FPG), bodyweight, blood pressure, insulin dose, fasting insulin levels, fasting C‐peptide, hypoglycaemia </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Total study duration</b>: 5 months </p> <p><b>Run‐in period:</b> no </p> <p><b>Study terminated early (for benefit/because of adverse events):</b> no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Language of publication</b>: English </p> <p><b>Funding source</b>: Bristol‐Myers‐Squibb </p> <p><b>Publication status</b>: peer‐reviewed journal </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim of study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Quote from publication: "To prospectively evaluate the efficacy of metformin added to insulin for patients with type 2 diabetes with less than optimal glycaemic control on insulin alone." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Publication is a letter</p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: not possible to judge whether the sequence generation was adequate </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: not possible to judge whether the allocation to the intervention and control group was concealed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "... a 5‐month single‐center prospective double‐blind placebo‐controlled study" </p> <p><b>Comment</b>: probably the participants and personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "... a 5‐month single‐center prospective double‐blind placebo‐controlled study" </p> <p><b>Comment</b>: probably the participants and personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "... a 5‐month single‐center prospective double‐blind placebo‐controlled study" </p> <p><b>Comment</b>: probably the participants and personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data on adverse events were reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: the outcome data were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data on insulin dose were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: short report of the trial </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: funded by a pharmaceutical company </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Hong 2012 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Parallel randomised controlled clinical trial</b> </p> <p><b>Randomisation ratio: 1:1</b> </p> <p><b>Superiority design</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Inclusion criteria</b>: type 2 diabetes mellitus; age 30–70 years; HbA1c 7.5%–11.0%; fasting plasma glucose (FPG) &lt; 15 mmol/L (270 mg/dL) and body mass index (BMI) 18–35 kg/m2. Female participants had to be non‐fertile or of childbearing potential using a medically approved birth control method. </p> <p><b>Exclusion criteria</b>: type 1 diabetes, gestational diabetes or diabetes with identifiable secondary causes, significant renal impairment (estimated creatinine clearance &lt; 50 ml/min) or elevated (&gt; 100) alanine or aspartate aminotransferase (ALT or AST). Participants who were taking medications, aside from antidiabetic medications, known to affect glycaemic control, such as glucocorticoids were also excluded. </p> <p><b>Diagnostic criteria</b>: not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Number of study centres</b>: 2 </p> <p><b>Treatment before study</b>: insulin injections for at least 3 months; at a dose of at least 10 U/day and for a minimum of 4 weeks prior to enrolment. </p> <p><b>Titration period</b>: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Primary outcome(s)</b> (as stated in the publication): change in HbA1c (from baseline to 24 weeks) </p> <p><b>Secondary outcomes</b> (as stated in the publication): proportion of participants achieving HbA1c &lt; 7%, body weight, waist circumference, change in insulin dose, change in C‐peptide, safety (AE, SAE, hypoglycaemia, liver/renal function) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Total study duration</b>: 24 weeks </p> <p><b>Study terminated early (for benefit/because of adverse events):</b> no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Language of publication</b>: English </p> <p><b>Funding source</b>: non commercial; National Research Foundation </p> <p><b>Publication status</b>: peer‐reviewed journal </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim of study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Quote from publication: "This study compared the efficacy and tolerability of adding sitagliptin, an oral dipeptidyl peptidase‐4 inhibitor, and an up to 20% increase in insulin dose in patients with uncontrolled type 2 diabetes on insulin therapy." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: not mentioned in the publication </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: not mentioned in the publication </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: participants and personnel were not blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: participants and personnel were not blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: participants and personnel were not blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: the outcome assessor was not blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: the outcome assessor was not blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: the outcome assessor was not blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: all end points shown </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: all end points shown </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: all end points shown </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: none </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Kitabchi 1987 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Cross‐over randomised controlled clinical trial</b> </p> <p><b>Randomisation ratio: 1:1</b> </p> <p><b>Superiority design</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Inclusion criteria</b>: obese (130%‐200% IBW) women with type 2 diabetes mellitus on prior insulin therapy who were poorly controlled but without severe diabetic complications. </p> <p><b>Exclusion criteria</b>: history of diabetic ketoacidosis </p> <p><b>Diagnostic criteria</b>: not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Number of study centres</b>: 1 </p> <p><b>Treatment before study</b>: insulin 0.89 ± 0.07 U/kg/BW </p> <p><b>Titration period</b>: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Primary outcome(s)</b> (as stated in the publication): glycaemic control (HbA1c, FBG, 2‐hour post prandial glucose), bodyweight, insulin requirement, total cholesterol, triglyceride, C‐peptide </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Total study duration</b>: 6 months </p> <p><b>Run‐in period:</b> no </p> <p><b>Study terminated early (for benefit/because of adverse events):</b> no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Language of publication</b>: English </p> <p><b>Funding source</b>: NIH, Abe Goodman Fund for Diabetes Research, Eli Lilly, Upjohn Company </p> <p><b>Publication status</b>: peer‐reviewed journal </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim of study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Quote from publication: "To assess the efficacy of combined NPH and tolazamide in enhancing insulin secretion and tissue sensitivity in obese patients with type 2 diabetes mellitus who were maintained at the same weight and glycaemic index during both phases of the study." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Several young participants with long‐term insulin use and without severe obesity</p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: not possible to judge whether the sequence generation was adequate </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: not possible to judge whether the allocation to the intervention and control group was concealed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "In a randomised cross‐over trial, ..." </p> <p><b>Comment</b>: unclear if it was a blinded trial </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "In a randomised cross‐over trial, ..." </p> <p><b>Comment</b>: unclear if it was a blinded trial </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "In a randomised cross‐over trial, ..." </p> <p><b>Comment</b>:unclear if it was a blinded trial </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "In a randomised cross‐over trial, ..." </p> <p><b>Comment</b>: unclear if it was a blinded trial </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "In a randomised cross‐over trial, ..." </p> <p><b>Comment</b>: unclear if it was a blinded trial </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "In a randomised cross‐over trial, ..." </p> <p><b>Comment</b>: unclear if it was a blinded trial </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data on weight gain were reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: outcome data were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data on insulin dose were reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: outcomes of interest were reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: funded by a pharmaceutical company </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Krawczyk 2005 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Parallel randomised controlled clinical trial</b> </p> <p><b>Randomisation ratio: 1:1</b> </p> <p><b>Superiority design</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Inclusion criteria</b>: type 2 diabetes patients, diabetes duration of at least 5 years, BMI &gt; 30, Insulin &gt; 40 IU/day </p> <p><b>Exclusion criteria</b>: contraindication for metformin, body weight change &gt; 5 kg last year </p> <p><b>Diagnostic criteria</b>: age &gt; 35 years at diagnosis and at least 1 year of effective treatment with oral glucose‐lowering agents </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Number of study centres</b>: 1 </p> <p><b>Treatment before study</b>: insulin 2dd, 59.5 (15.4) IU/day intervention, 55.6 (16.3) IU/day control </p> <p><b>Titration period</b>: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Primary outcome(s)</b> (as stated in the publication): glycaemic control (HbA1c, glucose), bodyweight, insulin dose, WHR </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Total study duration</b>: 6 months </p> <p><b>Run‐in period</b>: none </p> <p><b>Study terminated early (for benefit/because of adverse events):</b> no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Language of publication</b>: Polish </p> <p><b>Funding source</b>: not reported </p> <p><b>Publication status</b>: unknown </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim of study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Quote from publication: "To assess the influence of adding metformin to insulin monotherapy on metabolic control in type 2 diabetes patients." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Statistical methods not described</p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: randomisations in two groups of 20 participants </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: randomisations in blocks of 4 (20 participants per group) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: it is unclear if the study was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: it is unclear if the study was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: it is unclear if the study was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: it is unclear if the study was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: it is unclear if the study was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: it is unclear if the study was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: weight gain was reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: outcome data were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data on insulin dose were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: all outcomes of interest were reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: statistical methods were not described </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Kyllastinen 1985 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Cross‐over randomised controlled clinical trial</b> </p> <p><b>Randomisation ratio: 1:1</b> </p> <p><b>Superiority design</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Inclusion criteria</b>: elderly patients, type 2 diabetes inadequately controlled by insulin </p> <p><b>Exclusion criteria</b>: surgical operation; lack of co‐operation </p> <p><b>Diagnostic criteria</b>: not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Number of study centres</b>: 1 </p> <p><b>Treatment before study</b>: insulin 58 ± 3 IU/day (n = 1 once daily, n = 8 twice daily) </p> <p><b>Titration period</b>: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Primary outcome(s)</b> (as stated in the publication): glycaemic control (HbA1c, FPG), daily insulin dose, C‐peptide, bodyweight, triglyceride, total cholesterol, HDL‐cholesterol, Na, K, creatinine, chloride </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Total study duration</b>: 4 months </p> <p><b>Run‐in period: none</b> </p> <p><b>Study terminated early (for benefit/because of adverse events):</b> no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Language of publication</b>: English </p> <p><b>Funding source</b>: none </p> <p><b>Publication status</b>: peer‐reviewed journal </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim of study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Quote from publication: "To determine whether glibenclamide could improve glycaemic control in patients not adequately controlled by insulin." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: not possible to judge whether the sequence generation was adequate </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: not possible to judge whether the allocation to the intervention and control group was concealed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "A double blind, cross over trial was assigned ...after randomisation patients were given either glibenclamide or placebo....5 patients started with glibenclamide and 4 with placebo" </p> <p><b>Comment</b>: probably the participants and personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "A double blind, cross over trial was assigned...after randomisation patients were given either glibenclamide or placebo....5 patients started with glibenclamide and 4 with placebo" </p> <p><b>Comment</b>: probably the participants and personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data on weight gain were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: outcome data were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: all outcomes of interest were reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: only 9 participants included </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Lewitt 1989 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Cross‐over randomised controlled clinical trial</b> </p> <p><b>Randomisation ratio: 1:1</b> </p> <p><b>Superiority design</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Inclusion criteria</b>: insulin treated participants who were not ketosis prone and had previous primary or secondary oral hypoglycaemic failure. </p> <p><b>Exclusion criteria</b>: combined insulin‐sulphonylurea therapy </p> <p><b>Diagnostic criteria</b>: not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Number of study centres</b>: 1 </p> <p><b>Treatment before study</b>: insulin 47.3 ± 21.3 U/day. Insulin regimen: once or twice daily </p> <p><b>Titration period</b>: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Primary outcome(s)</b> (as stated in the publication): glycaemic control (HbA1c, self‐monitored fasting and postprandial glucose), BMI, C‐peptide, insulin dosage </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Total study duration</b>: 6 months </p> <p><b>Run‐in period: none</b> </p> <p><b>Study terminated early (for benefit/because of adverse events):</b> no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Language of publication</b>: English </p> <p><b>Funding source</b>: none </p> <p><b>Publication status</b>: peer‐reviewed journal </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim of study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Quote from publication: "To determine which patient characteristics best predict a beneficial response to combined Insulin‐gliburide therapy." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: not possible to judge whether the sequence generation was adequate </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: not possible to judge whether the allocation to the intervention and control group was concealed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "Glyburide was compared with placebo in a double‐blind crossover design" </p> <p><b>Comment</b>: probably the participants and the personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "Glyburide was compared with placebo in a double‐blind crossover design" </p> <p><b>Comment</b>: probably the participants and the personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "Glyburide was compared with placebo in a double‐blind crossover design" </p> <p><b>Comment</b>: probably the participants and the personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data on weight gain were reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: outcome data were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data on insulin dose were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: all outcomes of interest were reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: none </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Lindstrom 1999 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Cross‐over randomised controlled clinical trial</b> </p> <p><b>Randomisation ratio: 1:1</b> </p> <p><b>Superiority design</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Inclusion criteria</b>: participants with type 2 diabetes with insulin monotherapy for 6‐36 months. </p> <p><b>Exclusion criteria</b>: not stated </p> <p><b>Diagnostic criteria</b>: not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Number of study centres</b>: unclear </p> <p><b>Treatment before study</b>: insulin 54.5 ± 6.9 U/day (at the end of the run‐in period) Insulin regimen: four times daily, regular plus intermediate insulin </p> <p><b>Titration period</b>: 4‐8 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Primary outcome(s)</b> (as stated in the publication): glycaemic control (blood glucose, HbA1c), insulin dose, C‐peptide, lipoproteins, IGF‐1, SHBG, serum testosterone </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Total study duration</b>: 7‐8 months </p> <p><b>Run‐in period:</b> 4‐8 weeks </p> <p><b>Study terminated early (for benefit/because of adverse events):</b> no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Language of publication</b>: English </p> <p><b>Funding source</b>: Swedish Medical Research Council, Swedish Diabetes Association, County Council of Östergötland, Novo Nordisk Insulin Fund </p> <p><b>Publication status</b>: peer‐reviewed journal </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim of study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Quote from publication: "To study whether changes in endogenous insulin secretion at the same glycaemic control affect the plasma concentration of lipoproteins in patients with type 2 diabetes mellitus." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: not possible to judge whether the sequence generation was adequate </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: not possible to judge whether the allocation to the intervention and control group was concealed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "...in this randomised double‐blind crossover study." </p> <p><b>Comment</b>: probably the participants and the personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "...in this randomised double‐blind crossover study." </p> <p><b>Comment</b>: probably the participants and the personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "...in this randomised double‐blind crossover study." </p> <p><b>Comment</b>: probably the participants and the personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data on weight gain were reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: outcome data were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data on insulin dose were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: all outcomes of interest were reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: also funded by pharmaceutical company </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Longnecker 1986 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Cross‐over randomised controlled clinical trial</b> </p> <p><b>Randomisation ratio: 1:1</b> </p> <p><b>Superiority design</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Inclusion criteria</b>: severely hyperglycaemic patients with type 2 diabetes with insulin monotherapy failed to sulphonylurea therapy </p> <p>Controls were nondiabetic women comparable with patients in age and weight.</p> <p><b>Exclusion criteria</b>: not stated </p> <p><b>Diagnostic criteria</b>: not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Number of study centres</b>: 1 </p> <p><b>Treatment before study</b>: insulin 64 ± 5.6 U/day (insulin regimen: once or twice daily, regular and/or isophane insulin) </p> <p><b>Titration period</b>: 1 week </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Primary outcome(s)</b> (as stated in the publication): glycaemic control (HbA1c, fasting blood glucose), plasma glucose and C‐peptide before and after standardised meal, weight, C‐peptide, drug compliance, side effects </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Total study duration</b>: 20 weeks </p> <p><b>Run‐in period:</b> 1 week </p> <p><b>Study terminated early (for benefit/because of adverse events):</b> no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Language of publication</b>: English </p> <p><b>Funding source</b>: Public Health Service Grant, ADA, Upjohn </p> <p><b>Publication status</b>: peer‐reviewed journal </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim of study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Quote from publication: "To evaluate the efficacy of adding tolazamide, an oral agent, to insulin in a group of severely hyperglycaemic patients with NIDDM, all of whom had previously failed to respond to therapy with oral sulfonylurea agent alone." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Carry‐over effect not described</p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: not possible to judge whether the sequence generation was adequate </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: not possible to judge whether the allocation to the intervention and control group was concealed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: (from the abstract) "Using a double‐blind crossover design, ..." </p> <p><b>Comment</b>: probably the participants and the personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: (from the abstract) "Using a double‐blind crossover design, ..." </p> <p><b>Comment</b>: probably the participants and the personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: the effects on weight and side effects were not reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: outcome date were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: the effects on weight and side effects were not reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: only 12 participants were included </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Mattoo 2005 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Parallel randomised controlled clinical trial</b> </p> <p><b>Randomisation ratio: 1:1</b> </p> <p><b>Superiority design</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Inclusion criteria</b>: people with type 2 diabetes with insulin therapy with or without oral antihyperglycaemic agents for ≥ 3 months, HbA1c ≥ 7,5% and ≥ 30 years at the time of diagnosis </p> <p><b>Exclusion criteria</b>: type 1 DM, signs or symptoms of any chronic condition or drug or alcohol abuse, previous TZD, glucocorticoid, nicotinic acid or therapy for a malignancy (except basal cell or squamous cell cancer), breastfeeding, pregnancy, women of childbearing potential </p> <p><b>Diagnostic criteria</b>: WHO </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Number of study centres</b>: 39 </p> <p><b>Treatment before study</b>: intervention: insulin 0.96 (0.03) U/day/kg, control insulin 0.92 (0.03) U/day/kg. Insulin regimen: once, twice, thrice or four times a day. </p> <p><b>Titration period</b>: 2 weeks lead‐in (at the end oral agents were stopped) and 3 months insulin intensification period </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Primary outcome(s)</b> (as stated in the publication): glycaemic control (HbA1c, fasting blood glucose), lipids, hs‐CRP, PAI‐1, hypoglycaemia, bodyweight, insulin dose </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Total study duration</b>: 6 months </p> <p><b>Run‐in period:</b> 2 weeks </p> <p><b>Study terminated early (for benefit/because of adverse events):</b> no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Language of publication</b>: English </p> <p><b>Funding source</b>: Eli Lilly, Takeda Europe </p> <p><b>Publication status</b>: peer‐reviewed journal </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim of study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Quote from publication: "To determine the effect of pioglitazone 30 mg plus insulin versus placebo plus insulin on glycaemic control, the serum lipid profile, and selected cardiovascular risk factors in patients with type 2 diabetes mellitus whose disease was inadequately controlled with insulin therapy alone despite efforts to intensify such treatment." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Some participants also used oral antihyperglycaemic agents before study. Users and non‐users were separated in the analysis </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "randomised" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "randomised with equal probability.... according to a central randomisation table generated by the study sponsor and administered by an automated interactive voice response system at all sites" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "this 6‐month, randomised, double blind, prospective, multicenter, placebo‐controlled, parallel‐group study was ...." </p> <p><b>Comment</b>: probably the participants and the personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "this 6‐month, randomised, double blind, prospective, multicenter, placebo‐controlled, parallel‐group study was ...." </p> <p><b>Comment</b>: probably the participants and the personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "this 6‐month, randomised, double blind, prospective, multicenter, placebo‐controlled, parallel‐group study was ...." </p> <p><b>Comment</b>: probably the participants and the personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data on adverse events and weight gain were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: outcome data were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data on insulin dose were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: all outcomes of interest were reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: funded by pharmaceutical companies </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Mauerhoff 1986 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Parallel randomised controlled clinical trial</b> </p> <p><b>Randomisation ratio: 1:1</b> </p> <p><b>Superiority design</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Inclusion criteria</b>: people with type 2 diabetes with insulin therapy for ≥ 1 year. </p> <p><b>Exclusion criteria</b>: abnormal renal and hepatic functions, C‐peptide &gt; 0.2 pmol/mL </p> <p><b>Diagnostic criteria</b>: not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Number of study centres</b>: 1 </p> <p><b>Treatment before study</b>: intervention: insulin 0.50 (0.07) U/day/kg, control insulin 0.44 (0.05) U/day/kg </p> <p><b>Titration period</b>: 3 weeks lead‐in </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Primary outcome(s)</b> (as stated in the publication): plasma glucose and C‐peptide after standardised breakfast, HbA1c (no assessment for technical reasons), fasting cholesterol and triglyceride, hypoglycaemia, insulin requirements </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Total study duration</b>: 16 weeks </p> <p><b>Run‐in period:</b> 3 weeks </p> <p><b>Study terminated early (for benefit/because of adverse events):</b> no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Language of publication</b>: English </p> <p><b>Funding source</b>: Hoechst Belgium </p> <p><b>Publication status</b>: peer‐reviewed journal </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim of study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Quote from publication: "We have studied the effect of the combination of a sulphonylurea (Hb 420 or glibenclamide) with insulin in 22 type 2 diabetic patients, treated with insulin and with residual insulin secretion." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Use of intervention medication Hb420 (galenic form of glibenclamide)</p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: not possible to judge whether the sequence generation was adequate </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: not possible to judge whether the allocation to the intervention and control group was concealed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "The study was carried out double‐blind......" </p> <p><b>Comment</b>: probably the participants and the personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "The study was carried out double‐blind......" </p> <p><b>Comment</b>: probably the participants and the personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "The study was carried out double‐blind......" </p> <p><b>Comment</b>: probably the participants and the personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data on number of hypoglycaemia were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: HbA1c analyses not performed for technical reasons </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data on insulin dose were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: HbA1c analyses not performed for technical reasons </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: funded by a pharmaceutical company </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Mezitis 1992 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Parallel randomised controlled clinical trial</b> </p> <p><b>Randomisation ratio: 1:1</b> </p> <p><b>Superiority design</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>HbA1c</b> before randomisation (% (SD)): intervention 8.7, control 8.6 </p> <p><b>Inclusion criteria</b>: people with type 2 diabetes with insulin therapy for ≥ 1 year. </p> <p><b>Exclusion criteria</b>: endocrinologic disease other than diabetes mellitus, history of allergies to sulphonamides and/or insulin, history of impaired gastric emptying, active hepatic disease, renal disease significantly impairing creatinine clearance, current treatment with steroids, oestrogens, progestogens, beta‐blockers, Ca‐channel antagonists, diuretics, monoamine oxidase inhibitors, clonidine, probenecid, anticoagulants, NSAID </p> <p><b>Diagnostic criteria</b>: not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Number of study centres</b>: 1 </p> <p><b>Treatment before study</b>: insulin monotherapy, dosages not stated </p> <p><b>Titration period</b>: yes, duration not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Primary outcome(s)</b> (as stated in the publication): urinary C‐peptide, HbA1c, lipids, insulin requirement, glycaemic profiles in response to test meals </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Total study duration</b>: 20 weeks </p> <p><b>Run‐in period:</b> unclear </p> <p><b>Study terminated early (for benefit/because of adverse events):</b> no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Language of publication</b>: English </p> <p><b>Funding source</b>: UpJohn, Boehringer Mannheim, Becton Dickinson </p> <p><b>Publication status</b>: peer‐reviewed journal </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim of study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Quote from publication: "To investigate the effects of addition of glibenclamide to the regimen of insulin‐treated non‐insulin‐dependent diabetes mellitus (NIDDM) patients with regard to their overall insulin requirements and dosage schedule and to assess persistence of these effects." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>A lot of data were missing: dose of glibenclamide, incomplete study design and baseline data </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "random assignment to equal‐sized parallel‐groups" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: not possible to judge whether the allocation to the intervention and control group was concealed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "The study was double‐blinded with random assignment to equal‐sized parallel‐groups..." </p> <p><b>Comment</b>: probably the participants and the personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "The study was double‐blinded with random assignment to equal‐sized parallel‐groups..." </p> <p><b>Comment</b>: probably the participants and the personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: outcomes of C‐peptide, lipids and HbA1c assays were not reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: missing data on dose of glibenclamide </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: outcomes of C‐peptide, lipids and HbA1c assays were not reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: no data on adverse events and population size; funded by a pharmaceutical company </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Mudaliar 2010 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Parallel randomised controlled clinical trial</b> </p> <p><b>Randomisation ratio: 1:1</b> </p> <p><b>Superiority design</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Inclusion criteria</b>: obese people with type 2 diabetes on insulin therapy alone and with HbA1c between 7.5% and 10%. </p> <p><b>Exclusion criteria</b>: history of peripheral oedema, cardiac, hepatic or renal problems, or had been treated with NSAIDs or diuretics within 21 days of screening </p> <p><b>Diagnostic criteria</b>: not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Number of study centres</b>: 1 </p> <p><b>Treatment before study</b>: insulin monotherapy (IU/day (SD)): intervention: 105 (22), control 114 (11) </p> <p><b>Titration period</b>: 4 weeks: weight maintenance, carbohydrate diet </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Primary outcome(s)</b> (as stated in the publication): HbA1c, fasting plasma glucose, insulin dose, weight, total body water, extracellular fluid, renal measures, hormonal measures </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Total study duration</b>: 16‐20 weeks </p> <p><b>Run‐in period:</b> 4 weeks </p> <p><b>Study terminated early (for benefit/because of adverse events):</b> no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Language of publication</b>: English </p> <p><b>Funding source</b>: Takeda pharmaceuticals, Veterans Medical Research Foundation, Department of Veterans Affairs and the VA San Diego Healthcare System, University of California San Diego Clin Res. Centre NIH Grant </p> <p><b>Publication status</b>: peer‐reviewed journal </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim of study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Quote from publication: "To evaluate the effects of intensive insulin therapy alone or with added pioglitazone on renal salt/water balance and body fluid compartment shifts in type 2 diabetes." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Funded by pharmaceutical company</p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "After the completion of the baseline studies, subjects were randomised (in a double‐blind manner) to..." </p> <p><b>Comment</b>: not possible to judge whether the sequence generation was adequate </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: not possible to judge whether the allocation to the intervention and control group was concealed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "After the completion of the baseline studies, subjects were randomised (in a double‐blind manner) to..." </p> <p><b>Comment</b>: probably the participants and the personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "After the completion of the baseline studies, subjects were randomised (in a double‐blind manner) to..." </p> <p><b>Comment</b>: probably the participants and the personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "After the completion of the baseline studies, subjects were randomised (in a double‐blind manner) to..." </p> <p><b>Comment</b>: probably the participants and the personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data on weight gain were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: outcome data were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data on insulin dose were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: all outcomes of interest were reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: funding by pharmaceutical company; performed in clinical research centre </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Nemoto 2011 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Parallel randomised controlled clinical trial</b> </p> <p><b>Randomisation ratio: 1:1</b> </p> <p><b>Superiority design</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Inclusion criteria</b>: people with type 2 diabetes on insulin therapy alone, HbA1c ≥ 6.5%, outpatients, age at least 20 years </p> <p><b>Exclusion criteria</b>: not stated </p> <p><b>Diagnostic criteria</b>: plasma glucose level at either 1 or 2 h after meal was 180 mg/dL or higher; HbA1c ≥ 6.5% </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Number of study centres</b>: not stated </p> <p><b>Treatment before study</b>: insulin monotherapy (U/day (SD)): 31.7 (17.6) </p> <p><b>Titration period</b>: 4‐10 weeks observation period </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Primary outcome(s)</b> (as stated in the publication): meal tolerance test, plasma glucose AUC </p> <p><b>Secondary outcomes</b> (as stated in the publication): HbA1c, 1,5 AG, glycoalbumin, hypoglycaemic symptoms </p> <p><b>ADDITIONAL OUTCOMES</b>: safety </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Total study duration</b>: 16‐22 weeks (4‐10 weeks observation + 12 weeks treatment) </p> <p><b>Run‐in period:</b> 4‐10 weeks </p> <p><b>Study terminated early (for benefit/because of adverse events):</b> no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Language of publication</b>: English </p> <p><b>Funding source</b>: Sanwa Kagaku Kenkyusyo Co Ltd </p> <p><b>Publication status</b>: peer‐reviewed journal </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim of study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Quote from publication: "To investigate the efficacy of combination therapy with miglitol and insulin" in people with type 2 diabetes receiving insulin therapy </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "The enrolled patients were randomised to groups treated with miglitol or with placebo" </p> <p><b>Comment</b>: not possible to judge whether the sequence generation was adequate </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: not possible to judge whether the allocation to the intervention and control group was concealed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "We conducted a placebo‐controlled double‐blind comparative study..." </p> <p><b>Comment</b>: probably the participants and the personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "We conducted a placebo‐controlled double‐blind comparative study..." </p> <p><b>Comment</b>: probably the participants and the personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "We conducted a placebo‐controlled double‐blind comparative study..." </p> <p><b>Comment</b>: probably the participants and the personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: adverse events were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data on HbA1c were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: part of the results only described in figures, not in numbers </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: part of the results only described in figures, not in numbers </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: funding unclear, possibly commercial </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Osei 1984 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Parallel randomised controlled clinical trial</b> </p> <p><b>Randomisation ratio: 1:1</b> </p> <p><b>Superiority design</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Inclusion criteria</b>: people with type 2 diabetes with serum glucose levels &gt; 200 mg/dL and daily insulin requirement &gt; 30 IU </p> <p><b>Exclusion criteria</b>: renal and hepatic disease, allergies to sulphonylurea </p> <p><b>Diagnostic criteria</b>: NDDG </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Number of study centres</b>: 1 </p> <p><b>Control (route, total dose/day, frequency)</b>: placebo, oral </p> <p><b>Treatment before study</b>: intervention: insulin 60.3 (7.1) U/day, control insulin 50.27 (5.0) U/day </p> <p>(insulin regimen: once or twice daily, short‐acting and/or intermediate insulin)</p> <p><b>Titration period</b>: 4 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Primary outcome(s)</b> (as stated in the publication): fasting glucose, HbA1c and C‐peptide, after OGTT serum glucose and C‐peptide, lipids, lipoproteins, weight, dietary intake, compliance </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Total study duration</b>: 16 weeks </p> <p><b>Run‐in period:</b> 4 weeks </p> <p><b>Study terminated early (for benefit/because of adverse events):</b> no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Language of publication</b>: English </p> <p><b>Funding source</b>: UpJohn, Core Laboratory, Central Ohio Diabetes Association </p> <p><b>Publication status</b>: peer‐reviewed journal </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim of study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Quote from publication: "To evaluate, in a double‐blind, placebo‐controlled manner, glucose and lipoprotein responses after long‐term use of combination therapy in the management of insulin‐treated patients with poorly controlled type 2 diabetes mellitus." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "Patients were randomly assigned in a double‐blind manner to receive either glyburide or placebo..." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: not possible to judge whether the allocation to the intervention and control group was concealed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "Patients were randomly assigned in a double‐blind manner..." </p> <p><b>Comment</b>: probably the participants and the personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "Patients were randomly assigned in a double‐blind manner..." </p> <p><b>Comment</b>: probably the participants and the personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "Patients were randomly assigned in a double‐blind manner..." </p> <p><b>Comment</b>: probably the participants and the personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data on weight gain were reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: outcome data were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data on insulin dose were reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: all outcomes of interest were reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: funded by a pharmaceutical company </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Quatraro 1986 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Parallel randomised controlled clinical trial</b> </p> <p><b>Randomisation ratio: 1:1</b> </p> <p><b>Superiority design</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Inclusion criteria</b>: people with type 2 diabetes on insulin therapy </p> <p><b>Exclusion criteria</b>: not stated </p> <p><b>Diagnostic criteria</b>: not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Number of study centres</b>: 1 </p> <p><b>Treatment before study</b>: intervention: insulin 90 (6) U/day, control insulin 88 (5) U/day </p> <p>Insulin regimen: twice or thrice daily, porcine lente and/or rapid‐acting insulin</p> <p><b>Titration period</b>: 2 months + 1‐2 weeks inpatient period </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Primary outcome(s)</b> (as stated in the publication): diurnal glucose profile, HbA1c, C‐peptide, glucagon stimulated C‐peptide, insulin dose, weight </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Total study duration</b>: 14 months </p> <p><b>Run‐in period:</b> 2 weeks </p> <p><b>Study terminated early (for benefit/because of adverse events):</b> no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Language of publication</b>: English </p> <p><b>Funding source</b>: none </p> <p><b>Publication status</b>: peer‐reviewed journal </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim of study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Quote from publication: "We studied the influence of chronic sulphonylurea treatment on glucose metabolism and beta‐cell secretory activity in diabetic patients requiring insulin after secondary failure to oral drugs." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "They were allocated at random into two groups, each consisting of 15 subjects..." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: not possible to judge whether the allocation to the intervention and control group was concealed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the study was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the study was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the study was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the study was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the study was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the study was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "weight remained stable throughout the study period." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: outcome data were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data on insulin dose were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: all outcomes of interest were reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: different participant groups reported in figure and table </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Reich 1987 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Parallel randomised controlled clinical trial</b> </p> <p><b>Randomisation ratio: 1:1</b> </p> <p><b>Superiority design</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Inclusion criteria</b>: people with type 2 diabetes on insulin therapy </p> <p><b>Exclusion criteria</b>: significant surgery within 3 months before entry into the study, major organ or system disease, medication use affecting glucose metabolism or sulphonylurea activity </p> <p><b>Diagnostic criteria</b>: not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Number of study centres</b>: 2 </p> <p><b>Treatment before study</b>: intervention: 36.5 (6.3) insulin, placebo: insulin 48.2 (4.0) U/day. Insulin regimen: only intermediate insulin </p> <p><b>Titration period</b>: 12 days hospitalisation (after 6 weeks optimisation glycaemic control with insulin) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Primary outcome(s)</b> (as stated in the publication): serum and urinary glucoses, HbA1c, urinary C‐peptide, insulin dose, number of tablets prescribed, compliance </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Total study duration</b>: 5.5 months </p> <p><b>Run‐in period:</b> 12 days </p> <p><b>Study terminated early (for benefit/because of adverse events):</b> no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Language of publication</b>: English </p> <p><b>Funding source</b>: Upjohn </p> <p><b>Publication status</b>: peer‐reviewed journal </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim of study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Quote from publication: "To test the effect of combined glibenclamide‐insulin therapy over 4 months in 20 patients after achieving good control of fasting glucose with diet and intermediate insulin alone." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Participants had adequate glycaemic control</p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "randomised" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "randomised by the hospital pharmacy" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: (from abstract) "A placebo‐controlled, double‐blinded design..." </p> <p><b>Comment</b>: Probably the participants and the personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: (from abstract) "A placebo‐controlled, double‐blinded design..." </p> <p><b>Comment</b>: probably the participants and the personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: not all outcome values were reported, only graphical </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: insulin dose was collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: not all outcome values were reported, only graphical </p> <p><b>Comment</b>: dropouts were described; intention‐to‐treat </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: funded by a pharmaceutical company </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Relimpio 1998 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Parallel open‐label randomised controlled clinical trial</b> </p> <p><b>Randomisation ratio: 1:1</b> </p> <p><b>Superiority design</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Inclusion criteria</b>: poorly controlled (HbA1c &gt; 8%) people with type 2 diabetes on insulin therapy (≥ 0.5 IU/kg body weight in 2 or more daily doses)) </p> <p><b>Exclusion criteria</b>: life‐threatening condition, contraindication for biguanides, serum creatinine &lt; 132.6 μmol/L </p> <p><b>Diagnostic criteria</b>: not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Number of study centres</b>: 1 </p> <p><b>Treatment before study</b>: intervention: 47.9 (10) insulin, control: insulin 51.8 (9.6) U/day. Insulin regimen: twice or more daily, premixed soluble and NPH insulin or NPH insulin alone </p> <p><b>Titration period</b>: 4 weeks increase metformin dose (1,275 g ‐&gt; 2,550 g) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Primary outcome(s)</b> (as stated in the publication): HbA1c, glucose, lipids, blood pressure, height, weight, BMI, insulin dose, serum creatinine, albumin excretion rate, uric acid, compliance </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Total study duration</b>: 4 months </p> <p><b>Run‐in period:</b> 4 weeks </p> <p><b>Study terminated early (for benefit/because of adverse events):</b> no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Language of publication</b>: English </p> <p><b>Funding source</b>: Novo Nordisk </p> <p><b>Publication status</b>: peer‐reviewed journal </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim of study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Quote from publication: "To compare the effect of adding metformin to insulin therapy with a moderate increase in insulin dose alone in insulin‐treated, poorly controlled type 2 diabetes." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "... and were subsequently randomised (31 to insulin + metformin and 29 to insulin dose increase)" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>"patients were randomised into two study groups following an experimental design of open‐label randomisation." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "open‐label randomisation" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "open‐label randomisation" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "open‐label randomisation" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "open‐label randomisation" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "open‐label randomisation" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "open‐label randomisation" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data on weight gain were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: outcome data were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data on insulin dose were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: all outcomes of interest were reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: funded by a pharmaceutical company </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Robinson 1998 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Two cross‐over randomised controlled clinical trials</b> </p> <p><b>Randomisation ratio: 1:1</b> </p> <p><b>Superiority design</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Inclusion criteria</b>: study I: DM2 patients with insulin monotherapy for at least 1 year after secondary failure of maximum dose oral antihyperglycaemic agents; study II: see study I plus taking metformin (100‐2550 mg/day as the sole oral antihyperglycaemic agent for at least 1 year </p> <p><b>Exclusion criteria</b>: women of childbearing age, unable to give informed consent </p> <p><b>Diagnostic criteria</b>: fasting plasma glucose &gt; 7.8 mmol/L on 2 occasions </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Number of study centres</b>: 2 </p> <p><b>Treatment before study</b>: study I: insulin 71 (47) U/day, study II : insulin 41 (16) U/day + metformin 1000‐2550 </p> <p><b>Titration period</b>: 6 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Primary outcome(s)</b> (as stated in the publication): HbA1c, glucose, lipids, blood pressure, insulin dose, hypoglycaemia </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Total study duration</b>: 12 weeks (intervention period study I) </p> <p><b>Run‐in period:</b> 6 weeks </p> <p><b>Study terminated early (for benefit/because of adverse events):</b> no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Language of publication</b>: English </p> <p><b>Funding source</b>: Lipha Pharmaceuticals </p> <p><b>Publication status</b>: peer‐reviewed journal </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim of study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Quote from publication: "To test the hypothesis that metformin therapy, given as an adjunct to insulin therapy, improves metabolic control in insulin‐treated type 2 diabetes mellitus patients with sub optimal glycaemic control." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>2 studies, only study I fulfilled our inclusion criteria</p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "patients were randomised..." </p> <p><b>Comment</b>: not possible to judge whether the sequence generation was adequate </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: not possible to judge whether the allocation to the intervention and control group was concealed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: (from abstract) "Two randomised double‐blind placebo‐controlled crossover studies were run." </p> <p><b>Comment</b>: probably the participants and the personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: (from abstract) "Two randomised double‐blind placebo‐controlled crossover studies were run." </p> <p><b>Comment</b>:probably the participants and the personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: (from abstract) "Two randomised double‐blind placebo‐controlled crossover studies were run." </p> <p><b>Comment</b>: probably the participants and the personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data on weight gain were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: outcome data were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data on insulin dose were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: all outcomes of interest were described </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: funded by a pharmaceutical company </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Rosenstock 2002 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Parallel randomised controlled clinical trial</b> </p> <p><b>Randomisation ratio: 1:1:1</b> </p> <p><b>Superiority design</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Inclusion criteria</b>: people with type 2 diabetes on insulin therapy (≥ 30 IU/day) for 4 months, 30‐75 years, HbA1c ≥ 8.0%, fasting C‐peptide &gt; 0.7μg/l </p> <p><b>Exclusion criteria</b>: history of ketoacidosis; unstable retinopathy, nephropathy or neuropathy; impaired hepatic and renal function; anaemia; unstable cardiovascular or cerebrovascular condition; concomitant lipid lowering medication must be taken for a stable dose &gt; 60 days </p> <p><b>Diagnostic criteria</b>: not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Number of study centres</b>: 79 </p> <p><b>Treatment before study</b>: pioglitazone 15: 70.2 (34.0) insulin, pioglitazone 30: insulin 72.3 (38.5), placebo: insulin 70.7 (33.5) U/day (insulin regimen: 88% monotherapy) </p> <p><b>Titration period</b>: insulin monotherapy: 2 weeks screening + 1 week single‐blind placebo </p> <p>insulin with oral anti‐diabetic (OAD) medication: 2 weeks screening + 4 weeks single‐blind placebo (= washout) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Primary outcome(s)</b> (as stated in the publication): HbA1c, glucose, C‐peptide, lipids, insulin dose, safety profile: chemistry, haematology, urine analysis, vital signs, ECG, adverse events </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Total study duration</b>: 16 weeks </p> <p><b>Run‐in period:</b> 3 weeks for insulin users and 6 weeks for insulin + OAD users (last group discontinued oral agent at the beginning of the screening period </p> <p><b>Study terminated early (for benefit/because of adverse events):</b> no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Language of publication</b>: English </p> <p><b>Funding source</b>: Takeda Pharmaceuticals </p> <p><b>Publication status</b>: peer‐reviewed journal </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim of study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Quote from publication: "To evaluate the ability of two doses of pioglitazone in combination with a stable insulin regimen to improve glycaemic control in patient whose type 2 diabetes remained poorly controlled despite current insulin therapy." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: not possible to judge whether the sequence generation was adequate. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: not possible to judge whether the allocation to the intervention and control group was concealed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "... the 16‐weeks double‐blind treatment period" </p> <p><b>Comment</b>: Probably the participants and the personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "... the16‐weeks double‐blind treatment period" </p> <p><b>Comment</b>: probably the participants and the personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "During the single‐blinded period, patients received their stable insulin regimens" </p> <p><b>Quote from publication</b>: "... the16‐weeks double‐blind treatment period" </p> <p><b>Comment</b>: the single‐blind period refers to the run‐in period and the 16‐weeks to the treatment period. Probably the participants and the personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data on weight gain and drug‐related adverse events were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: outcome data were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data on insulin dose were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: all outcomes of interest were reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: funded by a pharmaceutical company </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Schade 1987 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Cross‐over randomised controlled clinical trial</b> </p> <p><b>Randomisation ratio: 1:1</b> </p> <p><b>Superiority design</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Inclusion criteria</b>: people with type 2 diabetes on insulin therapy (≥ 28 IU/day ≥ 3 months), C‐peptide‐positive on stimulation of endogenous insulin secretion (OGTT) </p> <p><b>Exclusion criteria</b>: hepatic or renal disease or other major diseases that might impair participation, use of sulphonylurea or other drugs that alter glucose control within 1 month of the study </p> <p><b>Diagnostic criteria</b>: NDDG </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Number of study centres</b>: &gt; 1? </p> <p><b>Treatment before study</b>: 55.4 (6.0) IU/day (insulin regimen: 10/16 twice daily) </p> <p><b>Titration period</b>: 4 weeks (washout) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Primary outcome(s)</b> (as stated in the publication): OGTT, insulin‐ C‐peptide, fasting blood glucose, HbA1c, ery‐glu binding capacity, compliance, insulin dose, weight </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Total study duration</b>: 32 weeks </p> <p><b>Run‐in period:</b> 4 weeks </p> <p><b>Study terminated early (for benefit/because of adverse events):</b> no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Language of publication</b>: English </p> <p><b>Funding source</b>: Upjohn, NIH </p> <p><b>Publication status</b>: peer‐reviewed journal </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim of study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Quote from publication: "To examine the potential beneficial effect of the addition of a second‐generation sulphonylurea to insulin therapy for poorly controlled type 2 diabetes." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "The order of the two treatment regimens was randomised..." </p> <p><b>Comment</b>: not possible to judge whether the sequence generation was adequate </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: not possible to judge whether the allocation to the intervention and control group was concealed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "...neither the patient nor the investigators knew until the completion of the study which treatment regimen the patients were receiving during each 16‐weeks period." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "...neither the patient nor the investigators knew until the completion of the study which treatment regimen the patients were receiving during each 16‐weeks period." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "...neither the patient nor the investigators knew until the completion of the study which treatment regimen the patients were receiving during each 16‐weeks period." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "...neither the patient nor the investigators knew until the completion of the study which treatment regimen the patients were receiving during each 16‐weeks period." </p> <p><b>Comment</b>: unclear if "end of the study" meant the end of the treatment period or after outcome analysis </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "...neither the patient nor the investigators knew until the completion of the study which treatment regimen the patients were receiving during each 16‐weeks period." </p> <p><b>Comment</b>: unclear if "end of the study" meant the end of the treatment period or after outcome analysis </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "...neither the patient nor the investigators knew until the completion of the study which treatment regimen the patients were receiving during each 16‐weeks period." </p> <p><b>Comment</b>: unclear if "end of the study" meant the end of the treatment period or after outcome analysis </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data on weight gain were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: outcome data were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data on insulin dose were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: all outcomes of interest were reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: funded by a pharmaceutical company </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Schiel 2007 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Parallel randomised controlled clinical trial</b> </p> <p><b>Randomisation ratio: 1:1:1</b> </p> <p><b>Superiority design</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Inclusion criteria</b>: people with type 2 diabetes with inadequate glycaemic control (HbA1c ≥ 8.0% or FBG ≥ 6.6 mmol/L) on premix insulin therapy (≤ 5 years), diabetes duration &gt; 5 years, BMI 27‐35 </p> <p><b>Exclusion criteria</b>: impaired hepatic or renal function, pregnancy, unable to understand the study, to cope or attend follow‐up visits </p> <p><b>Diagnostic criteria</b>: not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Number of study centres</b>: 1 </p> <p><b>Treatment before study</b>: mix insulin 75/25 or 70/30 A: 77.6 (32.1) , B: 64.9 (32.1), C: 65.2 (34.2) IU/day </p> <p><b>Titration period</b>: 4 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Primary outcome(s)</b> (as stated in the publication): fasting blood glucose, HbA1c, treatment satisfaction, hypoglycaemia, adverse events, blood pressure, creatinine, liver enzymes </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Total study duration</b>: 20 weeks (4 + 16 wks) </p> <p><b>Run‐in period:</b> 4 weeks </p> <p><b>Study terminated early (for benefit/because of adverse events):</b> no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Language of publication</b>: English </p> <p><b>Funding source</b>: Sanofi‐Aventis </p> <p><b>Publication status</b>: peer review journal </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim of study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Quote from publication: "To establish whether insulin plus OADs is effective in type 2 diabetes patients previously poorly controlled on premixed insulin therapy." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "Randomization was performed..." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "Randomization was performed by a central computer and patients were assigned (1:1:1) to one of the three treatment groups." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "In a open, controlled, randomised, parallel‐group, single‐centre, 16‐weeks pilot study..." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Health‐related quality of life, patient satisfaction </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "In a open, controlled, randomised, parallel‐group, single‐centre, 16‐weeks pilot study..." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "In a open, controlled, randomised, parallel‐group, single‐centre, 16‐weeks pilot study..." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "In a open, controlled, randomised, parallel‐group, single‐centre, 16‐weeks pilot study..." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "In a open, controlled, randomised, parallel‐group, single‐centre, 16‐weeks pilot study..." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Health‐related quality of life, patient satisfaction </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "In a open, controlled, randomised, parallel‐group, single‐centre, 16‐weeks pilot study..." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "In a open, controlled, randomised, parallel‐group, single‐centre, 16‐weeks pilot study..." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "In a open, controlled, randomised, parallel‐group, single‐centre, 16‐weeks pilot study..." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data on weight gain and hypoglycaemia were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Health‐related quality of life, patient satisfaction </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data on patient satisfaction were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: outcome data were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data on insulin dose were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: all outcomes of interest were reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: funded by a pharmaceutical company </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Simpson 1990 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Parallel randomised controlled clinical trial</b> </p> <p><b>Randomisation ratio: 1:1</b> </p> <p><b>Superiority design</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Inclusion criteria</b>: people with type 2 diabetes on insulin therapy, inadequate controlled (fasting glucose &gt; 8.0 mmol/L </p> <p><b>Exclusion criteria</b>: not stated </p> <p><b>Diagnostic criteria</b>: not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Number of study centres</b>: 1 </p> <p><b>Treatment before study</b>: intervention: 36 (10‐62) insulin , placebo: insulin 31 (14‐112) U/day. Insulin regimen: once (n = 5) or twice daily (n = 15) </p> <p><b>Titration period</b>: 2 months minimum run‐in period in which oral medication was stopped </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Primary outcome(s)</b> (as stated in the publication): serum and urinary glucoses, HbA1c, urinary C‐peptide, insulin dose, number of tablets prescribed, compliance </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Total study duration</b>: 2 months run‐in and 8 weeks intervention </p> <p><b>Run‐in period:</b> 2 months </p> <p><b>Study terminated early (for benefit/because of adverse events):</b> no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Language of publication</b>: English </p> <p><b>Funding source</b>: Farmaitalia </p> <p><b>Publication status</b>: peer‐reviewed journal </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim of study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Quote from publication: "To assess the relative contribution of endogenous insulin secretion and peripheral insulin sensitivity when SU was given in combination with insulin to 'secondary failure' type 2 diabetes patients." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "patients were randomised to receive either glipizide 10 mg twice daily or placebo, in addition to usual insulin" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: not possible to judge whether the allocation to the intervention and control group was concealed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "The treatment was blind to both the patient and investigators" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "The treatment was blind to both the patient and investigators" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "The treatment was blind to both the patient and investigators" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data on weight gain were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: outcome data were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data on insulin dose were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: all outcomes of interest were reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: funded by a pharmaceutical company </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Stenman 1988 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Cross‐over randomised controlled clinical trial</b> </p> <p><b>Randomisation ratio: 1:1</b> </p> <p><b>Superiority design</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Inclusion criteria</b>: people with type 2 diabetes failing on oral antidiabetic agents </p> <p><b>Exclusion criteria</b>: hepatic, renal or pulmonary dysfunction; secondary diabetes </p> <p><b>Diagnostic criteria</b>: not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Number of study centres</b>: 1 </p> <p><b>Treatment before study</b>: intervention: 34 (4) insulin, placebo: insulin 26 (3) U/day. Insulin regimen: once or twice daily intermediate or intermediate mixed with short‐acting insulin </p> <p><b>Titration period</b>: 4 months (2 weeks in hospital) initiation insulin therapy </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Primary outcome(s)</b> (as stated in the publication): HbA1c, fasting glucose, urinary glucose, C‐peptide after glucagon, insulin dose, lipids, body weight, free insulin </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Total study duration</b>: 8 months: 4 months run‐in and 4 months intervention </p> <p><b>Run‐in period:</b> 2 weeks </p> <p><b>Study terminated early (for benefit/because of adverse events):</b> no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Language of publication</b>: English </p> <p><b>Funding source</b>: Sigrid Juselius Foundation, Finnish Medical Association, Signe and Ane Gyllenberg foundation </p> <p><b>Publication status</b>: peer‐reviewed journal </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim of study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Quote from publication: "To examine the effect of the addition of glibenclamide to insulin therapy on glycaemic control and beta cell function." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "...the patients were randomised to a double‐blind treatment with insulin in combination with glibenclamide or insulin and placebo for four months" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: not possible to judge whether the allocation to the intervention and control group was concealed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "....the patients were randomised to a four‐months double‐blind cross‐over treatment...." </p> <p><b>Comment</b>: probably the participants and the personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "....the patients were randomised to a four‐months double‐blind cross‐over treatment...." </p> <p><b>Comment</b>: probably the participants and the personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "....the patients were randomised to a four‐months double‐blind cross‐over treatment...." </p> <p><b>Comment</b>: probably the participants and the personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data on weight gain and hypoglycaemia were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: outcome data were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data on insulin dose were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: some data were only reported graphically </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: none </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Strowig 2002 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Parallel randomised controlled clinical trial</b> </p> <p><b>Randomisation ratio: 1:1:1</b> </p> <p><b>Superiority design</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Inclusion criteria</b>: people with type 2 diabetes on insulin therapy (≥ 30 IU/day), 24‐70 years, HbA1c ≥ 7.0%, normal renal and hepatic function </p> <p><b>Exclusion criteria</b>: not stated </p> <p><b>Diagnostic criteria</b>: not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Number of study centres</b>: 1 </p> <p><b>Treatment before study</b>: metformin insulin 82.9 U/day, troglitazone insulin 96.5 U/day, control insulin 80.3 U/day. Insulin regimen: 2 or more daily, 70/30 mix insulin or intermediate and short‐acting insulin </p> <p><b>Titration period</b>: 4 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Primary outcome(s)</b> (as stated in the publication): insulin dose, lipids, HbA1c, glucose, C‐peptide, body weight, Alat, Asat, medical history, physical exam, waist‐hip measurement, 3‐day food record, serum chemistry </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Total study duration</b>: 4 weeks run‐in and 12 weeks intervention </p> <p><b>Run‐in period:</b> 4 weeks </p> <p><b>Study terminated early (for benefit/because of adverse events):</b> no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Language of publication</b>: English </p> <p><b>Funding source</b>: Bristol Myers Squibb </p> <p><b>Publication status</b>: peer‐reviewed journal </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim of study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Quote from publication: "To evaluate the safety and efficacy of treatment with insulin alone, insulin plus metformin, or insulin plus troglitazone for 4 months in type 2 DM." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "Subjects ... were randomly assigned ..." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "Random assignment was determined by the sponsor who provided sealed sequentially numbered envelopes" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "...were randomly assigned in an unmasked fashion..." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "...were randomly assigned in an unmasked fashion..." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "...were randomly assigned in an unmasked fashion..." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "...were randomly assigned in an unmasked fashion..." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "...were randomly assigned in an unmasked fashion..." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "...were randomly assigned in an unmasked fashion..." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data on adverse events were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: outcome data were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data on insulin dose were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: medical history and physical exam were not reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: funded by a pharmaceutical company </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Wulffelé 2002 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Parallel randomised controlled clinical trial</b> </p> <p><b>Randomisation ratio: 1:1</b> </p> <p><b>Superiority design</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Inclusion criteria</b>: people with type 2 diabetes on insulin therapy </p> <p><b>Exclusion criteria</b>: significant surgery within 3 months before entry into the study, major organ or system disease, medication use affecting glucose metabolism or sulphonylurea activity </p> <p><b>Diagnostic criteria</b>: not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Number of study centres</b>: 3 </p> <p><b>Treatment before study</b>: intervention: 71 (33) insulin, placebo: insulin 70 (33) U/day. Insulin regimen: 4 times daily intermediate plus short‐acting insulin or twice daily mix‐insulin </p> <p><b>Titration period</b>: 12 weeks (optimisation of insulin therapy, cessation of metformin, cessation of antihypertensive and lipid‐lowering medication) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Primary outcome(s)</b> (as stated in the publication): glucose, HbA1c, lipids, insulin dose, blood pressure, weight, BMI, waist‐hip‐ratio </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Total study duration</b>: 16 weeks </p> <p><b>Run‐in period:</b> 12 weeks </p> <p><b>Study terminated early (for benefit/because of adverse events):</b> no (results of the interim analysis) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Language of publication</b>: English </p> <p><b>Funding source</b>: Byk, Lifescan, Merck Lipha, MSD, Novo Nordsik </p> <p><b>Publication status</b>: peer‐reviewed journal </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim of study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Quote from publication: "To investigate the metabolic effects of metformin, as compared with placebo, in type 2 diabetes patients intensively treated with insulin." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "...all subject were randomly assigned..." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: not possible to judge whether the allocation to the intervention and control group was concealed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "...all subjects were randomly assigned in a double‐blind fashion..." </p> <p><b>Comment</b>: probably the participants and the personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "...all subjects were randomly assigned in a double‐blind fashion..." </p> <p><b>Comment</b>: probably the participants and the personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "...all subjects were randomly assigned in a double‐blind fashion..." </p> <p><b>Comment</b>: probably the participants and the personnel were blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear if the outcome assessor was blinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data on adverse events were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: outcome data were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data on insulin dose were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: all outcomes of interest were reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: funded by a pharmaceutical company </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Yilmaz 2007 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Parallel randomised controlled clinical trial</b> </p> <p><b>Randomisation ratio: 1:1:1</b> </p> <p><b>Superiority design</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Inclusion criteria</b>: people with poorly controlled type 2 diabetes on insulin monotherapy </p> <p><b>Exclusion criteria</b>: severe hypertension, repeated hypoglycaemic episodes, severe cardiovascular and cerebrovascular disease, renal or hepatic failure, acute diabetic complications, incipient heart failure, pregnancy, breastfeeding </p> <p><b>Diagnostic criteria</b>: not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Number of study centres</b>: 1 </p> <p><b>Treatment before study</b>: insulin MIX 30/70 aspart/NPH </p> <p><b>Titration period</b>: not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Primary outcome(s)</b> (as stated in the publication): change in HbA1c </p> <p><b>Secondary outcomes</b> (as stated in the publication): changes in insulin dosage, body weight, waist‐to‐hip ratio, lipids </p> <p><b>ADDITIONAL OUTCOMES</b>: incidence of hypoglycaemia and side effects </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Total study duration</b>: 6 months </p> <p><b>Run‐in period</b>: unclear </p> <p><b>Study terminated early (for benefit/because of adverse events):</b> no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Language of publication</b>: English </p> <p><b>Funding source</b>: not stated </p> <p><b>Publication status</b>: peer‐reviewed journal </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim of study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Quote from publication: "To investigate the glucose lowering effects of insulin alone, insulin plus metformin, insulin plus rosiglitazone, or insulin plus acarbose in subjects with type 2 diabetes mellitus and determine the type of treatment that would influence the serum level of total cholesterol, LDL‐C, HDL‐C, CRP and fibrinogen in these patients." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "After the initial assessment, subjects were randomly assigned to continue insulin therapy alone, or add acarbose (300 mg/day), or metformin (1,700 mg/day), or rosiglitazone (8 mg/day) to insulin therapy." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: not possible to judge whether the allocation to the intervention and control group was concealed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear, not described </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear, not described </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear, not described </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear, not described </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear, not described </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: unclear, not described </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data on weight gain were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> HbA1c, FPG, lipids </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: outcome data were collected and reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> Insulin dose </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: data on insulin dose were reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: all outcomes of interest were reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comment</b>: funding not disclosed; differences in baseline data between groups; people with heart failure excluded </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Note: where the judgement is 'Unclear' and the description is blank, the study did not report that particular outcome. </p> <p>NPH: Neutral Protamine Hagedorn</p> </div> </div> </p> </section> <section class="characteristicsOfExcludedStudies" lang=""> <div class="section-header" id="CD006992-sec2-0030"> <h3 class="title">Characteristics of excluded studies [ordered by study ID]</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a href="#CD006992-sec2-0029" class="jump-to">included studies</a></li> <li><a href="#CD006992-sec2-0031" class="jump-to">awaiting classification</a></li> <li><a href="#CD006992-sec2-0032" class="jump-to">ongoing studies</a></li> </ul> </div> </div> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Reason for exclusion</p> </td> </tr> </thead> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0038">Abraira 1998</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mixed population: insulin‐naive and previously insulin‐treated</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0039">Al‐Shaikh 2006</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0040">Altuntas 2003</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0041">Bachman 1988</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0042">Barranco 2006</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No insulin therapy arm</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0043">Berhanu 2007</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Impossible to analyse subgroup of insulin‐users separately</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0044">Bianchi 1996</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Trial on combination of benfluorex with insulin</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0045">Buse 1998</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Use of troglitazone (off the market)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0046">Carta 1984</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0047">Castillo 1987</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0048">Charbonnel 2010</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Impossible to analyse subgroup of insulin‐users separately</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0049">Chazan 2001</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0050">Chow1995</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0051">Clauson 1995</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0052">Cortes 1993</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Well‐controlled population</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0053">Dashora 2007</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Impossible to analyse subgroup of insulin‐users separately</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0054">Davidson 2006</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No arm without oral agent or placebo</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0055">De Luis 2001</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No RCT</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0056">Douek 2005</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0057">Fonseca 2006</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0058">Fonseca 2008</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Observational phase of RCT</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0059">Garg 2007</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No RCT</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0060">Gerstein 2006</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0061">Goudswaard 2004a</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0062">Greco 1998</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No RCT</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0063">Groop 1984</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0064">Groop 1991</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0065">Gutniak 1987</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0066">Hamelbeck 1982</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0067">Hermanns 2004</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Follow‐up less than 2 months</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0068">Hollander 2003</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Adding of non‐oral agent pramlintide</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0069">Hollander 2003a</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Adding of non‐oral agent pramlintide</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0070">Hollander 2004</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Adding of non‐oral agent pramlintide</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0071">Hollander 2007</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Adding of rosiglitazone (off the market)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0072">Holman 1987</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0073">Home 2007</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0074">Inoue1998</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0075">Jacob 2007</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Impossible to analyse subgroup of insulin‐users separately</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0076">Jacober 2006</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0077">Janka 2005</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0078">Janka 2007</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0079">Juurinen 2008</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No RCT</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0080">Juurinen 2009</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Impossible to analyse subgroup of insulin‐users separately</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0081">Kabadi 2003</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0082">Kanda 1996</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0083">Kandalintseva 2008</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Rosiglitazone combination therapy (off the market)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0084">Karlander 1991</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0085">Kilo 2003</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0086">Kokic 2003</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0087">Kothny 2013</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Impossible to analyse subgroup of insulin‐users separately</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0088">Kvapil 2006</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0089">LAPToP 2004</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0090">Lins 1988</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0091">Liu 2003</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Rosiglitazone combination therapy (off the market)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0092">Lotz 1988</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0093">Lund 2009</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0094">Lundershausen 1987</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0095">Makimattila 1999</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0096">Mohan 1990</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No RCT</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0097">Morrow 2011</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Combination with ligarglutide (non‐oral agent)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0098">Olsson 2002</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0099">Ose 2005</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not RCT</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0100">Ozbek 2006</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Well‐controlled population</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0101">Pan 2007</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0102">Peacock 1984</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0103">Peyrot 2008</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Addition of a non‐oral agent pramlintide</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0104">Ponssen 2000</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mixed group: insulin‐naive and previously insulin‐treated participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0105">Pontiroli 1990</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0106">Poulsen 2003</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Control group mixed: insulin‐ and insulin + metformin‐treated</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0107">Raskin 2001</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Addition of rosiglitazone (off the market)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0108">Ravnik 1989</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0109">Ravnik 1995</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0110">Raz 2005</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0111">Riddle 1989</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mixed group: insulin‐naive and previously insulin‐treated participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0112">Riddle 1992</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0113">Riddle 1998</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0114">Riddle 2007</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Adding of a non‐oral agent pramlintide</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0115">Rosak 1985</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Follow‐up less than 2 months</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0116">Sachse 1984</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0117">Sangiorgio 2000</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not RCT</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0118">Schmidt 1986</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0119">Schnell 2006</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0120">Schwartz 1998</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Use of troglitazone (off the market)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0121">Sun 1995</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0122">Tamemoto 2007</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0123">Vilsboll 2010</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Impossible to analyse subgroup of insulin‐users separately</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0124">Willey 1994</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mixed group: insulin‐ and insulin + metformin‐treated participants; trial on combination of insulin and dexfenfluramine </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0125">Wolffenbuttel 1991</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0126">Wolffenbuttel 1999</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0127">Wong 2005</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Special population: type 2 diabetes participants with peritoneal dialysis</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0128">Wright 2002</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Newly diagnosed type 2 diabetes participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0129">Yamada 2007</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No arm without oral agent or placebo</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0130">Yki‐Jarvinen 1992</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0131">Yki‐Jarvinen 1999</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0132">Yki‐Jarvinen 2013</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Impossible to analyse subgroup of insulin‐users separately</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0133">Yokoyama 2011</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Two arms: continuation and discontinuation of glimepiride</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006992-bbs2-0134">Zargar 2002</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin‐naive participants</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>RCT: randomised controlled trial</p> </div> </div> </p> </section> <section class="characteristicsOfAwaitingStudies" lang=""> <div class="section-header" id="CD006992-sec2-0031"> <h3 class="title">Characteristics of studies awaiting assessment [ordered by study ID]</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a href="#CD006992-sec2-0029" class="jump-to">included studies</a></li> <li><a href="#CD006992-sec2-0030" class="jump-to">excluded studies</a></li> <li><a href="#CD006992-sec2-0032" class="jump-to">ongoing studies</a></li> </ul> </div> </div> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Fargren 2014 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>A single‐centre, double‐blind, randomised, placebo‐controlled cross‐over study</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants with type 2 diabetes, mean age 59 + 6 (SD) years and mean HbA1c 7.7% + 0.8%, treated with exogenous insulin with or without oral antihyperglycaemic agents </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants received vildagliptin (50 mg twice a day) or placebo as add‐on to insulin for 4 weeks in random order with a 4‐week washout in between </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Glucose, glucagon</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Kaku 2014 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Randomised, double‐blind, 12‐week comparative trial, followed by a 40‐week, open‐label phase </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>179 participants with type 2 diabetes</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Alogliptin and insulin versus placebo and insulin</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>HbA1c, body weight, hypoglycaemia</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Mathieu 2015 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Multicenter, randomised, double‐blind, placebo‐controlled, 24‐week clinical trial</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>660 participants with type 2 diabetes and inadequate glycaemic control on insulin, with or without metformin (&gt; 1500 mg/day) or sulfonylurea, for &gt; 10 weeks. Participants could remain on metformin but not sulphonylurea after randomisation </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Sitagliptin 100 mg/day or placebo was administered concurrently with insulin glargine titration, targeting a fasting glucose of 4.0‐5.6 mmol/L (72‐100 mg/dL) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin dose, HbA1c, hypoglycaemia, adverse effects</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subgroup analysis with insulin monotherapy needs to be checked</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">McGill 2015 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Data for participants in two phase 3 trials with linagliptin who were receiving insulin were analysed separately (n = 811) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Type 2 diabetes mellitus participants with chronic kidney disease</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Linagliptin + insulin vs placebo + insulin</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>HbA1c, (severe) hypoglycaemia</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Inadequate control needs to be checked</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Ning 2014 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Multicentre, double‐blind, placebo‐controlled trial</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants with type 2 diabetes inadequately controlled (HbA1c 7.5%‐11.0%) on stable therapy with long‐acting, intermediate‐acting or premixed insulin, with or without concomitant metformin </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Vildagliptin 50 mg twice a day (n = 146) or placebo (n = 147)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>HbA1c, fasting blood glucose, BMI</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Need to determine if subgroup analysis with insulin monotherapy is possible</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Rosenstock 2009 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>26‐week, double‐blind, placebo‐controlled study</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>People with type 2 diabetes inadequately controlled with insulin alone or combined with metformin </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants received alogliptin 12.5 mg (n = 131), alogliptin 25 mg (n = 129) or placebo (n = 130) once daily, as add‐on to stable insulin therapy with or without metformin </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>HbA1c, body weight, hypoglycaemia, incidences of overall adverse events, and of gastrointestinal, dermatological and infection‐related events </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Need to determine whether subgroup analysis for insulin monotherapy group is possible</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Sato 2015 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>24‐week, prospective, randomised, open‐labelled, controlled trial</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants with type 2 diabetes who were suboptimally controlled despite receiving at least twice‐daily injections of insulin were enrolled in the trial </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The participants were randomised to continuation of insulin treatment (insulin group) or addition of sitagliptin 50 mg‐100 mg daily to insulin treatment </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>HbA1c, body weight, hypoglycaemia, treatment satisfaction</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Sheu 2015 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Randomised double‐blind trial</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Asian participants with type 2 diabetes mellitus inadequately controlled by basal insulin with/without oral agents </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Treatment with linagliptin 5 mg once daily or placebo. Basal insulin dose remained stable for 24 weeks, after which adjustments could be made according to the investigator's discretion to improve glycaemic control </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>HbA1c, adverse events</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Need to determine if subgroup analysis with insulin monotherapy is possible</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Srivanichakorn 2015 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8‐week randomised controlled trial</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants with type 2 diabetes who had been treated with insulin for at least 3 years plus moderate to high doses of sulphonylureas </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Withdrawal of sulphonylureas (insulin monotherapy) (n = 16) or continuation (n = 16) of sulphonylureas </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>HbA1c, insulin secretion</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Need to determine whether participants were adequately controlled</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Takahashi 2015 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Randomised controlled trial</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Type 2 diabetes participants receiving twice‐daily injections of premix analog insulin</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Group A, in which participants were switched to long‐acting insulin glargine at 80% of the insulin dose in the previous treatment regimen (23 participants), or group B (21 participants), given 50% of the previous dose, concurrently with the oral dipeptidyl‐peptidase 4 inhibitor sitagliptin </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>HbA1c, lipids, hyperglycaemia and nocturnal hypoglycaemia</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Need to determine if participants were adequately controlled before randomisation</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>BMI: body mass index; HbA1c: glycosylated haemoglobin A1c</p> </div> </div> </p> </section> <section class="characteristicsOfOngoingStudies" lang=""> <div class="section-header" id="CD006992-sec2-0032"> <h3 class="title">Characteristics of ongoing studies [ordered by study ID]</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a href="#CD006992-sec2-0029" class="jump-to">included studies</a></li> <li><a href="#CD006992-sec2-0030" class="jump-to">excluded studies</a></li> <li><a href="#CD006992-sec2-0031" class="jump-to">awaiting classification</a></li> </ul> </div> </div> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">EUCTR2011‐004622‐96‐ES </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Trial name or title</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study to test the safety, tolerability, and effectiveness of sitagliptin when compared to placebo in reducing the amount of insulin (with or without metformin) needed per day, to control blood sugar, over a 24‐week period </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>A phase III, multicenter, randomised, double‐blind, placebo‐controlled clinical trial to study the safety and insulin‐sparing efficacy of the addition of sitagliptin in ‐ Study to test the safety, tolerability, and effectiveness of sitagliptin when compared to placebo </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants with type 2 diabetes mellitus who have inadequate glycaemic control on insulin alone or in combination with metformin </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Sitagliptin compared with placebo on the change in insulin dose in IU per day in people with type 2 diabetes mellitus (T2DM) with inadequate glycaemic control on insulin with or without metformin, who titrate insulin glargine (treat‐to‐target) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Daily insulin dose, HbA1c, fasting plasma glucose, body weight</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Starting date</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>23 December 2011</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Contact information</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Merck Sharp &amp; Dohme Corp., a subsidiary of Merck &amp; Co., Inc</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">IRCT201204229536N1 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Trial name or title</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The comparison glycaemic control in two group patient treated with insulin alone and insulin plus sulfonylurea [<i>title as provided by study investigators]</i> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin 0.2 U/kg /day and sulphonylurea with previous dose vs insulin 0.3 U/kg /day</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blood glucose, body weight, hypoglycaemic events</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Starting date</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Contact information</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">JPRN‐UMIN000011851 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Trial name or title</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The efficacy of vildagliptin on type 2 diabetic patients with basal‐bolus insulin therapy in the short‐term hospitalisation (single‐center, randomised, open‐label, controlled study) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Single‐center, randomised, open‐label, controlled study</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Type 2 diabetes participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin + vildagliptin vs insulin alone</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blood glucose, lipids</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Starting date</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Contact information</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">JPRN‐UMIN000018784 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Trial name or title</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comparison of the effects of insulin monotherapy and combination therapy with ipragliflozin and insulin on glucose toxicity in type 2 diabetes mellitus : a randomised controlled trial </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not specified</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Combination therapy with ipragliflozin and insulin group. Oral administration of 50 mg ipragliflozin once a day, after breakfast. Multiple injection of rapid‐acting insulin and long‐acting insulin. Insulin monotherapy group: multiple injection of rapid‐acting insulin and long‐acting insulin </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Glucose, insulin dose, lipids, body weight</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Starting date</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Contact information</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">NCT00329225 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Trial name or title</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Rosiglitazone in subjects with type 2 diabetes mellitus who are inadequately controlled on insulin </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>A multicenter, randomised, double‐blind, parallel‐group, placebo‐controlled clinical evaluation of insulin plus rosiglitazone (2 mg and 4 mg) compared to insulin plus placebo for 24 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants with type 2 diabetes mellitus who are inadequately controlled on insulin</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Rosiglitazone + insulin vs insulin + placebo</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>HbA1c, fasting plasma glucose, lipids</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Starting date</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>22 May 2006</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Contact information</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>GlaxoSmithKline</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">NCT00757588 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Trial name or title</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Safety and efficacy of saxagliptin plus insulin with or without metformin</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Multicenter double‐blind parallel‐group randomised controlled trial, phase 3 trial</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Type 2 diabetes with inadequate glycaemic control</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Saxagliptin (5 mg) + insulin vs placebo for saxagliptin + insulin</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>HbA1c, fasting glucose, insulin dose, blood pressure, (serious) adverse events (hypoglycaemia)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Starting date</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>22 September 2008</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Contact information</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>AstraZeneca</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">NCT02104804 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Trial name or title</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Evaluate the efficacy and aafety of aaxagliptin added to insulin monotherapy or to insulin combined with metformin in Chinese subjects with type 2 diabetes who have inadequate glycaemic control </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Double‐blind parallel‐group randomised controlled trial, phase 3 trial</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Type 2 diabetes participants who have inadequate glycaemic control on insulin alone or on insulin in combination with metformin </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Saxagliptin (5 mg) + insulin vs placebo for saxagliptin + insulin</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>HbA1c, fasting glucose, insulin dose, (serious) adverse events (hypoglycaemia)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Starting date</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2 April 2014</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Contact information</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>AstraZeneca</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>HbA1c: glycosylated haemoglobin A1c</p> </div> </div> </p> </section> </section> <section class="dataAndAnalyses" id="dataAndAnalyses"> <section class="dataAndAnalyses" lang="en"> <div class="section-header section-collapse-header" id="CD006992-sec1-0011"> <h2 class="title section-collapse-title">Data and analyses<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <div class="table" id="CD006992-tbl-0006"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 1.</span>&nbsp;<span class="table-title">Insulin monotherapy versus insulin plus sulphonylurea</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Weight (change from baseline) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>220</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.57 [‐2.52, 3.67]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006992-fig-00101"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-001-01.png?filename=nCD006992-CMP-001-01.ppt&amp;title=1.1&amp;caption=Comparison%201%20Insulin%20monotherapy%20versus%20insulin%20plus%20sulphonylurea%2C%20Outcome%201%20Weight%20%28change%20from%20baseline%29.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.1</div> </div> <hr class="top"><img data-id="CD006992-fig-00101" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-001-01.png" alt="Comparison 1 Insulin monotherapy versus insulin plus sulphonylurea, Outcome 1 Weight (change from baseline)."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 Insulin monotherapy versus insulin plus sulphonylurea, Outcome 1 Weight (change from baseline). </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.1 Parallel‐group trials</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>86</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.12 [‐3.08, 5.32]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.2 Cross‐over trials</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>134</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.08 [‐4.66, 4.50]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Weight (change from baseline) [kg] GIV <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.13 [‐0.57, 0.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006992-fig-00102"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-001-02.png?filename=nCD006992-CMP-001-02.ppt&amp;title=1.2&amp;caption=Comparison%201%20Insulin%20monotherapy%20versus%20insulin%20plus%20sulphonylurea%2C%20Outcome%202%20Weight%20%28change%20from%20baseline%29%20%5Bkg%5D%20GIV.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.2</div> </div> <hr class="top"><img data-id="CD006992-fig-00102" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-001-02.png" alt="Comparison 1 Insulin monotherapy versus insulin plus sulphonylurea, Outcome 2 Weight (change from baseline) [kg] GIV."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 Insulin monotherapy versus insulin plus sulphonylurea, Outcome 2 Weight (change from baseline) [kg] GIV. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.1 Parallel‐group</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.12 [‐3.08, 5.32]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.2 Cross‐over group</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.14 [‐0.59, 0.31]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 HbA1c (change from baseline) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>316</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.02 [‐1.56, ‐0.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006992-fig-00103"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-001-03.png?filename=nCD006992-CMP-001-03.ppt&amp;title=1.3&amp;caption=Comparison%201%20Insulin%20monotherapy%20versus%20insulin%20plus%20sulphonylurea%2C%20Outcome%203%20HbA1c%20%28change%20from%20baseline%29.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.3</div> </div> <hr class="top"><img data-id="CD006992-fig-00103" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-001-03.png" alt="Comparison 1 Insulin monotherapy versus insulin plus sulphonylurea, Outcome 3 HbA1c (change from baseline)."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 Insulin monotherapy versus insulin plus sulphonylurea, Outcome 3 HbA1c (change from baseline). </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.1 Parallel‐group trials</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>150</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.25 [‐2.57, 0.06]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.2 Cross‐over trials</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>166</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.97 [‐1.38, ‐0.56]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">4 HbA1c (change from baseline) GIV <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.03 [‐1.58, ‐0.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006992-fig-00104"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-001-04.png?filename=nCD006992-CMP-001-04.ppt&amp;title=1.4&amp;caption=Comparison%201%20Insulin%20monotherapy%20versus%20insulin%20plus%20sulphonylurea%2C%20Outcome%204%20HbA1c%20%28change%20from%20baseline%29%20GIV.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.4</div> </div> <hr class="top"><img data-id="CD006992-fig-00104" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-001-04.png" alt="Comparison 1 Insulin monotherapy versus insulin plus sulphonylurea, Outcome 4 HbA1c (change from baseline) GIV."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 Insulin monotherapy versus insulin plus sulphonylurea, Outcome 4 HbA1c (change from baseline) GIV. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4.1 Parallel‐group trials</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.25 [‐2.57, 0.06]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4.2 Cross‐over trials</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.97 [‐1.42, ‐0.52]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">5 Fasting glucose (change from baseline) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>205</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐2.28 [‐3.23, ‐1.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006992-fig-00105"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-001-05.png?filename=nCD006992-CMP-001-05.ppt&amp;title=1.5&amp;caption=Comparison%201%20Insulin%20monotherapy%20versus%20insulin%20plus%20sulphonylurea%2C%20Outcome%205%20Fasting%20glucose%20%28change%20from%20baseline%29.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.5</div> </div> <hr class="top"><img data-id="CD006992-fig-00105" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-001-05.png" alt="Comparison 1 Insulin monotherapy versus insulin plus sulphonylurea, Outcome 5 Fasting glucose (change from baseline)."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 Insulin monotherapy versus insulin plus sulphonylurea, Outcome 5 Fasting glucose (change from baseline). </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5.1 Parallel‐group trials</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>71</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.97 [‐2.56, 0.61]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5.2 Cross‐over trials</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>134</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐2.72 [‐3.66, ‐1.78]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">6 Fasting plasma glucose (change from baseline) [mmol/L] GIV <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐2.29 [‐3.23, ‐1.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006992-fig-00106"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-001-06.png?filename=nCD006992-CMP-001-06.ppt&amp;title=1.6&amp;caption=Comparison%201%20Insulin%20monotherapy%20versus%20insulin%20plus%20sulphonylurea%2C%20Outcome%206%20Fasting%20plasma%20glucose%20%28change%20from%20baseline%29%20%5Bmmol%2FL%5D%20GIV.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.6</div> </div> <hr class="top"><img data-id="CD006992-fig-00106" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-001-06.png" alt="Comparison 1 Insulin monotherapy versus insulin plus sulphonylurea, Outcome 6 Fasting plasma glucose (change from baseline) [mmol/L] GIV."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 Insulin monotherapy versus insulin plus sulphonylurea, Outcome 6 Fasting plasma glucose (change from baseline) [mmol/L] GIV. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6.1 Parallel‐group</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.02 [‐2.48, 0.44]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6.2 Cross‐over group</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐2.73 [‐3.70, ‐1.75]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">7 Total cholesterol (change from baseline) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>132</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.03 [‐0.38, 0.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006992-fig-00107"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-001-07.png?filename=nCD006992-CMP-001-07.ppt&amp;title=1.7&amp;caption=Comparison%201%20Insulin%20monotherapy%20versus%20insulin%20plus%20sulphonylurea%2C%20Outcome%207%20Total%20cholesterol%20%28change%20from%20baseline%29.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.7</div> </div> <hr class="top"><img data-id="CD006992-fig-00107" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-001-07.png" alt="Comparison 1 Insulin monotherapy versus insulin plus sulphonylurea, Outcome 7 Total cholesterol (change from baseline)."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 Insulin monotherapy versus insulin plus sulphonylurea, Outcome 7 Total cholesterol (change from baseline). </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7.1 Parallel‐group trials</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>22</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.26 [‐0.49, 1.01]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7.2 Cross‐over trials</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>110</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.11 [‐0.50, 0.29]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">8 Total cholesterol (change from baseline) [mmol/l] GIV <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.04 [‐0.17, 0.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006992-fig-00108"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-001-08.png?filename=nCD006992-CMP-001-08.ppt&amp;title=1.8&amp;caption=Comparison%201%20Insulin%20monotherapy%20versus%20insulin%20plus%20sulphonylurea%2C%20Outcome%208%20Total%20cholesterol%20%28change%20from%20baseline%29%20%5Bmmol%2Fl%5D%20GIV.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.8</div> </div> <hr class="top"><img data-id="CD006992-fig-00108" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-001-08.png" alt="Comparison 1 Insulin monotherapy versus insulin plus sulphonylurea, Outcome 8 Total cholesterol (change from baseline) [mmol/l] GIV."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 Insulin monotherapy versus insulin plus sulphonylurea, Outcome 8 Total cholesterol (change from baseline) [mmol/l] GIV. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8.1 Parallel‐group</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.26 [‐0.49, 1.01]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8.2 Cross‐over group</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.05 [‐0.18, 0.08]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">9 HDL‐cholesterol (change from baseline) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>108</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.07 [‐0.17, 0.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006992-fig-00109"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-001-09.png?filename=nCD006992-CMP-001-09.ppt&amp;title=1.9&amp;caption=Comparison%201%20Insulin%20monotherapy%20versus%20insulin%20plus%20sulphonylurea%2C%20Outcome%209%20HDL%E2%80%90cholesterol%20%28change%20from%20baseline%29.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.9</div> </div> <hr class="top"><img data-id="CD006992-fig-00109" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-001-09.png" alt="Comparison 1 Insulin monotherapy versus insulin plus sulphonylurea, Outcome 9 HDL‐cholesterol (change from baseline)."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 Insulin monotherapy versus insulin plus sulphonylurea, Outcome 9 HDL‐cholesterol (change from baseline). </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9.1 Parallel‐group trials</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>22</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.0 [‐0.27, 0.27]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9.2 Cross‐over trials</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>86</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.08 [‐0.20, 0.04]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">10 HDL‐Cholesterol (change from baseline mmol/L) GIV <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.05 [‐0.15, 0.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006992-fig-00110"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-001-10.png?filename=nCD006992-CMP-001-10.ppt&amp;title=1.10&amp;caption=Comparison%201%20Insulin%20monotherapy%20versus%20insulin%20plus%20sulphonylurea%2C%20Outcome%2010%20HDL%E2%80%90Cholesterol%20%28change%20from%20baseline%20mmol%2FL%29%20GIV.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.10</div> </div> <hr class="top"><img data-id="CD006992-fig-00110" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-001-10.png" alt="Comparison 1 Insulin monotherapy versus insulin plus sulphonylurea, Outcome 10 HDL‐Cholesterol (change from baseline mmol/L) GIV."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 Insulin monotherapy versus insulin plus sulphonylurea, Outcome 10 HDL‐Cholesterol (change from baseline mmol/L) GIV. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10.1 Parallel‐group</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.0 [‐0.27, 0.27]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10.2 Cross‐over group</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.07 [‐0.19, 0.06]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">11 Triglyceride (change from baseline) [mmol/L] GIV <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.04 [‐0.21, 0.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006992-fig-00111"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-001-11.png?filename=nCD006992-CMP-001-11.ppt&amp;title=1.11&amp;caption=Comparison%201%20Insulin%20monotherapy%20versus%20insulin%20plus%20sulphonylurea%2C%20Outcome%2011%20Triglyceride%20%28change%20from%20baseline%29%20%5Bmmol%2FL%5D%20GIV.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.11</div> </div> <hr class="top"><img data-id="CD006992-fig-00111" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-001-11.png" alt="Comparison 1 Insulin monotherapy versus insulin plus sulphonylurea, Outcome 11 Triglyceride (change from baseline) [mmol/L] GIV."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 Insulin monotherapy versus insulin plus sulphonylurea, Outcome 11 Triglyceride (change from baseline) [mmol/L] GIV. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11.1 Parallel‐group</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.24 [‐1.37, 0.89]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11.2 Cross‐over group</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.05 [‐0.20, 0.30]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">12 Triglycerides (change from baseline) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>132</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.03 [‐0.17, 0.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006992-fig-00112"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-001-12.png?filename=nCD006992-CMP-001-12.ppt&amp;title=1.12&amp;caption=Comparison%201%20Insulin%20monotherapy%20versus%20insulin%20plus%20sulphonylurea%2C%20Outcome%2012%20Triglycerides%20%28change%20from%20baseline%29.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.12</div> </div> <hr class="top"><img data-id="CD006992-fig-00112" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-001-12.png" alt="Comparison 1 Insulin monotherapy versus insulin plus sulphonylurea, Outcome 12 Triglycerides (change from baseline)."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 Insulin monotherapy versus insulin plus sulphonylurea, Outcome 12 Triglycerides (change from baseline). </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12.1 Parallel‐group trials</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>22</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.24 [‐1.37, 0.89]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12.2 Cross‐over trials</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>110</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.03 [‐0.16, 0.23]</p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD006992-tbl-0007"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 2.</span>&nbsp;<span class="table-title">Insulin monotherapy versus insulin plus metformin</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Weight (change from baseline) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>615</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐2.12 [‐3.19, ‐1.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006992-fig-00201"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-002-01.png?filename=nCD006992-CMP-002-01.ppt&amp;title=2.1&amp;caption=Comparison%202%20Insulin%20monotherapy%20versus%20insulin%20plus%20metformin%2C%20Outcome%201%20Weight%20%28change%20from%20baseline%29.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 2.1</div> </div> <hr class="top"><img data-id="CD006992-fig-00201" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-002-01.png" alt="Comparison 2 Insulin monotherapy versus insulin plus metformin, Outcome 1 Weight (change from baseline)."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 2 Insulin monotherapy versus insulin plus metformin, Outcome 1 Weight (change from baseline). </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.1 Parallel‐group trials</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>577</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐2.45 [‐3.61, ‐1.29]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.2 Cross‐over trials</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>38</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.5 [‐2.11, 1.11]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Weight (change from baseline) [kg] GIV <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐2.11 [‐3.18, ‐1.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006992-fig-00202"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-002-02.png?filename=nCD006992-CMP-002-02.ppt&amp;title=2.2&amp;caption=Comparison%202%20Insulin%20monotherapy%20versus%20insulin%20plus%20metformin%2C%20Outcome%202%20Weight%20%28change%20from%20baseline%29%20%5Bkg%5D%20GIV.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 2.2</div> </div> <hr class="top"><img data-id="CD006992-fig-00202" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-002-02.png" alt="Comparison 2 Insulin monotherapy versus insulin plus metformin, Outcome 2 Weight (change from baseline) [kg] GIV."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 2 Insulin monotherapy versus insulin plus metformin, Outcome 2 Weight (change from baseline) [kg] GIV. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.1 Parallel‐group</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐2.45 [‐3.61, ‐1.29]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.2 Cross‐over group</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.5 [‐2.05, 1.05]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 HbA1c (change from baseline) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>698</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.86 [‐1.20, ‐0.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006992-fig-00203"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-002-03.png?filename=nCD006992-CMP-002-03.ppt&amp;title=2.3&amp;caption=Comparison%202%20Insulin%20monotherapy%20versus%20insulin%20plus%20metformin%2C%20Outcome%203%20HbA1c%20%28change%20from%20baseline%29.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 2.3</div> </div> <hr class="top"><img data-id="CD006992-fig-00203" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-002-03.png" alt="Comparison 2 Insulin monotherapy versus insulin plus metformin, Outcome 3 HbA1c (change from baseline)."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 2 Insulin monotherapy versus insulin plus metformin, Outcome 3 HbA1c (change from baseline). </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.1 Parallel‐group trials</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>634</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.77 [‐1.13, ‐0.41]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.2 Cross‐over trials</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>64</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.16 [‐2.13, ‐0.19]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">4 HbA1c (change from baseline) [%] GIV <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.86 [‐1.20, ‐0.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006992-fig-00204"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-002-04.png?filename=nCD006992-CMP-002-04.ppt&amp;title=2.4&amp;caption=Comparison%202%20Insulin%20monotherapy%20versus%20insulin%20plus%20metformin%2C%20Outcome%204%20HbA1c%20%28change%20from%20baseline%29%20%5B%25%5D%20GIV.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 2.4</div> </div> <hr class="top"><img data-id="CD006992-fig-00204" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-002-04.png" alt="Comparison 2 Insulin monotherapy versus insulin plus metformin, Outcome 4 HbA1c (change from baseline) [%] GIV."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 2 Insulin monotherapy versus insulin plus metformin, Outcome 4 HbA1c (change from baseline) [%] GIV. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4.1 Parallel‐group</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.77 [‐1.13, ‐0.41]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4.2 Cross‐over group</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.16 [‐2.13, ‐0.18]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">5 Total cholesterol (change from baseline) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>651</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.25 [‐0.41, ‐0.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006992-fig-00205"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-002-05.png?filename=nCD006992-CMP-002-05.ppt&amp;title=2.5&amp;caption=Comparison%202%20Insulin%20monotherapy%20versus%20insulin%20plus%20metformin%2C%20Outcome%205%20Total%20cholesterol%20%28change%20from%20baseline%29.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 2.5</div> </div> <hr class="top"><img data-id="CD006992-fig-00205" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-002-05.png" alt="Comparison 2 Insulin monotherapy versus insulin plus metformin, Outcome 5 Total cholesterol (change from baseline)."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 2 Insulin monotherapy versus insulin plus metformin, Outcome 5 Total cholesterol (change from baseline). </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5.1 Parallel‐group trials</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>587</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.20 [‐0.38, ‐0.02]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5.2 Cross‐over trials</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>64</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.47 [‐0.85, ‐0.09]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">6 Total cholesterol (change from baseline) [mmol/L] GIV <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.29 [‐0.50, ‐0.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006992-fig-00206"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-002-06.png?filename=nCD006992-CMP-002-06.ppt&amp;title=2.6&amp;caption=Comparison%202%20Insulin%20monotherapy%20versus%20insulin%20plus%20metformin%2C%20Outcome%206%20Total%20cholesterol%20%28change%20from%20baseline%29%20%5Bmmol%2FL%5D%20GIV.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 2.6</div> </div> <hr class="top"><img data-id="CD006992-fig-00206" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-002-06.png" alt="Comparison 2 Insulin monotherapy versus insulin plus metformin, Outcome 6 Total cholesterol (change from baseline) [mmol/L] GIV."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 2 Insulin monotherapy versus insulin plus metformin, Outcome 6 Total cholesterol (change from baseline) [mmol/L] GIV. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6.1 Parallel‐group</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.20 [‐0.38, ‐0.02]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6.2 Cross‐over group</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.57 [‐0.94, ‐0.20]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">7 HDL‐cholesterol (change from baseline) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>651</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.01 [‐0.06, 0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006992-fig-00207"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-002-07.png?filename=nCD006992-CMP-002-07.ppt&amp;title=2.7&amp;caption=Comparison%202%20Insulin%20monotherapy%20versus%20insulin%20plus%20metformin%2C%20Outcome%207%20HDL%E2%80%90cholesterol%20%28change%20from%20baseline%29.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 2.7</div> </div> <hr class="top"><img data-id="CD006992-fig-00207" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-002-07.png" alt="Comparison 2 Insulin monotherapy versus insulin plus metformin, Outcome 7 HDL‐cholesterol (change from baseline)."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 2 Insulin monotherapy versus insulin plus metformin, Outcome 7 HDL‐cholesterol (change from baseline). </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7.1 Parallel‐group trials</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>587</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.00 [‐0.05, 0.05]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7.2 Cross‐over trials</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>64</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.00 [‐0.25, 0.25]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">8 HDL‐cholesterol (change from baseline) [mmol/L] <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.01 [‐0.05, 0.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006992-fig-00208"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-002-08.png?filename=nCD006992-CMP-002-08.ppt&amp;title=2.8&amp;caption=Comparison%202%20Insulin%20monotherapy%20versus%20insulin%20plus%20metformin%2C%20Outcome%208%20HDL%E2%80%90cholesterol%20%28change%20from%20baseline%29%20%5Bmmol%2FL%5D.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 2.8</div> </div> <hr class="top"><img data-id="CD006992-fig-00208" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-002-08.png" alt="Comparison 2 Insulin monotherapy versus insulin plus metformin, Outcome 8 HDL‐cholesterol (change from baseline) [mmol/L]."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 2 Insulin monotherapy versus insulin plus metformin, Outcome 8 HDL‐cholesterol (change from baseline) [mmol/L]. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8.1 Parallel‐group</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.00 [‐0.05, 0.05]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8.2 Cross‐over group</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.04 [‐0.22, 0.31]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">9 Triglycerides (change from baseline) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>651</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.09 [‐0.22, 0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006992-fig-00209"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-002-09.png?filename=nCD006992-CMP-002-09.ppt&amp;title=2.9&amp;caption=Comparison%202%20Insulin%20monotherapy%20versus%20insulin%20plus%20metformin%2C%20Outcome%209%20Triglycerides%20%28change%20from%20baseline%29.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 2.9</div> </div> <hr class="top"><img data-id="CD006992-fig-00209" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-002-09.png" alt="Comparison 2 Insulin monotherapy versus insulin plus metformin, Outcome 9 Triglycerides (change from baseline)."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 2 Insulin monotherapy versus insulin plus metformin, Outcome 9 Triglycerides (change from baseline). </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9.1 Parallel‐group trials</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>587</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.07 [‐0.24, 0.11]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9.2 Cross‐over trials</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>64</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.17 [‐0.50, 0.16]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">10 Triglyceride (change from baseline) [mmol/L] GIV <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.15 [‐0.41, 0.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006992-fig-00210"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-002-10.png?filename=nCD006992-CMP-002-10.ppt&amp;title=2.10&amp;caption=Comparison%202%20Insulin%20monotherapy%20versus%20insulin%20plus%20metformin%2C%20Outcome%2010%20Triglyceride%20%28change%20from%20baseline%29%20%5Bmmol%2FL%5D%20GIV.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 2.10</div> </div> <hr class="top"><img data-id="CD006992-fig-00210" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-002-10.png" alt="Comparison 2 Insulin monotherapy versus insulin plus metformin, Outcome 10 Triglyceride (change from baseline) [mmol/L] GIV."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 2 Insulin monotherapy versus insulin plus metformin, Outcome 10 Triglyceride (change from baseline) [mmol/L] GIV. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10.1 Parallel‐group</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.07 [‐0.24, 0.11]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10.2 Cross‐over group</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.34 [‐0.79, 0.11]</p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD006992-tbl-0008"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 3.</span>&nbsp;<span class="table-title">Insulin monotherapy versus insulin plus pioglitazone</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 HbA1c (change from baseline) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006992-fig-00301"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-003-01.png?filename=nCD006992-CMP-003-01.ppt&amp;title=3.1&amp;caption=Comparison%203%20Insulin%20monotherapy%20versus%20insulin%20plus%20pioglitazone%2C%20Outcome%201%20HbA1c%20%28change%20from%20baseline%29.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 3.1</div> </div> <hr class="top"><img data-id="CD006992-fig-00301" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-003-01.png" alt="Comparison 3 Insulin monotherapy versus insulin plus pioglitazone, Outcome 1 HbA1c (change from baseline)."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 3 Insulin monotherapy versus insulin plus pioglitazone, Outcome 1 HbA1c (change from baseline). </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Fasting glucose (change from baseline) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>624</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.07 [‐3.61, 3.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006992-fig-00302"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-003-02.png?filename=nCD006992-CMP-003-02.ppt&amp;title=3.2&amp;caption=Comparison%203%20Insulin%20monotherapy%20versus%20insulin%20plus%20pioglitazone%2C%20Outcome%202%20Fasting%20glucose%20%28change%20from%20baseline%29.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 3.2</div> </div> <hr class="top"><img data-id="CD006992-fig-00302" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-003-02.png" alt="Comparison 3 Insulin monotherapy versus insulin plus pioglitazone, Outcome 2 Fasting glucose (change from baseline)."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 3 Insulin monotherapy versus insulin plus pioglitazone, Outcome 2 Fasting glucose (change from baseline). </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Weight (change from baseline) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>288</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.79 [2.97, 4.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006992-fig-00303"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-003-03.png?filename=nCD006992-CMP-003-03.ppt&amp;title=3.3&amp;caption=Comparison%203%20Insulin%20monotherapy%20versus%20insulin%20plus%20pioglitazone%2C%20Outcome%203%20Weight%20%28change%20from%20baseline%29.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 3.3</div> </div> <hr class="top"><img data-id="CD006992-fig-00303" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-003-03.png" alt="Comparison 3 Insulin monotherapy versus insulin plus pioglitazone, Outcome 3 Weight (change from baseline)."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 3 Insulin monotherapy versus insulin plus pioglitazone, Outcome 3 Weight (change from baseline). </p> </div> </div> </div> </td> </tr> </tbody> </table> </div> <div class="table" id="CD006992-tbl-0009"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 4.</span>&nbsp;<span class="table-title">Insulin monotherapy versus insulin plus alpha‐glucosidase inhibitor</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Weight (change from baseline) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>241</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.45 [‐1.22, 0.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006992-fig-00401"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-004-01.png?filename=nCD006992-CMP-004-01.ppt&amp;title=4.1&amp;caption=Comparison%204%20Insulin%20monotherapy%20versus%20insulin%20plus%20alpha%E2%80%90glucosidase%20inhibitor%2C%20Outcome%201%20Weight%20%28change%20from%20baseline%29.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 4.1</div> </div> <hr class="top"><img data-id="CD006992-fig-00401" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-004-01.png" alt="Comparison 4 Insulin monotherapy versus insulin plus alpha‐glucosidase inhibitor, Outcome 1 Weight (change from baseline)."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 4 Insulin monotherapy versus insulin plus alpha‐glucosidase inhibitor, Outcome 1 Weight (change from baseline). </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 HbA1c (change from baseline) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>448</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.39 [‐0.54, ‐0.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006992-fig-00402"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-004-02.png?filename=nCD006992-CMP-004-02.ppt&amp;title=4.2&amp;caption=Comparison%204%20Insulin%20monotherapy%20versus%20insulin%20plus%20alpha%E2%80%90glucosidase%20inhibitor%2C%20Outcome%202%20HbA1c%20%28change%20from%20baseline%29.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 4.2</div> </div> <hr class="top"><img data-id="CD006992-fig-00402" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-004-02.png" alt="Comparison 4 Insulin monotherapy versus insulin plus alpha‐glucosidase inhibitor, Outcome 2 HbA1c (change from baseline)."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 4 Insulin monotherapy versus insulin plus alpha‐glucosidase inhibitor, Outcome 2 HbA1c (change from baseline). </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Fasting glucose (change from baseline) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>113</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.33 [‐0.74, 1.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006992-fig-00403"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-004-03.png?filename=nCD006992-CMP-004-03.ppt&amp;title=4.3&amp;caption=Comparison%204%20Insulin%20monotherapy%20versus%20insulin%20plus%20alpha%E2%80%90glucosidase%20inhibitor%2C%20Outcome%203%20Fasting%20glucose%20%28change%20from%20baseline%29.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 4.3</div> </div> <hr class="top"><img data-id="CD006992-fig-00403" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-004-03.png" alt="Comparison 4 Insulin monotherapy versus insulin plus alpha‐glucosidase inhibitor, Outcome 3 Fasting glucose (change from baseline)."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 4 Insulin monotherapy versus insulin plus alpha‐glucosidase inhibitor, Outcome 3 Fasting glucose (change from baseline). </p> </div> </div> </div> </td> </tr> </tbody> </table> </div> <div class="table" id="CD006992-tbl-0010"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 5.</span>&nbsp;<span class="table-title">Insulin monotherapy versus insulin plus DPP‐4 inhibitor</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Weight (change from baseline) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>362</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.55 [‐1.00, 1.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006992-fig-00501"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-005-01.png?filename=nCD006992-CMP-005-01.ppt&amp;title=5.1&amp;caption=Comparison%205%20Insulin%20monotherapy%20versus%20insulin%20plus%20DPP%E2%80%904%20inhibitor%2C%20Outcome%201%20Weight%20%28change%20from%20baseline%29.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 5.1</div> </div> <hr class="top"><img data-id="CD006992-fig-00501" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-005-01.png" alt="Comparison 5 Insulin monotherapy versus insulin plus DPP‐4 inhibitor, Outcome 1 Weight (change from baseline)."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 5 Insulin monotherapy versus insulin plus DPP‐4 inhibitor, Outcome 1 Weight (change from baseline). </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 HbA1c (change from baseline) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>265</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.41 [‐0.46, ‐0.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006992-fig-00502"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-005-02.png?filename=nCD006992-CMP-005-02.ppt&amp;title=5.2&amp;caption=Comparison%205%20Insulin%20monotherapy%20versus%20insulin%20plus%20DPP%E2%80%904%20inhibitor%2C%20Outcome%202%20HbA1c%20%28change%20from%20baseline%29.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 5.2</div> </div> <hr class="top"><img data-id="CD006992-fig-00502" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-005-02.png" alt="Comparison 5 Insulin monotherapy versus insulin plus DPP‐4 inhibitor, Outcome 2 HbA1c (change from baseline)."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 5 Insulin monotherapy versus insulin plus DPP‐4 inhibitor, Outcome 2 HbA1c (change from baseline). </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Fasting glucose (change from baseline) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006992-fig-00503"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-005-03.png?filename=nCD006992-CMP-005-03.ppt&amp;title=5.3&amp;caption=Comparison%205%20Insulin%20monotherapy%20versus%20insulin%20plus%20DPP%E2%80%904%20inhibitor%2C%20Outcome%203%20Fasting%20glucose%20%28change%20from%20baseline%29.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 5.3</div> </div> <hr class="top"><img data-id="CD006992-fig-00503" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-005-03.png" alt="Comparison 5 Insulin monotherapy versus insulin plus DPP‐4 inhibitor, Outcome 3 Fasting glucose (change from baseline)."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 5 Insulin monotherapy versus insulin plus DPP‐4 inhibitor, Outcome 3 Fasting glucose (change from baseline). </p> </div> </div> </div> </td> </tr> </tbody> </table> </div> </section> </section> <div class="figures-list"> <div class="figure" id="CD006992-fig-0001"> <img data-id="CD006992-fig-0001" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-AFig-FIG01.png" alt="Study flow diagram."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/full#CD006992-fig-0001" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-AFig-FIG01.png?filename=nCD006992-AFig-FIG01.ppt&amp;title=1&amp;caption=Study%20flow%20diagram.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-AFig-FIG01.png">Open in new tab</a></div> </div> <div class="figure" id="CD006992-fig-0002"><img data-id="CD006992-fig-0002" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-AFig-FIG02.png" alt="'Risk of bias' graph (blank cells indicate that the particular outcome was not investigated in some studies)"> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' graph (blank cells indicate that the particular outcome was not investigated in some studies) </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/full#CD006992-fig-0002" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-AFig-FIG02.png?filename=nCD006992-AFig-FIG02.ppt&amp;title=2&amp;caption=%27Risk%20of%20bias%27%20graph%20%28blank%20cells%20indicate%20that%20the%20particular%20outcome%20was%20not%20investigated%20in%20some%20studies%29&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-AFig-FIG02.png">Open in new tab</a></div> </div> <div class="figure" id="CD006992-fig-0003"><img data-id="CD006992-fig-0003" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-AFig-FIG03.png" alt="'Risk of bias' summary (blank cells indicate that the study did not report that particular outcome)"> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>'Risk of bias' summary (blank cells indicate that the study did not report that particular outcome) </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/full#CD006992-fig-0003" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-AFig-FIG03.png?filename=nCD006992-AFig-FIG03.ppt&amp;title=3&amp;caption=%27Risk%20of%20bias%27%20summary%20%28blank%20cells%20indicate%20that%20the%20study%20did%20not%20report%20that%20particular%20outcome%29&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-AFig-FIG03.png">Open in new tab</a></div> </div> <div class="figure" id="CD006992-fig-00101"><img data-id="CD006992-fig-00101" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-001-01.png" alt="Comparison 1 Insulin monotherapy versus insulin plus sulphonylurea, Outcome 1 Weight (change from baseline)."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Insulin monotherapy versus insulin plus sulphonylurea, Outcome 1 Weight (change from baseline). </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/references#CD006992-fig-00101" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-001-01.png?filename=nCD006992-CMP-001-01.ppt&amp;title=1.1&amp;caption=Comparison%201%20Insulin%20monotherapy%20versus%20insulin%20plus%20sulphonylurea%2C%20Outcome%201%20Weight%20%28change%20from%20baseline%29.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-001-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD006992-fig-00102"><img data-id="CD006992-fig-00102" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-001-02.png" alt="Comparison 1 Insulin monotherapy versus insulin plus sulphonylurea, Outcome 2 Weight (change from baseline) [kg] GIV."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Insulin monotherapy versus insulin plus sulphonylurea, Outcome 2 Weight (change from baseline) [kg] GIV. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/references#CD006992-fig-00102" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-001-02.png?filename=nCD006992-CMP-001-02.ppt&amp;title=1.2&amp;caption=Comparison%201%20Insulin%20monotherapy%20versus%20insulin%20plus%20sulphonylurea%2C%20Outcome%202%20Weight%20%28change%20from%20baseline%29%20%5Bkg%5D%20GIV.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-001-02.png">Open in new tab</a></div> </div> <div class="figure" id="CD006992-fig-00103"><img data-id="CD006992-fig-00103" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-001-03.png" alt="Comparison 1 Insulin monotherapy versus insulin plus sulphonylurea, Outcome 3 HbA1c (change from baseline)."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Insulin monotherapy versus insulin plus sulphonylurea, Outcome 3 HbA1c (change from baseline). </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/references#CD006992-fig-00103" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-001-03.png?filename=nCD006992-CMP-001-03.ppt&amp;title=1.3&amp;caption=Comparison%201%20Insulin%20monotherapy%20versus%20insulin%20plus%20sulphonylurea%2C%20Outcome%203%20HbA1c%20%28change%20from%20baseline%29.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-001-03.png">Open in new tab</a></div> </div> <div class="figure" id="CD006992-fig-00104"><img data-id="CD006992-fig-00104" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-001-04.png" alt="Comparison 1 Insulin monotherapy versus insulin plus sulphonylurea, Outcome 4 HbA1c (change from baseline) GIV."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Insulin monotherapy versus insulin plus sulphonylurea, Outcome 4 HbA1c (change from baseline) GIV. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/references#CD006992-fig-00104" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-001-04.png?filename=nCD006992-CMP-001-04.ppt&amp;title=1.4&amp;caption=Comparison%201%20Insulin%20monotherapy%20versus%20insulin%20plus%20sulphonylurea%2C%20Outcome%204%20HbA1c%20%28change%20from%20baseline%29%20GIV.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-001-04.png">Open in new tab</a></div> </div> <div class="figure" id="CD006992-fig-00105"><img data-id="CD006992-fig-00105" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-001-05.png" alt="Comparison 1 Insulin monotherapy versus insulin plus sulphonylurea, Outcome 5 Fasting glucose (change from baseline)."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Insulin monotherapy versus insulin plus sulphonylurea, Outcome 5 Fasting glucose (change from baseline). </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/references#CD006992-fig-00105" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-001-05.png?filename=nCD006992-CMP-001-05.ppt&amp;title=1.5&amp;caption=Comparison%201%20Insulin%20monotherapy%20versus%20insulin%20plus%20sulphonylurea%2C%20Outcome%205%20Fasting%20glucose%20%28change%20from%20baseline%29.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-001-05.png">Open in new tab</a></div> </div> <div class="figure" id="CD006992-fig-00106"><img data-id="CD006992-fig-00106" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-001-06.png" alt="Comparison 1 Insulin monotherapy versus insulin plus sulphonylurea, Outcome 6 Fasting plasma glucose (change from baseline) [mmol/L] GIV."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Insulin monotherapy versus insulin plus sulphonylurea, Outcome 6 Fasting plasma glucose (change from baseline) [mmol/L] GIV. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/references#CD006992-fig-00106" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-001-06.png?filename=nCD006992-CMP-001-06.ppt&amp;title=1.6&amp;caption=Comparison%201%20Insulin%20monotherapy%20versus%20insulin%20plus%20sulphonylurea%2C%20Outcome%206%20Fasting%20plasma%20glucose%20%28change%20from%20baseline%29%20%5Bmmol%2FL%5D%20GIV.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-001-06.png">Open in new tab</a></div> </div> <div class="figure" id="CD006992-fig-00107"><img data-id="CD006992-fig-00107" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-001-07.png" alt="Comparison 1 Insulin monotherapy versus insulin plus sulphonylurea, Outcome 7 Total cholesterol (change from baseline)."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Insulin monotherapy versus insulin plus sulphonylurea, Outcome 7 Total cholesterol (change from baseline). </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/references#CD006992-fig-00107" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-001-07.png?filename=nCD006992-CMP-001-07.ppt&amp;title=1.7&amp;caption=Comparison%201%20Insulin%20monotherapy%20versus%20insulin%20plus%20sulphonylurea%2C%20Outcome%207%20Total%20cholesterol%20%28change%20from%20baseline%29.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-001-07.png">Open in new tab</a></div> </div> <div class="figure" id="CD006992-fig-00108"><img data-id="CD006992-fig-00108" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-001-08.png" alt="Comparison 1 Insulin monotherapy versus insulin plus sulphonylurea, Outcome 8 Total cholesterol (change from baseline) [mmol/l] GIV."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Insulin monotherapy versus insulin plus sulphonylurea, Outcome 8 Total cholesterol (change from baseline) [mmol/l] GIV. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/references#CD006992-fig-00108" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-001-08.png?filename=nCD006992-CMP-001-08.ppt&amp;title=1.8&amp;caption=Comparison%201%20Insulin%20monotherapy%20versus%20insulin%20plus%20sulphonylurea%2C%20Outcome%208%20Total%20cholesterol%20%28change%20from%20baseline%29%20%5Bmmol%2Fl%5D%20GIV.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-001-08.png">Open in new tab</a></div> </div> <div class="figure" id="CD006992-fig-00109"><img data-id="CD006992-fig-00109" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-001-09.png" alt="Comparison 1 Insulin monotherapy versus insulin plus sulphonylurea, Outcome 9 HDL‐cholesterol (change from baseline)."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Insulin monotherapy versus insulin plus sulphonylurea, Outcome 9 HDL‐cholesterol (change from baseline). </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/references#CD006992-fig-00109" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-001-09.png?filename=nCD006992-CMP-001-09.ppt&amp;title=1.9&amp;caption=Comparison%201%20Insulin%20monotherapy%20versus%20insulin%20plus%20sulphonylurea%2C%20Outcome%209%20HDL%E2%80%90cholesterol%20%28change%20from%20baseline%29.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-001-09.png">Open in new tab</a></div> </div> <div class="figure" id="CD006992-fig-00110"><img data-id="CD006992-fig-00110" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-001-10.png" alt="Comparison 1 Insulin monotherapy versus insulin plus sulphonylurea, Outcome 10 HDL‐Cholesterol (change from baseline mmol/L) GIV."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Insulin monotherapy versus insulin plus sulphonylurea, Outcome 10 HDL‐Cholesterol (change from baseline mmol/L) GIV. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/references#CD006992-fig-00110" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-001-10.png?filename=nCD006992-CMP-001-10.ppt&amp;title=1.10&amp;caption=Comparison%201%20Insulin%20monotherapy%20versus%20insulin%20plus%20sulphonylurea%2C%20Outcome%2010%20HDL%E2%80%90Cholesterol%20%28change%20from%20baseline%20mmol%2FL%29%20GIV.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-001-10.png">Open in new tab</a></div> </div> <div class="figure" id="CD006992-fig-00111"><img data-id="CD006992-fig-00111" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-001-11.png" alt="Comparison 1 Insulin monotherapy versus insulin plus sulphonylurea, Outcome 11 Triglyceride (change from baseline) [mmol/L] GIV."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 Insulin monotherapy versus insulin plus sulphonylurea, Outcome 11 Triglyceride (change from baseline) [mmol/L] GIV. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/references#CD006992-fig-00111" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-001-11.png?filename=nCD006992-CMP-001-11.ppt&amp;title=1.11&amp;caption=Comparison%201%20Insulin%20monotherapy%20versus%20insulin%20plus%20sulphonylurea%2C%20Outcome%2011%20Triglyceride%20%28change%20from%20baseline%29%20%5Bmmol%2FL%5D%20GIV.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-001-11.png">Open in new tab</a></div> </div> <div class="figure" id="CD006992-fig-00112"><img data-id="CD006992-fig-00112" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-001-12.png" alt="Comparison 1 Insulin monotherapy versus insulin plus sulphonylurea, Outcome 12 Triglycerides (change from baseline)."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 Insulin monotherapy versus insulin plus sulphonylurea, Outcome 12 Triglycerides (change from baseline). </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/references#CD006992-fig-00112" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-001-12.png?filename=nCD006992-CMP-001-12.ppt&amp;title=1.12&amp;caption=Comparison%201%20Insulin%20monotherapy%20versus%20insulin%20plus%20sulphonylurea%2C%20Outcome%2012%20Triglycerides%20%28change%20from%20baseline%29.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-001-12.png">Open in new tab</a></div> </div> <div class="figure" id="CD006992-fig-00201"><img data-id="CD006992-fig-00201" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-002-01.png" alt="Comparison 2 Insulin monotherapy versus insulin plus metformin, Outcome 1 Weight (change from baseline)."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Insulin monotherapy versus insulin plus metformin, Outcome 1 Weight (change from baseline). </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/references#CD006992-fig-00201" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-002-01.png?filename=nCD006992-CMP-002-01.ppt&amp;title=2.1&amp;caption=Comparison%202%20Insulin%20monotherapy%20versus%20insulin%20plus%20metformin%2C%20Outcome%201%20Weight%20%28change%20from%20baseline%29.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-002-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD006992-fig-00202"><img data-id="CD006992-fig-00202" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-002-02.png" alt="Comparison 2 Insulin monotherapy versus insulin plus metformin, Outcome 2 Weight (change from baseline) [kg] GIV."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Insulin monotherapy versus insulin plus metformin, Outcome 2 Weight (change from baseline) [kg] GIV. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/references#CD006992-fig-00202" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-002-02.png?filename=nCD006992-CMP-002-02.ppt&amp;title=2.2&amp;caption=Comparison%202%20Insulin%20monotherapy%20versus%20insulin%20plus%20metformin%2C%20Outcome%202%20Weight%20%28change%20from%20baseline%29%20%5Bkg%5D%20GIV.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-002-02.png">Open in new tab</a></div> </div> <div class="figure" id="CD006992-fig-00203"><img data-id="CD006992-fig-00203" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-002-03.png" alt="Comparison 2 Insulin monotherapy versus insulin plus metformin, Outcome 3 HbA1c (change from baseline)."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Insulin monotherapy versus insulin plus metformin, Outcome 3 HbA1c (change from baseline). </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/references#CD006992-fig-00203" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-002-03.png?filename=nCD006992-CMP-002-03.ppt&amp;title=2.3&amp;caption=Comparison%202%20Insulin%20monotherapy%20versus%20insulin%20plus%20metformin%2C%20Outcome%203%20HbA1c%20%28change%20from%20baseline%29.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-002-03.png">Open in new tab</a></div> </div> <div class="figure" id="CD006992-fig-00204"><img data-id="CD006992-fig-00204" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-002-04.png" alt="Comparison 2 Insulin monotherapy versus insulin plus metformin, Outcome 4 HbA1c (change from baseline) [%] GIV."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Insulin monotherapy versus insulin plus metformin, Outcome 4 HbA1c (change from baseline) [%] GIV. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/references#CD006992-fig-00204" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-002-04.png?filename=nCD006992-CMP-002-04.ppt&amp;title=2.4&amp;caption=Comparison%202%20Insulin%20monotherapy%20versus%20insulin%20plus%20metformin%2C%20Outcome%204%20HbA1c%20%28change%20from%20baseline%29%20%5B%25%5D%20GIV.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-002-04.png">Open in new tab</a></div> </div> <div class="figure" id="CD006992-fig-00205"><img data-id="CD006992-fig-00205" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-002-05.png" alt="Comparison 2 Insulin monotherapy versus insulin plus metformin, Outcome 5 Total cholesterol (change from baseline)."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Insulin monotherapy versus insulin plus metformin, Outcome 5 Total cholesterol (change from baseline). </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/references#CD006992-fig-00205" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-002-05.png?filename=nCD006992-CMP-002-05.ppt&amp;title=2.5&amp;caption=Comparison%202%20Insulin%20monotherapy%20versus%20insulin%20plus%20metformin%2C%20Outcome%205%20Total%20cholesterol%20%28change%20from%20baseline%29.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-002-05.png">Open in new tab</a></div> </div> <div class="figure" id="CD006992-fig-00206"><img data-id="CD006992-fig-00206" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-002-06.png" alt="Comparison 2 Insulin monotherapy versus insulin plus metformin, Outcome 6 Total cholesterol (change from baseline) [mmol/L] GIV."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 Insulin monotherapy versus insulin plus metformin, Outcome 6 Total cholesterol (change from baseline) [mmol/L] GIV. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/references#CD006992-fig-00206" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-002-06.png?filename=nCD006992-CMP-002-06.ppt&amp;title=2.6&amp;caption=Comparison%202%20Insulin%20monotherapy%20versus%20insulin%20plus%20metformin%2C%20Outcome%206%20Total%20cholesterol%20%28change%20from%20baseline%29%20%5Bmmol%2FL%5D%20GIV.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-002-06.png">Open in new tab</a></div> </div> <div class="figure" id="CD006992-fig-00207"><img data-id="CD006992-fig-00207" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-002-07.png" alt="Comparison 2 Insulin monotherapy versus insulin plus metformin, Outcome 7 HDL‐cholesterol (change from baseline)."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2 Insulin monotherapy versus insulin plus metformin, Outcome 7 HDL‐cholesterol (change from baseline). </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/references#CD006992-fig-00207" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-002-07.png?filename=nCD006992-CMP-002-07.ppt&amp;title=2.7&amp;caption=Comparison%202%20Insulin%20monotherapy%20versus%20insulin%20plus%20metformin%2C%20Outcome%207%20HDL%E2%80%90cholesterol%20%28change%20from%20baseline%29.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-002-07.png">Open in new tab</a></div> </div> <div class="figure" id="CD006992-fig-00208"><img data-id="CD006992-fig-00208" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-002-08.png" alt="Comparison 2 Insulin monotherapy versus insulin plus metformin, Outcome 8 HDL‐cholesterol (change from baseline) [mmol/L]."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2 Insulin monotherapy versus insulin plus metformin, Outcome 8 HDL‐cholesterol (change from baseline) [mmol/L]. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/references#CD006992-fig-00208" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-002-08.png?filename=nCD006992-CMP-002-08.ppt&amp;title=2.8&amp;caption=Comparison%202%20Insulin%20monotherapy%20versus%20insulin%20plus%20metformin%2C%20Outcome%208%20HDL%E2%80%90cholesterol%20%28change%20from%20baseline%29%20%5Bmmol%2FL%5D.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-002-08.png">Open in new tab</a></div> </div> <div class="figure" id="CD006992-fig-00209"><img data-id="CD006992-fig-00209" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-002-09.png" alt="Comparison 2 Insulin monotherapy versus insulin plus metformin, Outcome 9 Triglycerides (change from baseline)."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.9</div> <div class="figure-caption"> <p>Comparison 2 Insulin monotherapy versus insulin plus metformin, Outcome 9 Triglycerides (change from baseline). </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/references#CD006992-fig-00209" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-002-09.png?filename=nCD006992-CMP-002-09.ppt&amp;title=2.9&amp;caption=Comparison%202%20Insulin%20monotherapy%20versus%20insulin%20plus%20metformin%2C%20Outcome%209%20Triglycerides%20%28change%20from%20baseline%29.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-002-09.png">Open in new tab</a></div> </div> <div class="figure" id="CD006992-fig-00210"><img data-id="CD006992-fig-00210" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-002-10.png" alt="Comparison 2 Insulin monotherapy versus insulin plus metformin, Outcome 10 Triglyceride (change from baseline) [mmol/L] GIV."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.10</div> <div class="figure-caption"> <p>Comparison 2 Insulin monotherapy versus insulin plus metformin, Outcome 10 Triglyceride (change from baseline) [mmol/L] GIV. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/references#CD006992-fig-00210" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-002-10.png?filename=nCD006992-CMP-002-10.ppt&amp;title=2.10&amp;caption=Comparison%202%20Insulin%20monotherapy%20versus%20insulin%20plus%20metformin%2C%20Outcome%2010%20Triglyceride%20%28change%20from%20baseline%29%20%5Bmmol%2FL%5D%20GIV.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-002-10.png">Open in new tab</a></div> </div> <div class="figure" id="CD006992-fig-00301"><img data-id="CD006992-fig-00301" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-003-01.png" alt="Comparison 3 Insulin monotherapy versus insulin plus pioglitazone, Outcome 1 HbA1c (change from baseline)."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Insulin monotherapy versus insulin plus pioglitazone, Outcome 1 HbA1c (change from baseline). </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/references#CD006992-fig-00301" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-003-01.png?filename=nCD006992-CMP-003-01.ppt&amp;title=3.1&amp;caption=Comparison%203%20Insulin%20monotherapy%20versus%20insulin%20plus%20pioglitazone%2C%20Outcome%201%20HbA1c%20%28change%20from%20baseline%29.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-003-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD006992-fig-00302"><img data-id="CD006992-fig-00302" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-003-02.png" alt="Comparison 3 Insulin monotherapy versus insulin plus pioglitazone, Outcome 2 Fasting glucose (change from baseline)."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Insulin monotherapy versus insulin plus pioglitazone, Outcome 2 Fasting glucose (change from baseline). </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/references#CD006992-fig-00302" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-003-02.png?filename=nCD006992-CMP-003-02.ppt&amp;title=3.2&amp;caption=Comparison%203%20Insulin%20monotherapy%20versus%20insulin%20plus%20pioglitazone%2C%20Outcome%202%20Fasting%20glucose%20%28change%20from%20baseline%29.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-003-02.png">Open in new tab</a></div> </div> <div class="figure" id="CD006992-fig-00303"><img data-id="CD006992-fig-00303" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-003-03.png" alt="Comparison 3 Insulin monotherapy versus insulin plus pioglitazone, Outcome 3 Weight (change from baseline)."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Insulin monotherapy versus insulin plus pioglitazone, Outcome 3 Weight (change from baseline). </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/references#CD006992-fig-00303" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-003-03.png?filename=nCD006992-CMP-003-03.ppt&amp;title=3.3&amp;caption=Comparison%203%20Insulin%20monotherapy%20versus%20insulin%20plus%20pioglitazone%2C%20Outcome%203%20Weight%20%28change%20from%20baseline%29.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-003-03.png">Open in new tab</a></div> </div> <div class="figure" id="CD006992-fig-00401"><img data-id="CD006992-fig-00401" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-004-01.png" alt="Comparison 4 Insulin monotherapy versus insulin plus alpha‐glucosidase inhibitor, Outcome 1 Weight (change from baseline)."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Insulin monotherapy versus insulin plus alpha‐glucosidase inhibitor, Outcome 1 Weight (change from baseline). </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/references#CD006992-fig-00401" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-004-01.png?filename=nCD006992-CMP-004-01.ppt&amp;title=4.1&amp;caption=Comparison%204%20Insulin%20monotherapy%20versus%20insulin%20plus%20alpha%E2%80%90glucosidase%20inhibitor%2C%20Outcome%201%20Weight%20%28change%20from%20baseline%29.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-004-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD006992-fig-00402"><img data-id="CD006992-fig-00402" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-004-02.png" alt="Comparison 4 Insulin monotherapy versus insulin plus alpha‐glucosidase inhibitor, Outcome 2 HbA1c (change from baseline)."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Insulin monotherapy versus insulin plus alpha‐glucosidase inhibitor, Outcome 2 HbA1c (change from baseline). </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/references#CD006992-fig-00402" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-004-02.png?filename=nCD006992-CMP-004-02.ppt&amp;title=4.2&amp;caption=Comparison%204%20Insulin%20monotherapy%20versus%20insulin%20plus%20alpha%E2%80%90glucosidase%20inhibitor%2C%20Outcome%202%20HbA1c%20%28change%20from%20baseline%29.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-004-02.png">Open in new tab</a></div> </div> <div class="figure" id="CD006992-fig-00403"><img data-id="CD006992-fig-00403" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-004-03.png" alt="Comparison 4 Insulin monotherapy versus insulin plus alpha‐glucosidase inhibitor, Outcome 3 Fasting glucose (change from baseline)."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Insulin monotherapy versus insulin plus alpha‐glucosidase inhibitor, Outcome 3 Fasting glucose (change from baseline). </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/references#CD006992-fig-00403" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-004-03.png?filename=nCD006992-CMP-004-03.ppt&amp;title=4.3&amp;caption=Comparison%204%20Insulin%20monotherapy%20versus%20insulin%20plus%20alpha%E2%80%90glucosidase%20inhibitor%2C%20Outcome%203%20Fasting%20glucose%20%28change%20from%20baseline%29.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-004-03.png">Open in new tab</a></div> </div> <div class="figure" id="CD006992-fig-00501"><img data-id="CD006992-fig-00501" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-005-01.png" alt="Comparison 5 Insulin monotherapy versus insulin plus DPP‐4 inhibitor, Outcome 1 Weight (change from baseline)."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Insulin monotherapy versus insulin plus DPP‐4 inhibitor, Outcome 1 Weight (change from baseline). </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/references#CD006992-fig-00501" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-005-01.png?filename=nCD006992-CMP-005-01.ppt&amp;title=5.1&amp;caption=Comparison%205%20Insulin%20monotherapy%20versus%20insulin%20plus%20DPP%E2%80%904%20inhibitor%2C%20Outcome%201%20Weight%20%28change%20from%20baseline%29.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-005-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD006992-fig-00502"><img data-id="CD006992-fig-00502" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-005-02.png" alt="Comparison 5 Insulin monotherapy versus insulin plus DPP‐4 inhibitor, Outcome 2 HbA1c (change from baseline)."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 Insulin monotherapy versus insulin plus DPP‐4 inhibitor, Outcome 2 HbA1c (change from baseline). </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/references#CD006992-fig-00502" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-005-02.png?filename=nCD006992-CMP-005-02.ppt&amp;title=5.2&amp;caption=Comparison%205%20Insulin%20monotherapy%20versus%20insulin%20plus%20DPP%E2%80%904%20inhibitor%2C%20Outcome%202%20HbA1c%20%28change%20from%20baseline%29.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-005-02.png">Open in new tab</a></div> </div> <div class="figure" id="CD006992-fig-00503"><img data-id="CD006992-fig-00503" src="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-005-03.png" alt="Comparison 5 Insulin monotherapy versus insulin plus DPP‐4 inhibitor, Outcome 3 Fasting glucose (change from baseline)."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 Insulin monotherapy versus insulin plus DPP‐4 inhibitor, Outcome 3 Fasting glucose (change from baseline). </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/references#CD006992-fig-00503" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/ppt/CDSR/CD006992/image_n/nCD006992-CMP-005-03.png?filename=nCD006992-CMP-005-03.ppt&amp;title=5.3&amp;caption=Comparison%205%20Insulin%20monotherapy%20versus%20insulin%20plus%20DPP%E2%80%904%20inhibitor%2C%20Outcome%203%20Fasting%20glucose%20%28change%20from%20baseline%29.&amp;citation=Vos RC, van Avendonk MJP, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GEHM. Insulin monotherapy compared with the addition of oral glucose%E2%80%90lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, 9. Art. No.: CD006992. DOI: http://dx.doi.org/10.1002/14651858.CD006992.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006992.pub2/media/CDSR/CD006992/image_n/nCD006992-CMP-005-03.png">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table data-id="CD006992-tbl-0001" class="summary-of-findings framed"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span>&nbsp;<span class="table-title">Summary of findings: sulphonylureas</span></div> <tbody> <tr class="separated"> <td align="" valign="top" colspan="6" rowspan="1" bgcolor="#ffffff"> <p><b>Combinations of insulin and sulphonylureas compared with insulin monotherapy for diabetes mellitus</b> </p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="6" rowspan="1" bgcolor="#ffffff"> <p><b>Patient:</b> participants with type 2 diabetes mellitus </p> <p><b>Settings:</b> mostly secondary care outpatients and secondary care inpatients </p> <p><b>Intervention:</b> sulphonylureas plus insulin </p> <p><b>Comparison:</b> insulin monotherapy </p> </td> </tr> <tr class="table-header separated"> <td align="" valign="top" colspan="1" rowspan="1" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Insulin monotherapy</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Insulin plus sulphonylureas</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-header"> <p><b>No of participants<br> (studies)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-header"> <p><b>Quality of the evidence<br> (GRADE)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-header"> <p><b> Comments</b> </p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>All‐cause mortality</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not investigated</p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Diabetes‐related mortality</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not investigated</p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Diabetes‐related morbidity</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not investigated</p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Health‐related quality of life</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not investigated</p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Patient satisfaction</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not investigated</p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse events:</b> </p> <p><b>a. mild hypoglycaemia</b> (<b>episodes per participant</b>)<br> Follow‐up: 12 weeks to 12 months </p> <p><b>b. weight gain</b> (<b>kg</b>)<br> Follow‐up: 8 weeks to 12 months </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>a. range 2.0‐2.6</p> <p>b. the mean weight gain across control groups ranged from ‐0.8 kg to 2.1 kg</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>a. range 2.2‐6.1</p> <p>b. the mean weight gain across intervention groups ranged from 0.4 kg to 1.9 kg</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>a. 239 (8)</p> <p>b. 220 (7)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>a. ⊕⊕⊝⊝<br> <b>low<sup>a</sup> </b> </p> <p>b. ⊕⊕⊝⊝<br> <b>low<sup>a</sup> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>a. Serious hypoglycaemic episodes were rare</p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>HbA1c, change from baseline</b> (<b>%</b>) </p> <p>Follow‐up: 2 to 12 months</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean change in HbA1c ranged across control groups from ‐1.5% to 3%</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean change in HbA1c in the intervention groups was <b>1% lower</b> (1.6% lower to 0.5% lower) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>316 (9)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊝⊝<br> <b>low<sup>b</sup> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" valign="" colspan="6" rowspan="1" bgcolor="#ffffff"> <p><b>CI:</b> confidence interval; <b>HbA1c:</b> glycosylated haemoglobin A1c </p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="6" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence<br> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by two levels because of risk of performance and detection bias and indirectness<br> <sup>b</sup>Downgraded by two levels because of risk of performance bias and indirectness </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span>&nbsp;<span class="table-title">Summary of findings: sulphonylureas</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/full#CD006992-tbl-0001" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD006992-tbl-0002" class="summary-of-findings framed"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span>&nbsp;<span class="table-title">Summary of findings: metformin</span></div> <tbody> <tr class="separated"> <td align="" valign="top" colspan="6" rowspan="1" bgcolor="#ffffff"> <p><b>Combinations of insulin and metformin compared with insulin monotherapy for diabetes mellitus</b> </p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="6" rowspan="1" bgcolor="#ffffff"> <p><b>Patient:</b> participants with type 2 diabetes mellitus </p> <p><b>Settings:</b> mostly secondary care outpatients and secondary care inpatients </p> <p><b>Intervention:</b> metformin plus insulin </p> <p><b>Comparison:</b> insulin monotherapy </p> </td> </tr> <tr class="table-header separated"> <td align="" valign="top" colspan="1" rowspan="1" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Insulin monotherapy</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Insulin plus metformin</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-header"> <p><b>No of participants<br> (studies)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-header"> <p><b>Quality of the evidence<br> (GRADE)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-header"> <p><b>Comments</b> </p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>All‐cause mortality</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not investigated</p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Diabetes‐related mortality</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not investigated</p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Diabetes‐related morbidity</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not investigated</p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Health‐related quality of life</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not investigated</p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Patient satisfaction</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not investigated</p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse events:</b> </p> <p><b>a. mild hypoglycaemia</b> (<b>episodes per participant</b>) </p> <p>Follow‐up: 12 weeks to 12 months</p> <p><b>b. weight gain</b> (<b>kg</b>) </p> <p>Follow‐up: 12 weeks to 12 months</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>a. see comment</p> <p>b. the mean weight gain across control groups ranged from 0 kg to 4.4 kg</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>a. see comment</p> <p>b. the mean weight gain across intervention groups was <b>2.1 kg lower</b> (3.2 kg lower to 1.1 kg lower) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>a. 590 (8)</p> <p>b. 615 (7)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>a. ⊕⊕⊝⊝<br> <b>low<sup>a</sup> </b> </p> <p><b><sup>b.</sup> </b> ⊕⊕⊝⊝<br> <b>low<sup>a</sup> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>a. comparable occurrences of hypoglycaemic events, severe hypoglycaemic episodes were rare </p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>HbA1c, change from baseline</b> (<b>%</b>) </p> <p>Follow‐up: 3.5 to 6 months</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean change in HbA1c across control groups ranged from ‐1.6% to 0.5%</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean change in HbA1c in the intervention groups was <b>0.9% lower</b> (1.2% lower to 0.5% lower) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>698 (9)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊝⊝<br> <b>low<sup>b</sup> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" valign="" colspan="6" rowspan="1" bgcolor="#ffffff"> <p><b>CI:</b> confidence interval; <b>HbA1c:</b> glycosylated haemoglobin A1c </p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="6" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence<br> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by two levels because of risk of performance and detection bias and indirectness<br> <sup>b</sup>Downgraded by two levels because of risk of performance bias and indirectness </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span>&nbsp;<span class="table-title">Summary of findings: metformin</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/full#CD006992-tbl-0002" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD006992-tbl-0003" class="summary-of-findings framed"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span>&nbsp;<span class="table-title">Summary of findings: pioglitazone</span></div> <tbody> <tr class="separated"> <td align="" valign="top" colspan="6" rowspan="1" bgcolor="#ffffff"> <p><b>Combinations of insulin and pioglitazone compared with insulin monotherapy for diabetes mellitus</b> </p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="6" rowspan="1" bgcolor="#ffffff"> <p><b>Patient:</b> participants with type 2 diabetes mellitus </p> <p><b>Settings:</b> mostly secondary care outpatients and clinical research centre </p> <p><b>Intervention:</b> pioglitazone plus insulin </p> <p><b>Comparison:</b> insulin monotherapy </p> </td> </tr> <tr class="table-header separated"> <td align="" valign="top" colspan="1" rowspan="1" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Insulin monotherapy</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Insulin plus pioglitazone</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-header"> <p><b>No of participants<br> (studies)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-header"> <p><b>Quality of the evidence<br> (GRADE)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-header"> <p><b>Comments</b> </p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>All‐cause mortality</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not investigated</p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Diabetes‐related mortality</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not investigated</p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Diabetes‐related morbidity</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not investigated</p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Health‐related quality of life</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not investigated</p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Patient satisfaction</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not investigated</p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse events:</b> </p> <p><b>a. mild to moderate hypoglycaemia</b> (<b>episodes per participant</b>)<br> Follow‐up: 16 weeks to 6 months </p> <p><b>b. weight gain</b> (<b>kg</b>) </p> <p>Follow‐up: 16 weeks to 6 months</p> <p><b>c. oedema</b> (<b>%</b>)<br> Follow‐up: 16 weeks to 6 months </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>a. range 9‐75</p> <p>b. the mean weight gain across control groups ranged from 0.2 kg to 1.7 kg</p> <p>c. range 4%‐7%</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>a. range 15‐90</p> <p>b. the mean weight gain in the intervention groups was<b>3.8 kg higher</b> (3.0 kg higher to 4.6 kg higher) </p> <p>c. range 16%‐18%</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>a. 760 (2)</p> <p>b. 288 (2)</p> <p>c. 760 (2)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>a. ⊕⊕⊝⊝<br> <b>low<sup>a</sup> </b> </p> <p>b. ⊕⊕⊝⊝<br> <b>low<sup>b</sup> </b> </p> <p>c. ⊕⊕⊝⊝<br> <b>low<sup>b</sup> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>a. the proportion of all hypoglycaemic episodes was higher in the pioglitazone‐insulin combination group compared to insulin monotherapy; serious hypoglycaemic episodes were rare </p> <p>b. the minimum of 1.9 kg weight gain is clinically relevant, because it may have been partially caused by oedema </p> <p>c. pioglitazone was associated with a higher frequency of oedema which increased with dose. In addition, <a href="./references#CD006992-bbs2-0030">Rosenstock 2002</a> reported congestive heart failure for two participants receiving 15 mg pioglitazone and two participants receiving 30 mg pioglitazone. </p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>HbA1c, change from baseline</b> (<b>%</b>)<br> Follow‐up: 12 weeks to 6 months </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>785 (3)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊝⊝<br> <b>low<sup>c</sup> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The mean difference in HbA1c for insulin‐pioglitazone combination therapy ranged from ‐0.5% to ‐1.0% and for insulin monotherapy from ‐0.6% to 0% </p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="6" rowspan="1" bgcolor="#ffffff"> <p><b>CI:</b> confidence interval; <b>HbA1c:</b> glycosylated haemoglobin A1c </p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="6" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence<br> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by two levels because of risk of performance bias, indirectness and imprecision<br> <sup>b</sup>Downgraded by two levels because of unclear risk of bias in several risk of bias domains, indirectness and imprecision<br> <sup>c</sup>Downgraded by two levels because of unclear risk of bias in several risk of bias domains, indirectness and imprecision </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span>&nbsp;<span class="table-title">Summary of findings: pioglitazone</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/full#CD006992-tbl-0003" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD006992-tbl-0004" class="summary-of-findings framed"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span>&nbsp;<span class="table-title">Summary of findings: alpha‐glucosidase inhibitors</span></div> <tbody> <tr class="separated"> <td align="" valign="top" colspan="6" rowspan="1" bgcolor="#ffffff"> <p><b>Combinations of insulin and alpha‐glucosidase inhibitors compared with insulin monotherapy for diabetes mellitus</b> </p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="6" rowspan="1" bgcolor="#ffffff"> <p><b>Patient:</b> participants with type 2 diabetes mellitus </p> <p><b>Settings:</b> mostly secondary care outpatients </p> <p><b>Intervention:</b> alpha‐glucosidase inhibitors plus insulin </p> <p><b>Comparison:</b> insulin monotherapy </p> </td> </tr> <tr class="table-header separated"> <td align="" valign="top" colspan="1" rowspan="1" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Insulin monotherapy</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Insulin plus alpha‐glucosidase inhibitors</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-header"> <p><b>No of participants<br> (studies)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-header"> <p><b>Quality of the evidence<br> (GRADE)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-header"> <p><b>Comments</b> </p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>All‐cause mortality</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not investigated</p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Diabetes‐related mortality</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not investigated</p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Diabetes‐related morbidity</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not investigated</p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Health‐related quality of life</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not investigated</p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Patient satisfaction</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not investigated</p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse events:</b> </p> <p><b>a. mild hypoglycaemia</b> (<b>% of participants</b>) </p> <p>Follow‐up: 24 weeks to 12 months</p> <p><b>b. weight gain</b> (<b>kg</b>) </p> <p>Follow‐up: 24 weeks to 12 months</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>a. range 0%‐35%</p> <p>b. The mean weight gain across control groups ranged from +0.7 kg to +3.6 kg</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>a. range 0%‐39%</p> <p>b. the mean weight gain in the intervention groups was<b>0.5 kg lower</b> (1.2 kg lower to 0.3 kg higher) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>a. 583 (4)</p> <p>b. 241 (2)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>a) ⊕⊝⊝⊝<b>low<sup>a</sup> </b> </p> <p>b) ⊕⊝⊝⊝<b>low<sup>a</sup> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>a. serious hypoglycaemic episodes were rare</p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>HbA1c, change from baseline</b> (<b>%</b>) </p> <p>Follow‐up: 3 to 6 months</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean change in HbA1c across control groups ranged from ‐1.1% to 0.04%</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean change in HbA1c in the intervention groups was <b>0.4% lower</b> (0.5% lower to 0.2% lower) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>448 (3)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊝⊝⊝<b>low<sup>a</sup> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="6" rowspan="1" bgcolor="#ffffff"> <p><b>CI:</b> confidence interval; <b>HbA1c:</b> glycosylated haemoglobin A1c </p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="6" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence<br> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by two levels because of unclear or high risk of bias in several risk of bias domains, indirectness and imprecision </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span>&nbsp;<span class="table-title">Summary of findings: alpha‐glucosidase inhibitors</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/full#CD006992-tbl-0004" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD006992-tbl-0005" class="summary-of-findings framed"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span>&nbsp;<span class="table-title">Summary of findings: DPP‐4 inhibitors</span></div> <tbody> <tr class="separated"> <td align="" valign="" colspan="6" rowspan="1" bgcolor="#ffffff"> <p><b>Combinations of insulin and dipeptidyl peptidase 4 inhibitors compared with insulin monotherapy for diabetes mellitus</b> </p> </td> </tr> <tr class="separated"> <td align="" valign="" colspan="6" rowspan="1" bgcolor="#ffffff"> <p><b>Patient:</b> participants with type 2 diabetes mellitus </p> <p><b>Settings:</b> mostly secondary care outpatients </p> <p><b>Intervention:</b> dipeptidyl peptidase 4 (DPP‐4) inhibitors plus insulin </p> <p><b>Comparison:</b> insulin monotherapy </p> </td> </tr> <tr class="table-header separated"> <td align="" valign="top" colspan="1" rowspan="1" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Insulin monotherapy</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Insulin + DPP4‐inhibitor</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-header"> <p><b>No of participants<br> (studies)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-header"> <p><b>Quality of the evidence<br> (GRADE)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-header"> <p><b>Comments</b> </p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>All‐cause mortality</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not investigated</p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Diabetes‐related mortality</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not investigated</p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Diabetes‐related morbidity</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not investigated</p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Health‐related quality of life</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not investigated</p> </td> </tr> <tr class="separated"> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Patient satisfaction</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not investigated</p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse events:</b> </p> <p><b>a. hypoglycaemia</b> (% of participants) </p> <p>Follow‐up: 24 weeks to 52 weeks</p> <p><b>b. weight gain</b> (kg) </p> <p>Follow‐up: 24 weeks to 52 weeks</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>a. range 5%‐30% (0%‐5% severe)</p> <p>b. the mean weight gain across control groups ranged from 0.6 kg to 1.1 kg</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>a. range 8%‐23% (0%‐2% severe)</p> <p>b. the mean weight gain in the intervention groups ranged from ‐0.7 kg to 1.3 kg compared to 0.6 kg to 1.1 kg in the insulin (+ placebo) monotherapy group </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>a. 503 (3)</p> <p>b. 362 (2)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>a) ⊕⊕⊝⊝<br> <b>low<sup>a</sup> </b> </p> <p>b) ⊕⊕⊝⊝<br> <b>low<sup>a</sup> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr class="separated"> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>HbA1c, change from baseline</b> (<b>%</b>) </p> <p>Follow‐up: 24 weeks to 52 weeks</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean change in HbA1c across control groups ranged from ‐0.2% to ‐0.3%</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean change in HbA1c in the intervention groups was<br> <b>0.4% lower</b> (0.5% lower to 0.4% lower) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>265 (2)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊝⊝<br> <b>low<sup>a</sup> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr class="separated"> <td align="" valign="" colspan="6" rowspan="1" bgcolor="#ffffff"> <p><b>CI:</b> confidence interval; <b>DPP‐4:</b> dipeptidyl peptidase 4; <b>HbA1c:</b> glycosylated haemoglobin A1c </p> </td> </tr> <tr class="separated"> <td align="" valign="" colspan="6" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence<br> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by two levels because of unclear or high risk of bias in several risk of bias domains, indirectness and imprecision </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span>&nbsp;<span class="table-title">Summary of findings: DPP‐4 inhibitors</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/full#CD006992-tbl-0005" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD006992-tbl-0011"> <div class="table-heading"><span class="table-label">Table 1.</span>&nbsp;<span class="table-title">Overview of study populations</span></div> <tbody> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Intervention(s) and comparator(s)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Sample size<sup>a</sup> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Screened/eligible<br> (N)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Randomised<br> (N)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Safety<br> (N)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>ITT<br> (N)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Finishing study<br> (N)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Randomised finishing study<br> (%)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Follow‐up time<sup>b</sup> </b> </p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p><b>(1) Avilés 1999</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: metformin</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>54</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>22</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>22</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>21</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>95</p> </td> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>24 weeks</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C: placebo</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>23</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>23</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>22</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>96</p> </td> </tr> <tr> <td align="right" valign="top" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b>total:</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>45</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>45</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>‐</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>43</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p><b>(2) Barnett 2013</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I:saxagliptin</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>141</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>95</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>95</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>89</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>94</p> </td> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>52 weeks</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C:placebo</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>46</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>46</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>45</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>98</p> </td> </tr> <tr> <td align="right" valign="top" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b>total:</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>141</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>141</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>‐</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>134</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p><b>(3) Casner 1988</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: glibenclamide</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>42 needed, 50 recruitment goal</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>83</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>31</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>31</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>31</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>31</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>100</p> </td> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>1 year</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C: placebo</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>33</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>33</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>33</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>33</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>100</p> </td> </tr> <tr> <td align="right" valign="top" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b>total:</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>64</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>64</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>64</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>64</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p><b>(4) Chiasson 1994<sup>c</sup> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: acarbose</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>76 total, 38 per group</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>91</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>41</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>41</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>40</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>35</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>85</p> </td> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>1 year</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C: placebo</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>50</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>50</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>42</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>44</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>88</p> </td> </tr> <tr> <td align="right" valign="top" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b>total:</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>91</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>91</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>82</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>79</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p><b>(5) Coniff 1995</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: acarbose</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>103</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>103</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>103</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>100</p> </td> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>24 weeks</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C: placebo</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>104</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>104</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>104</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>100</p> </td> </tr> <tr> <td align="right" valign="top" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b>total:</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>207</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>207</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>‐</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>207</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p><b>(6) Feinglos 1998<sup>d</sup> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: glipizide</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>37</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>7 months</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C: placebo</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="right" valign="top" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b>total:</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>29</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>29</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>‐</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>29</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>100</b> </p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p><b>(7) Fonseca 2007</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: vildagliptin</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>461</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>144</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>144</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>114</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>79</p> </td> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>24 weeks</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C: placebo</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>152</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>152</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>124</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>82</p> </td> </tr> <tr> <td align="right" valign="top" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b>total:</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>296</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>296</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>290</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>238</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p><b>(8) Fritsche 2000<sup>d</sup> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: metformin</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>24 weeks</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C: placebo</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="right" valign="top" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b>total:</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>13</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>13</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>‐</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>13</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>100</b> </p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p><b>(9) Giugliano 1993</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: metformin</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>50</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>27</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>27</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>27</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>100</p> </td> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>7 months</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C: placebo</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>23</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>23</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>23</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>100</p> </td> </tr> <tr> <td align="right" valign="top" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b>total:</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>50</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>50</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>50</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p><b>(10) Groop 1985<sup>d</sup> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: glibenclamide</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>14</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>16 weeks (after 8 weeks run‐in)</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C: placebo</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="right" valign="top" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b>total:</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>14</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>14</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>‐</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>13</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>93</b> </p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p><b>(11) Hermann 2001</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: metformin</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>30, 15 in each group</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>37</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>16</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>16</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>16</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>75</p> </td> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>12 months</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C: placebo</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>19</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>19</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>19</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>18</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>95</p> </td> </tr> <tr> <td align="right" valign="top" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b>total:</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>35</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>35</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>35</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>30</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p><b>(12) Hong 2012</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: sitagliptin</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>140</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>70</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>61</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>61</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>61</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>87</p> </td> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>24 weeks</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C: insulin increase</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>70</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>63</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>63</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>63</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>90</p> </td> </tr> <tr> <td align="right" valign="top" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b>total:</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>140</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>124</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>124</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>124</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p><b>(13) Hirsch 1999</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: metformin</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>25</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>25</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>22</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>88</p> </td> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>5 months</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C: placebo</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>25</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>25</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>25</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>100</p> </td> </tr> <tr> <td align="right" valign="top" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b>total:</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>50</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>50</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>47</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p><b>(14) Kitabchi 1987<sup>d</sup> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: tolazamide</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>12</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>6 months</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C: insulin alone</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="right" valign="top" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b>total:</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>12</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>12</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>‐</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>12</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>100</b> </p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p><b>(15) Krawczyk 2005</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: metformin</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>20</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>20</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>20</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>20</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>100</p> </td> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>6 months</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C: insulin alone</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>20</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>20</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>20</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>20</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>100</p> </td> </tr> <tr> <td align="right" valign="top" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b>total:</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>40</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>40</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>40</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>40</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p><b>(16) Kyllastinen 1985<sup>d</sup> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: glibenclamide</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>11</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>4 months</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C: placebo</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="right" valign="top" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b>total:</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>9</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>9</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>‐</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>9</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>100</b> </p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p><b>(17) Lewitt 1989<sup>d</sup> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: glibenclamide</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>31</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>6 months</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C: placebo</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="right" valign="top" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b>total:</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>31</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>31</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>‐</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>31</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>100</b> </p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p><b>(18) Lindstrom 1999<sup>d</sup> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: glibenclamide</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>6 months</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C: placebo</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="right" valign="top" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b>total:</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>15</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>15</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>‐</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>15</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>100</b> </p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p><b>(19) Longnecker 1986<sup>d</sup> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: tolazamide</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>12</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>20 weeks</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C: placebo</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="right" valign="top" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b>total:</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>12</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>12</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>‐</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>11</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>92</b> </p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p><b>(20) Mattoo 2005</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: pioglitazone</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>250 (125 per treatment)</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>385</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>142</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>142</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>142</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>128</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>90</p> </td> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>6 months</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C: placebo</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>147</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>147</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>147</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>135</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>92</p> </td> </tr> <tr> <td align="right" valign="top" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b>total:</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>289</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>289</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>289</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>263</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p><b>(21) Mauerhoff 1986</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: glibenclamide</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>22</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>100</p> </td> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>19 weeks</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C: placebo</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>100</p> </td> </tr> <tr> <td align="right" valign="top" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b>total:</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>22</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>22</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>22</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p><b>(22) Mezitis 1992</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: glibenclamide</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>100</p> </td> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>20 weeks</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C: placebo</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>100</p> </td> </tr> <tr> <td align="right" valign="top" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b>total:</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>20</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>20</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>‐</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>20</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p><b>(23) Mudaliar 2010</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: pioglitazone</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>100</p> </td> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>12‐16 weeks</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C: placebo</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>13</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>13</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>13</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>100</p> </td> </tr> <tr> <td align="right" valign="top" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b>total:</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>25</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>25</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>25</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p><b>(24) Nemoto 2011</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: miglitol</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>276</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>107</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>107</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>107</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>100</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>93</p> </td> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>16‐22 weeks</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C: placebo</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>100</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>100</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>100</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>97</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>97</p> </td> </tr> <tr> <td align="right" valign="top" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b>total:</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>207</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>207</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>207</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>197</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p><b>(25) Osei 1984</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: glibenclamide</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>22</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>60</p> </td> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>16 weeks</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C: placebo</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>92</p> </td> </tr> <tr> <td align="right" valign="top" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b>total:</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>22</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>22</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>17</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p><b>(26) Quartraro 1986</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: gliclazide</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>40</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>15</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>15</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>15</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>100</p> </td> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>12 months</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C: insulin alone</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>15</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>15</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>15</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>100</p> </td> </tr> <tr> <td align="right" valign="top" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b>total:</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>30</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>30</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>30</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p><b>(27) Reich 1987<sup>e</sup> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: glibenclamide</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>20</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>90</p> </td> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>4 months</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C: placebo</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>100</p> </td> </tr> <tr> <td align="right" valign="top" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b>total:</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>20</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>20</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>19</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p><b>(28) Relimpio 1998</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: metformin</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>60</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>31</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>31</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>31</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>24</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>77</p> </td> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>4 months</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C: insulin dose increase</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>29</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>29</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>23</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>23</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>79</p> </td> </tr> <tr> <td align="right" valign="top" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b>total:</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>60</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>60</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>60</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>47</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p><b>(29) Robinson 1998<sup>d</sup> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: metformin</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>30 weeks</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C: placebo</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="right" valign="top" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b>total:</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>20</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>20</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>‐</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>19</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>95</b> </p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p><b>(30) Rosenstock 2002</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: pioglitazone 15 mg</p> </td> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>‐</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>191</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>191</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>191</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>161</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>89</p> </td> <td align="" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p>16 weeks</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I2: pioglitazone 30 mg</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>188</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>188</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>188</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>172</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>92</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C: placebo</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>187</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>187</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>187</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>164</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>88</p> </td> </tr> <tr> <td align="right" valign="top" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b>total:</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>566</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>566</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>566</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>497</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p><b>(31) Schade 1987<sup>d</sup> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: glibenclamide</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>16</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>16</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>32 weeks</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C: placebo</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="right" valign="top" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b>total:</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>16</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>16</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>16</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>15</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>94</b> </p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p><b>(32) Schiel 2007</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: glimepiride</p> </td> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>60 (20 participants in each group)</p> </td> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>54</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>100</p> </td> <td align="" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p>20 weeks</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I2: glimepiride + metformin</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>18</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>18</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>16</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>16</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>89</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C: insulin alone</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>100</p> </td> </tr> <tr> <td align="right" valign="top" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b>total:</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>52</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>52</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>50</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>50</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p><b>(33) Simpson 1990</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: glipizide</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>20</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>4 months</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C: placebo</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="right" valign="top" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b>total:</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>20</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>20</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>19</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>95</b> </p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p><b>(34) Stenman 1988<sup>d</sup> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: glibenclamide</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>16</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>5 months</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C: placebo</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="right" valign="top" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b>total:</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>16</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>16</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>‐</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>15</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>94</b> </p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p><b>(35) Strowig 2002</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: metformin</p> </td> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>92</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>30</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>30</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>27</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>90</p> </td> <td align="" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p>4 months</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I2: troglitazone</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>31</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>31</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>30</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>97</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C: insulin alone</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>31</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>31</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>31</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>100</p> </td> </tr> <tr> <td align="right" valign="top" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b>total:</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>92</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>92</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>88</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p><b>(36) Wulffelé 2002</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: metformin</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>390</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>745</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>196</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>195</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>196</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>171</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>87</p> </td> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>16 weeks</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C: placebo</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>194</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>193</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>194</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>182</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>94</p> </td> </tr> <tr> <td align="right" valign="top" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b>total:</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>390</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>388</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>390</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>353</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="5" bgcolor="#ffffff"> <p><b>(37) Yilmaz 2007</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I1: acarbose</p> </td> <td align="" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p>‐</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>15</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>15</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>15</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>100</p> </td> <td align="" valign="top" colspan="1" rowspan="5" bgcolor="#ffffff"> <p>6 months</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I2: metformin</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>100</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I3: rosiglitazone</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>15</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>15</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>15</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>100</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C: insulin alone</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>19</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>19</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>19</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>100</p> </td> </tr> <tr> <td align="right" valign="top" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b>total:</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>66</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>66</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>66</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p><b><i>Grand total</i> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b><i>All interventions</i> </b> </p> </td> <td align="" valign="top" colspan="2" rowspan="3" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b><i>1856<sup>f</sup> </i> </b> </p> </td> <td align="" valign="top" colspan="2" rowspan="3" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b><i>1677<sup>f</sup> </i> </b> </p> </td> <td align="" valign="top" colspan="2" rowspan="3" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b><i>All comparators</i> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b><i>1558<sup>f</sup> </i> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b><i>1460<sup>f</sup> </i> </b> </p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b><i>All interventions and comparators</i> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b><i>3227</i> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b><i>2951</i> </b> </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="10"> <div class="table-footnote"> <p><sup>a</sup>According to power calculation in study publication or report<br> <sup>b</sup>Duration of intervention and/or follow‐up under randomised conditions until end of study<br> <sup>c</sup>Subgroup of participants using insulin<br> <sup>d</sup>Cross‐over study<br> <sup>e</sup>Three participants in the intervention group discontinued insulin<br> <sup>f</sup>Participants in cross‐over trials were counted both in the intervention and comparator groups </p> <p>‐ denotes not reported</p> <p>C: comparator; I: intervention; ITT: intention‐to‐treat; N/A: not applicable</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span>&nbsp;<span class="table-title">Overview of study populations</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/full#CD006992-tbl-0011" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD006992-tbl-0006" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 1.</span>&nbsp;<span class="table-title">Insulin monotherapy versus insulin plus sulphonylurea</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Weight (change from baseline) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>220</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.57 [‐2.52, 3.67]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.1 Parallel‐group trials</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>86</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.12 [‐3.08, 5.32]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.2 Cross‐over trials</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>134</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.08 [‐4.66, 4.50]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Weight (change from baseline) [kg] GIV <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.13 [‐0.57, 0.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.1 Parallel‐group</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.12 [‐3.08, 5.32]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.2 Cross‐over group</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.14 [‐0.59, 0.31]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 HbA1c (change from baseline) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>316</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.02 [‐1.56, ‐0.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.1 Parallel‐group trials</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>150</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.25 [‐2.57, 0.06]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.2 Cross‐over trials</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>166</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.97 [‐1.38, ‐0.56]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">4 HbA1c (change from baseline) GIV <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.03 [‐1.58, ‐0.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4.1 Parallel‐group trials</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.25 [‐2.57, 0.06]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4.2 Cross‐over trials</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.97 [‐1.42, ‐0.52]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">5 Fasting glucose (change from baseline) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>205</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐2.28 [‐3.23, ‐1.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5.1 Parallel‐group trials</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>71</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.97 [‐2.56, 0.61]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5.2 Cross‐over trials</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>134</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐2.72 [‐3.66, ‐1.78]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">6 Fasting plasma glucose (change from baseline) [mmol/L] GIV <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐2.29 [‐3.23, ‐1.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6.1 Parallel‐group</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.02 [‐2.48, 0.44]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6.2 Cross‐over group</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐2.73 [‐3.70, ‐1.75]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">7 Total cholesterol (change from baseline) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>132</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.03 [‐0.38, 0.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7.1 Parallel‐group trials</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>22</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.26 [‐0.49, 1.01]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7.2 Cross‐over trials</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>110</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.11 [‐0.50, 0.29]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">8 Total cholesterol (change from baseline) [mmol/l] GIV <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.04 [‐0.17, 0.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8.1 Parallel‐group</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.26 [‐0.49, 1.01]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8.2 Cross‐over group</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.05 [‐0.18, 0.08]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">9 HDL‐cholesterol (change from baseline) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>108</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.07 [‐0.17, 0.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9.1 Parallel‐group trials</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>22</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.0 [‐0.27, 0.27]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9.2 Cross‐over trials</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>86</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.08 [‐0.20, 0.04]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">10 HDL‐Cholesterol (change from baseline mmol/L) GIV <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.05 [‐0.15, 0.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10.1 Parallel‐group</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.0 [‐0.27, 0.27]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10.2 Cross‐over group</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.07 [‐0.19, 0.06]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">11 Triglyceride (change from baseline) [mmol/L] GIV <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.04 [‐0.21, 0.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11.1 Parallel‐group</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.24 [‐1.37, 0.89]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11.2 Cross‐over group</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.05 [‐0.20, 0.30]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">12 Triglycerides (change from baseline) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>132</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.03 [‐0.17, 0.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12.1 Parallel‐group trials</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>22</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.24 [‐1.37, 0.89]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12.2 Cross‐over trials</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>110</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.03 [‐0.16, 0.23]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span>&nbsp;<span class="table-title">Insulin monotherapy versus insulin plus sulphonylurea</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/references#CD006992-tbl-0006" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD006992-tbl-0007" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 2.</span>&nbsp;<span class="table-title">Insulin monotherapy versus insulin plus metformin</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Weight (change from baseline) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>615</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐2.12 [‐3.19, ‐1.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.1 Parallel‐group trials</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>577</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐2.45 [‐3.61, ‐1.29]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.2 Cross‐over trials</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>38</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.5 [‐2.11, 1.11]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Weight (change from baseline) [kg] GIV <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐2.11 [‐3.18, ‐1.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.1 Parallel‐group</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐2.45 [‐3.61, ‐1.29]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.2 Cross‐over group</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.5 [‐2.05, 1.05]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 HbA1c (change from baseline) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>698</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.86 [‐1.20, ‐0.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.1 Parallel‐group trials</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>634</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.77 [‐1.13, ‐0.41]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.2 Cross‐over trials</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>64</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.16 [‐2.13, ‐0.19]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">4 HbA1c (change from baseline) [%] GIV <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.86 [‐1.20, ‐0.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4.1 Parallel‐group</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.77 [‐1.13, ‐0.41]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4.2 Cross‐over group</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.16 [‐2.13, ‐0.18]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">5 Total cholesterol (change from baseline) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>651</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.25 [‐0.41, ‐0.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5.1 Parallel‐group trials</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>587</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.20 [‐0.38, ‐0.02]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5.2 Cross‐over trials</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>64</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.47 [‐0.85, ‐0.09]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">6 Total cholesterol (change from baseline) [mmol/L] GIV <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.29 [‐0.50, ‐0.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6.1 Parallel‐group</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.20 [‐0.38, ‐0.02]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6.2 Cross‐over group</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.57 [‐0.94, ‐0.20]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">7 HDL‐cholesterol (change from baseline) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>651</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.01 [‐0.06, 0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7.1 Parallel‐group trials</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>587</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.00 [‐0.05, 0.05]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7.2 Cross‐over trials</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>64</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.00 [‐0.25, 0.25]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">8 HDL‐cholesterol (change from baseline) [mmol/L] <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.01 [‐0.05, 0.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8.1 Parallel‐group</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.00 [‐0.05, 0.05]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8.2 Cross‐over group</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.04 [‐0.22, 0.31]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">9 Triglycerides (change from baseline) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>651</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.09 [‐0.22, 0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9.1 Parallel‐group trials</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>587</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.07 [‐0.24, 0.11]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9.2 Cross‐over trials</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>64</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.17 [‐0.50, 0.16]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">10 Triglyceride (change from baseline) [mmol/L] GIV <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.15 [‐0.41, 0.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10.1 Parallel‐group</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.07 [‐0.24, 0.11]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10.2 Cross‐over group</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.34 [‐0.79, 0.11]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span>&nbsp;<span class="table-title">Insulin monotherapy versus insulin plus metformin</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/references#CD006992-tbl-0007" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD006992-tbl-0008" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 3.</span>&nbsp;<span class="table-title">Insulin monotherapy versus insulin plus pioglitazone</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 HbA1c (change from baseline) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Fasting glucose (change from baseline) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>624</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.07 [‐3.61, 3.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Weight (change from baseline) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>288</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.79 [2.97, 4.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span>&nbsp;<span class="table-title">Insulin monotherapy versus insulin plus pioglitazone</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/references#CD006992-tbl-0008" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD006992-tbl-0009" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 4.</span>&nbsp;<span class="table-title">Insulin monotherapy versus insulin plus alpha‐glucosidase inhibitor</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Weight (change from baseline) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>241</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.45 [‐1.22, 0.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 HbA1c (change from baseline) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>448</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.39 [‐0.54, ‐0.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Fasting glucose (change from baseline) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>113</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.33 [‐0.74, 1.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span>&nbsp;<span class="table-title">Insulin monotherapy versus insulin plus alpha‐glucosidase inhibitor</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/references#CD006992-tbl-0009" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD006992-tbl-0010" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 5.</span>&nbsp;<span class="table-title">Insulin monotherapy versus insulin plus DPP‐4 inhibitor</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Weight (change from baseline) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>362</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.55 [‐1.00, 1.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 HbA1c (change from baseline) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>265</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.41 [‐0.46, ‐0.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Fasting glucose (change from baseline) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span>&nbsp;<span class="table-title">Insulin monotherapy versus insulin plus DPP‐4 inhibitor</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006992.pub2/references#CD006992-tbl-0010" class="tableList">Navigate to table in Review</a></div> </div> </div> <section class="translation-notes-modal" style="display: none" data-modal-title="Translation notes" data-modal-class="translation-notes" data-ok-btn-selector=".ok-btn"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="fr#CD006992-note-1204">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD006992-note-1205">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ru#CD006992-note-1203">Русский</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" id="citeProcText" data-load-error="Unable to load citation data"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a href="#" class="addthis_button_citeulike at300b btn btn-link">CiteULike</a></li> <li><a href="#" class="addthis_button_mendeley at300b btn btn-link">Mendeley</a></li> <li><a href="#" class="citation-btn-refworks at300b btn btn-link" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <h4>Copy or download citation</h4> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button type="button" class="btn btn-link">Plain text</button></li> <li class="citation-option" data-option="endnote"><button type="button" class="btn btn-link">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button type="button" class="btn btn-link">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button type="button" class="btn btn-link">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button type="button" class="btn btn-link">BibteX</button></li> </nav> <div class="citation-content"> <pre id="citationContent" tabindex="0" data-load-error="Unable to load citation data"></pre> </div> <div class="clearfix"> <form class="download-citation-form" method="GET" target="citation-download-iframe" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=citation-citeproc&p_p_cacheability=cacheLevelPage&p_p_col_id=column-1&p_p_col_count=1"> <input type="hidden" id="siteId" name="siteId" value="" /> <input type="hidden" id="downloadType" name="downloadType" value="" /> <input type="hidden" id="style" name="style" value="" /> <input type="hidden" id="articleId" name="articleId" value="" /> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay" /><input name="p_p_lifecycle" type="hidden" value="2" /><input name="p_p_state" type="hidden" value="normal" /><input name="p_p_mode" type="hidden" value="view" /><input name="p_p_resource_id" type="hidden" value="citation-download" /><input name="p_p_cacheability" type="hidden" value="cacheLevelPage" /><input name="p_p_col_id" type="hidden" value="column-1" /><input name="p_p_col_count" type="hidden" value="1" /> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withAbstract"> <input class="checkbox" type="checkbox" name="withAbstract" /> <span class="checkbox-label">Include abstract</span> </label> </div> </form> <iframe title="Citation download frame" name="citation-download-iframe" src="" style="display: none; visibility: hidden" aria-hidden="true"></iframe> </div> </div> </div> </div> <div class="print-modal" style="display: none;" data-modal-title="Print this review"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input title="Select/deselect all" type="checkbox" class="print-options-select-all" checked="checked" /> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i class="fa fa-print" aria-hidden="true"></i> Print</button> </div> </div> <div class="download-stats-data-modal" style="display: none;" data-modal-title="Download statistical data"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <p> Downloaded data can only be viewed using <a class="external" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/tools/review-production-tools/revman-5" target="_blank">Review Manager software.</a> </p> <p> Please note that: <ul> <li>data are only available for Cochrane Reviews that contain one or more forest plots; and</li> <li>data in the downloaded RevMan file are editable and therefore the review data can be amended without warning.</li> </ul> </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input type="hidden" name="content-disposition" value="attachment" /> <input type="hidden" name="mime-type" value="application/octet-stream" /> <p class="print-options-controls"> <input type="checkbox" class="download-stats-data-toc-check-box" aria-label="I agree to these terms and conditions" /> <span class="checkbox-label" aria-hidden="true">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i class="fa fa-download" aria-hidden="true"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" style="display:none;" data-modal-title="Share this review"> <div class="add-this"> <div class="addthis_toolbox addthis_default_style addthis_32x32_style"> <nav class="stacked-nav-list"> <li> <a href="#" class="addthis_button_twitter at300b" title="Tweet">Twitter</a> </li> <li> <a href="#" class="addthis_button_mendeley at300b" target="_blank" title="Mendeley">Mendeley</a> </li> <li> <a href="#" class="addthis_button_facebook at300b" title="Facebook">Facebook</a> </li> <li> <a href="#" class="addthis_button_linkedin at300b" target="_blank" title="LinkedIn">LinkedIn</a> </li> <li> <a href="#" class="addthis_button_email at300b" target="_blank" title="Email">Email</a> </li> <li> <a href="#" class="addthis_button_whatsapp at300b" target="_blank" title="WhatsApp">WhatsApp</a> </li> <li class="clearfix"> <a href="#" class="addthis_button_more btn primary pull-right" target="_blank" title="View more"> <i class="fa fa-plus" aria-hidden="true"></i> View more</a> </li> </ul> </div> </div> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button type="button" class="btn btn-link" id="figureOptionBtn">Figures</button></li> <li class="table-options-btn-container"><button type="button" class="btn btn-link" id="tableOptionBtn">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div id="figureThumbnails" class="figure-thumbnails is-visible"></div> <div id="tableThumbnails" class="table-thumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a href="#" class="figure-viewer-menu-toggle"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-table-show-text="Show table list" data-table-hide-text="Hide table list" data-figure-show-text="Show thumbnails" data-figure-hide-text="Hide thumbnails">Hide thumbnails</span> </a> <a href="#" class="figure-viewer-zoomin"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a href="#" class="figure-viewer-zoomout"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a href="#" class="figure-viewer-nav previous"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a href="#" class="figure-viewer-nav next"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_  portlet-static portlet-static-end kaleo-designer-portlet " id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a title="Cochrane logo" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUDN7SXR6UBN3TT655TMH/">
<img class="footer-logo logo-part-1" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/footer-logo-part-1.png" alt="Cochrane logo" /> <img class="footer-logo logo-part-2" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/footer-logo-part-2.png" alt="" /> </a> </div> <nav class="footer-links"> <ul class="root"> <li class="footer-item"> <a class="footer-item-link" href="/about-cochrane1">About Cochrane</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/evidence" target="_blank">Cochrane.org</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/about-us" target="_blank">Who we are</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/NJYXT5SPMNYXG4DTMFYGKLUQPJUB/" target="_blank">Get involved</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX665WNWTYE63PMNYXG4DTMFYGKLUQPJUB/" target="_blank">Consumer Network</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/about-us/our-funders-and-partners" target="_blank">Partners</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYXZ5DQPF4XT7LNF3SX8Z5IPJRX63JPN73GH/" target="_blank">Colloquium</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/news" target="_blank">In the news</a> </li> </ul> </li> <li class="footer-item"> <a class="footer-item-link" href="/publications">Publications</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="/library">Cochrane Library</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/" target="_blank">Library Homepage</a> </li> <li class="footer-item"> <a class="footer-item-link" href="cdsr/about-cdsr" target="_blank">Cochrane Reviews (CDSR)</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/central" target="_blank">Trials (CENTRAL)</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/cca/about" target="_blank">Cochrane Clinical Answers</a> </li> </ul> </li> <li class="footer-item"> <a class="footer-item-link" href="/about/cochrane-library-app" target="_blank">Cochrane Library App</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/cdsr/journal-club" target="_blank">Journal Club</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/about/podcasts" target="_blank">Podcasts</a> </li> </ul> </li> <li class="footer-item"> <a class="footer-item-link" href="/community">Community</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/" target="_blank">Community</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MF3GG4DJMVYGG55DNB3GC5UFF3YYE3D/" target="_blank">Archie log-in</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/PS3GC4LPNFYGPLUDN7SXR6UBN3TT655TMH/" target="_blank">Training and support</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/NWTYI4DQMS3T6Z5QMNVHEZLPMVYG86UH/" target="_blank">Methods</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/help" target="_blank">Software</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/news/jobs" target="_blank">Jobs and opportunities</a> </li> </ul> </li> <li class="footer-item"> <a class="footer-item-link" href="/contact-us">Contact Us</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUDN7SXR6UBN3TT655TMH/contact" target="_blank">General enquiries</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/help/contact-us" target="_blank">Cochrane Library support</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/organizational-info/people/central-executive-team/chief-executive-officers-office/team" target="_blank">Chief Executive Officer</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/organizational-info/people/central-executive-team/editorial-methods/team" target="_blank">Editor in Chief</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/about-us/our-global-community" target="_blank">Cochrane groups</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUDN7SXR6UBN3TT655TMH/media" target="_blank">Media</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/accessibility" target="_blank">Accessibility</a> </li> </ul> </li> </ul> </nav> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/advertisers">Advertisers & Agents</a></li> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/NB4XELUYNFXGK8JPMNYXN/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/NB4XELUYNFXGK8JPMNYXN/community/support/cochrane-library">Help & Support</a></li> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/terms-and-conditions">Terms & Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright &copy; 2000 - 2020 by <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUYNFXGK8JPMNYXN/" class="">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br /> Review our <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUYNFXGK8JPMNYXN/en-gb/privacy"><strong>Privacy Policy</strong></a> </p> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MW4T675JNSTYTLUDN7XB/"><img class="logo" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/en-US_wiley-footer-logo.png" alt="Wiley logo" /></a> </div> </div> <span class="wiley-semi-circle"></span> </div> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" style="display: none" data-modal-title="Feature in English only" data-modal-class="english-only-modal"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1581423095000" type="text/javascript"></script> <!--<![endif]--> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/js/theme.js?t=1581423095000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX67DFN34C66UFMFTGG7LCMVYGG55N/cochrane/checkout.js"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX67DFN34C66UFMFTGG7LCMVYGG55N/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MN3G865UNWRYE43NMNTG6LUDPJYYG65TMWUC655TMH/widget/v2.0/widget.js" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MRZXE8DIHB4XC63SNWYHPN3PMNXG87LEM33G85UVF3YGK7A/assets/embed.js" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717708000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717777000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717709000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717714000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006992\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006992\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dreferences\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006992\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006992\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006992\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006992\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006992\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006992\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dreferences\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006992\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006992\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006992\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006992\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dreferences\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006992\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006992\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006992\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006992\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dreferences\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006992\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006992\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581423095000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a href="#" class="rh-nav-close-btn"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a href="#" class="rh-nav-open-btn"> <span>Review tools & navigation</span> </a> </div> <iframe title="Print frame" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" aria-hidden="true"></iframe> <div class="mobile-navigation"> <div class="close-container"> <a href="#" class="main-nav-back-btn" aria-label="Navigate back"><i class="fa fa-chevron-left"></i></a> <a href="#" class="main-nav-close-btn" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end " id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img id="ymag__null__null" src="/scolaris-search/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_auth=y8F68iId&p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=1&p_p_state=normal&p_p_mode=view&_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input type="hidden" name="searchType" value="basic" /> <input type="hidden" name="facetDisplayName" value="" /> <input type="hidden" name="facetQueryTerm" value="" /> <input type="hidden" name="facetQueryField" value="" /> <input type="hidden" name="facetCategory" value="" /> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select title="Search by options" aria-label="Search by options" name="searchBy" class="custom-select-enabled search-type"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" style="display: none;" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=topics-list&p_p_cacheability=cacheLevelPage"> <select class="search-select-topic-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input type="text" size="30" class="field browser-search search-text ui-autocomplete-input" value="" aria-label="Enter search term" id="searchText" name="searchText" placeholder="Search">
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button type="submit" class="searchByBtn" aria-label="Search">
<i class="fa fa-search" aria-hidden="true"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=references&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006992.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006992.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
<a href="/en/browse-by-topic" class="btn secondary">Browse </a>
<a href="/en/advanced-search" class="btn secondary advanced-search-button">Advanced search</a>
</div>
<div class="menu-items parent">
<ul>
<li class="nav-root-item parent">
<a href="#" title="Select language" class="language-selection-title-link">
<span class="mobile-nav-language-title">Select your preferred language</span><span class="icon fa fa-caret-down"></span>
<ul class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_  portlet-static portlet-static-end  " id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img id="fdkn__null__null" src="/scolaris-language-portlet/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hr, ja, ko, ms, pl, pt, ru, ta, th, zh, za]"> <a title="Select your preferred language" class="language-select-mobile" href="#"> <i class="fa fa-file-text"></i> English </a> <a title="Select your preferred language" class="language-select-mobile" href="#"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane Review language</h3> <p>Select your preferred language for Cochrane Reviews. You will see translated Review sections in your preferred language. Sections without translation will be in English.</p> <div id="active-content-language" class="dropdown-trigger"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de" class="content-language-selector " data-languagecode="de">Deutsch</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en" class="content-language-selector is-active" data-languagecode="en">English</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es" class="content-language-selector " data-languagecode="es">Español</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa" class="content-language-selector " data-languagecode="fa">فارسی</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr" class="content-language-selector " data-languagecode="fr">Français</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr" class="content-language-selector " data-languagecode="hr">Hrvatski</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja" class="content-language-selector " data-languagecode="ja">日本語</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko" class="content-language-selector " data-languagecode="ko">한국어</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms" class="content-language-selector " data-languagecode="ms">Bahasa Malaysia</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl" class="content-language-selector " data-languagecode="pl">Polski</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt" class="content-language-selector " data-languagecode="pt">Português</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru" class="content-language-selector " data-languagecode="ru">Русский</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta" class="content-language-selector " data-languagecode="ta">தமிழ்</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th" class="content-language-selector " data-languagecode="th">ภาษาไทย</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh" class="content-language-selector " data-languagecode="zh">简体中文</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=za" class="content-language-selector " data-languagecode="za">繁體中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div id="active-portal-language" class="dropdown-trigger"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a href="/en/cdsr/doi/10.1002/14651858.CD006992.pub2/references/en" class="portal-language-selector is-active" data-portallanguage="en">English</a> <a href="/es/cdsr/doi/10.1002/14651858.CD006992.pub2/references/es" class="portal-language-selector " data-portallanguage="es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</ul>
</a>
</li>
<li class="parent">
<a class="mobile-link signin" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/c/portal/login?p_l_id=20757&redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006992.pub2%2Freferences" data-redirect="false" rel="nofollow">
Sign In
</a>
</li>
</ul>
<div class="menu-items-footer">
<div class="utility-links">
<a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUDN7SXR6UBN3TT655TMH/" class="cochrane-link" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
<div class="basic-login-form-content" style="display: none;" data-modal-title="Sign in">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_  portlet-static portlet-static-end portlet-login " id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img id="dbam__null__null" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/spacer.png" alt="" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;" /> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <form action="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" class="form sign-in-form " id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm" autocomplete="on"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1583239766408" /> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false" /> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006992&#x2e;pub2&#x2f;references" /> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false" /> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value="" /> </div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value="" /> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true" /> <input checked class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onClick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true" /> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button type="submit" class="btn primary">Sign in</button> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/user-registration" target="_blank" class="btn secondary">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&p_p_lifecycle=0&p_p_state=normal&p_p_mode=view&_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </fieldset> </form> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" style="display: none;" data-modal-title="Institutional login">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_  portlet-static portlet-static-end scolaris-content-display-portlet " id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img id="obft__null__null" src="/scolaris-content-display/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form method="post" action="/shibboleth" id="institutionLoginForm"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" name="institutionName" id="institutionName" value="" type="text">
</div>
<button class="btn primary" type="submit" name="button">Go</button>
</div>
<div id="institutionLookupErrorDiv" class="message error" style="display:none">
'<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
</div>
</div>
<input type="hidden" id="entityId" name="entityId" value="">
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_  portlet-static portlet-static-end portlet-login " id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img id="joiu__null__null" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/spacer.png" alt="" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;" /> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" class="form sign-in-form " id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm" autocomplete="on"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1583239766412" /> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false" /> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006992&#x2e;pub2&#x2f;references" /> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false" /> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value="" /> </div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value="" /> </div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true" /> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button type="submit" class="btn primary">Sign in</button> </div> </div> </fieldset> </form> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" style="display: none;" data-modal-title="Unlock the potential of Cochrane evidence">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_  portlet-static portlet-static-end scolaris-content-display-portlet " id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img id="wpdq__null__null" src="/scolaris-content-display/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form method="post" action="/shibboleth" id="institutionLoginForm"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" name="institutionName" id="institutionName" value="" type="text"> </div> <button class="btn primary" type="submit" name="button">Go</button> </div> <div id="institutionLookupErrorDiv" class="message error" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input type="hidden" id="entityId" name="entityId" value=""> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'> <input type="hidden" name="openlabel" id="openlabel" value='Open access'> </div> </section> </div> </div>  <script>window.urlTitle="/cdsr/doi/10.1002/14651858.CD006992.pub2";addthis_config={pubid:"ra-593597d01cdf9a55",ui_508_compliant:true};addthis_share={url:window.location.href,title:document.title};</script> <script src="//s7.addthis.com/js/300/addthis_widget.js#pubid=ra-593597d01cdf9a55"></script> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> </body> </html> 